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Abstract 
The pulmonary vein (PV) constricts to hypoxia however little is known about the underlying 
mechanisms.  Hypoxic PV constriction is proposed to recruit upstream capillary beds and optimise 
gas exchange in healthy humans and may play a role in high altitude pulmonary oedema.  The PV is 
also intrinsic to disease states including pulmonary hypertension and pulmonary veno-occlusive 
disease.  Blood vessel culture can be a powerful tool to enable assessment of the impact of 
environmental factors on vessel function and as a disease model.  However culture conditions alone 
affect vessel contractility; the effect of culture conditions on PV function remained to be established.  
The aim of this project was to investigate hypoxic responses of porcine PVs including the impact of 
maintenance in culture. 
Maintenance of PVs in culture conditions for 24 hours increased contraction to hypoxia and inhibited 
hypoxic relaxation post-contraction.  These changes to PV hypoxic responses were thought to result 
from endothelial dysfunction.  However, the endothelial nitric oxide synthase inhibitor L-NAME 
inhibited PV hypoxic contraction and enhanced relaxation.  The impact of K+ channel inhibitors on 
hypoxic contraction was also investigated.  Penitrem A, 4AP, DPO-1, ZnCl2 and glyburide had no 
significant effect however TEA and BDM inhibited the hypoxic contraction.  This suggested that TASK, 
KV1.5, BKCa and KATP do not play a role in the mechanism of hypoxic pulmonary venoconstriction 
however KV channels containing KV2.1 α subunits may modulate the response.   
Results with L-NAME suggested endothelial dysfunction may not fully account for the change in PV 
function after exposure to culture.  Therefore the impact of PV maintenance in culture was further 
explored using an isolated PV smooth muscle cell (PVSMC) model.  Maintenance of PVs in culture 
conditions had minimal impact on morphology and electrical properties of PVSMCs.  Notably, resting 
membrane potential and hypoxia-induced depolarisation were not significantly different. 
Based on the findings of this study, the endothelium in PVs appears to a) play a major role in 
modulation of the hypoxic response b) be sensitive to short-term exposure to culture conditions.  K+ 
channels appear to play a minor role in PV hypoxic contraction and SMCs isolated from PVs 
maintained in culture conditions have similar morphological and electrophysiological characteristics 
to freshly isolated PVSMCs.  Taking all this into account, endothelial regulation of contractility should 
be a key focus for future PV research. 
Keywords:  hypoxia; pulmonary vein; potassium channels; nitric oxide; vasoconstriction; smooth 
muscle cells; blood vessel culture; endothelium 
vi 
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Chapter 1 
General Introduction 
 
 
The pulmonary vein (PV) constricts to hypoxia however little is known about the underlying 
mechanisms.  Hypoxic PV constriction is proposed to recruit upstream capillary beds and optimise 
gas exchange in healthy humans (Taylor et al., 2011) and may play a role in disease states including 
high altitude pulmonary oedema (Bärtsch and Gibbs, 2007, Maggiorini et al., 2001). 
 
Pulmonary Circulation 
The function of the lung is respiratory gas exchange and the pulmonary circulation is designed to aid 
with this function.  Systemic venous blood (oxygen saturation 70-80%) (Muralidhar, 2002, Reyer, 
2013) is returned to the right side of the heart and pumped to the lungs for oxygenation via 
pulmonary arteries and arterioles to capillary beds that surround the respiratory units of the lung 
(alveoli).  At the interface between the alveoli and capillary bed, oxygen moves from the alveoli into 
blood and carbon dioxide moves in the opposite direction.  Oxygenated blood then travels from the 
capillary beds via pulmonary venules and veins back to the left atrium to be pumped round the 
systemic circulation (Tortora and Derrickson, 2006). 
Pulmonary blood vessels have thinner walls and less smooth muscle than their systemic counterparts 
resulting in lower pressures (Dembinski et al., 2004). Pulmonary arterial pressure (systolic/diastolic) 
is approximately 23/9 mmHg and pulmonary capillary wedge pressure is approximately 10 mmHg in 
healthy humans (Muralidhar, 2002).  Pulmonary venous pressure is suggested to lie somewhere 
between pulmonary arterial and pulmonary capillary wedge pressure (Chaliki et al., 2002).  In 
contrast, pressures within the systemic circulation are approximately six times higher than those 
recorded in the pulmonary circulation (Dembinski et al., 2004) with anything up to 120/80 mmHg 
(systolic/diastolic) being considered normal (Viera, 2007).   Resistance values are also approximately 
six times higher in the systemic circulation (900-1400 dyne.sec.cm-5) than in the pulmonary 
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circulation (150-250 dyne.sec.cm-5)(Muralidhar, 2002).  The lower resistance in the pulmonary 
circulation is attributable to the shorter blood vessels present within the blood vessel network and 
the larger diameter of pulmonary vessels compared with systemic vessels (Boron and Boulpaep, 
2005).  Diameter in particular makes a significant contribution to resistance with resistance being 
inversely proportional to (diameter)4 (Tortora and Derrickson, 2006). 
 
Anatomy and Structure of the Pulmonary Vein 
The primary role of the pulmonary vein (PV) as the last segment of the pulmonary circulation is to 
return oxygenated blood from the lungs to the left atrium the heart.  In humans, the pulmonary 
venous tree comprises 15 branching orders with the first formed by post-capillary venules.  These 
small PVs merge and form one PV for each lobule of the lung and eventually, one PV for each lobe of 
the lung (Hughes and Morrell, 2001).  Four extrapulmonary veins leave the lung and empty into the 
left atrium and are named: right superior, right inferior, left superior and left inferior pulmonary 
veins (Porres et al., 2013). 
Similar to all other veins, PVs have endothelial, smooth muscle and adventitial layers and have less 
smooth muscle than size-matched pulmonary arteries (PAs) (Hughes and Morrell, 2001).  In humans, 
PVs larger than 100µm diameter have an internal elastic lamina lined by the endothelial layer and a 
disorganised medial layer composed of smooth muscle, collagen and elastic fibres with no clearly 
marked adventitial layer (Kay, 1983).  Small PVs located near capillaries are “partially muscular” 
whereas larger PVs have a continuous layer of smooth muscle (Hislop and Reid, 1973). 
 
Regulation of Tone in the Pulmonary Vein 
Historically, PVs have been regarded as passive conduit blood vessels with no significant impact on 
regulation of blood flow or total vascular resistance within the lung.  Consequently, in comparison to 
PAs, relatively little research has been conducted in order to understand the underlying functions 
and mechanisms of PVs involved in normal physiology and pathophysiology.   
There is a significant body of research suggesting PVs as an important origin of ectopic beats and 
arrythmogenic activity in patients with atrial fibrillation (Haissaguerre et al., 1998, reviewed by Fynn 
and Kalman, 2004, Khan, 2004,). However, there is an outstanding gap in the field in terms of 
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pulmonary venous contribution to pulmonary hypertension (Tuder et al., 2013) highlighting the need 
for a better understanding of pulmonary venous tone regulation and contribution to disease states.  
PVs demonstrate vasoconstriction in response to a number of agonists and in some cases to a greater 
extent than PAs.  Histamine (acting on smooth muscle H1 receptors; Shi et al., 1998, Toda, 1990) has 
a more specific/exclusive constrictor effect on PVs when compared with size-matched PAs in isolated 
lungs and lung slices (Glazier and Murray, 1971, Hasebe et al., 1992, Shi et al., 1998).  In vivo canine 
studies showed increased PA and PV pressure (Kadowitz et al., 1975) and pulmonary vascular 
resistance (PVR) (Hyman et al., 1978) on administration of PGF2α (FP receptor agonist; Walch et al., 
2001).  However in isolated canine pulmonary vessels, PGF2α was a more potent vasoconstrictor in 
PVs than in PAs (Kadowitz et al., 1975) and in isolated goat PAs, PGF2α constricted PVs but PAs were 
unresponsive (Chand, 1981).    U46619 (thromboxane A2 mimetic, TP receptor agonist; Walch et al., 
2001) is a known robust, potent and dose-dependent vasoconstrictor of human and canine PVs (Ding 
and Murray, 2005, Walch et al., 2001) and PVs from piglets are more reactive to U46619 than PAs 
(Arrigoni et al., 1999).   
Substantial innervation of the pulmonary vasculature exists and is likely to play an important role in 
regulation of tone within PVs and PAs. Neuronal input is mainly derived from branches of vagus and 
cervicothoracic sympathetic nerves including adrenergic, cholinergic and sensory fibers.  In general, 
across species, adrenergic innervation of the pulmonary circulation is greater than cholinergic.  
Neuropeptidic transmission is also present with contributions from neuropeptide Y, vasoactive 
intestinal peptide and substance P.  Neuropeptides are either co-expressed in autonomic fibers or 
expressed within sensory nerves.  Nerve fibers extend from a plexus at the hilus of the lung (which 
contains parasympathetic ganglia as well as sympathetic fibers) to form a perivascular neural 
network within the adventitial layer of pulmonary blood vessels.  A small number of nerve fibers 
within PAs and PVs extend into the medial layer.  Innervation of the pulmonary vasculature extends 
down into small PAs and PVs (approximately 50 to 100µm diameter) however less 
autonomic/substance P containing nerves are present in PVs compared with size-matched PAs 
(reviewed in Townsley, 2012). 
These data suggest PVs are not merely passive conduits but are intrinsically vasoactive, involved in 
blood flow regulation and therefore likely contribute to disease states including pulmonary 
hypertension. 
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Contribution of Pulmonary Veins to Total Pulmonary Vascular Resistance 
In contrast to the systemic circulation where arteries contribute to approximately 70% of total 
vascular resistance, PVR is divided more equally between PAs, capillaries and PVs (Levitzky, 2002).  
This would suggest that PVs play a vital role in blood flow regulation with PV resistance directly 
impacting on flow within the pulmonary circulation (Fung and Huang, 2004).  A review by Gao and 
Raj (2005) considered a wide range of studies which investigated contributions of blood vessels 
across the pulmonary circulation towards total PVR.  The conclusions were that PVs appear to make a 
significant contribution to total PVR and that this percentage contribution decreases with increasing 
age in animals.  There is a general shift from the main contributors to PVR being larger pulmonary 
vessels (PAs and PVs) in infant lungs towards more contribution from microvessels and capillaries in 
the adult lung.  This may be due to increased alveolar size with age resulting in compression of 
capillary lumen and increased resistance.  In addition, the smooth muscle layer is thicker in neonatal 
PAs and vascular smooth muscle decreases in mass with increasing age leading to larger PA lumen 
(reviewed by Gao and Raj, 2005) which may explain the reduced contribution of PAs to PVR.  A 
similar reduction in vascular smooth muscle mass and increased lumen diameter may occur in PVs. 
Contribution of PVs to total PVR ranged from 7% in a study using lung micropuncture in rabbits (Raj 
et al., 1986) to 49% when using morphometric measurements in cats (Zhuang et al., 1983).  It is 
difficult to determine whether the wide range of values were a result of the different experimental 
techniques or species differences.   
 
Endothelial Contribution to Pulmonary Venous Tone 
The endothelium plays a vital role in regulation of pulmonary and systemic vascular tone (Barnes and 
Liu, 1995) .  A range of contractile and relaxant mediators are released from the endothelium which 
all have a significant effect on vasoactivity. 
Endothelin-1 (ET-1, ETA/ETB receptor agonist; Lopez-Valverde et al., 2005) is a more potent 
vasoconstrictor in PVs than PAs in the rat (Rodman et al., 1992), sheep (Toga et al., 1992) and human 
(Brink et al., 1991).  In very low concentrations (1-100 pM), ET-1 caused relaxation in porcine 
pulmonary vessels and the magnitude of relaxations were greater in PVs than PAs (Zellers et al., 
1994).  ET-1 mediated relaxations were inhibited by blocking endothelial nitric oxide synthase (eNOS) 
and the release of endothelium-derived nitric oxide (NO) appeared higher in PVs than PAs (Zellers et 
al., 1994).  In a different study also using a pig model, the amount and activity of eNOS protein were 
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greater in PVs than PAs (Bina et al., 1998).   Inhibition of eNOS caused an increase in baseline tension 
in PVs from newborn lambs with no effect on PAs and endothelium-dependent relaxations mediated 
by NO were larger in PVs than PAs (Gao et al., 1995).  The process of NO-mediated regulation of 
pulmonary venous tone during the perinatal period is an oxygen-dependent process which is 
suggested to contribute to the reduction in PVR on birth when pO2 increases from <25mmHg (in 
utero) to 100 mmHg (reviewed by Gao and Raj, 2005).  Hence, PV activity appears to be more 
sensitive to modulation by endothelium-derived constricting and relaxing factors than PA activity. 
 
Effects of Hypoxia in the Systemic Circulation 
Hypoxic vasoconstriction is a physiological response which is generally considered specific to the 
pulmonary circulation; blood vessels in the systemic circulation normally respond to hypoxia with 
vasodilation (Staub, 1985, Leach et al., 1994).  The physiological function of this dilation is to ensure 
adequate oxygenated blood flow towards hypoxic tissues and organs (Hampl et al., 2002).  Risso et 
al. (2012) proposed the physiological relevance of hypoxic dilation within systemic veins was to 
ensure maintenance of blood flow away from hypoxic tissue in order to avoid an increase in post-
capillary resistance.   
In some instances, blood vessels in the systemic circulation constrict when exposed to hypoxia; one 
example is the foetoplacental vasculature. This makes sense, bearing in mind that the physiological 
function of the placenta is to oxygenate foetal blood (Hampl et al., 2002, Jakoubek et al., 2006); the 
placenta in utero has a function similar to the lung upon birth.  Hypoxic foetoplacental 
vasoconstriction (HFPV) ensures diversion of foetal blood flow to better maternally perfused (and 
therefore oxygenated) areas of the placenta to ensure maximal oxygenation of foetal blood (Hampl 
et al., 2002).  The phenomenon has been demonstrated in isolated human cotyledons where 
exposure to hypoxia results in an increased perfusion pressure due to HFPV (Hampl et al., 2002, 
Jakoubek et al., 2006).  Microvessels are proposed as the most likely mediators of HFPV; larger 
conduit arteries and veins play less of a role.  The specific microvessels involved in HFPV were not 
identified but microvessels on the venous side could play a role. 
Hypoxic constriction in the systemic circulation has also been demonstrated within the bovine digital 
vein (Risso et al., 2012) but is dependent on the priming vasoconstrictor.  Preconstriction with KCl 
and phenylephrine (α1-adrenoceptor agonist) resulted in hypoxic vasodilation and constriction, 
respectively.  The investigators proposed that the use of phenylephrine as a priming agent may 
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demonstrate more closely the hypoxic response in vivo.  They reasoned that vascular tone is 
normally maintained via activation of α-adrenoceptors by the sympathetic nervous system. The 
physiological role of hypoxic constriction in the bovine digital vein still remains to be established 
although it is thought to contribute to the pathophysiology of laminitis (Risso et al., 2012).  
These documented effects of hypoxia on the systemic circulation suggest that, in certain 
circumstances, hypoxia may cause vasoconstriction and that this response may involve veins (Risso et 
al., 2012) however the physiological implications are not fully understood. 
 
Effects of Hypoxia in the Pulmonary Circulation 
The physiological purpose of hypoxic vasoconstriction within the pulmonary circulation is to maintain 
ventilation-perfusion matching within the lung by diverting blood flow from hypoxic to better 
oxygenated areas (von Euler and Liljestrand, 1946 cited from Hillier et al., 1997).  Hypoxic pulmonary 
vasoconstriction (HPV) is more efficient in situations where the hypoxic area is smaller because this 
increases the fraction of blood redirected to areas with better ventilation (Marshall et al., 1981 cited 
from Hillier et al., 1997).  The current consensus within the field of HPV research is that small 
resistance pulmonary arteries are the most important mediators (Archer et al., 1996, Archer et al., 
2004, Sylvester et al., 2012); vasoconstriction of the pulmonary artery (PA) results in redirection of 
blood flow away from hypoxic areas (Hillier et al., 1997).  More specifically, the underlying 
mechanism is thought to reside within the PA smooth muscle cell (PASMC) (Sylvester et al., 2012).  
Research to date has therefore focussed on underlying mechanisms of HPV within the PA (reviewed 
by Sylvester et al. (2012)).  
 
Effects of Hypoxia in the Pulmonary Vein and Comparison to Pulmonary Artery 
Despite the focus of research on the PA, the PV is also known to constrict in response to hypoxia.  
One of the earliest studies suggesting hypoxic pulmonary venoconstriction was an in vivo canine 
study showing hypoxia-induced increases in pulmonary arterial wedge and venous pressures with 
little increase in left atrial pressure indicating active venoconstriction (Rivera-Estrada et al., 1958).  
The magnitude of PV contraction to hypoxia has been shown to be similar to and often greater than 
the PA response (Bressack and Bland, 1980, Félétou et al., 1995, Miller et al., 1989, Raj et al., 1990, 
Sheehan et al., 1992, Zhao et al., 1993, Zhao et al., 1996).  Furthermore, HPV is triggered by alveolar 
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hypoxia as opposed to PA hypoxaemia therefore the logical sensor would be pulmonary capillaries or 
downstream vessels i.e. PVs (Dawson, 1984).  Many of the studies showing robust hypoxic 
contraction in isolated PVs did so in large diameter PVs (3 to 7mm) from both rat (Zhao et al., 1993, 
Zhao et al., 1996) and pig (Félétou et al., 1995, Miller et al., 1989) in contrast to the smaller 
resistance vessels which are considered more important on the arterial side of the pulmonary 
circulation (Archer et al., 1996, Archer et al., 2004, Sylvester et al., 2012).  Isolated lung studies in 
lamb (Raj and Chen, 1986), ferrets (Raj et al., 1990) and cats (Nagasaka et al., 1984) have all shown 
an increase in pulmonary venous resistance in response to hypoxia, further implicating a role for the 
PV in the overall HPV response.  PVs and PAs appear to contribute equally to the increase in PVR 
under hypoxic conditions in lamb and ferret lungs (Raj and Chen, 1986, Raj et al., 1990) whereas, in 
cats, PAs contribute more than PVs (Nagasaka et al., 1984).  This could indicate a species and/or 
developmental variation in HPV.  Developmental variation in the hypoxic response was identified and 
characterised within the ovine pulmonary circulation (Bland et al., 1977, Bressack and Bland, 1980).  
In vivo studies of lamb showed an increase in PA pressure and lung lymph flow and decrease in 
lymph protein concentration in response to hypoxia suggesting a rise in transvascular pressure due 
to HPV in post-capillary vessels (Bressack and Bland, 1980).  Similar studies in adult sheep showed 
only an increase in PA pressure in response to hypoxia suggesting predominance of HPV in PAs (Bland 
et al., 1977).  
Hasebe et al. (1992) demonstrated HPV in both arterial and venous sides of the canine pulmonary 
circulation in an isolated caudal lobe system using antegrade and retrograde pulsatile perfusion 
techniques.  Their results indicated that the main sites of HPV were the small pulmonary arterioles 
and venules located between more muscular vessels.  Audi et al. (1991) used a constant flow 
perfusion system and arterial/venous occlusion techniques in canine lung lobes and concluded that 
the main site of HPV was in the small resistance arteries with limited contribution of PVs.  These 
differences are most likely linked to the different experimental conditions used by the two groups.  
Notably, the conditions used by Hasebe et al. (1992) could be considered more physiologically 
relevant as they used pulsatile perfusion rather than constant perfusion (Audi et al., 1991) and also 
used a ventilator with a respirator to maintain normal ventilatory movement.   
Further evidence supporting the involvement of small venous vessels in the HPV response came from 
studies of the effect of hypoxia directly on pulmonary venules in dogs (Hillier et al, 1997) and guinea 
pigs (Tracey et al., 1989a, Tracey et al., 1989b).  In the canine study subpleural venules (< 70 μM 
diameter) were visualised using a videomicroscopic technique in an intact lung lobe; hypoxia caused 
active venoconstriction with a mean reduction in vessel diameter of ~25% (Hillier et al., 1997).  
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Myography studies in guinea pig pulmonary venules revealed larger contractions when PO2 ~ 0 Torr 
compared to PO2 ~ 25 Torr but under both conditions the response was fast in onset and sustained 
without the need for pharmacological preconstriction (Tracey et al., 1989a, Tracey et al., 1989b).   
These findings in pulmonary venules dispute the assumption that venules are unable to contract due 
to having an incomplete vascular media (Fishman, 1961 cited from Hiller et al., 1997, Hillier et al., 
1997).  Interestingly, Hillier et al. (1997, p. 1089) proposed that: 
“hypoxic venoconstriction occurs predominantly in venules <200μM and most likely tapers to 
insignificance by the time veins of several millimetres are reached” 
Taking into account results from larger veins discussed earlier, this does not appear to be the case.  
Therefore investigation of HPV responses along the pulmonary venous system is warranted.   
A recent review (Sylvester et al., 2012) largely disregarded the PV as having an important role in the 
overall hypoxic response.   As limited research has been undertaken there is still a large degree of 
uncertainty around the physiological role of PV hypoxic contraction.  However, the hypoxic response 
in PV is robust and appears to contribute to the overall response in the lung and therefore requires 
further attention in its own right. 
Other characteristics of HPV, in addition to magnitude, are different when comparing PAs and PVs.  
The hypoxic contraction of isolated PVs is monophasic, generally involving one peak of contraction 
followed by relaxation (Dospinescu et al., 2012, Uzun and Demiryürek, 2003, Zhao et al., 1993, Zhao 
et al., 1996).  HPV in the isolated PA is often biphasic involving an initial, short-lived peak of 
contraction (phase 1) followed by relaxation then a gradually developing second prolonged 
contraction (phase 2) (Dipp and Evans, 2001, Dipp et al., 2001, Leach et al., 1994, Robertson et al., 
2004, Zhao et al., 1993, Zhao et al., 1996).  However some research groups have found hypoxic PA 
contraction to be monophasic and sustained (Archer et al., 1996, Archer et al., 2001, Archer et al., 
2004). 
Furthermore, Miller et al. (1989) found vast differences in the sensitivity of porcine PAs and PVs to 
hypoxia. The constrictor response in PAs was poor in 7.5% oxygen; exposure to 0% oxygen was 
required for substantial contraction whereas robust constriction of the PV was elicited in 7.5% 
oxygen.  They discovered that PAs required pharmacological preconstriction in order to develop a 
contractile response to hypoxia whereas PVs did not; a finding confirmed by Félétou et al. (1995). 
PVs and PAs also differ in terms of the mechanism of energy generation for hypoxic contraction.  PVs 
rely more on oxidative phosphorylation to generate ATP for hypoxic contraction whereas in PAs, 
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phase 1 requires oxidative phosphorylation and glycolysis and phase 2 requires glycolysis but not 
oxidative phosphorylation (Zhao et al., 1996).  Importantly, phase 2 is the prolonged phase (Dipp and 
Evans, 2001, Dipp et al., 2001, Leach et al., 1994, Robertson et al., 2004, Zhao et al., 1993, Zhao et 
al., 1996) thereby maintaining the HPV response in PAs and contributing more to the overall 
pulmonary vascular response to hypoxia (Dipp and Evans, 2001).  Hence the predominating 
mechanism of energy production during HPV is completely different between PVs and PAs (Zhao et 
al., 1996). 
These differential features of hypoxic contraction in PAs and PVs suggest that underlying 
mechanisms may be different.  These findings further support the rationale for investigating the 
underlying mechanisms and regulation of hypoxic responses in the PV specifically. 
 
Underlying Mechanisms of Hypoxic Contraction – Potassium Channels 
Despite extensive study, a degree of debate remains with regard to the underlying mechanisms of 
hypoxic contraction in resistance PAs.  However one potential mechanism involving voltage-gated 
potassium (K+) channels (KV) is well consolidated.  The mechanism is thought to involve hypoxic 
inhibition of a rapidly-activating, noninactivating potassium current through one or more delayed 
rectifier K+ channels.  This ultimately results in depolarisation of the PASMC membrane, calcium 
(Ca2+) influx via L-type voltage-gated Ca2+ channels (VGCC) and vasoconstriction of the PA (Archer et 
al., 1996, Archer et al., 1998, Archer and Michelakis, 2002, Archer et al., 2004, Leach et al., 1994, 
McMurtry et al., 1976, Moudgil et al., 2005, Platoshyn et al., 2006).  The delayed rectifier channel 
involved was later identified as a KV channel (Archer et al., 2004) and further investigation revealed 
that these hypoxia sensitive channels contain KV1.5 and KV2.1 α subunits (Archer et al., 1998, Archer 
et al., 2004, Moudgil et al., 2005). The hypoxia-sensitive current in PASMCs is sensitive to 4-
aminopyridine (4AP, (KV inhibitor (Dospinescu et al., 2012)) and correolide (KV1.x inhibitor, Archer et 
al., 2004) confirming the involvement of KV channels and those containing α subunits from the KV1.x 
family specifically (Archer et al., 1996, Archer et al., 2001, Archer and Michelakis, 2002, Archer et al., 
2004).   
Antibodies for both KV1.5 and KV2.1 can inhibit a portion of the hypoxia-sensitive current in PASMCs; 
hypoxic depolarisation is completely abolished when the antibodies are administered together and 
KV1.5 appears to play a larger role than KV2.1 (Archer et al., 2004).  KV1.5 knockout mice have a 
reduced response to hypoxia in both isolated perfused lung and isolated PA ring studies (Archer et 
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al., 2001).  Current flow through homomeric KV1.5 channels is inhibited during hypoxia in rat PASMCs 
over-expressing the KV1.5 gene.  Overexpression of the gene in other cell types including rat 
mesenteric artery smooth muscle cells, HEK-293 and COS-7 did not confer a hypoxia-sensitive current 
suggesting that block of KV1.5 channels under hypoxic conditions is a PASMC specific mechanism 
(Platoshyn et al., 2006).  Taking all this into account, KV channels (specifically containing KV1.5 and 2.1 
α subunits) play an important role in the mechanism of HPV in PAs. 
TASK-1 (acid-sensitive member of the two-pore domain K+ channel family) is another K+ channel 
candidate proposed to mediate hypoxic contraction of the PA.  In human PA smooth muscle, TASK-1 
is involved in controlling resting membrane potential (RMP) and is inhibited by hypoxia.  Knockdown 
of TASK-1 mRNA caused depolarisation of the RMP and inhibited depolarisation in response to 
hypoxia in primary cultures of human PASMCs (Olschewski et al., 2006).  However, large conductance 
Ca2+-sensitive K+ (BKCa) channels are thought to make a negligible contribution to the mechanism of 
HPV in PAs as the hypoxia-sensitive current in PASMCs is insensitive to the BKCa channel inhibitors 
iberiotoxin, charybdotoxin and tetraethylammonium chloride (TEA) (Archer et al., 1996, Archer and 
Michelakis 2002, Archer et al., 2004).   
As discussed, inhibition of KV currents is proposed to mediate hypoxic vasoconstriction of PAs via Ca
2+ 
entry through L-type Ca2+ channels (Archer et al., 1996, Archer et al., 1998, Archer and Michelakis, 
2002, Archer et al., 2004, Leach et al., 1994, McMurtry et al., 1976, Moudgil et al., 2005, Platoshyn et 
al., 2006), however there is some dispute over the importance of L-type calcium channels during 
HPV.  Some researchers have found that Ca2+ release from the sarcoplasmic reticulum (SR) plays a 
more prominent role in HPV in PAs (Dipp and Evans, 2001, Dipp et al., 2001).  Others argue that these 
results may be due to the use of a pharmacological preconstrictor before initiation of HPV whereby 
the preconstrictor may itself cause Ca2+ release which might be misinterpreted as being a result of 
HPV (Archer and Michelakis, 2002).  However Dipp and Evans (2001) and Dipp et al. (2001) showed 
abolition of the HPV response by inhibiting Ca2+ release from the SR (with ryanodine and caffeine) in 
the absence of preconstriction. 
Inhibition of K+ channels (KV and/or TASK) appears to play an important role in hypoxic responses of 
the PASMC yet controversy remains over the signalling pathways linking PASMC depolarisation to PA 
constriction.  Porcine pulmonary vein smooth muscle cells (PVSMCs) demonstrate a K+ current which 
is sensitive to hypoxia and 4AP.  In contrast to PASMCs, this hypoxia-sensitive current in PVSMCs is 
also sensitive to TEA.  4-aminopyridine (4AP) and TEA reduced contractile responses to hypoxia in 
isolated PVs however Penitrem-A (a more selective BKCa channel inhibitor than TEA) failed to alter 
11 
 
hypoxic contraction which may suggest BKCa channels are not involved in the underlying mechanism 
(Dospinescu et al., 2012).   
In addition to functional characterisation of the PV, Dospinescu et al. (2012) provided a comparative 
mRNA expression profile for K+ channels between PVs and size-matched PAs. A hypoxia sensitive BKCa 
channel variant (STREX) (McCartney et al., 2005) was identified in porcine PVs and STREX, KV1.5 and 
2.1 mRNA were all expressed to a greater extent in PVs than in PAs (Dospinescu et al., 2012).  These 
findings highlight further differences between PAs and PVs however it is not possible to conclude 
whether these increased levels of KV1.5, KV2.1 and STREX mRNA would result in increased expression 
at the cell membrane.  Archer et al. (2004) found that the mRNA expression of KV1.2, KV1.5, KV2.1, 
KV4.3, KV9.3 and BKCa was significantly greater in small PAs (<40μM) compared to large PAs (100-
200μM) but immunoblotting revealed that only KV1.5 showed increased expression at the protein 
level.  Further investigation of K+ channel expression and function in the PV is warranted as 
preliminary research suggests an important role for K+ channels during PV hypoxic responses. 
 
Underlying Mechanisms of Hypoxic Contraction – Reactive Oxygen Species and AMP Kinase 
K+ channels appear to be effectors of hypoxic contraction however mitochondria have been proposed 
as the sensors of hypoxia in PASMCs (Archer et al., 1993, Leach et al., 2001, Rounds and McMurtry, 
1981, Waypa et al., 2001, Weissman et al., 2003).  This theory is substantiated by the strategic 
positioning of mitochondria in PASMCs when compared with mesenteric artery smooth muscle cells.  
In PASMCs, mitochondria are located near the plasma membrane and mitochondrial by-products are 
thought to have an effect on KV channels in the membrane (Firth et al., 2009).  Despite most 
investigators being in agreement about the sensor of hypoxia within PASMCs, there is some 
controversy over the trigger for HPV.  Some authors have found that HPV increases reactive oxygen 
species (ROS) production at complex III of the mitochondrial electron transport chain (Leach et al., 
2001, Waypa et al., 2001).  An increase in ROS causes an increase in cytosolic Ca2+ in PASMCs (Waypa 
et al., 2002) and this Ca2+ may lead to inhibition of KV channels and cell depolarisation (Post et al., 
1995).  The opposing HPV theory involves reduced ROS production which is proposed to inhibit K+ 
channels (Archer et al., 1993) causing membrane depolarisation (Yuan, 1995, Michelakis et al., 2001) 
and VGCC influx (McMurtry et al., 1976).  KV channels have a high cysteine content (sulfhydryl groups) 
and could be controlled by the redox balance within the cell, channels would be open when oxidised 
and closed when reduced which ties in with the reduced ROS theory (Conforti and Millhorn, 2000).  
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Mitochondrial hyperpolarisation and reduced ROS have been suggested as an underlying mechanism 
of pulmonary arterial hypertension (PAH).  Decreased ROS are hypothesised to activate the 
transcription factor hypoxia-inducible factor-1α (HIF-1α) which results in reduced expression of 
KV1.5, membrane depolarisation, calcium influx, vasoconstriction and ultimately, PAH (Bonnet et al., 
2006). 
AMP-activated kinase (AMPK) may provide a link between mitochondrial oxygen sensing and Ca2+ 
signalling during HPV in PAs (Evans et al., 2005). Hypoxia is suggested to activate AMPK via inhibition 
of mitochondrial oxidative phosphorylation (Archer et al., 1993, Evans, 2006, Rounds and McMurtry, 
1981) resulting in reduced ATP levels, an elevated AMP/ATP ratio and activation of AMPK (Hardie 
and Hawley, 2001).  Whether by this mechanism or another, hypoxia has been demonstrated to 
double the AMP/ATP ratio in PASMC (Evans et al., 2005) and inhibition of AMPK with Compound C 
inhibits HPV in rat pulmonary artery (Robertson et al., 2008).  AMPK activation is proposed thereafter 
to cause cyclic ADP-ribose (cADPr)-mediated Ca2+ release via the ryanodine receptor on the SR in 
PASMCs (Evans et al., 2005).  An overview diagram of the proposed mechanisms of HPV in PASMCs 
highlighting the link between mitochondria, AMPK, Ca2+ signalling and K+ channels is shown in Figure 
1. 
Another notable finding of Evans et al. (2005) was that a particular isoform of AMPK (AMPK-α1) is 
predominant within resistance PAs and expression of this isoform was reduced in systemic arteries.  
Expression of this particular isoform may help towards explaining the differential response of 
pulmonary and systemic vascular beds to hypoxia.   
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Figure 1.  Diagram showing the proposed roles of K+ channels, Ca2+ signalling, mitochondria and 
AMPK in the hypoxic response of PASMCs.  N.B. KV – voltage-activated K
+ channels, VGCC – L-type 
voltage-gated Ca2+ channels, ROS –reactive oxygen species, AMPK – AMP-activated kinase, cADPr – 
cyclic ADP ribose.  Adapted from Murray et al.(2006). 
 
Differential Responses to Hypoxia Along the Vascular Tree 
Studies of hypoxic contraction in PAs have identified a difference in responses along the vascular 
tree.  Conduit/proximal PAs tend to exhibit relaxation or a small contraction in response to hypoxia.  
In contrast small resistance/distal PAs show a strong hypoxic contraction (Archer et al., 1996, Archer 
et al., 2004, Audi et al., 1991).  These findings have been disputed by others who demonstrated that 
large PAs do constrict in response to hypoxia (Leach et al., 1994) however HPV remains primarily 
associated with resistance PAs.  Archer et al. (2004) proposed that by having the strongest HPV 
response in small resistance PAs this would aid ventilation-perfusion matching without raising PVR as 
would be the case if larger PAs were the main site of HPV.  Furthermore, if larger PAs had a strong 
HPV response, this could be detrimental to the right heart by increasing afterload.   
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Small resistance venules have been proposed as a site of HPV (Hillier et al., 1997, Tracey et al., 
1989a, Tracey et al., 1989b) however large diameter PVs (3 to 7mm) also exhibit robust hypoxic 
contraction (Félétou et al., 1995, Miller et al., 1989, Zhao et al., 1993, Zhao et al., 1996).  Hypoxic 
constriction of small veins or venules too close to the capillary bed could result in oedema formation 
(Gao and Raj, 2005, Maggiorini et al., 2001).  If hypoxic contraction was stronger further downstream 
from the capillary bed then this could help with upstream capillary recruitment (Taylor et al., 2011) 
and redistribution of perfusion within a larger section of the lobe.  This could maximise oxygenation 
whilst minimising any increase in capillary pressure.  A strong HPV response occurring closer to the 
left atrium could result in redistribution of blood into a larger lung area and restriction of oxygenated 
blood outflow from the lungs to the left heart and would therefore be less beneficial.   
 
Proposed Physiological Relevance of Hypoxic Pulmonary Venoconstriction 
The importance of hypoxic pulmonary venoconstriction has been largely disregarded and therefore 
the potential physiological relevance has not been explored.  Hypoxia-induced contraction of the PV 
has been proposed to facilitate capillary recruitment and optimise gas exchange capacity within the 
lung in healthy human subjects (Taylor et al., 2011).  The underlying mechanism is thought to involve 
an increase in upstream pressure resulting from downstream PV constriction.  This theory requires 
further investigation as it was founded on a study which excluded a number of factors in 
combination (other than direct pulmonary venoconstriction) as fully accounting for capillary 
recruitment during hypoxia in healthy human subjects.  Less than 40% of the observed hypoxia-
induced increase in pulmonary capillary blood volume was attributable to changes in cardiac output, 
pulmonary arterial pressure or left ventricular diastolic function (Taylor et al., 2011). Hypoxic 
contraction of the PV may also play a role in the manifestation of disease including the rise in 
capillary pressure seen during high altitude pulmonary oedema (Bärtsch and Gibbs, 2007). 
The theory of capillary recruitment is disputed by the findings of others who have found hypoxic 
exposure reduces overall pulmonary blood volume and microvascular volume specifically (Bressack 
and Bland, 1980, Clough et al., 2000).  This may suggest a process involving reduced capillary 
recruitment and is more in keeping with the body of research supporting pre-capillary constriction of 
small pulmonary arteries as the predominant response during hypoxia.  Due to this dispute and 
general lack of knowledge in the area, research is required to explore the potential physiological role 
for hypoxic pulmonary venoconstriction and the role it may play in pulmonary disease states. 
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Morphological Changes in Pulmonary Arteries and Veins Exposed to Chronic Hypoxia  
Chronic hypoxia can result in structural remodelling of both PAs and PVs; one physiological example 
of chronic hypoxia is high-altitude.  Exposure of cattle to high-altitude resulted in hyperplasia and 
hypertrophy of the smooth muscle in the media of PA yet only hyperplasia was evident in PVs (Naeye 
et al., 1965). Moreover, in humans, high-altitude exposure resulted in hypertrophy and thickening of 
the media particularly in small PVs (less than 150 μM diameter).  Small PVs became arterialised in 
nature and the findings were suggested to indicate a prolonged increase in tone within these vessels 
under conditions of high-altitude (Wagenvoort and Wagenvoort, 1976, Wagenvoort and 
Wagenvoort, 1982).  Notably, the study only included subjects with no pre-existing left cardiac 
dysfunction or failure or heart valve disease which could have been alternative causes of the 
morphological changes observed in PVs (Wagenvoort and Wagenvoort, 1976).  This may suggest that 
high-altitude/chronic hypoxia exposure has a direct effect on the PV causing increased basal tone 
and structural alterations.   
Experimental models of chronic hypoxia in rats (using animal-holding chambers with 10-11% O2) have 
demonstrated medial thickening in small PVs and medial hypertrophy in pulmonary arteries, 
arterioles, veins and venules (Takahashi et al., 2001, Dingemans and Wagenvoort, 1978).  Crenation 
of the vascular walls and excrescences (protrusion of SMCs into the intimal layer) indicated 
constriction of both arteries and veins in response to hypoxia (Dingemans and Wagenvoort, 1978).  
Hence, morphological changes in PVs exposed to chronic hypoxia are consistent across a range of 
methods, species and researchers and appear similar to the changes seen in PAs. 
 
Pathological Consequences of Hypoxic Exposure 
HPV is an essential physiological response in healthy humans however it can also contribute to a 
number of disease states.  HPV tends to be more beneficial in diseases affecting a smaller, more 
focussed area of the lung such as pneumonia and atelectasis.  In these cases, HPV results in 
optimisation of blood oxygenation by diverting flow away from the small hypoxic area to other better 
ventilated areas without significantly raising PVR.  When the whole lung is exposed to hypoxia (for 
example under high altitude conditions or sleep apnoea), HPV is global and can result in elevated 
PVR, pulmonary hypertension and ultimately right ventricular hypertrophy if the exposure is 
prolonged (Archer and Michelakis, 2002, Dingemans and Wagenvoort, 1978, Félétou et al., 1995, Lal 
et al., 1999, Moudgil et al., 2005, Sheehan et al., 1992). 
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Increased resistance in small pulmonary veins and venules during hypoxia can result in increased 
microvascular pressure leading to an increase in fluid and/or protein filtration and oedema formation 
(Gao and Raj, 2005, Hillier et al., 1997, Raj et al., 1990).  Global hypoxic exposure in lamb lungs 
resulted in an increased rate of weight gain representing increased fluid filtration and interstitial 
oedema (Raj and Chen, 1986). 
PVs are proposed to play a role in the pathological manifestations of high altitude pulmonary 
oedema.  One theory is that high altitude pulmonary oedema results from inhomogeneous hypoxic 
pulmonary venoconstriction and subsequent regional overperfusion in the lung (Bärtsch and Gibbs, 
2007).  Others postulated that hypoxic contraction occurs in the smallest venules resulting in 
increased upstream capillary pressure and hydrostatic pulmonary oedema (Maggiorini et al., 2001).  
Investigation of underlying mechanisms of the hypoxic response in PVs is required to help identify 
potential therapeutic targets during diseases resulting from hypoxic exposure. 
 
The Role of the Pulmonary Vein in Disease 
In addition to high altitude pulmonary oedema, evidence from other areas of clinical research 
suggests the PV is an area worthy of investigation.  Elevated pulmonary venous resistance is strongly 
correlated with the increase in pressure gradient across the pulmonary circulation seen in morbidly 
obese patients without daytime hypoxia undergoing bariatric surgery and those with acute 
respiratory distress syndrome (ARDS).  The increased resistance within the pulmonary venous system 
in patients undergoing bariatric surgery was thought to be caused by increased prostanoid 
production and thromboxane (TP) receptor expression in morbid obesity.  In ARDS endotoxin-
mediated venoconstriction and leukocyte aggregation are proposed to contribute (Her et al., 2005, 
Her et al., 2010).  In each of these groups there was no history of left heart failure therefore it may 
be the case that the increased resistance generated was attributable to an intrinsic PV mechanism 
involving constriction and/or remodelling.   
Furthermore, hypoxaemia in human inferior PVs is positively correlated with body mass index (BMI) 
(Yamane et al., 2008) yet there was no such relationship in superior PVs.  This may be due to 
impairment of HPV and ventilation-perfusion mismatch in inferior PVs specifically. This proposes not 
only a difference between inferior and superior PVs but also a role for inferior PVs specifically in 
obesity-related respiratory disorders including sleep apnoea.   
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Additionally, a link between metabolic syndrome and pulmonary venous hypertension (PVH) 
resulting from left ventricular diastolic dysfunction (LVDD) has been identified by Robbins et al. 
(2009). Compared to patients with PAH, patients with PVH due to LVDD showed a higher prevalence 
of hypertension, obesity, diabetes mellitus and hyperlipidaemia (characteristics of metabolic 
syndrome).  In this study, patient numbers were small (17 patients with PVH; 35 patients with PAH), 
however the finding is still important.  Interestingly, the authors’ acknowledged that their 
assessment of left ventricular diastolic dysfunction was suboptimal and this could suggest metabolic 
dysregulation in PVs may contribute to PVH independently of heart dysfunction. 
It is unclear whether the observations by Her et al., 2005, Her et al., 2010, Robbins et al., 2009 and 
Yamane et al., 2008 indicate intrinsic pathophysiological mechanisms within the PV however 
pullmonary veno-occlusive disease (PVOD) is a disease known to originate in the PV.  Lesions occur 
primarily in the PV and involve fibrotic tissue occlusion of the lumen and an increased production of 
smooth muscle, elastic fibers and myofibroblasts (Montani et al., 2009, Pietra et al., 2004) leading to 
the development of interstitial oedema (Palmer et al., 1998).  The PV itself is directly involved in the 
changes in compliance and structure which occur with these conditions.  Patients may present in a 
similar manner to patients with idiopathic PAH (Simonneau et al., 2004) with approximately 5-10% of 
cases initially diagnosed as PAH being later identified histologically as PVOD (Iwaki et al., 2009, 
Montani et al., 2009).  This can have significant clinical implications as a number of treatments for 
PAH may precipitate pulmonary oedema in PVOD patients including prostacyclin (epoprostenol, a 
vasodilatory prostanoid), bosentan (endothelin receptor antagonist) and calcium channel blockers 
(Creagh-Brown et al., 2008, Montani et al., 2008, Palmer et al., 1998).  In the case of prostacyclin, a 
low dose infusion has resulted in fatal pulmonary oedema in a patient with PVOD (Palmer et al., 
1998).  This highlights the importance of diseases originating in the PV and the difference between 
PA and PV pathophysiology.   
Hence there is direct evidence (from PVOD patients and high-altitude exposure studies) and indirect 
evidence (from the studies of Her et al., 2005, Her et al., 2010, Robbins et al., 2009 and Yamane et 
al., 2008) for the PV as an origin of disease.  However a sound scientific knowledge base of regulatory 
mechanisms within the PV is lacking.  Further exploration of the underlying regulatory and metabolic 
pathways within isolated vessels and cells is essential and could help identify potential therapeutic 
targets which could contribute to the development of treatments for PV-related disease.  
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Blood Vessel Culture as a Model for Disease 
The maintenance of functional, isolated blood vessels under culture conditions is a potentially 
powerful tool to enable assessment of the impact of various environmental conditions on vessel 
function.  For example, it has been used to investigate the effects of high glucose on mouse aorta 
function (Tian et al., 2012).  However culture conditions alone can affect blood vessel function 
including examples from both pulmonary (Guibert et al., 2005, Manoury et al., 2009) and systemic 
vascular beds (Alm et al., 2002, Binko et al., 1999, Cao et al., 2005, De Mey et al., 1989, Morita et al., 
2013, Thorne et al., 2001, Thorne et al., 2002, Thorne and Paul, 2003). 
In PAs, exposure to culture conditions for 3-4 days appears to mimic chronic hypoxia (Manoury et al., 
2009) in terms of reduced functional K+ channels (Osipenko et al., 1998, Platoshyn et al., 2001), 
smooth muscle cell depolarisation (Bonnet et al., 2001, Osipenko et al., 1998, Platoshyn et al., 2001), 
and the emergence of basal tone due to Ca2+ influx (Bonnet et al., 2001, Platoshyn et al., 2001).    
Isolated PVSMCs exposed to culture conditions for 4-6 days exhibit store-operated Ca2+ entry and 
raised intracellular Ca2+ in response to acute hypoxia (Peng et al., 2013).  Unfortunately these Ca2+ 
responses were not directly compared to those of freshly isolated PVSMCs so no further conclusions 
can be drawn.  The effect of maintaining isolated PVs in culture conditions remains to be established.  
  
Sex and Species Differences in Pulmonary Vasculature and Utililty of the Porcine Model 
Human epidemiological studies have revealed a higher prevalance of PAH in females compared to 
males (Martin and Pabelick, 2014).  However, opposing sex differences exist within rat models of 
hypoxic pulmonary hypertension where male rats have increased disease severity compared with 
females (Rabinovitch et al., 1981) and 17β-oestradiol and oestrogen receptors have protective 
effects (Lahm et al., 2012).  This is known within the field as the “oestrogen paradox” whereby 
oestrogen is protective within experimental rodent models yet clinically, the female sex is associated 
with a higher risk of PAH occurrence (Martin and Pabelick, 2014).  This paradox raises potential 
questions as to the relevance of rodent models in the study of pulmonary vasculature and disease. 
Despite this, the majority of the fundamental research in the area of pulmonary circulation (including 
hypoxic pulmonary vasoconstriction) has been conducted in rodent models. Reliance on rodents to 
investigate the pulmonary circulation has been challenged due to profound differences from human 
physiology in terms of K+ channel function (Manoury et al., 2011) and anatomy in terms of 
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cardiomyocyte distribution (Bonnet and Archer, 2007, Michelakis et al., 2001, Roux et al., 2004).  
Cardiomyocytes within the rat extend into fifth order PVs (Michelakis et al., 2001) whereas, in 
humans, cardiomyocytes are confined to extrapulmonary veins (Bonnet and Archer, 2007, Roux et 
al., 2004).  The distribution of cardiomyocytes in PVs in large domestic mammals including sheep and 
pigs are similar to that seen in humans (Nathan and Gloobe, 1970).   
Morphological studies of fibrous tissue, collagen and smooth muscle content of mammalian PVs 
revealed that PVs in cat, dog, ferret, goat, rabbit and human were less distensible and contained a 
higher proportion of fibrous tissue and collagen (Kay, 1983) indicating they were less vasoactive.   
PVs from cow, sheep, guinea pig and pig were more highly muscularised (Kay, 1983) indicating 
increased vasoactivity compared with other mammals.  However, Taylor et al. (2011) challenged the 
suggestion of reduced vasoactivity in humans PVs when they proposed a role for hypoxic pulmonary 
venoconstriction in hypoxic pulmonary capillary recruitment suggesting human PVs may be more 
vasoactive than first suspected.   
Therefore the pulmonary vascular system in large domestic mammals such as pigs may more closely 
represent the human model and provide a suitable alternative for study of PV function.  Porcine PVs 
are also known to have a robust hypoxic vasoconstrictor response (Miller et al., 1989) and a hypoxia-
sensitive K+ current is present within PVSMCs (Dospinescu et al., 2012).   
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Aims and Objectives 
As previous HPV research has focussed on PAs, there is relatively less known about the mechanism of 
hypoxic contraction in PVs.  Hypoxic pulmonary venoconstriction is proposed to recruit upstream 
capillary beds and optimise gas exchange in the lungs of healthy human subjects (Taylor et al., 2011) 
and also to play an important role in disease states, for example, pulmonary oedema (Bärtsch and 
Gibbs, 2007, Maggiorini et al., 2001).  The PV directly contributes to disease states including 
pulmonary hypertension (Iwaki et al., 2009, Montani et al., 2009, Tuder et al., 2013) and pulmonary-
veno occlusive disease (Pietra et al., 2004, Montani et al., 2009).  Blood vessel culture can be a 
powerful tool to enable assessment of the impact of environmental factors on vessel function (e.g. 
high glucose (Tian et al., 2012) and as a model for disease.  However culture conditions alone affect 
vessel contractility (Manoury et al., 2009); the effect of culture conditions alone on PV function 
remains to be established.   
Hypoxaemia is positively correlated with BMI in inferior but not superior PVs (Yamane et al., 2008) 
however it is unknown whether functional differences exist between PVs from different locations.  
Previous research has characterised contractile function and SMC morphology and electrophysiology 
in superior/middle PVs (Dospinescu, 2009) therefore work presented here will have a focus on 
inferior PVs.  Characterisation of the inferior PV in terms of underlying functional mechanisms and 
regulation at the isolated vessel and cellular level and gene expression is required before potential 
therapeutic targets can be identified. 
The aim of this project was to investigate hypoxic responses of porcine intrapulmonary veins and 
PVSMCs (with a focus on inferior PVs) including the impact of PV maintenance in culture. 
 
Objectives 
The objectives detailed below were proposed to address this aim: 
1. to characterise contractile responses of porcine inferior and superior PVs to pharmacological 
agonists and hypoxia 
2. to investigate underlying mechanisms and pathways of hypoxia-induced responses in inferior PVs 
3. to investigate the mRNA expression profile of K+ channels in inferior and superior PVs  
4. to develop a protocol to freshly isolate PVSMCs from inferior PVs in order to examine 
morphological and passive electrical properties 
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5. to characterise electrical properties of inferior PVSMCs in terms of membrane potential and 
voltage-activated whole-cell currents 
6. to develop an appropriate blood vessel culture technique for PVs and evaluate the impact of 
maintenance in culture conditions on contractile function, K+ channel expression and PVSMC 
morphology and electrical properties  
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Chapter 2 
General Methods 
 
 
Porcine Abattoir Tissue 
All experiments were performed in accordance with UK legislation.  Porcine heart and lung tissue (sus 
scrofa domesticus) was obtained from either Scotch Premier Meat Ltd (Inverurie, Aberdeenshire) or 
Quality Pork Producers Ltd (Brechin, Angus).  Tissue was obtained from animals aged between 18 – 
28 weeks, weighing 70-80kg of either sex.  
 
Dissection Procedure 
 Heart and lung tissue (see Figure 2) from Scotch Premier Meat Ltd arrived in the lab for dissection 
within ~1 hour of kill.  Tissue from Quality Pork Producers Ltd arrived in the lab for dissection within 
~1-2 hours of kill.   
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Figure 2. Porcine heart and lungs.  Ventral view of heart and lungs en bloc. Pulmonary veins were 
mainly dissected from right cranial (A) and caudal (B) lobes for use in all experiments. 
 
Pulmonary veins (PVs) were dissected from the right cranial (A in Figure 2) and caudal (B in Figure 2) 
lobes and cleared of any adherent tissue.  For clarity, in terms of anatomy, cranial lobes will be 
considered analogous to superior and caudal to inferior for the purpose of this study and will be 
referred to as such from this point forwards (Srebnik, 2002).  If these lobes were unavailable or badly 
damaged then the corresponding veins from the left lung were used instead.  Size-matched 3rd-4th 
order superior and 4th-5th order inferior PVs of external diameter 3.4 ± 1.0 mm (mean  ± SD, N=49) 
were used for isolated vessel experiments (see Figure 3).    
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Figure 3. Dissection of inferior and superior pulmonary veins .  A: Right inferior pulmonary lobe with 
4th and 5th order pulmonary veins (PVs) shown in situ.  B: Left superior pulmonary lobe with 3rd and 
4th order PVs shown in situ. C:  Isolated segments of 3rd-4th order superior and 4th-5th order inferior 
PVs shown side-by-side to illustrate size matching. 
 
Vein were dissected free from lung tissue.  To maintain tissue during dissection for myography 
experiments, tissue was regularly washed with KREB’s solution (composition in mM: 119 NaCl, 4.7 
KCl, 1.18 KH2PO4, 1.18 MgSO4, 25 NaHCO3, 2.52 CaCl2, 10.88 glucose).  During dissection for 
electrophysiology experiments tissue was regularly washed with calcium-free dissecting solution 
(composition in mM: 119 NaCl, 4.7 KCl, 1.18 KH2PO4, 1.17 MgSO4, 25 NaHCO3, 10HEPES, 5.5 glucose; 
pH adjusted to 7.4 with NaOH).  PVs were used immediately for experiments or kept in KREB’s or 
calcium-free dissection solution as above before placing in culture conditions.   
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Culture Conditions 
In order to develop a tool for use as a disease model and for investigation of the effects of a range of 
environmental conditions (e.g. high glucose) on vessel function (Tian et al., 2012), vessels were 
maintained under tissue culture conditions.  Culture conditions alone affect contractile function of 
blood vessels including PAs, where they appear to mimic chronic hypoxia (Manoury et al., 2009).  
Therefore the effect of culture conditions alone on PVs needed to be established.   
PVs to be maintained in culture conditions were transferred to a laminar flow hood (Bioair 
Instruments, Italy).  Vessels were removed from KREB’s/dissection solution using sterile forceps and 
placed in a sterile bijou tube containing approximately 6mL Eagle Minimum Essential Medium (Sigma 
Aldrich, UK) supplemented with 2% penicillin-streptomycin for rinsing.  This rinsing procedure was 
repeated before placing the unpressurised vessels in sterile untreated 6-well tissue culture plates 
containing approximately 3mL of the supplemented medium per well.  The plates were maintained in 
a humidified Galaxy S incubator (Wolf Laboratories, UK) at 37oC in 95%air/5%CO2 for 24 hours. 
 
Myography 
Myography provides a convenient way to study in vitro physiology and pharmacology of a range of 
tissues, including blood vessels.  Experiments can be performed over several hours in a temperature 
controlled, oxygenated environment.  Blood vessels were attached to a force transducer via a pair of 
stainless steel hooks allowing for measurement of isometric tension responses under fixed strain to a 
range of stimuli. 
 
Equipment and Calibration 
Each 4-channel Myobath (World Precision Instruments, UK) consisted of four individual 25mL glass 
baths which meant different stimuli could be used in each bath and adjacent time controls were 
readily achievable.  The baths were filled with KREB’s solution and bubbled with 95%O2/5%CO2 in 
order to maintain pH at 7.4.  Temperature was maintained at 36.7 ± 0.3°C (mean ± SD, N=8) by a 
thermocycler (Grant FH16-D) which heated water in the external water jacket.   
A two-point calibration of each myograph channel was performed at 0 and 5g (using a 5g calibration 
weight).  PVs were cut into rings of length 4.0 ± 1.0mm (mean ± SD, N=49) and two tissue hooks were 
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passed through the lumen of the vessel rings.  One tissue hook was attached to a tissue holder and 
the other was connected to a force-transducer.  Mounted PV rings were then lowered into the baths.  
The force-transducer signal was amplified via a TBM4M trans-bridge amplifier (World Precision 
Instruments, UK) set to gain of x10.  The amplified signal was recorded by PowerLab 4/25 data 
acquisition system (ADInstruments, UK) and LabChart 7 software (©ADInstruments 2010).  Data 
readings were acquired at a frequency of 20Hz.  Figure 4 shows the equipment used during 
myography experiments. 
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Figure 4. Equipment used during myography.  A: Equipment used for myography - trans-bridge 
amplifier, thermocycler, myograph baths and gas cylinder.  B: Four myograph channels mounted with 
vessel rings. C: Myograph bath showing mounted vessel between two stainless steel hooks.  
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Equilibration, Optimal Resting Tension and Calculation of Equivalent Pressure 
After mounting and submerging in the bath the vein rings were allowed to equilibrate for 60 minutes 
at 1.5g resting tension.  This tension was determined to produce optimal responses to 80mM KCl 
during preliminary experiments and was set manually using tensiometers. 
As part of evaluation of the experimental model, approximate equivalent physiological pressures for 
this tension (1.5g) were calculated using the Laplace equation (Thomas, 2003): 
𝑃𝑟𝑒𝑠𝑠𝑢𝑟𝑒  𝑚𝑚𝐻𝑔 =
𝐹𝑜𝑟𝑐𝑒(𝑁𝑒𝑤𝑡𝑜𝑛𝑠)
𝑅𝑎𝑑𝑖𝑢𝑠  𝑚 𝑥 𝑉𝑒𝑠𝑠𝑒𝑙 𝑊𝑎𝑙𝑙 𝐿𝑒𝑛𝑔𝑡𝑕 (𝑚)
 𝑥 0.0075 
(Equation 1) 
Note that 1.5g was converted to Kg force (0.0015Kg) and then to Newtons using a conversion factor 
of 0.102 (0.0147 Newtons).  Using a radius of 1.7mm (0.0017m) and a vessel wall length of 4.0mm 
(0.004m) which were the mean values for PVs used in this study, this gave an equivalent pressure of 
16.2 mmHg.  Within in vivo canine studies, pulmonary venous pressure was 17.1 ± 6.5 mmHg which 
was between PA pressure (20.2 ± 6.2 mmHg) and pulmonary wedge pressure (13.3 ± 6.2 mmHg) 
(Chaliki et al., 2002).  Therefore a pressure of 16.2 mmHg seems reasonable when compared to 
physiological values in canine studies.  Human values for PA pressure range between 10 and 20 
mmHg and pulmonary capillary wedge pressure between 5 and 15 mmHg (Muralidhar, 2002) 
therefore according to canine studies, human pulmonary venous pressure would lie somewhere 
between these values (Chaliki et al., 2002).  Although these pressures cannot be directly extrapolated 
to the pig, both dogs and humans are also large mammals so it seems likely that a pressure of 16.2 
mmHg may lie within physiological range for a pig. 
 
Functional Testing 
After a 60 minute equilibration period, viability of the tissue was tested by exposing to 80mM KCl 
three times.  Endothelial function was checked by preconstricting with a submaximal concentration 
of a vasoconstriction (either 2 µM Prostagandin F2α (PGF2α) or 1µM histamine) then applying 10µM 
carbamoylcholine chloride (carbachol (synthetic acetylcholine analogue, cholinergic agonist)). 
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Hypoxic Exposures 
The gas mixture bubbling the bath was changed from 95%O2/5%CO2 (normoxia) to 95%N2/5%CO2 in 
order to achieve hypoxic levels in the bath.  The exposures lasted for 15-20 minutes with at least 30 
minutes for recovery (in 95%O2/5%CO2) between exposures. 
 
Oxygen Monitoring in Myography  
Oxygen was monitored during myography experiments in Chapter 4 on separate days in different 
channels each time using a thin flexible needle-type housing (NTH) trace oxygen microsensor 
connected to a Single Channel Fiber-Optic Oxygen Meter (Microx TX3-trace, Precision Sensing GmbH, 
Germany).  A two point calibration of the Microx TX3-trace was performed by first exposing the 
oxygen and temperature sensors to deionised water bubbled with 95%N2/5%CO2 for 40 minutes at 
room temperature for a 0% air saturation reading.  The sensors were then placed in deionised water 
exposed to room air for 40 minutes at room temperature for a 100% air saturation reading. 
Oxygen measurements were recorded within the OxyView-TX3 v5.31 software (© PreSens GmbH) as 
% air saturation at a sampling rate of 1Hz.  All recorded values were normalised as a percentage of 
the mean %air saturation over the first 15 minutes of normoxia for all recordings as it was assumed 
that the oxygen level was stable at this point as the bath had been bubbled with 95%O2/5%CO2 for at 
least 1 hour.  During the first 15 minutes of recording under normoxic conditions, oxygen tension was 
101.3 ± 1.2 %mean normoxic air saturation (mean ± standard error of the mean (S.E.M), N=8).  Over 
the 15 minute hypoxic exposure the mean oxygen tension reached was 7.2 ± 1.1 % mean normoxic 
air saturation (N=8, P<0.001 compared to normoxia).  The average time taken to reach minimum 
oxygen tension on exposure to hypoxia was 724.6 ± 45.3s.  On reoxygenation, oxygen tension 
recovered to 89.2 ± 2.1 %mean normoxic air saturation (N=8, P<0.001 compared to initial normoxia 
and hypoxia).  After reinstating 95%O2/5%CO2, oxygen levels reached a steady state in 199.8 ± 39.7s.  
The time course for mean oxygen levels before, during and after hypoxia exposure is shown in Figure 
5. 
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Figure 5. Mean oxygen tension before, during and after exposure to hypoxia within the myograph 
bath.   Trace represents mean oxygen levels over 15 minutes normoxia (95%O2/5%CO2), 15 minutes 
hypoxia (95%N2/5%CO2) and approximately 11 minutes reoxygenation with 95%O2/5%CO2 (N=8).  
Data are normalised to mean %air saturation over the first 15 minutes of normoxia for all recordings. 
Grey and black bars represent normoxia and hypoxia, respectively. 
 
Oxygen readings were made by placing the fibre-optic recording electrode within the myobath which 
allowed for simultaneous recording of oxygen and tension.  Figure 6 shows a representative trace 
illustrating simultaneous recording. 
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Figure 6. Representative sample trace for pulmonary vein tension and oxygen tension before, 
during and after hypoxia.  Black trace represents tension (left y-axis) and grey trace represents mean 
oxygen levels (right y-axis) over 15 minutes normoxia (95%O2/5%CO2), 15 minutes hypoxia 
(95%N2/5%CO2) and approximately 15 minutes reoxygenation with 95%O2/5%CO2.  Oxygen tension is 
normalised to mean %air saturation over the first 15 minutes of normoxia for all recordings. Grey and 
black bars at top of figure represent normoxia and hypoxia, respectively. 
 
Temperature Monitoring in Myography  
The Microx TX3-trace oxygen meter also measured temperature simultaneously.  Temperature was 
stable over time during hypoxic/normoxic conditions (36.7 ± 0.3°C, mean ± SD, N=8) therefore it is 
unlikely that this acted as a stimulus for the contractile responses observed within PVs. 
 
pH Monitoring in Myography  
A digital pH meter (SevenEasy, Mettler-Toledo Ltd., Leicester, UK) was used to measure pH within 
different myograph baths to determine the effect of changing bubbling from hypoxic to normoxic gas 
mixtures both immediately and at 1-5 minute intervals thereafter.  During experiments with 4AP in 
Chapter 4, HEPES bath solution (composition in mM: 150 NaCl, 5.4 KCl, 1.2 MgCl2, 1.8 CaCl2, 10 
HEPES, 10 glucose) was used therefore similar pH measurements were taken in this solution bubbled 
with 95%O2/5% CO2 and 95%N2/5%CO2.   
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In Kreb’s solution, the mean pH over the initial 15 minutes of normoxia before hypoxia exposure was 
7.45 ± 0.01.  During the 15 minutes of hypoxia, the mean pH was 7.45 ± 0.01 and then during the 
final 15 minutes of normoxia pH remained at 7.45 ± 0.01 (P<0.05, N=3).  The time course for mean 
pH levels before, during and after hypoxia exposure in Kreb’s is shown in Figure 7. 
 
Figure 7. Mean pH before, during and after exposure to hypoxia in Kreb’s solution.   Trace 
represents mean (±S.E.M)  pH levels over 15 minutes normoxia (95%O2/5%CO2), 15 minutes hypoxia 
(95%N2/5%CO2) and 15 minutes reoxygenation with 95%O2/5%CO2 (N=3).  Grey and black bars 
represent normoxia and hypoxia, respectively. 
 
As can be seen from Figure 7 there was a sharp change in pH of Kreb’s solution on gas changeover at 
hypoxia and normoxia.  When gas was changed from normoxia to hypoxia pH increased from 7.45 ± 
0.01 (1 minute before gas change) to 7.48 ± 0.02 (immediately after gas change), however this 
difference in pH was not statistically significant (P>0.05, N=3).  When gas was changed from hypoxia 
back to normoxia pH increased from 7.45 ± 0.01 (1 minute before gas change) to 7.47 ± 0.02 
(immediately after gas change) and again this was not statistically significant (P>0.05).  These sharp 
increases on gas changeover are most likely because the buffer within Kreb’s solution is a 
bicarbonate buffer which requires 5% CO2 for maintenance at pH 7.4.  On gas changeover this 5% 
CO2 is absent and it takes a period of time of bubbling for the level to rise to 5%.  Generally, during 
gas changeover, pH levels had stabilised after 5 minutes (see Figure 7).   
In HEPES solution, the mean pH increased over time.  During the initial 10 minutes of normoxia 
before hypoxia exposure, the mean pH was 6.56 ± 0.02.  During the 15 minutes of hypoxia, the mean 
pH increased to 6.58 ± 0.03 although this was not statistically significant (P>0.05, N=3).  In the final 
15 minutes of normoxia pH increased further to 6.59 ± 0.03, a level significantly higher than initial 
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period of normoxia (P<0.05, N=3).  The time course for mean pH levels before, during and after 
hypoxia exposure in HEPES is shown in Figure 8. 
 
Figure 8. Mean pH before, during and after exposure to hypoxia in HEPES solution.   Trace 
represents mean (±S.E.M) pH levels over 10 minutes normoxia (95%O2/5%CO2), 15 minutes hypoxia 
(95%N2/5%CO2) and 15 minutes reoxygenation with 95%O2/5%CO2 (N=3).  Grey and black bars 
represent normoxia and hypoxia, respectively. 
 
When gas was changed from normoxia to hypoxia in HEPES solution pH increased slightly from 6.56 ± 
0.02 (1 minute before gas change) to 6.57 ± 0.02 (immediately after gas change), but this was not 
statistically significant (P>0.05, N=3).  When gas was changed from hypoxia back to normoxia pH did 
not change (hypoxia (1 minute before gas change): 6.58 ± 0.03, normoxia (immediately after gas 
change):  6.58 ± 0.02, P>0.05). 
In HEPES solution, pH gradually increased over time.  As the HEPES solution was bubbled with 5% 
CO2, pH would be expected to decrease (Elder et al., 2015).  HEPES solutions were prepared and pH 
buffered at room temperature and then used in myography experiments at 37°C; the increase in 
temperature could have caused the increase in pH (Barron et al., 2006).   
To investigate whether there was a relationship between O2 levels and pH, an x-y scatter graph (O2 
vs. pH) was plotted however there was no significant correlation between O2 level and pH (P>0.05). 
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Reverse Transcriptase Polymerase Chain Reaction 
Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) was used to investigate the molecular 
basis of K+ channels in PVs in order to help identify potential targets for electrophysiology studies.  
Details of RNA extraction and RT-PCR are covered within Appendix 1. 
 
Smooth Muscle Cell Isolation from PVs 
Smooth muscle cells (SMCs) were isolated either from freshly dissected inferior PVs or from inferior 
PVs maintained in tissue culture conditions for 24 hours for use in electrophysiology studies.  SMCs 
were identified based on morphological and functional responses; no other identification of cell 
phenotype was undertaken.   
A protocol was developed and optimised in order to yield healthy, functional cells for whole-cell 
patch clamping.  Ideally, the protocol would achieve a high yield (10-20 cells per field at 20x 
magnification) of spindle-like relaxed cells with intact membranes however partially contracted cells 
could also be used as this was considered another indicator of viability. 
 
Cell Isolation Optimisation 
A modified version of a protocol devised by Dospinescu (2009) was used in order to effectively 
isolate viable smooth muscle cells as this protocol was devised using porcine PV.  However 
optimisation was required as the size and order of PVs used was different; Dospinescu (2009) used 
5th to 7th order superior PVs which were much smaller and had thinner walls than the 4th to 5th order 
inferior PVs used in this study. 
The main modifications involved removing rinsing steps, amending the order of enzyme addition and 
changing enzyme digestion times (described in more detail later).  Yield and quality were 
documented for every batch of cells produced.  Yield was rated on a scale from 0 to 5, with 0 being 
no cells to 5 being very many cells.  Quality was a descriptive comment on the membrane 
appearance (healthy, fragile, blebbed) and contractile state (contracted/partially contracted, relaxed) 
of the cells.  Optimal digestion times produced a yield high enough for numerous patch-clamping 
attempts and also cells healthy enough to withstand patch clamping protocols for approximately 20-
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30 minutes.  Under-digestion resulted in few cells with blebbed membranes and over-digestion 
produced a high yield of poor quality, fragile cells (refer to Figure 9 for examples of different qualities 
of isolated cells).   
 
 
Figure 9. Various qualities of freshly isolated inferior pulmonary venous smooth muscle cells 
(phase contrast microscopy). (top left) Two relaxed elongated single smooth muscle cells with bright 
halos indicating intact and healthy cell membranes. (top right) Smooth muscle cell with blebs of 
membrane shown by white arrows.  Contracted smooth muscle cell with bright halo indicating intact 
membrane shown by black arrow. (bottom) Cell on left - poor quality translucent smooth muscle cell 
with fragile membrane. 
37 
 
Cell Isolation Protocol 
Inferior PVs (4th-5th order) with an outer diameter of 3.0 ± 0.7 mm (mean ± SD, N= 87) were dissected 
from the right lung as earlier described for use in cell isolation experiments.  If these lobes were 
unavailable or badly damaged then the corresponding veins from the left lung were used instead 
without any noticeable variation in results. 
PVs were then cut open longitudinally and pinned out in a dish containing Ca2+ free dissecting 
solution.  A razor blade was used to gently scrape off the endothelial layer then the vein was turned 
over, pinned again and the adventitial layer was carefully removed using a pair of forceps and 
scissors.  At this stage the vessel was then cut using the “feathering” technique (alternating cuts on 
either side of the pinned out vessel) which increased the surface area for enzymatic activity. 
 
Smooth Muscle Cell Dispersion from PV Segments 
After removing endothelial and adventitial layers and “feathering”, the vein was cut into segments 
approximately 0.5-0.75cm long and then placed into a 1.5mL microcentrifuge tube containing Ca2+ 
free dissociation solution (composition in mM: 128 NaCl, 5.4 KCl, 0.95 KH2PO4, 0.35 Na2HPO4, 4.16 
NaHCO3, 10 HEPES, 10 glucose, 2.9 sucrose; pH adjusted to 7.3 with NaOH) supplemented with 
1.5mg/mL papain from Papaya latex (Sigma Aldrich, UK).  
Vessel segments were then placed in a refrigerator (2 to 8°C) for 1-2 hours followed by addition of 
0.75mg/mL DL-dithiothreitol and incubation in a dri-block (DB-2A, Techne, UK) at 37°C for 10 minutes 
(original protocol by Dospinescu (2009) involved addition of both papain and DL-dithiothreitol before 
incubation on ice).  Vessel samples were then transferred to a separate 1.5mL microcentrifuge tube 
containing Ca2+ free dissociation solution supplemented with 1.5mg/ml collagenase from Collagenase 
histolyticum Type VIII (Sigma Aldrich, UK) using a wide bore fire-polished glass Pasteur pipette.   
Following transfer, the vein segment was incubated in a dri-block at 37°C for approximately 25-40 
minutes depending on prior assessment of vessel wall thickness and segment size. 
After this final digestion stage vein samples were transferred into 1mL enzyme free fresh dissociation 
solution and rinsed three times before final transfer into 0.5mL enzyme free fresh dissociation 
solution.  Tissue was left at room temperature for 30-60 minutes followed by trituration via a fire 
polished glass Pasteur pipette (usually 5 times) which produced viable SMCs.  At this stage cells were 
visualised using a Leica DMI4000B microscope, images were taken using attached Leica DFC 300 FX 
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camera and yield and quality were recorded as previously described.  Triturated cells were stored at 
room temperature and used for patch clamping over 4-6 hours. 
 
Whole-Cell Patch Clamping 
Whole-cell patch clamping was used to record resting membrane potential (in current-clamp mode) 
and whole-cell voltage activated currents (in voltage-clamp mode) within inferior PVSMCs.  Changes 
in membrane potential and voltage activated currents were characterised in response to 
pharmacological agents which modify K+ currents.  The effect of hypoxia on resting membrane 
potential (RMP) was also investigated. 
 
Preparation of Pulmonary Vein Smooth Muscle Cells 
Patch clamping experiments were performed at room temperature.  Approximately 80-100µL of cell 
suspension was pipetted onto a glass coverslip.  The glass coverslip was attached to a low profile 
large bath recording chamber (RC-26GPL, Harvard Apparatus, Kent, UK) with silicon grease (Dow 
Corning, Belgium).  Cells were allowed to settle onto the coverslip for 15-20 minutes.   The recording 
chamber was mounted on the stage of a Nikon Eclipse inverted microscope TS100 using a platform 
(PH-1, Harvard Apparatus, Kent, UK) and Nikon stage adaptor (TS1M, Harvard Apparatus, Kent, UK).  
Once cells had settled, the recording chamber was filled with HEPES-based extracellular bath solution 
(of composition (in mM):  150 NaCl, 5.4 KCl, 1.2 MgCl2, 1.8 CaCl2, 10 HEPES, 10 glucose; pH adjusted 
to 7.4 with NaOH) with a plastic Pasteur pipette. 
 
Patch Pipette Pulling 
Pipettes were pulled from Clark borosilicate standard wall glass capillaries with filament (1.5mm O.D. 
x 0.86mm I.D.; Biochrom Ltd, Cambridge, UK) using a Flaming Brown P-87 micropipette puller (Sutter 
Instruments Co., USA).  Fire-polishing of the pipettes was then performed using a microforge (MF-
830, Narishige, Tokyo, Japan) to a final resistance of approximately 2-6 MΩ when filled with 
intracellular pipette solution (composition (mM): 110 KCl, 2.5 MgCl2, 10 HEPES, 3.6 ATP (magnesium 
salt); pH adjusted to 7.2 with KOH) through a Nalgene 0.2µM syringe filter (25 mm surfactant free 
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cellulose acetate membrane).  Small batches of 8-10 pipettes were made prior to immediate use 
during the course of each experimental day.  Making pipettes in small batches reduced the chances 
of pipette tips becoming blocked with dust and debris. 
 
Electrode Preparation and Reference Electrode 
The main electrode consisted of a piece of thin silver wire (diameter 0.25mm) soldered to a brass 
pin; the brass pin made contact with the CV 201A/CV 203BU Axopatch headstage (Axon Instruments, 
California, USA) which allowed for current to flow and hence be amplified (via Axopatch 200A/200B 
amplifier) and recorded.  This combination in turn was connected to a plastic airtight pipette holder.   
The silver wire was placed in concentrated chloride solution (Presept tablets, Fisher, UK) at the start 
of every experimental day to produce a silver chloride (AgCl) outer layer on the silver wire in order to 
reduce electrode polarisation which can increase resistance and delay potential changes.  Changing 
pipettes can lead to the AgCl layer being scraped off hence the need for regular maintenance 
(Molleman, 2003).  A reference electrode was required for recording intracellular potential relative 
to extracellular.  The reference electrode was also connected to the Axopatch headstage by a brass 
pin and placed directly into the bath solution beside the outflow point of the recording chamber. 
 
Giga-Seal Formation 
Cells were selected for attempting giga-seal formation based on their appearance - the aim was to 
find cells with healthy, intact membranes (relaxed or partially contracted).  After selection of a 
suitable cell, filled intracellular pipettes were mounted onto the pipette holder (attached to the 
Axopatch headstage); this reduced the period of time the pipette was exposed to the air to prevent 
blockage of the tip.  Positive pressure was applied via mouth through a plastic pipette tip and silicon 
tubing (1mm I.D., 2mm O.D.) attached to a side arm of the pipette holder before the pipette was 
lowered into solution in the chamber using a coarse micromanipulator (Narishige, Tokyo, Japan).  
Applying positive pressure helped prevent blockage of the pipette tip with fibres and extracellular 
material when moving through the bath solution. 
Progress of the patch clamp attempt was monitored through the “pipette seal test/signal monitor” 
function of the WinEDR software v3.7.0 (© John Dempster, University of Strathclyde).  The voltage-
clamp mode of the amplifier was selected with an initial holding voltage of 0mV with a 5mV voltage 
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step of 50ms duration; this allowed for monitoring of seal formation and for the software to calculate 
pipette resistance.  When the pipette was near the cell, a three-axes vernier-type water hydraulic 
micromanipulator (MHW-3, Narishige, Tokyo, Japan) for finer adjustment to move it closer.  Pipette 
resistance was logged 3-4 times to give an average value of 3.7 ± 0.9 MΩ (mean ± SD, n=1064).  
Pipette offset control of the Axopatch was used to adjust the offset current to zero.  Series resistance 
was not compensated electronically however pipette resistance was compensated using Fast TAU 
and Fast MAG controls. 
The hydraulic micromanipulator was then used to bring the pipette into contact with the cell and 
then press the pipette down gently on the membrane.  To attempt formation of a giga-seal, positive 
pressure was switched to negative suction whilst observing resistance on WinEDR software – the aim 
was for a resistance greater than 1GΩ (cell-attached configuration).  Once a giga-seal was formed, 
holding voltage was changed to -80mV with no voltage step.  The known RMP of SMCs is more 
positive than -80mV therefore this protocol was used to stabilise the giga-seal and prevent 
depolarisation of the membrane prior to attempting going to whole-cell configuration (Molleman, 
2003).  Before this, WinEDR was switched to either -80mV with a 90mV step to +10mV or -80mV with 
a small 10mV voltage to -70mV (50ms duration) which allowed for monitoring the transition from 
seal to whole-cell configuration.  A larger voltage step often resulted in seal break therefore the 
smaller voltage step was used in latter experiments. 
When the seal was stable, resistance was logged with an average value of 6.5 ± 5.5 GΩ (mean ± SD, 
n=379) before attempting to achieve the whole-cell configuration.  If the final outcome was a seal or 
patch break, pipettes were removed from the chamber and discarded before the next attempt. 
 
Whole-cell configuration 
For whole-cell configuration, the area of cell membrane (patch) attached to the pipette tip has to be 
ruptured to allow for full contact between the intracellular pipette solution and the cytosol of the 
cell.  In order to achieve this, a short, sharp application of negative suction was applied whilst 
monitoring the progression from cell-attached to whole-cell; successful breakthrough was indicated 
by a dramatic increase in the capacitance transients at the start and end of the voltage step.  
Thereafter, the cell and pipette solution were allowed to exchange contents by diffusion for 
approximately 4 minutes.  During this time the hydraulic manipulator was used to lift the cell off the 
base of the coverslip and into the main body of solution.  Access conductance (Ga), membrane 
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conductance (Gm) and membrane capacitance (Cm) were logged for the cell and the amplifier was 
then switched to current-clamp mode to check initial RMP.  The bath was perfused and any RMP 
changes recorded over a 30 second period.  All subsequent voltage protocols and resting RMP 
recordings were made under constant perfusion. 
 
Liquid Junction Potentials 
Liquid junction potentials (LJPs) occur when two solutions of different ionic concentrations and 
mobilities come into contact (Figl et al., 2004).  Some ions move faster than others down their 
concentration gradients and if, for example, the anions move faster than the cations in solution then 
a potential difference (LJP) can be set up.  In the case of these electrophysiology experiments, the LJP 
may arise between the bath and pipette solutions and could result in a difference between the 
measured and the actual membrane potential of the smooth muscle cell. 
LJPs were calculated using an Excel spread sheet developed by Jim Kenyon, University of Nevada 
(2007) using the ionic concentrations of the bath and pipette solutions and the temperature in 
degrees Kelvin and a number of constants: the mobilities and valences for each ion and physical 
constants R and F.  The LJP between the bath and pipette solutions was calculated as 4.91 mV and 
therefore considered negligible when compared to previously published values (Selyanko et al., 
1995, Selyanko et al., 2000).  On this basis, measured membrane potentials/voltages were not 
corrected for errors resulting from LJPs. 
 
Perfusion System 
Multiple syringe barrels were used to create a perfusion system for continuous flow of bath solution 
to the chamber and to supply hypoxic solution (bubbled with 100% N2) where appropriate.  The 
system consisted of two 60mL syringes and one 5mL syringe connected using three-way taps and 
some flexible thin tubing which transported solution to the inflow point of the chamber (see image in 
Figure 10).  Excess bath solution was drained through the outflow point connected to more tubing 
and a Dymax 30 pump (Charles Austen Pumps, UK). 
All experiments were carried out under maximum, unrestricted flow conditions which had a mean 
flow rate of 5.31 ± 0.57 mL/min.  The volume of liquid required to prime/fill the inflow tubing was 
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1.17 ± 0.06 mL and after priming the tubing it took 7.33 ± 1.53 seconds to fill the chamber at 
maximum flow (values are mean ± SD, N=3). 
 
 
Figure 10. Flow system for electrophysiology bath solution.  Direction of flow of solution and tubing 
for supply of nitrogen to solution in syringe barrel are shown by black arrows.  Left 60mL syringe 
contains normoxic solution (equilibrated with room air) and right 60mL syringe contains hypoxic 
solution (bubbled with 100% nitrogen). Three-way taps were used to change from normoxic to 
hypoxic flow. 
 
Picospritzer® Drug Application 
All pharmacological agents were applied by Picospritzer® (Model III, Parker Instruments, USA).   The 
inflow point of the Picospritzer® was connected to a compressed air cylinder by rigid plastic tubing.  
The outflow was attached by flexible tubing to a micropipette holder mounted onto a coarse 
micromanipulator on the opposite side of the microscope platform to the Axopatch headstage.  
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Pipettes were pulled and fire polished as previously described and filled with drug solution before 
mounting in the holder.  For drug application, after a suitable cell was identified, the Picospritzer® 
pipette was placed into solution (before the microelectrode pipette) above the base of the chamber.  
Pipettes were regularly checked for blockage at the tip.  After whole-cell configuration was achieved 
and drug application was required, the Picospritzer® pipette was brought into the same focal plane 
as the cell and moved to within approximately 25-50µM of the cell membrane (see Figure 11).  The 
duration of application was set on the system and the manual button was pressed to apply the drug 
directly onto the cell. 
The Picospritzer® system was connected to the Axopatch 200A/200B amplifier which in turn meant 
that a 3rd channel could be set up on WinEDR for logging Picospritzer® ON/OFF modes accurately. 
 
Figure 11. Microelectrode attached to smooth muscle cell and Picospritzer® in position for drug 
application.  White arrows show microelectrode pipette attached to cell (left) and Picospritzer® 
pipette filled with drug solution (right) in the same focal plane. 
 
Oxygen Monitoring in the Electrophysiology Chamber 
Oxygen monitoring was performed in the recording chamber using the Microx TX3-trace after 
calibration (described earlier in this chapter).  Control experiments (in the absence of cells and 
recordings) were performed on three separate experimental days.  Recordings were made at 
different locations and depths in the bath as it was likely that flow and distance from the surface 
(and hence potential for re-equilibration with room air) could have an impact on the level of hypoxia 
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reached.  Normoxia in these set of experiments means the perfusing bath solution was passively 
oxygenated with room air (i.e. not bubbled with oxygen as in myography experiments).  Hypoxic 
solutions were bubbled with 100% N2 for at least 10 minutes before flow into the recording chamber 
commenced.  Previous work suggests that 10 minutes bubbling is adequate to reach maximal hypoxic 
levels with 5 minutes N2 bubbling producing an O2 level of 5-6% (Dospinescu, 2009).  The different 
locations for recordings in the bath are indicated in Figure 12.  
 
Figure 12. The RC-26GPL bath recording chamber labelled with sites of oxygen measurement.  
White arrows highlight inflow and outflow sites; numbers 1-5 represent sites within the chamber 
that were used for measurements during control oxygen monitoring experiments. 
 
Oxygen measurements were recorded as described previously.  Measurements were made for a total 
of 11 minutes: 1 minute normoxia followed by 5 minutes hypoxia and 5 minutes reoxygenation.  
Values were normalised as a percentage of the mean %air saturation over the initial 1 minute of 
normoxia for all recordings.   
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In the first set of control oxygen monitoring experiments, measurements were taken at each location 
(1-5) at a similar depth to where cell recordings were made.  During the first minute of recording 
under normoxic conditions, mean oxygen tension across all locations was 101.8 ± 1.8% mean 
normoxic air saturation (mean ± S.E.M, N=3).  Over the 5 minute hypoxic exposure the mean oxygen 
tension was 36.9 ± 1.5% mean normoxic air saturation (N=3, P<0.001 compared to normoxia).  The 
average time taken to reach minimum oxygen tension on exposure to hypoxia was 188.5 ± 18.9s.  On 
returning to normoxia, oxygen tension then recovered to 96.2 ± 1.8 %mean normoxic air saturation 
(N=3, P<0.001 compared to hypoxia).  After stopping hypoxic perfusion, oxygen levels reached a 
steady state in 119.9 ± 27.0s.  On hypoxic perfusion, temperature fell from 22.3 ± 0.3°C to 21.3 ± 
0.3°C (mean ± SD, N=3, P<0.01 compared to during initial normoxia) and then recovered to 22.1 ± 
0.2°C when hypoxic perfusion was stopped (P<0.05 compared to during hypoxia).  The time course 
for mean oxygen levels before, during and after hypoxia exposure alongside corresponding 
temperature readings are shown in Figure 13. 
 
Figure 13. Mean oxygen tension and temperature before, during and after exposure to hypoxia 
within the electrophysiology chamber.   Black trace represents mean oxygen levels over 1 minute 
normoxia (room air), 5 minutes hypoxia (100% N2) and approximately 5 minutes reoxygenation with 
room air (N=3).  Data are normalised to mean %air saturation over the first minute of normoxia for 
all recordings performed. Grey trace represents mean temperature over the same time course.  Grey 
and black bars represent normoxia and hypoxia, respectively. 
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Oxygen levels during hypoxic perfusion at the same depth in all 5 locations (shown in Figure 12) were 
compared to assess whether assumed differences in laminar flow had an effect on the tensions 
reached (Figure 14).   
 
Figure 14. Oxygen levels during hypoxic perfusion at different locations within the 
electrophysiology chamber.  Mean oxygen levels reached during hypoxia at each of the 5 locations 
(shown in Figure 12). Data are normalised to mean %air saturation over the first minute of normoxia 
for all recordings performed (N=3 for each location tested). 
 
There was no significant difference between the oxygen levels reached during hypoxic perfusion at 
any of the locations tested (data shown in Figure 14).  However, it is worthy of note that oxygen 
levels reached during hypoxia (30-40 %mean normoxic air saturation) were much higher than the low 
levels seen in similar control experiments performed by Dospinescu (2009): 5-6% after 5 minute 
hypoxic flow.  The oxygen level reached could be influenced by flow rates and depth in the bath 
solution.  Flow rates were comparable (5.31 mL/min compared to 3.53-6.06 mL/min (Dospinescu, 
2009).  Measurements of oxygen levels reached during hypoxia at different depths in the chamber 
bath solution are shown in Figure 15.  All measurements at different depths were recorded at the 
central point (position 1 in Figure 12).   
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Figure 15. Oxygen levels during hypoxic perfusion at different depths within the electrophysiology 
chamber bath solution. Mean oxygen levels during hypoxia at each of the 3 depths – all recordings 
performed at position 1 in Figure 12.  Data are normalised to mean %air saturation over the first 
minute of normoxia for all recordings (N=3 for each depth tested). *P<0.05 compared with mean 
oxygen level measured during hypoxic perfusion at bottom of chamber. 
 
The oxygen levels reached during hypoxic perfusion were lower with increasing depth in the chamber 
bath solution; oxygen levels were significantly greater during hypoxia at the surface compared to the 
bottom of the chamber (P<0.05).  This indicates that reoxygenation and re-equilibration with room 
air occurs more readily at the surface meaning lower levels of oxygen cannot be reached.  Despite 
levels of oxygen being lowest at the bottom of the chamber, they still did not reach the levels seen 
by Dospinescu (2009).  Oxygen levels were averaged over the full 5 minute hypoxic exposure rather 
than taken from a minimum point which may partially explain the higher levels seen in these 
experiments.  However the mean time course plot for oxygen (Figure 13) shows levels remained 
around 30% mean normoxic air saturation at the minimum point. 
 
Statistical Analysis 
Data were stored, processed and statistically analysed using Microsoft Excel 2007 (Microsoft 
Corporation, USA) and GraphPad Prism 5/7 software (GraphPad Software Inc., USA).  Data are mainly 
presented as mean ± S.E.M unless otherwise stated; N represents number of different pigs used and 
n represents number of cells, where appropriate.  Mean data were analysed using either Students 
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unpaired t-test, repeated measures one-way ANOVA  or standard one-way ANOVA with Tukey’s post 
test or repeated measures two-way ANOVA with Bonferroni’s post test, as appropriate (see 
individual chapters).  A P value of less than 0.05 was considered statistically significant.   
 
Solutions 
KREB’s solution (mM): 119 NaCl, 4.7 KCl, 1.18 KH2PO4, 1.18 MgSO4, 25 NaHCO3, 2.52 CaCl2, 10.88 
glucose 
Ca2+ free KREB’s solution (mM): 119 NaCl, 4.7 KCl, 1.18 KH2PO4, 1.18 MgSO4, 25 NaHCO3, 2.52 MgCl2, 
10.88 glucose 
Dissecting solution (mM): 119 NaCl, 4.7 KCl, 1.18 KH2PO4, 1.17 MgSO4, 25 NaHCO3, 10 HEPES, 5.5 
glucose; pH adjusted to 7.4 with NaOH 
HEPES-based extracellular (bath) solution (mM):  150 NaCl, 5.4 KCl, 1.2 MgCl2, 1.8 CaCl2, 10 HEPES, 
10 glucose; pH adjusted to 7.4 with NaOH 
Dissociation solution (mM): 128 NaCl, 5.4 KCl, 0.95 KH2PO4 , 0.35 Na2HPO4, 4.16 NaHCO3, 10 HEPES, 
10 glucose, 2.9 sucrose; pH adjusted to 7.3 with NaOH 
Intracellular pipette solution (mM): 110 KCl, 2.5 MgCl2, 10 HEPES, 3.6 ATP (magnesium salt); pH 
adjusted to 7.2 with KOH and filtered through a Nalgene 0.2µM syringe filter (25 mm surfactant free 
cellulose acetate membrane). 
All solutions were prepared in deionised water and all except KREB’s and intracellular solution were 
titrated to the desired pH with 1-2M NaOH and HCl and stored in a refrigerator at 2-8°C.  Intracellular 
solution was titrated with 1M KOH and divided into 1mL aliquots in 1.5mL microcentrifuge tubes 
which were frozen at -20°C and defrosted on day of use.  All pH measurements were made using a 
digital pH meter (SevenEasy, Mettler-Toledo Ltd., UK). 
As solutions were used over a range of temperatures, pH of bath and dissociation solutions were 
checked at fridge temperature (7.2 ± 0.3°C), room temperature (21.6 ± 1.6°C) and approximately 
37°C (36.8 ± 0.2°C).  All temperature values mean ± SD, N=3.   The pH results are shown in Table 1. 
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Table 1. Effect of Temperature on pH of HEPES-based Bath and Dissociation Solutions 
 Fridge Temperature Room Temperature 37°C 
Bath Solution pH 7.55 ± 0.02 7.40 ± 0.02 7.24 ± 0.01 
Dissociation Solution pH 7.49 ± 0.04 7.36 ± 0.03 7.23 ± 0.02 
 
Drugs 
4AP (Sigma Aldrich, UK): final concentration of 5mM by dissolving in 0.4706g of 4AP in 1L HEPES 
bath for organ bath (stored in fridge) or 0.047g in 100mL HEPES bath for electrophysiology (aliquoted 
in 1mL aliquots and frozen).   The 4AP solution in HEPES was pH adjusted to 7.4 with HCl (at room 
temperature). 
BDM (Sigma Aldrich, UK): 1M stock prepared in KREB’s, final concentration of 0.1 - 10mM in KREB’s 
(for 0.1mM concentration stock was diluted 1 in 10 before use) 
Caffeine (Sigma Aldrich, UK): final concentration of 20mM by dissolving in 3.8838g of caffeine in 1L 
KREB’s 
Carbamoylcholine (Carbachol) (Sigma Aldrich, UK):  10mM stock prepared in KREB’s, final 
concentration of 10µM by adding 25µL to 25mL KREB’s 
DPO-1 (Tocris Bioscience, UK): 10mM stock prepared in ethanol, final concentration of 10µM by 
adding 25µL to 25mL KREB’s 
Glyburide (Enzo Life Sciences (UK) LTD., UK): 10mM stock prepared in DMSO, final concentration of 
10µM by adding 25µL to 25mL KREB’s 
Histamine (Sigma Aldrich, UK): 10mM stock prepared in KREB’s, final concentration 1nM to 100µM 
by diluting original stock as required (1 in 10 to 1 in 10000) for a measurable volume to add to 25mL 
KREB’s (minimum 22.5µL).  For endothelial tests stock was diluted 1 in 10 in KREB’s before adding by 
adding 25µL to 25mL KREB’s to give a final concentration of 1µM. 
KCl (Sigma Aldrich, UK): 2M stock prepared in deionised water.  Myograph - final concentration of 
80mM by adding 1mL stock to 25mL KREB’s.   Electrophysiology - final concentration of 80mM by 
diluting 40µL in 1mL HEPES bath solution. 
L-NAME (Sigma Aldrich, UK): 100mM stock prepared in KREB’s, final concentration of 100µM by 
adding 25µL to 25mL KREB’s 
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Penitrem A (Enzo Life Sciences (UK) LTD., UK): 5mM stock prepared in DMSO, diluted 1 in 10 in 
KREB’s before adding by adding 25µL to 25mL KREB’s to give a final concentration of 500nM 
PGF2α  (Enzo Life Sciences (UK) LTD., UK): 1mM stock prepared in ethanol, final concentration 10nM 
to 10µM by diluting original stock as required (1 in 10 to 1 in 1000) for a measurable volume to add 
to 25mL KREB’s (minimum 22.5µL).  Alternatively a 2mM stock was prepared in ethanol, final 
concentration of 2µM by adding 25µL to 25mL KREB’s for endothelial function tests. 
Ryanodine (Enzo Life Sciences (UK) LTD., UK): 2mM stock prepared in DMSO, final concentration of 
2µM by adding 25µL to 25mL KREB’s 
TEA (Sigma Aldrich, UK): final concentration of 5mM by dissolving in 0.0828g of TEA in 100mL KREB’s 
for organ bath (made fresh daily) or 100mL HEPES bath for electrophysiology (aliquoted in 1mL 
aliquots and frozen) 
U46619 (Enzo Life Sciences (UK) LTD., UK): 10mM stock prepared in DMSO, final concentration 
10pM to 1µM by diluting original stock as required (1 in 10 to 1 in 100000) for a measurable volume 
to add to 25mL KREB’s (minimum 22.5µL).  
Zinc Chloride (Fisher Scientific, UK): 1M stock prepared in KREB’s, final concentration of 1mM by 
adding 25µL to 25mL KREB’s (organ bath); 1mM stock prepared in HEPES bath by dissolving 0.0136g 
in 100mL for electrophysiology (aliquoted in 1mL aliquots and frozen)  
 
See Table 2 for details of concentration values for half maximal inhibition of target (IC50 values) for 
drugs used in myography and electrophysiology experiments. 
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Table 2.  IC50 values for inhibitors used in myography and electrophysiology experiments.  
Drug Target for inhibition IC50 value Cell/tissue type and 
species 
Reference (s) 
4AP KV  232µM Conduit PASMCs (rat) Smirnov et al., 
2002 
BDM KV2.1  16.7mM Xenopus oocytes 
expressing rat KV2.1 
Lopatin and 
Nichols, 1993 
DPO-1 KV1.5 0.16-
0.76µM 
Chinese hamster ovary 
cells expressing human 
KV1.5  
Lagrutta et al., 
2006 
 
Glyburide KATP 86 ± 17nM A10 cells (vascular 
smooth muscle cell line 
derived from rat 
thoracic aorta) 
Russ et al., 1997 
L-NAME Nitric oxide synthase 
(NOS) 
0.87 ± 
0.02 µM 
Mouse cerebellar NOS Moore et al., 
1993 
Penitrem A BKCa 64.4 nM Human embryonic 
kidney 293 cells 
expressing human BKCa 
Asano et al., 
2012 
Ryanodine Ryanodine receptor 4.5-5.5µM Ileal smooth muscle 
cells (rabbit) 
Sakai et al., 
1988 
TEA BKCa ~0.3mM Skeletal muscle cells 
(rat) 
Blatz and 
Magleby, 1984 
Zinc chloride TASK-1 
 
 
TASK-3 
175µM 
 
 
~12-20µM 
Xenopus oocytes 
expressing rat TASK-1 
 
Human embryonic 
kidney 293 cells/ 
Xenopus oocytes 
expressing TASK-3 
Leonoudakis, 
1998 
 
Gruss et al., 
2004, Clarke et 
al., 2004 
 
52 
 
Solvent Controls  
Levels of ethanol and DMSO did not exceed 0.1% total organ bath volume; the effect of the maximal 
level of solvent on baseline tension was investigated.   
 
Dissociation Enzymes 
Papain (from Papaya Latex, product number P4762), collagenase from Clostridium histolyticum (Type 
VIII, product number C2139) and DL-Dithiothreitol (product number D0632) were all acquired from 
Sigma Aldrich, UK.  Another batch of papain was also used for some experiments (Acros Organics, 
Fisher Scientific, UK, product number 10701262).  Enzymes were dissolved in HEPES-based 
dissociation solution at a concentration of 10mg/mL and aliquoted in volumes between 350µL and 
1mL and stored at -20°C.  Stock aliquots were defrosted on a daily basis and an appropriate volume 
was added to 1mL dissociation solution to give the desired concentration. 
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Chapter 3 
Impact of Maintenance in Culture Conditions on Hypoxia and 
Agonist Induced Responses in Porcine Inferior and Superior 
Pulmonary Veins 
 
 
Introduction 
The maintenance of functional, isolated blood vessels under culture conditions is a potentially 
powerful tool to enable assessment of the impact of various environmental conditions on vessel 
function as outlined in Chapter 1 – General Introduction.  However culture conditions alone can 
affect blood vessel function (Alm et al., 2002, Binko et al., 1999, Cao et al., 2005, De Mey et al., 1989, 
Manoury et al., 2009, Morita et al., 2013, Guibert et al., 2005, Thorne et al., 2001, Thorne et al., 
2002, Thorne and Paul, 2003).   
Receptor mediated contractility can be affected when blood vessels are maintained in culture.  For 
example, contractions to 5HT in rat mesenteric arteries are enhanced within 6 hours and in rat 
pulmonary arteries (PAs) after 4 days exposure to culture conditions (Cao et al., 2005, Guibert et al., 
2005).  In contrast, others have shown that rat mesenteric arteries display a similar contractile 
response to 5HT after 3 days in serum-free culture conditions (Morita et al., 2010).  Responses to 
other contractile agonists including U46619 (in rat mesenteric arteries and porcine coronary 
arteries), endothelin-1 (in rat PAs) and phenylephrine (in rat aorta) are unchanged after maintenance 
in culture conditions as compared with responses of freshly isolated vessels (Alm et al., 2002, Binko 
et al., 1999, Guibert et al., 2005, Thorne et al., 2001).   
Receptor independent mechanisms may also be affected.  KCl-mediated contractions (between 10 
and 40mM) are significantly increased in rat PAs after 3-4 days (Guibert et al., 2005, Manoury et al., 
2009) whereas contraction to 50mM KCl is diminished after 3 days maintenance in culture conditions 
(Manoury et al., 2009).  In addition, KCl sensitivity is reduced in rat renal arteries after 6 days and 
porcine coronary arteries after 24 hours exposure to culture conditions (De Mey et al., 1989, Thorne 
et al., 2002).  4AP mediated contraction is significantly reduced and caffeine contraction significantly 
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increased in porcine coronary artery after exposure to 24 hours in culture conditions at 37°C as 
compared to control arteries stored in culture medium for 24 hours at 4°C (Thorne et al., 2002, 
Thorne and Paul, 2003).  Storing vessels for 24 hours at 4°C in culture medium appears to have no 
significant impact on function compared to freshly isolated vessels (Thorne et al., 2001). 
Contraction is not the only functional mechanism affected by maintenance in culture conditions; 
relaxation may also be altered.  Exposure to serum-free culture conditions for as little as 20-24 hours 
impairs cholinergic-mediated endothelial dependent relaxation in both pulmonary and mesenteric 
arteries (Alm et al., 2002, Manoury et al., 2009).  Addition of adult serum to the culture medium can 
normalise this impairment of endothelial dependent relaxation (Morita et al., 2013).  Hypoxia-
induced relaxation is significantly inhibited by 24 hours in culture conditions at 37°C in porcine 
coronary and carotid arteries and rat and mouse aorta as compared to vessels stored in culture 
medium for 24 hours at 4°C (Thorne et al., 2001, Thorne et al., 2002).  Relaxation via K+ channel 
activation with pinacidil is also impaired in porcine coronary artery (Thorne et al., 2002) however 
relaxation with SNP (nitric oxide donor), isoproterenol (β-adrenoceptor agonist) and forskolin 
(adenylate cyclase activator) remains unchanged (Thorne et al., 2001) after maintenance in culture 
conditions. 
Maintenance in culture conditions has a significant impact on blood vessel function.  Before using the 
method for future applications, the impact of maintenance in culture conditions alone on pulmonary 
vein (PV) contractility required investigation. 
In PAs, exposure to culture conditions appears to mimic chronic hypoxia (Manoury et al., 2009) as 
discussed in Chapter 1 – General Introduction.  The potential for mimicry between culture conditions 
and chronic hypoxic requires further investigation in PVs.  Exposure to culture conditions augments 
responses to KCl in PAs within 3-4 days (Guibert et al., 2005, Manoury et al., 2009) yet exposure of 
rats to chronic hypoxia (10% O2 for 2-7 days) has no effect on KCl responses (20-100mM) in PVs (Zhao 
et al., 1995).  PVs isolated from rats kept in a normobaric hypoxic chamber (10% pO2) for 3 weeks 
behave differently to PAs isolated from hypoxic rats when compared to their respective normoxic 
controls (Lal et al., 1999).  Exposure of rats to chronic hypoxia augmented PV responses to the 
endothelin ETB receptor agonist sarafotoxin-6c compared to normoxic controls; this effect was not 
observed in PAs.  PAs from chronically hypoxic rats showed reduced sensitivity to U46619 than 
control rats whereas potency in the PV was unchanged (Lal et al., 1999).  In PVs, acute hypoxia-
mediated contraction appears to be enhanced after exposure to chronic hypoxia, yet contractile 
responses to angiotensin II (AT1 receptor agonist; Ardaillou, 1999), phenylephrine and KCl are 
significantly reduced after 2, 7 and 14 days of chronic global hypoxia, respectively (Zhao et al., 1995).  
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After 20 hours lobar hypoxia (as opposed to global), acute hypoxic contractions of ovine PVs were 
also enhanced compared to PVs from the normoxic control lobe.  This enhancement did not occur in 
PAs from the lobe exposed to chronic hypoxia compared to control PAs (Sheehan et al., 1992).  
Selective maintenance/enhancement of this intrinsic pulmonary venous response to hypoxia may 
indicate the clinical importance of the PV as suggested by Taylor et al. (2011).  The hypoxic response 
of the porcine PV required further characterisation. 
As PV contraction during hypoxia may facilitate recruitment of lung capillaries and therefore 
maximise surface area for gas exchange (Taylor et al., 2011); maintenance of this response under 
chronic hypoxic conditions would be advantageous. However, in obese patients undergoing surgical 
procedures, evidence suggests an inverse relationship between body BMI and PO2 values in inferior 
PVs, with no such relationship existing in superior PVs (Yamane et al., 2008).  This may be due to 
impairment of hypoxia-induced contraction and V-Q mismatch in inferior PVs specifically.  
Differences in the function of inferior and superior PVs required identification and characterisation, 
specifically in relation to hypoxic PV responses. 
PVs are also known to contract in response to a number of agonists and in some cases to a greater 
extent than PAs, for example, histamine (Shi et al., 1998, Toda, 1990), PGF2α (Chand, 1981, Kadowitz 
et al., 1975) and U46619 (Arrigoni et al., 1999).  These enhanced responses are described in more 
detail within Chapter 1 – General Introduction. 
The aim of this study was to investigate the impact of maintenance in culture conditions on inferior 
and superior PV function including endothelial function and contractile responses to pharmacological 
agonists (histamine, PGF2α and U46619) and hypoxia.     
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Methods and Experimental Protocols 
Myography was used to investigate the contractility of porcine 3rd-4th order superior and 4th-5th order 
inferior intrapulmonary veins.  Tissue for experiments in this chapter was obtained from Scotch 
Premier Meat Ltd (Inverurie, Aberdeenshire).  Contractile responses to KCl, histamine, PGF2α, U46619 
and hypoxia were explored.  Possible mechanisms underlying the PV hypoxic response were also 
investigated using Ca2+ free conditions, by depleting SR Ca2+ with ryanodine and caffeine (Jabr et al., 
1997) and by blocking BKCa channels with Penitrem A (Dospinescu et al., 2012). 
Inferior and superior PVs were size-matched and were dissected from porcine lungs as described in 
Chapter 2.  After dissection 3-4th order vessels were used fresh and 4th-5th order were maintained in 
culture conditions for 24 hours (see Chapter 2 for more details). 
On each experimental day, two myograph set-ups were used, each comprising of four channels.  One 
set-up contained 4 vessel rings from a superior PV and the other 4 rings from an inferior PV; on 
alternate days fresh vessels and those maintained in culture were mounted and tested.  Set-ups were 
also swapped on a daily basis, i.e. one day set-up 1 would be inferior PV and the next superior PV. 
 
Equilibration, Resting Tone and Functional Testing 
Once PVs were mounted and set to optimal resting tension of 1.5g (see Chapter 2), they were left to 
equilibrate for 60 minutes.  After this time the vessels were checked for viability by exposing to 
80mM KCl three times.  If no constriction occurred in response to 80mM KCl then vessels were 
considered non-viable and not included in further analysis however endothelial integrity and 
responses to hypoxia were still assessed. 
Endothelial integrity was assessed by preconstricting with a sub-maximal level of contractile agonist 
(2µM PGF2α) followed by application of a cholinergic agonist (acetylcholine synthetic analogue 
carbamoylcholine chloride- carbachol (10µM)).  If the blood vessel relaxed in response to the 
cholinergic agonist this confirmed endothelial function; if further contraction occurred then this 
indicated endothelial damage (Furchgott and Zawadzki, 1980).  PVs which failed to relax in response 
to carbachol were not excluded from further testing. 
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Concentration-Dependent Responses to Histamine, PGF2α and U46619 
Concentration response studies were performed with histamine, PGFα and U46619.  The aim of these 
studies was to identify any differences in contractile responses between inferior and superior PVs 
and those which were fresh or exposed to culture conditions for 24 hours.  Drugs were applied 
cumulatively to determine response curves.  Concentration ranges used were 1nM - 100µM for 
histamine, 10nM- 10µM for PGF2α and 10pM - 1µM for U46619. Contractions were allowed to reach 
steady state before addition of the next concentration.  Agonist response studies were either 
conducted before or after hypoxia studies as described below. 
 
Hypoxia Response Studies 
Pulmonary veins were exposed to hypoxia by changing the myograph bubbling from 95%O2/5%CO2 
to 95%N2/5%CO2.  CO2 levels were maintained at 5% to maintain the pH of KREB’s at 7.4.  Hypoxic 
exposures lasted approximately 15-20 minutes and at least 30 minutes in 95%O2/5%CO2 were 
allowed for recovery between exposures.  Tension was re-adjusted to the optimal resting tension of 
1.5g before the first exposure to hypoxia.  Two initial hypoxic exposures were conducted before PVs 
were exposed to pharmacological agents or altered Ca2+ conditions; this was due to the second 
hypoxic response being a more robust response and therefore control for comparison with the third 
“test” response.  More information is provided in Results section. 
 
Initial Investigation of Pathways Underlying the Hypoxic Response 
To investigate the role of extracellular Ca2+ in hypoxic responses of inferior and superior PVs, KREB’s 
was washed out and vessels were incubated in Ca2+ free KREB’s solution (CaCl2 substituted with 
equimolar MgCl2).   
Ryanodine and caffeine have been previously used to investigate the effect of SR depletion on the 
hypoxic response in canine PAs (Jabr et al., 1997).  For SR depletion, PVs were exposed to 20mM 
caffeine four times at 15-20 minute intervals.  For exposure to caffeine, KREB’s was washed out and 
replaced with KREB’s solution containing 20mM caffeine.  On the 3rd caffeine exposure 2µM 
ryanodine was added.   
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BKCa channels have been proposed to play a role in attenuating HPV in PAs (Peinado et al., 2008, Yan 
et al., 2014).  A positive correlation between RNA expression of BKCa and HPV magnitude has been 
established in human PAs (Peinado et al., 2008).  Furthermore, activation of BKCa by docosahexaenoic 
acid has been suggested to attenuate HPV in rat PAs; the inhibitory effect of docosahexaenoic acid 
on hypoxic contraction was reversed by the BKCa blocker iberiotoxin (Yan et al., 2014).  The potential 
for BKCa inhibition of the hypoxic response was investigated using the blocker Penitrem A (500nm) 
(Dospinescu et al., 2012).   
PVs were incubated in these conditions for at least 20 minutes before the third hypoxic “test” 
exposure. 
 
Solvent Controls  
Experiments using ryanodine, Penitrem A and U46619 involved adding 25µL of DMSO to the bath and 
those using PGF2α involved adding 25µL ethanol.  Therefore the impact of these volumes of solvent 
alone (absence of drug) on baseline tension was investigated. 
 
Data Analysis 
Hypoxic/reoxygenation (see Results) magnitude data are expressed normalised to baseline tension 
(A.U).  For the sake of clarity hypoxic relaxation is expressed with a value of 1 subtracted to more 
clearly illustrate where relaxation below baseline occurs.  Contractile data for KCl and agonists were 
standardised to final mean 80mM KCl response (FMKCl) in fresh inferior/superior PVs as appropriate 
and expressed as %FMKCl.  Where appropriate data are presented as mean ± S.E.M and N represents 
the number of vessels from different animals.  Statistical significance was determined at P<0.05 using 
Students unpaired t-test, repeated measures one-way ANOVA or one-way ANOVA with Tukey’s post-
test (GraphPad Prism 5, CA, USA). 
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Results 
KCl Viability Testing 
To test for smooth muscle viability, at the start of each experimental day, PVs were exposed to 
80mM KCl three times.  In fresh inferior PVs, 100% contracted to 80mM KCl and first (3.2 ± 0.4 g), 
second (3.6 ± 0.4 g) and third (3.8 ± 0.4g) responses were not significantly different from one another 
(P>0.05, N=11).  In fresh superior PVs there was also no significant difference between first (1.9± 
0.4g), second (2.1 ± 0.4g) and third (2.1 ± 0.4g) KCl responses (P>0.05, N=11).  First, second and third 
responses to 80mM KCl were significantly larger in magnitude in fresh inferior PVs than superior PVs 
(P<0.05). 
PVs maintained in culture for 24 hours also did not show a significant increase in KCl contraction with 
repeated exposure; 97.5% of inferior and 85% of superior PVs successfully responded.  In inferior 
PVs, first (5.0 ± 0.6g), second (5.1 ± 0.6g) and third (5.0 ± 0.6g) responses did not differ in magnitude 
(P>0.05, N=10).  The same trend was observed in superior PVs (2.3 ± 0.4g, 2.2 ± 0.3g, 2.3 ± 0.3g; 1st, 
2nd and 3rd responses, respectively, P>0.05, N=10).  Similar to fresh PVs all three responses to 80mM 
KCl were significantly larger in magnitude in inferior PVs than superior PVs (P<0.01). 
Maintenance in culture conditions significantly increased the first KCl contraction in inferior PVs 
(P<0.05) but did not alter KCl responses in superior PVs or subsequent KCl contractions 
(second/third) in inferior PVs (P>0.05).  All further agonist data were standardised to mean 3rd/final 
KCl response (FMKCl) in fresh inferior/superior PVs (as appropriate) demonstrating absolute changes 
as a result of exposure to 24 hours of culture conditions.  The final KCl response was used for 
standardisation as it was demonstrably reproducible and considered more stable than 1st and 2nd 
responses as Ca2+-sensitisation occurs in response to KCl (Ratz et al., 2005). 
 
Endothelial Function Testing 
In order to test for endothelial function, PVs were preconstricted with a submaximal concentration of 
PGF2α (2µM) before exposing to a synthetic analogue of acetylcholine- carbachol (10µM).  If vessels 
relaxed to carbachol, this indicated a functional endothelium. 
In fresh PVs, 2µM PGF2α produced a sustained contraction in 100% of vessels tested before 
assessment of endothelial relaxation with 10µM carbachol.  The level of preconstriction produced 
60 
 
with a submaximal concentration of PGF2α (2µM) was not significantly different between inferior and 
superior PVs (1.5 ± 0.4g and 1.0 ± 0.2g, inferior and superior, respectively, P>0.05, N=8). When 
standardised to FMKCl, the difference was still not significant, response magnitude was 39.1 ± 
11.3%FMKCl (inferior) and 46.9 ± 8.8%FMKCl (superior). 
PGF2α (2µM) produced a contraction in 81.25% of both inferior and superior PVs maintained in 
culture. Unfortunately, this was a transient contraction in 46.2% of inferior PVs and 73.0% of superior 
PVs which responded.  This made subsequent analysis of endothelial relaxation challenging.  The 
level of preconstriction before carbachol was applied was 1.1 ± 0.3g in inferior and 0.8 ± 0.2g in 
superior PVs maintained in culture for 24 hours (N=8).  When standardised to FMKCl the magnitude 
was 29.5 ± 7.9% in inferior PVs and 39.0 ± 9.5% in superior PVs.  Contraction to PGF2α was not 
significantly different between inferior and superior PVs maintained in culture and there was also no 
difference between the level of preconstriction achieved in fresh PVs and those maintained in culture 
(P>0.05).  However as stated earlier the contraction in PVs exposed to culture conditions was 
transient therefore results should be interpreted with caution. 
To calculate % endothelial relaxation, the following equation was used: 
% 𝐸𝑛𝑑𝑜𝑡𝑕𝑒𝑙𝑖𝑎𝑙 𝑅𝑒𝑙𝑎𝑥𝑎𝑡𝑖𝑜𝑛 =
𝐶𝑜𝑛𝑡𝑟𝑎𝑐𝑡𝑖𝑜𝑛  𝑔 − 𝑅𝑒𝑙𝑎𝑥𝑎𝑡𝑖𝑜𝑛 (𝑔)
𝐶𝑜𝑛𝑡𝑟𝑎𝑐𝑡𝑖𝑜𝑛 (𝑔)
 × 100 
(Equation 2) 
Contraction was the absolute value of tension in response to PGF2α before carbachol was applied (i.e. 
not a Δ value).  Relaxation was the absolute value of tension once the response to carbachol had 
reached a steady plateau. 
Almost all fresh PVs (96.9%) successfully relaxed in response to 10µM carbachol.  Fresh inferior PVs 
produced a greater relaxation in response to carbachol than superior PVs (79.0 ± 3.4% and 62.7 ± 
6.2%, inferior and superior respectively, P<0.001, N=8).  When maintained in culture 96.9% of 
inferior and 87.5% of superior PVs relaxed in response to carbachol.  There was no significant 
difference in endothelial-mediated relaxation between inferior/superior; inferior PVs produced a 
relaxation of 55.5 ± 7.7% and superior PVs relaxed 49.8 ± 7.2% (P>0.05, N=8).  Notably, the 
endothelial relaxation was significantly impaired in PVs maintained in culture for 24 hours compared 
to fresh PVs (inferior PVs: P<0.001, superior PVs: P<0.01).  To reiterate, these data should still be 
interpreted with caution as the PGF2α contraction was often not sustained and this could influence 
results.  Example traces from superior PVs illustrating the difference between preconstriction to 
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PGF2α and endothelial relaxation to carbachol are shown in Figure 16.  Similar results were observed 
in inferior PV. 
 
Figure 16.  Representation of endothelial relaxation responses in fresh superior pulmonary vein 
and those maintained in culture for 24 hours.  Preconstriction to 2µM PGF2α and relaxation with 
10µM carbachol in fresh superior PV and after maintenance in culture conditions for 24 hours. 
Sample traces for A: fresh superior PV and B: superior PV maintained in culture for 24 hours. Black 
and grey bars represent PGF2α and carbachol exposure, respectively.  N.B sustained constriction to 
PGF2α in fresh superior PVs and transient constriction in superior PVs maintained in culture which is 
relaxing before application of carbachol.  However an increase in the relaxation slope seen after 
application of carbachol suggests a functional endothelium. 
 
Agonist Cumulative Concentration-Dependent Responses  
Concentration-dependent responses to histamine, PGF2α and U46619 were investigated in fresh PVs 
and those maintained in culture for 24 hours by applying drugs cumulatively. 
Response curves were fitted with the sigmoidal dose-response curve function within GraphPad Prism 
5 (California, USA); equation as follows: 
𝑌 = 𝐵𝑜𝑡𝑡𝑜𝑚 + 
(𝑇𝑜𝑝 − 𝐵𝑜𝑡𝑡𝑜𝑚)
1 + 10𝐿𝑜𝑔  𝐸𝐶50−𝑋
 
(Equation 3) 
Where bottom is the y value at bottom sigmoid plateau, top is y value at top sigmoid plateau and log 
EC50 is x value for y response at half distance between bottom and top plateaus. 
62 
 
Histamine 
Maximum contractile responses to histamine were significantly increased in inferior PVs maintained 
in culture (292.6 ± 11.3%FMKCl) compared to fresh (167.2 ± 10.5% FMKCl; P<0.001, N=7).  Superior 
PVs maintained in culture for 24 hours also showed an increased maximum response to histamine 
compared to fresh PVs (308.5 ± 25.9 and 194.6 ± 30.6%FMKCl, respectively; P<0.05, N=6-7).  There 
was no difference in maximum responses between inferior and superior PVs or between EC50 values 
for any of the four groups (P>0.05, see Figure 17 C&D and Table 3). 
 
PGF2α 
Maximum contractile responses to PGF2α were not different in inferior PVs maintained in culture 
(115.1 ± 13.6%FMKCl) compared to fresh (94.1 ± 16.9%FMKCl; P>0.05, N=7).  Maximum contractions 
were also not significantly altered in fresh superior PVs (197 ± 127%FMKCl) compared to those 
maintained in culture for 24 hours (117.2 ± 22.7%FMKCl P>0.05, N=6-7).  Maximum contractions 
between inferior and superior PVs and EC50 values between groups were not significantly different 
(P>0.05, N=6-7, see Figure 17 E&F and Table 3). 
 
U46619 
Maintenance of inferior PVs in culture conditions for 24 hours significantly augmented the maximum 
contractile response to U46619 (225.7 ± 11.2% and 173.4 ± 7.1%FMKCl, culture/fresh, respectively; 
P<0.01, N=7).  There was no significant effect of maintaining superior PVs in culture conditions on 
maximum U46619 contraction (181.2 ± 19.6% and 227.5 ± 22%FMKCl, culture/fresh, respectively; 
P>0.05, N=7).  However fresh superior PVs showed a greater maximal response to U46619 than fresh 
inferior PVs (P<0.05, N=7).  Maximum contractions between superior and inferior PVs kept in culture 
and U46619 potency between groups were not significantly changed (P>0.05, N=7, see Figure 17 
G&H and Table 3). 
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Table 3. EC50 values for fresh inferior and superior pulmonary veins and those maintained in 
culture for 24 hours.  Values for histamine, PGF2α and U46619 quoted as mean with 95% confidence 
intervals (in brackets) and taken from fitting concentration-response curves with sigmoidal dose-
response curve equation (GraphPad Prism 5, CA, USA) – see Equation 3.  EC50 values for all agonists 
across all groups were not significantly different (P>0.05 using Students unpaired t-tests, N=6-7). 
EC50 values 
(M) 
Fresh Inferior PV Fresh Superior PV Inferior PV – 24 
hours culture 
Superior PV – 24 
hours culture 
Histamine 2.2x10-7 
(8.5x10-8 - 6.0x10-7) 
2.3x10-7 
(1.9x10-8 - 2.8x10-6) 
1.8x10-7 
(1.0x10-7-3.3x 10-7) 
7.1x10-8 
(1.9x10-8 - 2.7x10-7) 
PGF2α 2.3x10
-6 
(7.0x10-7 - 7.6x10-6) 
8.6x10-6 
(6.1x10-7 - 1.2x10-4) 
1.3x10-6 
(5.1x10-7 - 3.4x10-6) 
8.6x10-7 
(1.3x10-7 - 5.6x10-6) 
U46619 3.1x10-9 
(1.7x10-9 - 5.7x10-9) 
3.7x10-9 
(9.5x10-10 - 1.5x10-8) 
3.5x10-9 
(1.6x10-9 - 7.3x10-9) 
1.4x10-9 
(2.9x10-10- 6.8x10-9) 
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Figure 17. Impact of 24 hours maintenance in culture conditions on pulmonary vein contractile 
responses.  Impact of maintenance in culture on 1st 80mM KCl response in inferior (A) and superior 
(B) pulmonary veins (PVs), N=9-10. Impact of maintenance in culture on responses to histamine (C: 
inferior and D: superior PVs), PGF2α (E: inferior and F: superior PVs) and U46619 (G: inferior and H: 
superior PVs).  All data for concentration-response curves expressed are standardised to mean 3rd 
response to KCl in fresh inferior/superior PV, N=6-7.  N.B.   = fresh,  = 24 hours in culture 
conditions. All data represent mean ± S.E.M. *P<0.05, ** P<0.01, ***P<0.001 compared to fresh PV 
(analysis using Students unpaired t-test). 
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Characterisation of PV Hypoxic Responses  
Hypoxia caused a transient contraction in 88% and 99% of fresh PVs (1st and 2nd exposure 
respectively).  In PVs maintained in culture conditions for 24 hours, hypoxia caused a transient 
contraction in 57% and 86% (1st and 2nd exposure respectively).  Hence 2nd exposures were used for 
further analysis and as controls.  The consistency of these contractile hypoxic responses is clearly 
demonstrated in Figures 17 and 18 with all raw traces plotted standardise to baseline on the same 
axes.  After contraction, relaxation to below baseline occurred in 94% of fresh PVs but only 37% of 
PVs maintained in culture during 2nd hypoxic exposure (highlighted in Figures 19 and 20).   
The hypoxic peak was significantly larger in inferior PVs maintained in culture for 24 hours (6.4 ± 1.5 
A.U, N=10) than fresh inferior PVs (2.8 ± 0.4 A.U, N=9; P<0.05).  Hypoxic peak was not significantly 
augmented in superior PVs kept in culture (4.3 ± 1.1 A.U, N=10) compared to fresh (2.0 ± 0.3 A.U, 
N=9; P>0.05). There was no difference in hypoxic peak magnitude between fresh inferior and to 
superior PVs (P>0.05); there was also no change in magnitude between inferior and superior PVs 
maintained under culture conditions (P>0.05).  Peak magnitude data are expressed standardised to 
baseline (A.U), see Figure 22A.    
There was a significant reduction in the magnitude of hypoxic relaxation when inferior PVs were 
exposed to culture conditions (0.16 ±0.15 and -0.4 ± 0.1 A.U, culture/fresh respectively, P<0.01).  The 
same was also observed in superior PVs (0.1 ± 0.1 and -0.3 ± 0.1 A.U, culture/fresh respectively, 
P<0.01).  Hypoxic relaxation was not significantly different between inferior and superior PVs either 
fresh or maintained in culture (P>0.05).  For the sake of clarity hypoxic relaxation data are expressed 
standardised to baseline with a value of 1 subtracted to more clearly illustrate where relaxation 
below baseline occurs, see Figure 22B.    
With regard to hypoxic response dynamics, time to 50% peak magnitude (T0.5 peak) was not 
significantly different between fresh inferior (181.0 ± 26.0s) and superior PVs (141.0 ± 24.0s; P>0.05); 
the same was seen in vessels exposed to 24 hours culture conditions (146.2 ± 26.7 and 163.2 ±  37.6, 
inferior/superior PVs, respectively; P>0.05).  There was also no significant difference in T0.5 peak 
between fresh PVs and those maintained in culture (P>0.05).  Time to 75% maximal relaxation (T0.75 
relaxation) was no different in inferior PVs kept in culture (384.4 ± 31.0s) than in fresh (461.6 ± 38.2s; 
P>0.05) and maintenance in culture did not significantly change T0.75 relaxation in superior PVs (448.1 
± 61.9 and 480.5 ± 55.2s, culture/fresh, respectively; P>0.05).  There was also no significant 
difference for T0.75 relaxation between superior and inferior PVs either fresh or maintained in culture 
conditions (P>0.05).  To investigate whether there was a time dependency of hypoxic response 
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according to vessel size, x-y scatter graphs were plotted with external diameter against T0.5 peak 
orT0.75 relaxation.  There was no significant correlation between external diameter and either of these 
parameters of response dynamics (P>0.05). 
Area under the curve (AUC) was increased in inferior PVs kept in culture (2044.4 ± 327.0) compared 
to fresh (969.7 ± 64.4, P<0.01).  AUC was also augmented in superior PVs maintained in culture 
(1449.9 ± 248.9) compared to superior PVs (869.2 ± 58.0; P<0.05).  As for all other parameters 
analysed, there was no significant change in AUC between inferior and superior PVs either fresh or 
after maintenance in culture conditions (P>0.05).  See Figure 22 C-E. 
 
Novel Reoxygenation Contraction 
Under control conditions, oxygenation did not induce contraction. However, unexpectedly, it was 
discovered that reoxygenation after the 2nd hypoxic insult caused a further contraction in 97% of 
fresh PVs and 81% of those maintained in culture.  The reoxygenation peak was not significantly 
different between inferior (2.5 ± 0.4 A.U) and superior PVs maintained in culture (1.8 ± 0.2; P>0.05); 
there was also no change in magnitude when comparing fresh inferior PVs (3.2 ± 0.5 A.U) to superior 
PVs (2.8 ± 0.4 A.U, P>0.05).  Reoxygenation peak was significantly reduced in superior PVs exposed to 
culture conditions compared to fresh (P<0.05).  There was no significant difference in reoxygenation 
peak magnitude between fresh inferior PVs and those kept in culture (P>0.05).  Peak magnitude data 
are also expressed standardised to baseline (A.U). 
Maintenance in culture conditions altered reoxygenation response dynamics, significantly reducing 
AUC in inferior (from 839.7 ± 113.8 (fresh) to 424.7 ± 61.7 (culture)) and superior PVs (from 728.6 ± 
94.6 (fresh) to 432.5 ± 28.4 (culture); P<0.01).  Maintenance in culture shortened T0.5 peak in inferior 
PVs (from 80.2 ± 10.6s (fresh) to 39.8 ± 6.3s (culture); P<0.01).  T0.5 peak was not significantly 
different in inferior compared to superior PVs maintained in culture (39.8 ± 6.3s and 64.3 ± 13.4s, 
respectively; P>0.05).  There was also no significant change in T0.5 peak between fresh superior PVs 
(85.2 ± 16.3s) and those exposed to 24 hours culture conditions or in AUC or T0.5 peak for fresh 
inferior and superior PVs (P>0.05).  These data are illustrated in Figures 19, 20 and 22. 
To investigate whether there was a time dependency of reoxygenation response according to vessel 
size, x-y scatter graphs were plotted with external diameter against T0.5 peak.  There was no 
significant correlation between external diameter and T0.5 peak (P>0.05).  
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Figure 18. Standardised raw traces of hypoxia-induced contractions in fresh inferior pulmonary 
veins (PVs) and those maintained in culture for 24 hours.  Hypoxic contraction of fresh inferior 
pulmonary veins (left) and those maintained in culture conditions for 24 hours (right).  Raw traces 
plotted on same graph over same time period (12.26 minutes).  Tension values are standardised to 
the initial baseline tension (A.U).  Black bars represent hypoxia exposure. N=9 for fresh inferior PVs 
and N=10 for those maintained in culture. 
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Figure 19. Standardised raw traces of hypoxia-induced contractions in fresh superior pulmonary 
veins (PVs) and those maintained in culture for 24 hours.  Hypoxic contraction of fresh superior 
pulmonary veins (left) and those maintained in culture conditions for 24 hours (on right).  Raw traces 
plotted on same graph over same time period (12.22 minutes).  Tension values are standardised to 
the initial baseline tension (A.U).  Black bars represent hypoxia exposure. N=9 for fresh superior PVs 
and N=10 for those maintained in culture. 
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Figure 20.  Representation of hypoxic and reoxygenation responses in fresh inferior pulmonary 
veins and those maintained in culture for 24 hours.  Sample traces for hypoxic and reoxygenation 
responses in fresh inferior pulmonary vein (A) and after maintenance in culture conditions for 24 
hours (B).  Grey and black bars represent reoxygenation and hypoxia, respectively. Dotted line 
highlights level of baseline before hypoxic exposure initiated. 
 
 
 
 
Figure 21. Representation of hypoxic and reoxygenation responses in fresh superior pulmonary 
veins and those maintained in culture for 24 hours.  Sample traces for hypoxic and reoxygenation 
responses in fresh superior pulmonary vein (A) and after maintenance in culture conditions for 24 
hours (B).  Grey and black bars represent reoxygenation and hypoxia, respectively. Dotted line 
highlights level of baseline before hypoxic exposure initiated. 
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Figure 22. Hypoxic responses: differences between inferior and superior pulmonary veins and 
effect of maintenance in culture conditions for 24 hours. A: magnitude of hypoxic peak and B: 
magnitude of hypoxic relaxation post-contraction expressed as tension normalised to baseline 
tension.  For the sake of clarity hypoxic relaxation data are expressed with a value of 1 subtracted to 
more clearly illustrate when relaxation below baseline occurs.  C: area under the curve (AUC) for the 
hypoxic response (traces for AUC were plotted standardised to baseline over a time period of 759 
seconds); D: time to 50% peak magnitude and E: time to 75% maximal relaxation post-contraction 
peak.  All data represent mean ± S.E.M. *P<0.05, ** P<0.01 (analysis using Students unpaired t-tests), 
compared to fresh inferior/superior pulmonary vein (PV), N=9 for fresh inferior and superior PV and 
superior PV maintained in culture; N=10 for inferior PV maintained in culture.  
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Figure 23.  Reoxygenation contraction: differences between inferior and superior pulmonary veins 
and effect of maintenance in culture conditions for 24 hours. A: magnitude of the reoxygenation 
contraction after hypoxic exposure.  Data are expressed as tension normalised to baseline tension. B: 
area under the curve (AUC) for reoxygenation contraction (traces for AUC were plotted standardised 
to baseline over a time period of 371.75 seconds) and C: time to 50% peak magnitude. Data 
represent mean ± S.E.M.*P<0.05, ** P<0.01 compared to fresh inferior/superior pulmonary vein (PV) 
(analysis using Students unpaired t-tests). N=9 for fresh inferior and superior PV and superior PV 
maintained in culture; N=10 for inferior PV maintained in culture. 
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Underlying Mechanisms of Hypoxic and Reoxygenation Responses 
Ca2+ free conditions were used to investigate Ca2+ influx pathways involved in hypoxic and 
reoxygenation responses; ryanodine (2µM) and caffeine (20mM) were used to investigate SR Ca2+ 
release (all data is taken from fresh inferior/superior PVs).  The hypoxic contraction in inferior PVs 
(2.8 ± 0.4 A.U, N=9) was not significantly reduced by Ca2+ free conditions (2.9 ± 0.5 A.U, N=5; P>0.05).  
The same was seen in superior PVs (2.0 ± 0.3 (N=9) and 1.8 ± 0.2 A.U (N=7), control/Ca2+ free 
respectively; P>0.05).  On the other hand exposure to ryanodine (and caffeine) significantly inhibited 
the hypoxic contraction in both inferior and superior PVs (from 2.8 ± 0.4 to 1.2 ± 0.1 A.U (N=6) in 
inferior PVs (P<0.01) and from 2.0 ± 0.3 to 1.0 ± 0.1 A.U in superior PVs (P<0.05)) – see Figure 24. 
In inferior PVs hypoxic relaxation was significantly reduced from -0.4 ± 0.1 to 0.1 ± 0.1 and -0.01 ± 0.1 
A.U using ryanodine and Ca2+ free conditions, respectively (P<0.05 for Ca2+ free; P<0.001 for 
ryanodine).  Relaxation was significantly inhibited in superior PVs from -0.3 ± 0.1 to and -0.04 ± 0.1 
A.U in the presence of ryanodine (P<0.05) whereas Ca2+ free conditions had no significant effect (-0.1 
± 0.1 A.U, P>0.05).  Reoxygenation peak was significantly inhibited by ryanodine in inferior PVs (from 
3.2 ± 0.5 (N=9) to 1.0 ± 0.1(N=7); P<0.01) and superior PVs (from 2.8 ± 0.4 (N=9) to 1.1 ± 0.1 (N=5); 
P<0.05) whereas Ca2+ free conditions had no significant effect (hyperoxia peak 2.5 ± 0.5 A.U in 
inferior PVs (N=5) and 3.2 ± 0.6 A.U in superior PVs (N=6); P>0.05).  See Figure 25. 
Penitrem A (500nM) was used to investigate BKCa channel contribution to hypoxic and reoxygenation 
responses of fresh PVs.  The hypoxic peak in the presence of Penitrem A was 3.1 ± 0.7 and 2.0 ± 0.5 
A.U (inferior and superior, respectively, inferior: N=6, superior: N=5) and not significantly different 
(P>0.05) from controls (2.8 ± 0.4 (inferior) and 2.0 ± 0.3 A.U (superior); both N=9).  Hypoxic relaxation 
was -0.3 ± 0.1 and -0.2 ± 0.1A.U (inferior and superior, respectively): again not significantly different 
(P>0.05) from controls (-0.40 ± 0.1 (inferior) and -0.3 ± 0.1 A.U (superior)).  See Figure 26.  The 
reoxygenation response was similarly unaffected by Penitrem A: 2.9 ± 0.5 and 2.3 ± 1.0 A.U (inferior 
(N=6) and superior (N=3), respectively) compared to controls: 3.2 ± 0.5 (inferior) and 2.8 ± 0.4 A.U 
(superior); N=9, P>0.05). See Figure 27. 
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Figure 24.  Hypoxic contraction of fresh inferior and superior pulmonary veins in control and Ca2+ 
free conditions and after exposure to 2μM ryanodine. Representative traces from A: inferior and B: 
superior pulmonary vein (PV). N.B. control (black), Ca2+ free (dark grey) and ryanodine (light grey). 
Black bar at bottom shows hypoxic exposure duration. C: Hypoxic peak magnitude and D: hypoxic 
relaxation post peak seen with control (N=9), Ca2+ free (N=4(inferior); N=6(superior)) and 2μM 
ryanodine (N=6(inferior); N=5(superior)) for inferior and superior PVs.  All data expressed as tension 
normalised to baseline tension.  For the sake of clarity hypoxic relaxation data are expressed with a 
value of 1 subtracted to more clearly illustrate when relaxation below baseline occurs.   In C and D 
data represent mean ± S.E.M., *P<0.05, **P<0.01 and ***P<0.001   compared to control inferior or 
superior PV (analysis using Students unpaired t-tests). 
  
74 
 
 
Figure 25.  Reoxygenation contraction of fresh inferior and superior pulmonary veins in control and 
Ca2+ free conditions and after exposure to 2μM ryanodine. Representative traces from A: inferior 
and B: superior pulmonary veins (PVs). N.B. control (black), Ca2+ free (dark grey) and ryanodine (light 
grey). Grey bar at bottom shows reoxygenation exposure duration. C: Reoxygenation peak 
magnitudes (mean ± S.E.M.) seen with control (N=9), Ca2+ free (N=5(inferior); N=6(superior)) and 
2μM ryanodine (N=7(inferior); N=5 (superior)).  All data expressed as tension normalised to baseline 
tension.  *P<0.05; **P<0.01 compared to control inferior or superior PV (analysis using Students 
unpaired t-tests). 
 
  
75 
 
 
Figure 26. Hypoxic contraction of fresh inferior and superior pulmonary veins in control conditions 
and after exposure to 500nM Penitrem A. Representative traces from A: inferior and B: superior 
pulmonary vein (PV). N.B. control (black) and Penitrem A (Pen A, dark grey). Black bar at bottom 
shows hypoxic exposure duration. C: Hypoxic peak magnitude and D: hypoxic relaxation post peak 
seen with control (N=9) and 500nM Penitrem A (N=6(inferior); N=5(superior)).  All data expressed as 
tension normalised to baseline tension.  For the sake of clarity hypoxic relaxation data are expressed 
with a value of 1 subtracted to more clearly illustrate when relaxation below baseline occurs.   In C 
and D data represent mean ± S.E.M (analysis using Students unpaired t-tests). 
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Figure 27.  Reoxygenation contraction of fresh inferior and superior pulmonary veins in control 
conditions and after exposure to 500nM Penitrem A. Representative traces from A: inferior and B: 
superior pulmonary veins (PVs). N.B. control (black) and Penitrem A (Pen A, dark grey). Grey bar at 
bottom shows reoxygenation exposure duration. C: Reoxygenation peak magnitudes (mean ± S.E.M.) 
seen with control (N=9) and Penitrem A (N=6(inferior); N=3(superior)) in inferior and superior PVs.  
All data expressed as tension normalised to baseline tension (analysis using Students unpaired t-
tests).  
 
Solvent Controls 
Adding 25µL of ethanol to the bath solution caused fresh inferior PVs to relax to a level significantly 
lower than baseline tension (P<0.05, N=3).  All other PVs showed no change in baseline tension on 
application of 25µL ethanol and 25µL DMSO also had no impact on baseline tension (P>0.05, N=3).  
The results are shown in Table 4. 
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Table 4.  Impact of solvents on baseline tension of pulmonary veins.  Impact of adding solvents 
ethanol (25µL) and DMSO (25µL) on baseline tension in fresh inferior and superior PVs and those 
maintained in culture conditions for 24 hours (N=3). *P<0.05 compared to baseline tension (analysis 
using Students unpaired t-tests). 
Ethanol (25µL) Baseline Tension (g) Tension after adding solvent (g) 
Inferior - Fresh 1.4 ± 0.3 1.1 ± 0.2* 
Superior - Fresh 1.5 ± 0.3 1.4 ± 0.3 
Inferior – Culture 0.5 ± 0.1 0.6 ± 0.1 
Superior - Culture 0.8 ± 0.3 0.8 ± 0.3 
DMSO (25µL)   
Inferior - Fresh 1.5 ± 0.4 1.3 ± 0.3 
Superior - Fresh 1.7 ± 0.4 1.6 ± 0.4 
Inferior – Culture 0.5 ± 0.1 0.4 ± 0.1 
Superior - Culture 0.8 ± 0.4 1.0 ± 0.2 
 
It appears from Table 4 that baseline tension is lower in PVs kept in culture than fresh PVs.  Tension 
data from before addition of either ethanol or DMSO were combined for comparison of baseline 
tension fresh PVs and those kept in culture.  The average baseline tension level in fresh inferior PVs 
was significantly greater (1.5 ± 0.3g) and in inferior PVs kept in culture was (0.5 ± 0.1g, P<0.05, N=3).  
The baseline tension was also greater in fresh superior PVs (1.6 ± 0.3g) compared to those kept in 
culture (0.8 ± 0.3g) but this trend did not reach statistical significance (P>0.05, N=3).  
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Discussion 
This study set out to identify the impact of maintenance in culture conditions on inferior and superior 
PV contractile responses to KCl, histamine, PGF2α, U46619 and hypoxia.  Possible mechanisms 
underlying the PV hypoxic response were also investigated using Ca2+ free conditions, by depleting SR 
Ca2+ with ryanodine and caffeine and by blocking BKCa channels with Penitrem A. 
Maintenance in culture conditions for 24 hours enhanced contractile responses to KCl and U46619 in 
inferior PVs and histamine in both inferior and superior PVs and impaired endothelial-mediated 
relaxation.  Hypoxia-mediated contraction was augmented in terms of peak magnitude in inferior 
and AUC in inferior and superior PVs.  Hypoxic relaxation after peak response was inhibited in both 
inferior and superior PVs.  There was no significant change in dynamics of the hypoxic response (time 
taken to 50% contraction or 75% relaxation). 
Differences were also seen between inferior and superior PVs.  In fresh vessels, maximal contraction 
to U46619 was larger in superior than inferior PVs and contractile responses to KCl were greater in 
inferior PVs.  There was no significant difference in magnitude or dynamics of the hypoxic response 
between inferior and superior PVs.  In vessels maintained in culture, KCl responses were greater in 
inferior PVs compared to superior PVs.  Similar to fresh PVs, there was no difference in the hypoxic 
response between inferior and superior PVs. 
Ca2+ release from a ryanodine-sensitive store contributes to hypoxia-mediated contraction in PVs 
however Ca2+ influx and BKCa channels appear to play less of a role.  The relaxation phase of the 
hypoxic response is impaired in Ca2+ free conditions in inferior PVs and by depleting the SR in both 
inferior and superior PVs. 
Whilst carrying out these experiments, a novel PV contractile response was uncovered on 
reoxygenation after hypoxic exposure.  This response was inhibited when ryanodine and caffeine 
were present during hypoxia and reoxygenation but Ca2+ free conditions and blocking BKCa channels 
had no effect.  Maintenance in culture for 24 hours reduced peak magnitude and AUC of the 
reoxygenation contraction in superior PVs; AUC and time taken to 50% peak were reduced in inferior 
PVs. 
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Maintenance in Culture Conditions: Influence on PV Functional Responses 
Maintaining PVs in culture conditions for 24 hours enhanced contractile responses to a range of 
stimuli including KCl, histamine and U46619 in inferior PVs and histamine in superior PVs and 
endothelial-mediated relaxation was impaired. 
 
KCl 
Maintenance of blood vessels in culture is suggested to mimic chronic hypoxia (Manoury et al., 
2009).  Exposure of rats to 10% O2 for 2-7 days had no effect on KCl responses (20-100mM) in PVs 
(Zhao et al., 1995); this agrees with the findings from this study in superior but not inferior PVs.  
Hypersensitivity to 10mM KCl is evident in PAs after 3-4 days of culture (Guibert et al., 2005, 
Manoury et al., 2009) however the augmented first response to 80mM KCl in inferior PVs contrasts 
with PA studies showing no change in contraction to higher KCl concentrations (50mM) after 1 day 
culture (similar to superior PVs) and diminished responses by day 3 (Manoury et al., 2009).  KCl 
contractions are mediated by smooth muscle membrane depolarisation and Ca2+ influx (Zhao et al., 
1995) therefore the results of these experiments may suggest inferior PV smooth muscle is more 
sensitive to the depolarising effects of culture conditions than that of PAs or superior PVs.  On the 
other hand, there may be an alteration of Ca2+ channel expression or activation. 
 
Endothelial Function Testing 
Maintenance in serum-free culture conditions impairs endothelium-dependent relaxation in both rat 
pulmonary and mesenteric arteries (Alm et al., 2002, Manoury et al., 2009, Morita et al., 2013) and 
the same occurred in this study in porcine PVs.  Endothelial function was still present but was 
significantly reduced in PVs kept in culture compared to freshly isolated PVs.  Unfortunately, the 
submaximal constriction with PGF2α (before addition of carbachol) was often not sustained after PVs 
had been maintained in culture.  This must be borne in mind and results should be interpreted with 
caution.  In PVs which showed this type of response, the relaxation slope changed on addition of 
carbachol indicating that endothelial function remained.  However, the value for contraction for 
calculations was taken from a transient point in the response (i.e. not a plateau) and this could 
influence results. 
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Optimisation of the PV culture method could involve addition of adult serum to the culture medium 
which can normalise endothelium-dependent relaxation in rat mesenteric arteries (Morita et al., 
2013).  This method would be difficult to apply to the current procedure as tissue is acquired from an 
abattoir and fresh blood is not available in order to obtain porcine serum through centrifugation as 
suggested by Morita et al. (2013). 
Alternatively, the endothelium could be removed prior to culture as this has been demonstrated to 
provide partial protection against PA smooth muscle cell depolarisation thought to be caused by 
altered endothelial function (Manoury et al., 2009).  Endothelium could be removed by rubbing the 
intimal layer with a cotton wool swab, stainless steel wire or emery paper.  Removing PV 
endothelium was attempted in later experiments with both metal wire and emery paper but was 
problematic as the result was either failure (confirmed by a positive endothelial function test) or 
complete loss of contractile function.  Further optimisation of endothelial denudation in PVs is 
required before this can be used as a potential means of protection against the effects of 
maintenance in culture conditions.  This could help reduce variation in responses between fresh PVs 
and those maintained in culture for future studies.   
 
Agonist Cumulative Concentration-Dependent Responses 
Histamine 
There appears to be no published research investigating histamine responses before and after 
maintenance of blood vessels in culture.  The main focus of pulmonary vascular research is PAs and 
histamine has a more specific constrictor effect on PVs (Hasebe et al., 1992).  Maximum contractile 
responses to histamine in inferior and superior PVs are augmented after 24 hours maintenance in 
culture conditions and there may be several possible explanations for this.  Contractile histamine 
receptors in smooth muscle (Shi et al., 1998, Toda, 1990) may be upregulated after 1 day exposure to 
culture.  Alternatively, histamine responses in fresh tissue may be a balance between endothelial 
relaxation and smooth muscle contraction; after maintenance in culture there is a balance shift due 
to impaired endothelial-derived relaxation therefore contraction is potentiated.  The latter possibility 
ties in with the impairment in cholinergic-mediated endothelial relaxation also observed in PVs after 
maintenance in culture. 
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PGF2α 
There appears to be no readily available research which has investigated the direct impact of 
maintenance in culture conditions on contractile responses to PGF2α.  As already mentioned, organ 
culture has been suggested to mimic chronic hypoxia in PAs (Manoury et al., 2009)and exposure of 
rats to chronic hypoxia (4-6 weeks at high altitude, 4270m) lead to increased lung pressor responses 
to PGF2α compared to control (low altitude, 1520m) (McMurtry et al., 1978).  The current study 
suggests maintenance in culture for 24 hours has no impact on PGF2α contractile responses.  This may 
contest the link between culture and chronic hypoxia or may suggest that the duration of 
maintenance in culture may be important.  It is difficult to draw any solid conclusions due to the lack 
of previous research. 
 
U46619 
Responses to U46619 were enhanced in inferior PVs but were not different in superior PVs after 
maintenance in culture conditions.  There was no significant effect on contractile responses to 
U46619 in mesenteric arteries exposed to serum-free culture conditions for 20 hours (Alm et al., 
2002) in accordance with the results observed in superior PVs.  Similarly, coronary arteries exposed 
to serum-free culture media at 37°C for 24 hours showed no difference in response to 10-6M U46619 
compared to control arteries stored in the same media at 4°C (Thorne et al., 2001).  Therefore the 
augmented response appears unique to inferior PVs. 
Global hypoxia in rats (10% O2 for 3 weeks) caused no change in U46619 responses over the same 
concentration range used in this study (Lal et al., 1999) suggesting that mimicry between 
maintenance in culture and chronic hypoxia may exist in porcine superior PVs.  In contrast, exposure 
to lobar hypoxia for 20 hours significantly augmented contraction to U46619 in sheep (Sheehan et 
al., 1992), more in keeping with the findings from inferior PVs.  Unfortunately this does not help 
explain the differences between U46619 responses in inferior and superior PVs or provide further 
insight into the link between organ culture and chronic hypoxia.  When different methodologies are 
used (for example in chronic hypoxia studies), this only raises confusion when comparing results and 
makes drawing conclusions difficult. 
Maximum contractile responses to U46619 were significantly greater in fresh superior PVs than 
inferior PVs.  There is currently no known research comparing inferior/superior PVs specifically.  
Contractions to U46619 in ovine medium (1st order) and large (main) PVs are known to be similar 
(73.9 ± 3.0% and 74.3 ± 6.6% response to 75mM KCl).  In contrast, ovine PAs larger than 200µM 
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diameter showed no response to U46619; smaller PAs around 200µM diameter contracted but to a 
lower level than PVs (45.0 ± 11.8% response to 75mM KCl) (Kemp et al., 1997).  Other researchers 
have compared U46619 responses of systemic arteries from different locations.  Angus et al. (1986) 
demonstrated significantly larger maximal contraction to U46619 in canine mesenteric and renal 
arteries than femoral, coronary and carotid arteries.  EC50 values also varied between artery types 
with the lowest value in mesenteric arteries and highest in carotid arteries; in contrast, there was no 
difference in EC50 values between inferior and superior PVs. 
Within vascular smooth muscle, U46619 is an agonist at TP receptors (Gq protein), which leads to 
activation of phospholipase C, increased IP3 production, Ca
2+ release and contraction.  TP receptors 
are also present in vascular endothelial cells however signalling pathways and their role in 
vasomotion is less well established (Coleman et al., 1994). They may play a regulatory role in 
dampening contraction which could be one explanation for the enhanced responses after 
maintenance in culture in inferior PVs and the difference between fresh superior and inferior PVs.  
Upregulation or different expression levels of TP receptors at the smooth muscle level may be an 
alternative explanation. 
There are many possible reasons why PV contractile function changes after maintenance in culture 
conditions.  As seen in this study, endothelial function is impaired and contractions enhanced after 
PV maintenance in culture.  In normal conditions endothelium is in contact with blood including 
essential nutritional components (e.g. proteins, vitamins) for maintenance of vascular homeostasis.  
Serum-free culture media does not contain these components hence why endothelial/vascular 
function may be altered (Morita et al., 2013).  PV function may also change due to moving vessels 
from in vivo to serum-free conditions and the resulting loss of shear stress (Cao et al., 2005) or 
distension (De Mey et al., 1989).  Comparison of undistended and distended rat renal arteries after 6 
days maintenance in culture conditions revealed contraction to phenylephrine and angiotensin II was 
reduced to a greater extent in the undistended arteries (De Mey et al., 1989). 
Despite maintenance in culture conditions for 24 hours enhancing PV contractile responses to KCl, 
U46619 and histamine, overall contractile phenotype remained intact.  Unfortunately, maintenance 
in culture conditions for 24 hours also appears to impair endothelial function hence use of the 
method for manipulation of environmental conditions would require appropriate controls.  One 
example is, for high glucose, use of PV kept in isosmotic culture medium as a control instead of 
making direct comparison to freshly isolated vessels.  If the protocol is applied in this way, the 
maintenance in culture technique remains feasible for further studies.  
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Hypoxia-induced Contraction in Porcine Inferior and Superior PVs 
This study found no difference in hypoxia-induced constriction between inferior and superior PVs in 
terms of peak magnitude, AUC and response dynamics (time taken to 50% maximum contraction and 
75% relaxation).  There was a trend for hypoxic peak contraction to be larger in inferior PVs than 
superior as can be seen from sample traces but this did not reach statistical significance. 
The occurrence of hypoxia-induced contraction in PVs is well established.  The transient, monophasic 
nature of hypoxic contraction in fresh inferior and superior PVs (Figure 18-21) was similar to that 
seen by other researchers (Dospinescu et al., 2012, Félétou et al., 1995, Miller et al., 1989, Sheehan 
et al., 1992, Uzun and Demiryürek, 2003, Zhao et al., 1993, Zhao et al., 1996).  In accordance with 
other studies, hypoxia-induced contraction in PVs did not require pharmacological preconstriction 
(Dospinescu et al., 2012, Félétou et al., 1995, Miller et al., 1989, Sheehan et al., 1992, Uzun and 
Demiryürek, 2003).  Preconstriction can help replicate the basal pulmonary vascular tone seen to fall 
during exercise (Merkus et al., 2008) however the level and type of preconstriction agent are likely to 
significantly affect properties of the hypoxic contraction  (Connolly et al., 2013). 
The increase in AUC (non-significant trend) seen in fresh inferior compared to superior PV is likely 
due to both an increased peak magnitude and T0.5 peak (trends also did not reach significance) 
suggesting a slightly longer duration of response.  Sample traces clearly demonstrate the larger peak 
in fresh inferior PV.   
The consistent relaxation below baseline post hypoxic-contraction in PVs has not been demonstrated 
or analysed in previous published research.  Physiologically, transient contraction and subsequent 
relaxation below baseline tone may be relevant to minimise the upstream pressure generated by 3rd-
5th order PV constriction (Taylor et al., 2011) and prevent pulmonary oedema (Gao and Raj, 2005, 
Maggiorini et al., 2001).  In addition, a prolonged hypoxic contraction occurring closer to the left 
atrium could result in back-up of blood to a larger area of the lung and restriction of oxygenated 
blood outflow.  There are no known publications directly comparing hypoxia-induced contraction in 
inferior and superior PVs and often the lobe from which PVs are sourced is not specified (Félétou et 
al., 1995, Uzun and Demiryürek, 2003).  Sheehan et al. (1992) compared hypoxic contraction of PVs 
from apical (cranial) and cardiac (middle) ovine lung lobes however this was in the context of chronic 
apical lobar hypoxia with PVs from the cardiac lobe acting as controls.  The increased response in 
apical PVs was therefore most likely due to chronic hypoxia exposure rather than spatial variation.  
The similar hypoxic responses observed in this study comparing PVs from inferior and superior lobes 
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is not in keeping with previous work suggesting a stronger hypoxic contraction in cranial lobes 
(Hlastala et al., 2004, Hopkins et al., 2007, Starr et al., 2005).  
 
Constriction of PVs in Response to Reoxygenation: A Novel Finding 
An unexpected and novel finding of this study was that inferior and superior PVs constrict in 
response to reoxygenation after a hypoxic insult.  Previous research has identified a transient, 
reversible constriction in response to reoxygenation after hypoxia in PAs (Liu et al., 2001).  
Unfortunately this information was only included as a discussion point and no analysis was 
conducted, however the authors did propose that it may be mediated by reactive oxygen species 
(ROS; Liu et al., 2001).  Reoxygenation constriction after 30 minutes hypoxic exposure (described by 
the authors as “hyperoxic constriction”) was also identified in human PAs by Ariyaratnam et al. 
(2013).  The authors suggested that this may contribute to acutely elevated PA pressure in patients 
with post infarction ventricular septal defects resulting from PA exposure to highly oxygenated 
blood.  However, as alveolar gas content is the stimulus for hypoxic contraction (Dawson, 1984) and 
PVs are normally exposed to highly oxygenated blood (Widmaier et al., 2006), this is an unlikely 
clinical context for PV constriction on reoxygenation.  Physiologically, pulmonary venoconstriction as 
a result of reoxygenation post hypoxic insult may allow for capillary recruitment (as in hypoxia-
induced contraction (Taylor et al., 2011) and subsequent CO2 offloading.  
Long term hyperoxic exposure, in an experimental setting, is detrimental to PVs, resulting in 
morphology changes (including increased medial thickness), narrowing and occlusion (Hu and Jones, 
1989).  Clinically, hyperoxic exposure can contribute to pulmonary oedema in hyperbaric O2 therapy 
(Weaver and Churchill, 2001) and after inhalation of hyperoxic gas mixtures by SCUBA divers during 
immersion (Coulange et al., 2010).   Furthermore, cardio-pulmonary bypass and hypoxia-
reoxygenation lung injury can result in pulmonary oedema (Asimakopoulos et al., 1999, reviewed in 
den Hengst et al., 2010). Hypoxic pulmonary venoconstriction is thought to increase upstream 
capillary pressure which increases fluid and/or protein filtration resulting in oedema (Gao and Raj, 
2005, Hillier et al., 1997, Lal et al., 1999, Maggiorini et al., 2001, Raj and Chen, 1986, Raj et al., 1990).  
Pulmonary venoconstriction on reoxygenation could contribute to oedema in a similar way, providing 
a potential clinical context for this phenomenon. 
Reoxygenation peak magnitude, AUC and time to 50% peak magnitude were not significantly 
different between superior and inferior PVs.  The term “reoxygenation” was chosen as studies have 
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shown that high oxygen tension (for example 95% O2) is required to adequately oxygenate cells 
deepest within isolated vessels (Pittman and Duling, 1973 cf Gao et al., 2008).  The use of 94-95%O2 
for oxygenation is commonplace in the study of isolated PVs (Dospinescu et al., 2012, Félétou et al., 
1995, Gao et al., 2008, Miller et al., 1989, Sheehan et al., 1992, Zhao et al., 1993, Zhao et al., 1996).  
However others have used room air or 20-21%O2 for normoxic conditions suggesting 95% may be 
hyperoxic (Archer et al., 1996, Archer et al., 1998, Connolly et al., 2013, Dipp and Evans, 2001, Dipp 
et al., 2001, Ng et al., 2005).  The level of oxygen reaching the tissues by physical diffusion (Pittman 
and Duling, 1973 cf Gao et al., 2008) may be affected by vessel wall thickness.  Considering veins 
have thinner walls than arteries (Widmaier et al., 2006) this is an important methodological 
consideration.  Leach et al. (1994) found the magnitude of hypoxic contraction in PAs was reduced 
after equilibration with 21% compared to 95% O2.  This comparative approach could be adopted in 
future experiments to investigate whether contraction would also occur on restoration of 21% O2.   
 
Maintenance in Culture Conditions: Significant Influence on Hypoxia/Reoxygenation Responses 
This findings of this study suggest that maintenance of PVs in culture conditions for 24 hours alters 
hypoxic and reoxygenation response magnitude and dynamics.  Hypoxia-induced contraction was 
increased in terms of magnitude in inferior PVs and AUC in inferior and superior PVs and hypoxic 
relaxation post-peak was inhibited in both inferior and superior PVs exposed to culture conditions for 
24 hours.  There was no significant change in dynamics (time taken to 50% maximum relaxation and 
75% relaxation) of the hypoxic response after maintenance in culture conditions. 
As previously mentioned, earlier research investigating the impact of organ culture on rat PAs 
suggested it mimics chronic hypoxia (Manoury et al., 2009).  Taking this into consideration, the 
results of Sheehan et al. (1992) who found 20 hours lobar hypoxia in sheep increased acute HPV in 
isolated apical PVs are in disagreement with this study which found no change in hypoxia peak after 
maintenance in culture in superior PVs (anatomically correspond to apical).  However, an increase in 
AUC was observed which may be interpreted as an increased overall contraction.  Zhao et al. (1995) 
found no change in the absolute magnitude of acute hypoxic pulmonary venoconstriction in rats 
exposed to 10% O2 for 14 days compared to normoxic controls (room air).  However, Zhao et al. 
(1995) interpreted that PVs may actually have an increased acute hypoxic response because smooth 
muscle content relative to connective tissue may be decreased after 14 days exposure to hypoxia.  
This explanation was deduced from their results showing that general contractility for example, in 
response to KCl, was impaired after 14 days and KCl was used as the preconstricting agent yet the 
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hypoxic contraction itself was maintained.  Another proposal was that PVs were already constricted 
in response to chronic hypoxia therefore further contraction to acute hypoxia was expected to be 
impaired but this was not the case.  Caution must be used when interpreting results from chronic 
hypoxia studies as there are a number of differing factors.  These factors include the nature of 
chronic hypoxia (local vs. global), duration, species differences and methods of data normalisation.  
Hence maintenance of PVs in 24 hours culture conditions may mimic the effects of chronic hypoxia in 
terms of acute hypoxic responses yet further investigation is required. 
Maintenance of blood vessels in serum-free culture conditions impairs endothelium-dependent 
relaxation (EDR) (Manoury et al., 2009, Morita et al., 2013). Endothelial function also appears to be 
impaired in PVs kept in serum-free culture media in this study.  However as PGF2α did not always 
reach a stable plateau, results must be interpreted with caution.  Perhaps using KCl for submaximal 
constriction instead of PGF2α (Morita et al., 2013) may have optimised this test as 80mM KCl 
produced a stable contraction in inferior and superior PVs after maintenance in culture conditions.  
Preconstriction agents for endothelial function testing therefore must be considered carefully. 
There is a lack of consensus on endothelial contribution to hypoxic pulmonary venoconstriction.  
Some have found hypoxic response magnitude is endothelium-dependent (Félétou et al., 1995, 
Sheehan et al., 1992); others showed no endothelial contribution (Zhao et al., 1993).  This could be 
due to different HPV mechanisms between PV branches (main PV branch (Zhao et al., 1993) vs. 
intralobar PVs (Félétou et al., 1995, Sheehan et al., 1992)) or species differences (rat (Zhao et al., 
1993), pig (Félétou et al., 1995) and sheep (Sheehan et al., 1992)).  Similar controversy exists over the 
endothelial-dependence of HPV in PAs.  Hypoxic contractions in PAs preconstricted with PGF2α show 
a biphasic response.  Denuding the endothelium in rat and rabbit PAs (using 1µM for PGF2α 
preconstriction) did not affect transient phase 1 of the response but full development of sustained 
phase 2 was impaired (Dipp et al., 2001, Dipp and Evans, 2001).  Removal of endothelium in rat PAs 
(preconstricted with 10µM PGF2α) had no impact on phase 1 in large PAs (~2mm) but inhibited phase 
1 in small PAs (100-350µm); phase 2 was abolished in both (Leach et al., 1994).   
When no pharmacological preconstriction is used, PA hypoxic responses are monophasic.  Research 
in rats suggests the PA hypoxic response in the absence of preconstriction is endothelium 
independent (Archer et al., 2004) whereas in pig it is endothelium dependent (Liu et al., 2001).  
Hence, absence/presence and level of preconstriction affects both response dynamics and 
endothelial dependence of responses and species differences likely play a role.  Interestingly, PV 
studies showing an endothelial contribution to hypoxic responses did so in the absence of 
preconstriction (Félétou et al., 1995, Sheehan et al., 1992) whereas those showing no endothelial 
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dependence used preconstriction (20mM KCl, Zhao et al., 1993).  A possible candidate for endothelial 
mediation of hypoxic contraction is endothelin-1.  Blocking endothelin-1 ETA receptors (with BQ-123) 
and removal of the endothelium both abolished hypoxic PA constriction yet introduction of 
endothelin-1 as a priming agent in endothelium-denuded PAs restored hypoxic contraction (Liu et al., 
2001).  This possible candidate could be investigated further by testing the impact the ETA antagonist 
BQ-123 in PV hypoxic studies. 
Since maintenance in culture conditions appears to alter PV endothelial function in this study, the 
results may suggest endothelial regulation of hypoxic contraction in inferior/superior PVs however 
this would require further investigation by performing experiments after endothelial denudation.  
Removal of endothelium was attempted in later experiments, however this was unsuccessful.  The 
increased hypoxic contraction and reduced relaxation after maintenance in culture conditions could 
result from reduced production of an endothelial relaxing factor.  This could be investigated using a 
nitric oxide (NO) synthase inhibitor (e.g. L-nitro-arginine (L-NAME)) and/or cyclooxygenase inhibitor 
(e.g. indomethacin) (Félétou et al., 1995).  If NO synthase or cyclooxygenase inhibition increase 
hypoxic contraction in fresh PVs to a similar extent as seen after maintenance in culture this could 
help suggest the possible mechanism.    The effect of L-NAME on hypoxic contraction of inferior PVs 
was investigated in later experiments (see Chapter 4).  A positive control to investigate impact of NO 
on hypoxic responses in PVs would involve the use of ionomycin to stimulate NO release from 
endothelial cells (Cosentino et al., 1997).  Manoury et al. (2009) speculate that maintenance in 
culture changes the activity of an endothelial mediator resulting in PA smooth muscle cell 
depolarisation; this may provide an alternative explanation for the findings of this study.  
The variation in magnitude of hypoxic responses observed after PVs were maintained in culture 
conditions for 24 hours (see Figures 17 and 18) could be explained by sex differences as pigs of either 
sex were killed at the abattoir and used for experiments.  Unfortunately, the sex of pig tissue used on 
a daily basis was unknown therefore specific conclusions cannot be drawn.  Sex differences are 
known to exist within rat models of hypoxic pulmonary hypertension with male rats having increased 
disease severity compared with females (Rabinovitch et al., 1981) and 17β-oestradiol and oestrogen 
receptors having protective effects (Lahm et al., 2012). 
Reoxygenation contraction was reduced in terms of AUC (inferior and superior PVs) and magnitude 
(superior PV only) after maintenance in culture conditions for 24 hours.  Dynamics of the 
reoxygenation contraction were also affected in inferior PVs with time taken to 50% peak being 
significantly shortened after maintenance in culture.  As maintenance in culture disrupts endothelial 
function, a possible explanation for this reduced reoxygenation response could be reduced 
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production of an endothelial contracting factor.  Endothelin-1 may be a potential candidate; 
damaged endothelial cells may produce less endothelin-1 which in turn results in less contraction via 
ETA receptors in smooth muscle (Liu et al., 2001). This could be explored by introducing a low level of 
endothelin-1 in the bath solution to see whether the response can be restored (Liu et al., 2001). 
Another suggestion is that the normoxic contraction is reduced simply because the hypoxic 
contraction was larger meaning  the ability of the venous smooth muscle to contract further is 
impaired.  Others have proposed that ROS are involved in normoxic contraction (Liu et al., 2001).  
Use of antioxidants such as pyrrolidinedithiocarbamate and ebselen or the superoxide dismutase 
(SOD) inhibitor diethyldithiocarbamate (Waypa et al., 2001) could help uncover whether ROS have a 
role to play in normoxic contraction.  For example, if antioxidants/SOD inhibitors reduced normoxic 
contraction in fresh PVs to a similar extent as seen after maintenance in culture this could help 
suggest the possible mechanism.  However extensive further characterisation of the normoxic 
contraction itself is required before the mechanism of inhibition via maintenance in culture can be 
uncovered. 
 
Ryanodine-sensitive Ca2+ Source: Key to Hypoxic and Reoxygenation Responses 
This study found that application of ryanodine abolished hypoxic and normoxic contractions along 
with hypoxic relaxation post peak in both inferior and superior porcine PVs.  Exposure of 
inferior/superior PVs to Ca2+ free conditions had no significant effect on hypoxic or normoxic 
contraction but inhibited hypoxic relaxation in inferior PVs.  Application of Penitrem A had no effect 
on any of the hypoxic/normoxic responses investigated. 
Hence from these results, hypoxic contraction in porcine inferior and superior PVs appears to require 
an intact ryanodine-sensitive Ca2+ store.  This is important as little is known about the underlying 
mechanisms of hypoxic contraction in PVs.   Many researchers have shown SR release of Ca2+ 
(Connolly et al., 2013, Dipp and Evans, 2001, Dipp et al., 2001, Jabr et al., 1997) is essential for 
hypoxic responses in PAs.  The lack of an inhibitory effect in the absence of extracellular Ca2+ 
contrasts with previous work in PVs (Dospinescu et al., 2012) and PAs (Archer and Michelakis, 2002, 
Connolly et al., 2013, Leach et al., 1994, McMurtry et al., 1976, Moudgil et al., 2005, Ng et al., 2005).  
In fact, in inferior PVs, Ca2+ free conditions appeared to enhance the hypoxic response (although this 
trend was not statistically significant).  A potential explanation for this may lie in the experimental 
protocol as control data were taken from the second hypoxic response and test data from the 3rd 
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response.  If hypoxic responses increase with repeated exposure then this may be why the response 
appears to be enhanced slightly. 
Speculatively, as Ca2+ free conditions significantly impaired hypoxic relaxation in inferior PVs and 
ryanodine reduced relaxation in both inferior and superior PVs, it could be suggested that BKCa 
channels play a role in hypoxic relaxation.  However, the application of Penitrem A had no effect 
suggesting that BKCa were not involved.  
Contraction of PVs on reoxygenation also appeared dependent on an intact ryanodine-sensitive Ca2+ 
store.  However, it could be argued that the overall contractility of the tissue was impaired because 
the hypoxic response was inhibited therefore it was unlikely that normoxic contraction would occur.  
Unfortunately, the protocol did not involve a final viability test with 80mM KCl which could 
prove/disprove this theory.  Further experiments would be required and good practice would involve 
a final KCl test for all PVs.  Ca2+ free conditions failed to have an inhibitory effect and  there was a 
non-significant trend for enhancement of reoxygenation contraction in superior PVs in the absence 
of Ca2+; this may also be a result of time-dependency of the responses.  The contractile response to 
hyperoxia/reoxygenation in PAs is dependent on voltage gated Ca2+ channels (Ariyaratnam et al., 
2013); further studies with voltage gated Ca2+ channel blockers (e.g. nifedipine) could be used to 
investigate their contribution to PV reoxygenation responses. 
 
Solvent controls 
Solvent controls showed ethanol and DMSO (at a level of 0.1% in the bath solution) had no impact on 
baseline tension apart from ethanol (25µL) which caused significant relaxation in fresh inferior PVs.  
Ethanol was only used a solvent for PGF2α in this set of experiments and overall response was 
contraction, therefore the response to PGF2α in these vessels is most likely due to the drug itself 
rather than the solvent.  Therefore, these controls provide reassurance that the responses seen are 
caused by the drugs being used and not the solvent.  Interestingly, baseline tension levels were lower 
in PVs maintained in culture compared to fresh PVs, but this trend only reached statistical 
significance in inferior PVs.  This contrasts with previous findings in PAs where maintenance in 
culture appeared to result in a level of basal tone from Ca2+ influx.  PAs kept under culture conditions 
relaxed in response to removal of extracellular Ca2+ whereas fresh PAs did not (Manoury et al., 2009).  
However, it should be noted that PAs were maintained in culture for 4 days therefore the results are 
not directly comparable with this study. 
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Another point to note is that tension levels were measured at the same time point each day for fresh 
PVs (after 2nd hypoxic exposure) whereas tension was measured at various time points for PVs which 
had been maintained in culture.  One day it was after the 2nd hypoxic response, another after the 2nd 
hypoxic response and cumulative concentration response curves to PGF2α and the third after only 
one hypoxic exposure.  This variability adds a time factor which could influence baseline tension and 
may be the reason for the difference rather than maintenance in culture per se.  The N numbers are 
also small – results from only 3 different animals hence results should be interpreted with caution.  
All hypoxia/normoxia data were standardised to baseline before further analysis so baseline tension 
was already taken into account. 
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Key Findings 
Maintenance of PVs in culture conditions augmented contractions to agonists and hypoxia and may 
be a result of impaired endothelial function.  A ryanodine-sensitive Ca2+ source appears central to the 
hypoxic responses of PVs whereas influx of extracellular Ca2+ and BKCa channels play less of a role.  
Little was previously known as to the underlying mechanism of hypoxic responses in PVs and the 
impact of maintenance in culture conditions on PV function had not been investigated.  The 
experimental protocol also revealed a novel PV normoxic contraction post-hypoxic exposure.   
 
Understanding more about functional regulation of PVs and particularly the hypoxic response could 
help identify pathways contributing to hypoxia-related diseases such as high altitude pulmonary 
oedema (Bärtsch and Gibbs, 2007, Maggiorini et al., 2001)  and ultimately, potential therapeutic 
targets. 
 
Further Work 
Endothelial contribution to hypoxic responses of the PV will be further investigated and the impact of 
PV maintenance in culture will be explored at the smooth muscle level in terms of morphology and 
electrophysiology.  Pathways underlying the hypoxic response in porcine PVs are not fully 
understood based on these initial studies and require further investigation, particularly the 
contribution of different K+ channels since a hypoxia-sensitive K+ current has already been identified 
in porcine PVs from superior/middle lobes (Dospinescu et al., 2012).   
The main focus of remaining studies will be on PVs from inferior lobes as little is known about 
mechanisms of hypoxic contraction in PVs from this location.  As mentioned previously, there is a 
positive correlation between BMI and level of hypoxaemia in inferior PVs in obese patients which is 
not observed in superior PVs suggesting a clinical difference between PVs from these locations 
(Yamane et al., 2008). 
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Chapter 4 
Investigation of Underlying Pathways and Mechanisms of Hypoxia-
Induced Responses in Porcine Inferior Pulmonary Veins 
 
 
Introduction 
Hypoxaemia in human inferior PVs is positively correlated with BMI in supine obese subjects 
(Yamane et al., 2008) but this relationship is not evident in superior PVs.  This suggests insufficient 
gas exchange in regions of the lung linked to inferior PVs and could be due to impairment of hypoxic 
pulmonary venoconstriction and ventilation-perfusion mismatch in inferior PVs specifically.  Previous 
research has highlighted spatial variation in hypoxic responses within the lung during in vivo 
experiments in human and pig however the techniques used in these studies did not allow for 
identification of the specific blood vessels involved (Dehnert et al., 2006, Hlastala et al., 2004, 
Hopkins et al., 2007, Starr et al., 2005). Results from Chapter 3 suggest that hypoxic contraction in 
isolated inferior and superior PVs was similar in terms of magnitude and response dynamics.  
However in vivo studies suggest a stronger HPV response exists in superior than inferior blood 
vessels (from cranial and caudal lobes, respectively) (Hlastala et al., 2004, Hopkins et al., 2007, Starr 
et al., 2005).  To date, little is known as to the pathways and mechanisms of hypoxic responses within 
PVs and in particular, the potential for variation in responses between PVs from different locations.   
Characterisation of underlying mechanisms of PV hypoxic contraction was previously performed in 
superior/middle PVs (Dospinescu et al., 2012) although some investigators do not state the lung 
location from which they dissect PVs (Félétou et al., 1995, Zhao et al., 1993, Zhao et al., 1996).  It 
cannot be assumed that mechanisms underlying the hypoxic response are the same in PVs from 
different lung lobes since there appears to be spatial variation in HPV (Dehnert et al., 2006, Hlastala 
et al., 2004, Hopkins et al., 2007, Starr et al., 2005) and differences between inferior and superior 
PVs in a clinical setting (Yamane et al., 2008).  This spatial variation identified in lung lobes and PVs 
highlights the need for characterisation of mechanisms and pathways underlying hypoxic responses 
within the inferior PV specifically. 
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The current consensus within the field of HPV is that small resistance PAs are the main vessels 
involved (Archer et al., 1996, Archer et al., 2004) and the majority of research into the underlying 
mechanisms has focused on PAs.  Comparatively little is established about the mechanisms of 
hypoxic contraction in PVs yet PVs are known to constrict to hypoxia with a magnitude similar to or 
greater than PAs (Bressack and Bland, 1980, Félétou et al., 1995, Miller et al., 1989, Raj et al., 1990, 
Sheehan et al., 1992, Zhao et al., 1993, Zhao et al., 1996).  
Despite extensive research, there is no overall consensus on the mechanism of HPV in PAs. One 
proposed mechanism involves inhibition of KV channels (particularly KV1.5 and KV2.1) by hypoxia 
(Archer et al., 1996, Archer et al., 1998, Archer and Michelakis, 2002, Archer et al., 2004, Moudgil et 
al., 2005, Platoshyn et al., 2006).  TASK-1 may also be involved as it controls RMP and is inhibited by 
hypoxia in human PA smooth muscle (Olschewski et al., 2006).   
A K+ current sensitive to hypoxia, 4-aminopyridine (4AP) and tetraethylammonium chloride (TEA) has 
been identified within superior/middle PVSMCs suggesting a role for KV and possibly large BKCa 
channels in hypoxic contraction.  RT-PCR studies identified the presence of BKCa at the mRNA level in 
PV tissue and the BKCa blocker Penitrem A reduced outward currents in single PVSMC however it had 
no effect on hypoxic contraction of isolated PVs (Dospinescu et al., 2012).  Experiments in Chapter 3 
also showed that Penitrem A had no effect on hypoxic contraction of superior/inferior PVs.  In rats, 
basal PV tone and RMP in PVSMCs are regulated by KV channels (Michelakis et al., 2001) and 
inhibiting KV with 4AP resulted in an increase in baseline tension within superior/middle porcine PVs 
(Dospinescu et al., 2012).  K+ channels appear to play a role in the regulation of basal tone and 
hypoxic responses of PVs hence investigation of the role of different K+ channels, especially within 
the inferior PV, will be explored within this study.  
Experiments exploring the impact of maintenance of PVs in culture conditions (Chapter 3) proposed 
the idea that endothelial damage or dysfunction may be involved in enhancement of the hypoxic 
response compared to fresh PVs. Within PVs, there is a lack of consensus on endothelial contribution 
to hypoxic contraction.  Some have found the magnitude of contraction is endothelium-dependent 
(Félétou et al., 1995, Sheehan et al., 1992); others showed no endothelial contribution (Zhao et al., 
1993).  L-NAME is commonly used as a NOS inhibitor to investigate the role of endothelial NO 
production/endothelial dysfunction (Bardou et al., 2001, Félétou et al., 1995) therefore it was used in 
an attempt to simulate the effects of maintenance in culture.  
The aim of this study was to investigate the involvement of K+ channels and NOS in pathways and 
mechanisms regulating hypoxia-induced responses in inferior PVs. 
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Methods and Experimental Protocols 
Myography was used to investigate the contractility of porcine 4th-5th order inferior intrapulmonary 
veins (as described previously).  Tissue for experiments in this chapter was obtained from Quality 
Pork Producers Ltd (Brechin, Angus).  Initially, two sets of heart and lungs were transported together 
but this procedure was found to compromise tissue viability hence only one set of heart and lungs 
were collected daily (see Results section).  All 4th-5th order inferior PVs were used immediately after 
dissection within this study. 
The contribution of different K+ channels to the hypoxia-induced response of inferior pulmonary 
veins was investigated.  Hypoxic responses were measured in the presence of the KV channel 
inhibitor 4AP (Dospinescu et al., 2012), BKCa inhibitor TEA (Archer et al., 1996, Moudgil et al., 2005), 
KATP channel blocker glyburide (Yuan, 1995), TASK-1/3 blocker zinc chloride (ZnCl2) (Ali et al., 2014, 
Patel et al., 2013), KV2.1 channel inhibitor BDM (Lopatin and Nichols, 1993) and KV1.5 inhibitor DPO-1 
(Lagrutta et al., 2006).   
As endothelial damage was proposed to enhance hypoxic contraction after maintenance in culture 
(see Chapter 3), L-NAME was used to study the impact of inhibiting nitric oxide synthase (NOS) 
(MacLean and Morecroft, 2001, Bardou et al., 2001) on the hypoxic response.   
 
Equilibration, Resting Tone and Functional Testing 
Optimal resting tension (1.5g) and KCl viability tests were the same as described in Chapters 2&3.  
Due to inconsistent contractile responses with PGF2α seen within this series of experiments, 
histamine (1µM) was used as the preconstriction agent for endothelial integrity testing followed by 
application of carbachol (10µM).  As the NOS inhibitor L-NAME (MacLean and Morecroft, 2001, 
Bardou et al., 2001) was being used to simulate endothelium dysfunction, endothelial integrity tests 
were conducted before and after application of L-NAME (100µM).  Vessel rings which had a 
successful endothelial function test were selected and exposed to L-NAME (100µM) for 10 minutes 
after which another endothelial test was performed.  Time controls were also conducted whereby a 
second endothelial test was performed but vessels were not exposed to L-NAME. 
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Hypoxia Response Studies 
PVs were exposed to hypoxia as described in Chapter 2.  Hypoxic exposures lasted 15 minutes with at 
least 30 minutes for recovery (in 95%O2/5%CO2) between exposures.  Tension was readjusted to the 
optimal resting tension of 1.5g (as determined during preliminary experiments) before the first two 
exposures to hypoxia (in the absence of drugs).  These two initial hypoxic exposures were conducted, 
followed by 15 minutes of normoxia and then 30 minutes incubation with a pharmacological agent.  
A third hypoxic exposure was then performed in the presence of the pharmacological agent, 
followed by 15 minutes normoxia and a single washout of drug with fresh bath solution.  PVs were 
left in fresh solution under normoxia for 30 minutes then exposed to a final 15 minutes of hypoxia 
before normoxic washout.  This final step was added to the pre-existing protocol to assess whether 
drug actions were reversible.   
 
Investigation of Pathways Underlying the Hypoxic Response  
K+ Channel Inhibitors 
K+ channels are known to regulate tone in rat PVs with 4AP increasing basal tone, TEA causing 
minimal constriction and glyburide and the BKCa blocker iberiotoxin having no effect on resting 
tension (Michelakis et al., 2001).  4AP and TEA can also inhibit hypoxic contraction in superior/middle 
lobe PVs and a current identified in SMCs from these vessels was hypoxia, 4AP and TEA sensitive 
(Dospinescu et al., 2012).  Therefore, TEA and 4AP were chosen in order to confirm whether similar 
mechanisms of hypoxic contraction exist in inferior PVs.  As KV1.5 and KV2.1 are proposed mediators 
of hypoxic contraction in PAs (Archer et al., 1998, Archer and Michelakis, 2002, Archer et al., 2004, 
Moudgil et al., 2005, Platoshyn et al., 2006), antagonists of these two channel subunits (DPO-1 and 
BDM, respectively; Lagrutta et al., 2006, Lopatin and Nichols, 1993) were used to investigate whether 
they are also involved in hypoxic contraction of PVs (Archer et al., 1998, Archer and Michelakis, 
2002).   
Concentrations of drugs were chosen based on values in the literature; TEA is documented as 
preferential for BKCa channels at 5mM (Archer et al., 1996, Moudgil et al., 2005).  Although Penitrem 
A had no effect on hypoxic responses (see Chapter 3), it was decided to investigate this further 
because BKCa channels have a proposed role in attenuating HPV in PAs (Peinado et al., 2008, Yan et 
al., 2014).  4AP used at a concentration of 5mM is preferential for KV channels (Archer et al., 1996, 
Yuan, 1995).  BDM inhibits KV2.1 channels with an IC50 of 16.7mM (Lopatin and Nichols, 1993) 
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however preliminary experiments showed inhibition of the PV hypoxic response with concentrations 
as low as 10mM therefore concentrations of 1, 5 and 10mM were chosen.  DPO-1 inhibits KV1.5 
current with an IC50 of 30 – 266nM (Lagrutta et al., 2006, Karczewski et al., 2009) and myography 
experiments in arteries from brain and skeletal muscle showed contractile responses to DPO-1 in the 
range of 10nm to 10µM (Fancher et al., 2015) therefore a concentration of 10µM was chosen to 
achieve effective block of the channel. 
Glyburide (also known as glibenclamide) blocks KATP channels and has been shown to potentiate 
hypoxic vasoconstriction in rat main pulmonary artery (Bardou et al., 2001) and small intrapulmonary 
arteries (Lopez-Valverde et al., 2005) at concentrations of 1 and 10µM, respectively.  Exposure to 
10µM glyburide in superior/middle lobe porcine PVs did not alter hypoxia-induced contraction and 
the hypoxia sensitive current in SMCs was insensitive to glyburide (Dospinescu et al., 2012) however 
mechanisms of the hypoxic response are yet to be established in inferior PV.  A concentration of 
10µM was chosen, as per the literature.  TASK-1 has also been suggested to be involved in hypoxic 
contraction (Olschewski et al., 2006).  ZnCl2 was chosen to investigate TASK-1 involvement in hypoxic 
contraction of the porcine PV at a concentration of 1mM as this has been used for inhibition of TASK-
1/3 in isolated chorionic plate arteries (Ali et al., 2014). 
 
L-NAME 
L-NAME was chosen to investigate the impact of NOS inhibition (MacLean and Morecroft, 2001, 
Bardou et al., 2001) on the hypoxic response of inferior PVs.  The hypoxic response of PVs was 
potentiated after maintenance in culture conditions and this was suspected to occur due to 
endothelial dysfunction.  It was thought that interfering with NO production may mimic the effects of 
culture and support the proposed mechanism of enhanced hypoxic contraction.  Inhibition of NO 
synthesis significantly inhibits hypoxic contraction in pig PVs (5-7mm) (Félétou et al., 1995).  
 
Data Analysis 
Hypoxia/reoxygenation response magnitude data are expressed normalised to baseline tension 
(A.U).  For the sake of clarity hypoxic relaxation is expressed with a value of 1 subtracted to more 
clearly illustrate where relaxation below baseline occurs.  Raw traces had tension normalised to 
baseline tension before AUC was calculated.  In experiments where drugs were applied peak 
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magnitude and AUC data were further standardised to the mean time control data to take account 
for changes in responses over time.  This helped identify changes which occurred due to the drug 
exposure specifically.  Where appropriate data are presented as mean ± S.E.M and N represents the 
number of vessels from different animals.  Statistical significance was determined at P<0.05 using 
Students unpaired t-test, repeated measures one-way ANOVA or one-way ANOVA with Tukey’s post-
test (GraphPad Prism 5, CA, USA). 
Please note that for experiments which were considered preliminary or for control purposes, only 
peak magnitude and relaxation were calculated.  These traces were not analysed in terms of 
response dynamics (AUC, time to 50% peak and time to 75% relaxation) as this in-depth analysis was 
prioritised for other experiments which were more integral to the main objectives. 
Parameters of response dynamics (AUC, time to 50% peak and time to 75% relaxation) were 
measured in order to fully characterise the hypoxic contractile response within PVs where current 
research is lacking.  Furthermore, pharmacological agents may not change the absolute magnitude of 
the response but could alter the response dynamics/time course and this could have a physiological 
impact by advancing or delaying the onset of hypoxic venoconstriction.  The measurements also 
acted as surrogate markers for example time to 75% relaxation (T0.75 relax) could act as a surrogate 
marker for absolute relaxation where the PV did not fully relax within the 15 minute exposure to 
hypoxia. 
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Results 
KCl Viability Testing 
KCl viability testing was conducted as described previously (Chapters 2&3).  On exposure to 80mM 
KCl 95.3% of inferior PV rings contracted.  There was no significant difference in the magnitude of 
80mM KCl responses comparing 1st, 2nd and 3rd exposures to 80mM KCl (4.3 ± 0.5g, 5.1 ± 0.5g and 5.2 
± 0.6, respectively,  P>0.05, N=30). 
 
Endothelial Function Testing and Impact of L-NAME  
During this set of experiments PGF2α produced inconsistent results therefore histamine was chosen 
as an alternative preconstrictor for endothelial tests.  Histamine (1µM) produced a mean (± S.E.M) 
change in tension of 3.6 ± 0.5g (N=28) in 92.6% of inferior PVs.  When carbachol (10µM) was applied 
after histamine exposure, 87.8% of inferior PVs relaxed with a mean relaxation of 50.9 ± 3.7% (N=29).   
To test whether L-NAME impaired endothelial relaxation via carbachol, endothelial function tests 
were performed in the presence of the drug.  Endothelial relaxation was significantly inhibited in the 
presence of 100µM L-NAME (before: 48.8 ± 6.4%, after: -13.7 ± 8.4% (negative relaxation indicating 
contraction with carbachol), P<0.001, N=5).  Time controls were also conducted whereby no L-NAME 
was applied but a second endothelial test was performed.  Endothelial relaxation in the time control 
PV ring was not significantly different than the initial endothelial test (before: 59.8 ± 8.6%, after: 50.2 
± 9.1%, P>0.05, N=4) but significantly greater than the relaxation seen in the presence of L-NAME 
(P<0.01). 
It was also observed that introducing L-NAME significantly enhanced contraction to 1µM histamine 
(before: 1.7 ± 0.5g, after: 4.0 ± 2.0g, P<0.01, N=5) however in the time control, histamine contraction 
was significantly reduced (before: 4.8 ± 1.6g, after: 2.7 ± 1.3g, P<0.01, N=4).  There was no significant 
difference when comparing the contraction to histamine in the presence of L-NAME compared to 
time control directly (P>0.05). 
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Hypoxic Responses in Fresh Inferior PV from New Tissue Source 
Initially, two heart and lungs were transported from the abattoir daily for testing.  The success rate 
for hypoxic contractions was reduced to only 23% on 1st exposure and 37.5% on 2nd exposure (N=12).  
Because of the poor response rate, from this point onwards, only one heart and lungs was collected 
per day.  Success rates for hypoxia-induced contraction then increased to 82% (1st exposure) and 91% 
(2nd exposure) which was a lot closer to the success seen in previous experiments (88 and 99%, 
respectively). 
As per previous results (Chapter 3), 2nd exposures to hypoxia were more consistent and robust hence 
they were used for further analysis and as controls (2nd exposures will be referred to as 1st exposures 
for time control data or “Before” responses where PVs were exposed to drugs).   
 
Comparison of Responses to Repeated Hypoxic Exposure in Inferior PV  
Time control data showed that contractile responses of inferior PVs to hypoxia increased in 
magnitude on repeated exposure.  Time controls were not exposed to any drug other than initial KCl 
viability tests and drugs used in endothelial function tests.  Third hypoxic responses were significantly 
larger than responses on 1st exposure; 2nd hypoxic responses were not significantly different from 
either first or third response.  Both hypoxic peak magnitude and AUC values were larger in 3rd than 
1st exposures.  Peak magnitudes were 7.2 ± 1.0 A.U and 3.4 ± 0.6 A.U, respectively (P<0.01).  AUC 
values were 2203.3 ± 232.7 and 1394.9 ± 175.6, respectively (P<0.05).  For 2nd exposures, peak 
magnitude was 5.9 ± 0.9 A.U and AUC was 1941.7 ± 163.1.  Hypoxic relaxation post contraction did 
not change significantly over time; 1st, 2nd and 3rd exposures resulted in relaxations of 0.01 ± 0.04 
A.U, 0.3 ± 0.1 A.U and 0.06 ± 0.09 A.U, respectively (P>0.05).  See Figure 28 for representative traces 
and mean data.   
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Figure 28. Hypoxic responses in inferior pulmonary veins with repeated exposure.  A: 
representative trace of time course showing increasing contractile response to hypoxia with 
repeated exposure in inferior pulmonary veins (PVs) in time control vessels, tension values are 
expressed normalised to initial baseline tension.  B: 1st, 2nd and 3rd hypoxic responses in a 
representative time control plotted on same scale, tension values are expressed normalised to 
baseline tension.  C: magnitude of hypoxic peak and D: magnitude of hypoxic relaxation post-
contraction for 1st, 2nd and 3rd exposures in time control vessels; expressed as tension normalised to 
baseline tension.  For the sake of clarity hypoxic relaxation data are expressed with a value of 1 
subtracted to more clearly illustrate when relaxation below baseline occurs.  E: area under the curve 
(AUC) for the 1st, 2nd and 3rd hypoxic responses in time controls (traces for AUC were plotted 
standardised to baseline over a time period of 759 seconds).  All data represent mean ± S.E.M, N=18; 
*P<0.05, ** P<0.01 compared with 1st exposure (analysed using one-way ANOVA with Tukey’s post-
test). 
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Impact of K+ Channel Inhibitors on Inferior PV Basal Tone and Hypoxic Responses 
4AP 
Initial experiments to investigate the impact of 4AP on inferior PV basal tone and hypoxia-induced 
responses used Kreb’s solution for control (before drug application) and washout (after drug 
exposure) responses whereas 4AP was dissolved in HEPES buffer.  Washout of Kreb’s solution with 
4AP in HEPES bath led to a transient increase in tension from a baseline of 0.7 ± 0.2g to a peak of 2.4 
± 0.4g (N=8, P<0.01); after 30 minutes of exposure, tension had returned to the baseline level of 0.7 
± 0.2g (P>0.05 compared to baseline). 
For investigation of the impact of 4AP on hypoxic responses of inferior PVs, peak and relaxation data 
was firstly analysed as tension normalised to baseline tension.  The hypoxic peak during exposure to 
4AP (in HEPES) was not significantly different from the control hypoxic peak (in Kreb’s) before 
exposure to 4AP (during: 3.2 ± 0.5 A.U, before: 4.3 ± 1.0 A.U; P>0.05, N=7).  However the hypoxic 
peak magnitude after washout of 4AP with Kreb’s solution (7.3 ± 1.8A.U) was significantly larger than 
both before (P<0.05) and during (P<0.01) peaks.  Hypoxic relaxation post peak before, during and 
after exposure to 4AP (Kreb’s control and washout) was -0.05 ± 0.1 A.U, -0.2 ± 0.1 A.U and 0.1 ± 0.1 
A.U, respectively.  Relaxation after washout with Kreb’s was significantly greater than relaxation 
during exposure to 4AP (P<0.05, N=7).  See Figure 29 for sample traces and mean data. 
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Figure 29. Hypoxic responses in inferior pulmonary veins before, during and after washout of 5mM 
4AP (in HEPES buffer), before and after responses in Kreb’s solution.   A: representative trace of 
time course showing contractile responses to hypoxia before, during and after 4AP exposure in 
inferior pulmonary veins (PVs), tension values are expressed normalised to initial baseline tension. B: 
Representative traces plotted on same scale showing responses to hypoxia in inferior PVs before, 
during and after 4AP exposure, tension values are expressed normalised to baseline tension.  C: 
magnitude of hypoxic peak and D: magnitude of hypoxic relaxation post-contraction for before 
(Kreb’s), during (4AP in HEPES) and after (Kreb’s) exposure to 4AP; expressed as tension normalised 
to baseline tension.  For the sake of clarity hypoxic relaxation data are expressed with a value of 1 
subtracted to more clearly illustrate when relaxation below baseline occurs. All data represent mean 
± S.E.M, N=7; *P<0.05 compared to “Before”, # P<0.05 and ## P<0.01 compared with “During” 
(analysed using repeated measures one-way ANOVA with Tukey’s post-test). 
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Within these experiments and time control experiments, the peak of hypoxic contraction increases 
over time.  The final (after) response is significantly different from the first (before) response and 
second (during) response however there is a clear trend for hypoxic peak magnitude to increase over 
time anyway (see time control data in Figure 28).  Considering time control data further, the same 
trend is evident for AUC data but there is no obvious trend for relaxation data over time.  Therefore, 
to take account of known changes in response over time and to assess the effect of the drug 
specifically, from this point in the chapter onwards all peak magnitude and AUC data (but not 
relaxation data) have been further standardised to the corresponding mean time control data.  The 
axis title will remain as “Hypoxia Peak Normalised tension (A.U)” or “Normalised AUC” but will 
indicate that data has been normalised firstly to baseline tension and then normalised again to mean 
time control data, as appropriate for 1st, 2nd and 3rd (before, during and after) responses.  This will 
also mean that mean data for peak magnitude will be on a different scale from sample trace data; 
sample trace data will only be standardised to baseline to allow for ease of comparison of before, 
during and after traces.   
When peak magnitude data was standardised to time control mean data for the above 4AP data, 
peak before (in Kreb’s) was 1.3 ± 0.3 A.U, during (4AP in HEPES) was 0.5 ± 0.1 A.U and after (washout 
in Kreb’s) was 1.0 ± 0.2 A.U .  Using the data from this analysis, the peak of hypoxic contraction 
during exposure to 4AP was significantly reduced compared to the initial control (before) peak 
(P<0.01).  Normalising data in this way shows more clearly the effect of the drug exposure by taking 
account of changing magnitude over time – a comparison of data analysed in this way to data 
normalised to baseline tension only (same as graph in Figure 29 C) is shown in Figure 30. 
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Figure 30. Hypoxic peak magnitude in inferior pulmonary veins before, during and after washout of 
5mM 4AP (in HEPES buffer), before and after responses in Kreb’s solution: comparison of data 
analysis methods.   A: magnitude of hypoxic peak expressed as tension normalised to baseline 
tension and then standardised to mean time control data.  B: magnitude of hypoxic peak expressed 
as tension normalised to baseline tension only (same as Figure 29 C).  All data represent mean ± 
S.E.M, N=7; *P<0.05 and **P<0.01 compared to “Before” magnitude of hypoxic peak, ## P<0.01 
compared with “During” (analysed using repeated measures one-way ANOVA with Tukey’s post-test). 
 
The results above could reflect differences between Kreb’s and HEPES buffered solutions and 
therefore be independent of any 4AP induced effects.  Hence specific experiments were undertaken 
to determine what this effect could be.  One group of control experiments (N=6) investigated 
whether HEPES buffer alone had an impact on baseline tension and/or hypoxic contraction in inferior 
PVs (with control and washout responses in Kreb’s).  Another group of experiments (N=6) involved 
running the control and washout responses in HEPES bath solution as well as during 4AP exposure to 
investigate the effect of 4AP alone. 
Washout of Kreb’s solution with HEPES bath, in the control experiment, led to a transient contraction 
of inferior PVs which was significantly higher than baseline tension (from a baseline of 0.6 ± 0.1g to a 
peak of 1.8 ± 0.5g (N=7, P<0.05)).  After 30 minutes of exposure, tension was not significantly 
different from baseline (0.7 ± 0.2g, P>0.05). 
There was a trend for peak of hypoxic contraction to be smaller when inferior PVs were exposed to 
HEPEs bath (0.6 ± 0.1 A.U) compared to before (1.4 ± 0.3 A.U) and after washout (1.5 ±0.4 A.U) when 
vessels were in Kreb’s bath solution.  However this trend did not reach statistical significance.  
Relaxation post-hypoxic contraction was significantly inhibited after washout of HEPES with Kreb’s 
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compared to relaxation in the presence of HEPES solution (after: 0.9 ± 0.3 A.U, during: -0.1 ± 0.2 A.U, 
N=6, P<0.05).  Relaxation before application of HEPES (in Kreb’s) was 0.1 ± 0.1 A.U and was not 
significantly different from responses during HEPES or after washout in Kreb’s.  See Figure 31 for 
sample traces and mean data. 
 
 
Figure 31. Hypoxic responses in inferior pulmonary veins before, during and after washout of 
HEPES buffer, before and after responses in Kreb’s solution: control experiment.   A: Representative 
traces showing responses to hypoxia in inferior pulmonary veins before (Kreb’s), during (HEPES) and 
after (Kreb’s), tension values are expressed normalised to baseline tension.  B: magnitude of hypoxic 
peak (normalised to baseline tension and mean time control for 1st, 2nd and 3rd responses, as 
appropriate) and C: magnitude of hypoxic relaxation post-contraction (normalised to baseline 
tension) for before (Kreb’s), during (HEPES) and after (Kreb’s).  For the sake of clarity hypoxic 
relaxation data are expressed with a value of 1 subtracted to more clearly illustrate when relaxation 
below baseline occurs. All data represent mean ± S.E.M, N=6; # P<0.05 compared with “During” 
(analysed using repeated measures one-way ANOVA with Tukey’s post-test). 
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In the second experiment investigating 4AP alone (HEPES bath solution present throughout), 
washout of HEPES bath with HEPES bath containing 4AP also led to a transient contraction in inferior 
PVs which was significantly larger than baseline tension – 2.3 ± 0.5g (peak) compared to 1.3 ± 0.4g 
(baseline level, P<0.01).  After 30 minutes, tension had reduced to 1.5 ± 0.4g (P>0.05 compared to 
baseline, N=7). 
The peak hypoxic contraction was not significantly different before (0.7 ± 0.1 A.U), during (0.6 ± 0.2) 
or after washout (0.5 ± 0.1 A.U) of 4AP (P>0.05, N=6).  There was also no significant trend for hypoxic 
relaxation with 4AP exposure (before: -0.01 ± 0.1 A.U, during: 0.1 ± 0.05 A.U, after: 0.3 ±0.1 A.U; 
P>0.05, N=6).  In terms of response dynamics, time to 50% hypoxic peak magnitude (T0.5 peak) was 
not significantly different before (258.7 ± 30.5s), during (250.5 ± 20.7s) or after washout (246.0 ± 
30.0s) of 4AP (P>0.05, N=6).  The same applied for time to 75% hypoxic relaxation (before: 487.0 ± 
45.2s, during: 470.2 ± 44.3s, after: 447.0 ± 59.7s; P>0.05, N=6).  AUC (normalised to time control AUC 
data) after washout of 4AP with HEPES (0.5 ± 0.05 A.U) was significantly smaller than the initial 
response before exposure to 4AP (0.8 ± 0.1 A.U, P<0.01, N=6).  However, AUC during 4AP exposure 
(0.7 ± 0.1 A.U) was not significantly different from responses before or after 4AP exposure (P>0.05).  
See Figure 32 for sample trace and mean data for hypoxic responses with 4AP (control and washout 
responses in HEPES). 
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Figure 32. Hypoxic responses in inferior pulmonary veins before, during and after washout of 5mM 
4AP, before and after responses in HEPES solution.   A: Representative traces showing responses to 
hypoxia in inferior pulmonary veins before (HEPES), during (5mM 4AP in HEPES) and after (HEPES), 
tension values are expressed normalised to baseline tension.  B: magnitude of hypoxic peak 
(normalised to baseline tension and mean time control for 1st, 2nd and 3rd responses, as appropriate) 
and C: magnitude of hypoxic relaxation post-contraction (normalised to baseline tension) before, 
during and after 4AP exposure.  For the sake of clarity hypoxic relaxation data are expressed with a 
value of 1 subtracted to more clearly illustrate when relaxation below baseline occurs. D: area under 
the curve (AUC) for the hypoxic response normalised to mean time control data (traces for AUC were 
plotted standardised to baseline over a time period of 759 seconds); E: time to 50% peak magnitude 
and F: time to 75% maximal relaxation post-contraction peak before, during and after 4AP exposure. 
All data represent mean ± S.E.M, N=6; ** P<0.01 compared with “Before” (analysed using repeated 
measures one-way ANOVA with Tukey’s post-test). 
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TEA 
Exposure to 5mM TEA increased baseline tension in the PV from 0.7 ± 0.1g to a peak of 2.8 ± 0.5g 
(P<0.01 compared to baseline, N=7).  This increase in tension was sustained and remained 
significantly higher than baseline tension at a level of 1.7 ± 0.3g after 30 minutes of exposure to 5mM 
TEA (P<0.01 compared to baseline). 
TEA inhibited hypoxic contraction of PVs by 50% (peak before TEA: 2.0 ± 0.4 A.U; peak during TEA: 
1.0 ± 0.1 A.U, P<0.05, N=5) although there was no significant recovery after washout (1.3 ± 0.2 A.U, 
P>0.05).  Hypoxic relaxation post-peak was inhibited on washout (0.4 ± 0.2 A.U) compared to during 
TEA exposure (-0.1 ± 0.1 A.U, P<0.05, N=5).  Hypoxic relaxation in control (before) responses did not 
differ from during/after responses (0.1 ± 0.05 A.U, P>0.05).  AUC showed the same trend as hypoxic 
peak, with inhibition on exposure to 5mM TEA (AUC before: 1.6 ± 0.3 A.U; peak during: 1.0 ± 0.1 A.U, 
P<0.05, N=5) whereas AUC after washout did not recover (1.2 ± 0.1 A.U, P>0.05).  Time to half 
maximal contraction was not significantly different comparing all three responses (before: 211.2 ± 
20.9s, during: 174.9 ± 13.8s, after: 156.1 ± 15.5s; P>0.05).  There was also no significant trend for 
time to 75% relaxation (before: 473.8 ± 40.3s, during: 430.4 ± 11.8s, after: 466.9 ± 45.8s; P>0.05). See 
Figure 33 for sample trace and mean data for 5mM TEA. 
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Figure 33. Hypoxic responses in inferior pulmonary veins before, during and after washout of 5mM 
TEA.   A: Representative traces showing responses to hypoxia in inferior pulmonary veins before, 
during and after application of 5mM TEA, tension values are expressed normalised to baseline 
tension.  B: magnitude of hypoxic peak (normalised to baseline tension and mean time control for 1st, 
2nd and 3rd responses, as appropriate) and C: magnitude of hypoxic relaxation post-contraction 
(normalised to baseline tension) before, during and after 5mM TEA exposure.  For the sake of clarity 
hypoxic relaxation data are expressed with a value of 1 subtracted to more clearly illustrate when 
relaxation below baseline occurs. D: area under the curve (AUC) for the hypoxic response normalised 
to mean time control data (traces for AUC were plotted standardised to baseline over a time period 
of 759 seconds); E: time to 50% peak magnitude and F: time to 75% maximal relaxation post-
contraction peak before, during and after TEA exposure. All data represent mean ± S.E.M, N=5; * 
P<0.05 compared with “Before”, #P<0.05 compared with “During” (analysed using repeated 
measures one-way ANOVA with Tukey’s post-test). 
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DPO-1 
In order to examine any putative role for KV1.5 in baseline tone and hypoxia-induced contractility in 
the PV, the KV1.5 inhibitor (Lagrutta et al., 2006, Karczewski et al., 2009) was used.  Before 
application of DPO-1 (10µM) application, initial baseline tension was 0.5 ± 0.2g which increased 
slightly to 0.6 ± 0.1g after exposure (P>0.05 compared to baseline, N=7).  Ethanol was used as the 
solvent for DPO-1 at a level of 0.1% and in previous experiments (see Chapter 3), this level of ethanol 
was found to cause significant relaxation in fresh inferior PVs (from a baseline of 1.4 ± 0.3g down to 
1.1 ± 0.2g, N=3) but no relaxation was seen by adding DPO-1 in ethanol.  This suggests that DPO-1 
inhibits the vehicle effect.  A direct comparison of the effects of ethanol and DPO-1 + ethanol on 
baseline tension is shown in Figure 34. 
 
Figure 34.  Effect of ethanol alone and DPO-1 (10µM) dissolved in ethanol on baseline tension in 
inferior pulmonary veins. Absolute change in tension of inferior pulmonary veins on application of 
either ethanol alone (N=3) or DPO-1 + ethanol (N=7).  Please note that 25µL ethanol was added in 
each case (0.1% final concentration in the bath). **P<0.01 compared to ethanol alone (analysed 
using Students unpaired t-test). 
 
Application of 10 µM DPO-1 had no significant effect on the hypoxic response in inferior PVs.  There 
was a trend for an enhanced peak of contraction (before: 1.1 ± 0.3 A.U, during: 1.4 ± 0.2 A.U and 
after: 1.2 ± 0.2 A.U) and AUC with DPO-1 exposure (before: 1.0 ± 0.2 A.U, during: 1.6 ± 0.3 A.U and 
after: 1.3 ± 0.2 A.U), however this trend did not reach statistical significance (P>0.05, N=5).  There 
was also no significant difference in hypoxic relaxation (before:  -0.1 ± 0.1 A.U, during: 0.3 ± 0.2 A.U 
and after: 0.1 ± 0.1 A.U), time to 50% hypoxic peak (before: 213.4 ± 18.4s, during: 184.1 ± 6.4s and 
after 174.8 ± 9.8s) or time to 75% relaxation (before: 498.3 ± 25.0s, during: 514.3 ± 24.8s and after 
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521.3 ± 29.9s) with DPO-1 exposure (P>0.05, N=5).  Representative traces and mean data are shown 
in Figure 35. 
 
Figure 35. Hypoxic responses in inferior pulmonary veins before, during and after washout of 
10µM DPO-1.   A: Representative traces showing responses to hypoxia in inferior pulmonary veins 
before, during and after application of 10µM DPO-1, tension values are expressed normalised to 
baseline tension.  B: magnitude of hypoxic peak (normalised to baseline tension and mean time 
control for 1st, 2nd and 3rd responses, as appropriate) and C: magnitude of hypoxic relaxation post-
contraction (normalised to baseline tension) before, during and after 10µM DPO-1 exposure.  For the 
sake of clarity hypoxic relaxation data are expressed with a value of 1 subtracted to more clearly 
illustrate when relaxation below baseline occurs. D: area under the curve (AUC) for the hypoxic 
response normalised to mean time control data (traces for AUC were plotted standardised to 
baseline over a time period of 759 seconds); E: time to 50% peak magnitude and F: time to 75% 
maximal relaxation post-contraction peak before, during and after DPO-1 exposure. All data 
113 
 
represent mean ± S.E.M, N=5 (analysed using repeated measures one-way ANOVA with Tukey’s post-
test). 
 
BDM 
In order to examine any putative role for KV2.1 in baseline tone and hypoxia-induced contractility in 
the PV, the KV2.1 inhibitor BDM (Lopatin and Nichols, 1993) was used.  Please note that investigation 
of the effects of 1, 5 and 10mM BDM on baseline tension and PV hypoxic responses were performed 
in different pieces of tissue rather than adding cumulatively for a response curve in a single piece of 
tissue.  The effect of BDM on baseline tension of inferior PVs was concentration-dependent.  At a 
concentration of 1mM, BDM had no impact on baseline tension.  Initial mean tension was 0.6 ± 0.1g 
before application of 1mM BDM and after was 0.7 ± 0.3g (P>0.05, N=5).  At a higher concentration of 
5mM, BDM resulted in a small transient contraction of PVs which was not significantly greater than 
baseline tension (baseline: 1.0 ± 0.4g, peak: 1.1 ± 0.4g, P>0.05, N=5) followed by relaxation to a level 
below baseline (0.7 ± 0.5g, P<0.05).  Application of 10mM BDM resulted in transient contraction in 4 
out of 6 PVs tested.  The peak (0.9 ± 0.3g) was significantly greater than baseline in these 4 vessels 
(0.8 ± 0.2g, P<0.05, N=4).  All inferior PVs were significantly relaxed compared to baseline after 30 
minutes exposure to 10mM BDM (PVs relaxed from a baseline of 0.7 ± 0.2g to a level of 0.3 ± 0.1g, 
P<0.05, N=6).  The magnitude of relaxation seen with 10mM BDM was not significantly different from 
that seen with 5mM (10mM: -0.4 ± 0.1g; 5mM: -0.2 ± 0.1g, P>0.05). 
Application of 1mM BDM had no significant impact on hypoxic responses in inferior porcine PVs.  The 
peak of hypoxic contraction was no different before (1.0 ± 0.4 A.U), during (1.0 ± 0.3 A.U) or after 
exposure to 1mM BDM (1.4 ± 0.6 A.U, P>0.05, N=5).  Relaxation post-hypoxic contraction also did not 
change before (-0.1 ± 0.1 A.U), during (0.4 ± 0.2 A.U) or after exposure to 1mM BDM (0.4 ± 0.4 A.U, 
P>0.05).  BDM at a concentration of 1mM had no impact on AUC (before: 0.8 ± 0.2 A.U, during: 0.9 ± 
0.2 A.U and after: 2.0 ± 1.3 A.U), time to 50% peak of hypoxic contraction (before: 185.1 ± 15.4s, 
during: 167.1 ± 17.7s and after: 174.1 ± 17.7s) and time to 75% relaxation (before: 449.5 ± 38.0s, 
during: 463.6 ± 57.2s and after: 497.6 ± 39.2s) (P>0.05).  See Figure 36 for sample traces and mean 
data for 1mM BDM. 
Increasing the concentration of BDM to 5mM abolished the peak of hypoxic contraction compared to 
control (before) response (before: 0.7 ± 0.2 A.U and during: 0.2 ± 0.004; P<0.05, N=4).  There was 
also significant recovery of the hypoxic contraction after washout of 5mM BDM (0.8 ± 0.1; P<0.01 
compared to during and P>0.05 compared to before response).  AUC was also significantly reduced 
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on exposure to 5mM BDM (before: 0.7 ± 0.1 A.U and during: 0.4 ± 0.03; P<0.05) and recovered on 
washout (0.8 ± 0.1 A.U; P<0.05 compared to during and P>0.05 compared to before response).  There 
was no effect on hypoxic relaxation (before: -0.1 ± 0.05 A.U, during: -0.1 ±0.1 A.U and after: 0.04 ± 
0.1 A.U; P>0.05) and time to 50% peak and 75% relaxation were not calculated as there was no 
hypoxic contraction to measure from for the “During” response.  Representative traces and mean 
data for 5mM BDM are shown in Figure 37. 
The highest concentration of BDM used (10mM) also abolished the hypoxic contraction in inferior 
PVs (peak before: 1.4 ± 0.2 A.U, peak during: 0.2 ± 0.001 A.U; P<0.01, N=5). However, the peak 
hypoxic contraction seen after washout of 10mM BDM was not significantly different from 
before/during responses (0.8 ± 0.1 A.U, P>0.05).  A similar trend was observed with AUC data; AUC 
during 10mM BDM exposure (0.4 ± 0.02 A.U) was significantly smaller than before exposure (1.2 ± 
0.2 A.U; P<0.05).  AUC after washout was 1.0 ± 0.1 A.U which was not significantly different from 
hypoxic responses before or during exposure (P>0.05).  Similar to 5mM BDM, there was no effect on 
hypoxic relaxation (before: -0.1 ± 0.1 A.U, during: 0.01 ±0.01 A.U and after: 0.2 ± 0.2 A.U; P>0.05) and 
time to 50% peak and 75% relaxation were not calculated as again there was no hypoxic contraction 
to measure from for the “During” response.  Representative traces and mean data for 10mM BDM 
are shown in Figure 38. 
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Figure 36. Hypoxic responses in inferior pulmonary veins before, during and after washout of 1mM 
BDM.   A: Representative traces showing responses to hypoxia in inferior pulmonary veins before, 
during and after application of 1mM BDM, tension values are expressed normalised to baseline 
tension.  B: magnitude of hypoxic peak (normalised to baseline tension and mean time control for 1st, 
2nd and 3rd responses, as appropriate) and C: magnitude of hypoxic relaxation post-contraction 
(normalised to baseline tension) before, during and after 1mM BDM exposure.  For the sake of clarity 
hypoxic relaxation data are expressed with a value of 1 subtracted to more clearly illustrate when 
relaxation below baseline occurs. D: area under the curve (AUC) for the hypoxic response normalised 
to mean time control data (traces for AUC were plotted standardised to baseline over a time period 
of 759 seconds); E: time to 50% peak magnitude and F: time to 75% maximal relaxation post-
contraction peak before, during and after 1mM BDM exposure. All data represent mean ± S.E.M, N=5 
(analysed using repeated measures one-way ANOVA with Tukey’s post-test). 
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Figure 37. Hypoxic responses in inferior pulmonary veins before, during and after washout of 5mM 
BDM.   A: Representative traces showing responses to hypoxia in inferior pulmonary veins before, 
during and after application of 5mM BDM, tension values are expressed normalised to baseline 
tension.  B: magnitude of hypoxic peak (normalised to baseline tension and mean time control for 1st, 
2nd and 3rd responses, as appropriate) and C: magnitude of hypoxic relaxation post-contraction 
(normalised to baseline tension) before, during and after 5mM BDM exposure.  For the sake of clarity 
hypoxic relaxation data are expressed with a value of 1 subtracted to more clearly illustrate when 
relaxation below baseline occurs. D: area under the curve (AUC) for the hypoxic response normalised 
to mean time control data (traces for AUC were plotted standardised to baseline over a time period 
of 759 seconds before, during and after 5mM BDM exposure. All data represent mean ± S.E.M, N=4. 
*P<0.05 compared to “Before”, #P<0.05 and ##P<0.01 compared to “During” (analysed using 
repeated measures one-way ANOVA with Tukey’s post-test). 
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Figure 38. Hypoxic responses in inferior pulmonary veins before, during and after washout of 
10mM BDM.   A: Representative traces showing responses to hypoxia in inferior pulmonary veins 
before, during and after application of 10mM BDM, tension values are expressed normalised to 
baseline tension.  B: magnitude of hypoxic peak (normalised to baseline tension and mean time 
control for 1st, 2nd and 3rd responses, as appropriate) and C: magnitude of hypoxic relaxation post-
contraction (normalised to baseline tension) before, during and after 10mM BDM exposure.  For the 
sake of clarity hypoxic relaxation data are expressed with a value of 1 subtracted to more clearly 
illustrate when relaxation below baseline occurs. D: area under the curve (AUC) for the hypoxic 
response normalised to mean time control data (traces for AUC were plotted standardised to 
baseline over a time period of 759 seconds before, during and after 10mM BDM exposure. All data 
represent mean ± S.E.M, N=5. *P<0.05 and **P<0.01 compared to “Before” (analysed using repeated 
measures one-way ANOVA with Tukey’s post-test). 
 
To investigate the possibility of non-specific effects of BDM at higher concentrations, contractile 
responses to 80mM KCl were measured before, during and after washout of 1, 5 and 10mM BDM.  
BDM at the lowest concentration of 1mM had no effect on KCl-induced contraction (before: 13.3 ± 
1.9g, during: 13.1 ± 5.3g and after: 12.5 ± 1.6g; P>0.05, N=5).  When 5mM BDM was applied, 
contraction to KCl was significantly reduced (before: 14.2 ± 2.1g, during: 9.5 ± 1.6g; P<0.001, N=5).  
On washout of 5mM BDM, KCl contraction recovered to the same level as before exposure (13.9 ± 
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2.0g; P<0.001 compared to “During”, P>0.05 compared to “Before”).  The same pattern was observed 
with 10mM BDM, KCl contraction was inhibited (before: 14.6 ± 1.7g, during: 5.3 ± 0.7g; P<0.001, N=7) 
and responses recovered to a similar level as before exposure when 10mM BDM was washed out 
(13.2 ± 1.8g, P<0.001 compared to “During”, P>0.05 compared to “Before”). 
 
Glyburide 
To determine the role of KATP channels in baseline tone and hypoxia-induced contraction of the PV, 
the KATP blocker glyburide (Dospinescu et al., 2012) was used.  Glyburide (10µM) did not significantly 
change baseline tension in inferior PVs during 30 minutes exposure.  Initial mean tension was 0.7 ± 
0.1g and after glyburide application was 0.5 ± 0.2g (P>0.05).  DMSO was used as the solvent for 
glyburide at a level of 0.1%.  In previous experiments (see Chapter 3), this level of DMSO was found 
to have no effect on baseline tension in fresh inferior PVs. 
Application of 10µM glyburide had no impact on peak magnitude of the hypoxic response in inferior 
PVs (before: 1.4 ± 0.4 A.U, during: 1.1 ± 0.3 A.U and after: 1.1 ± 0.2 A.U; P>0.05, N=6) and there was 
also no effect on AUC (before: 1.2 ± 0.2 A.U, during: 1.4 ± 0.6 A.U and after: 1.3 ± 0.2 A.U; P>0.05). 
Relaxation post-hypoxic contraction was significantly inhibited after washout (0.6 ± 0.2 A.U) 
compared to control responses before glyburide application (-0.03 ± 0.1 A.U, P<0.05) however 
relaxation during glyburide exposure (0.4 ± 0.2 A.U) was not significantly different to before/after 
responses (P>0.05).  Time to 50% peak (before: 178.1 ± 10.9s, during: 192.1 ± 19.0s and after: 183.4 ± 
11.2s) and time to 75% relaxation (before: 421.3 ± 12.0s, during: 453.8 ± 36.9s and after: 472.3 ± 
29.5s) were not significantly different before, during exposure to or after washout of glyburide 
(P>0.05).  See Figure 39 for sample traces and mean data from experiments using 10µM glyburide. 
119 
 
 
Figure 39. Hypoxic responses in inferior pulmonary veins before, during and after washout of 
10µM glyburide.   A: Representative traces showing responses to hypoxia in inferior pulmonary veins 
before, during and after application of 10µM glyburide, tension values are expressed normalised to 
baseline tension.  B: magnitude of hypoxic peak (normalised to baseline tension and mean time 
control for 1st, 2nd and 3rd responses, as appropriate) and C: magnitude of hypoxic relaxation post-
contraction (normalised to baseline tension) before, during and after 10µM glyburide exposure.  For 
the sake of clarity hypoxic relaxation data are expressed with a value of 1 subtracted to more clearly 
illustrate when relaxation below baseline occurs. D: area under the curve (AUC) for the hypoxic 
response normalised to mean time control data (traces for AUC were plotted standardised to 
baseline over a time period of 759 seconds); E: time to 50% peak magnitude and F: time to 75% 
maximal relaxation post-contraction peak before, during and after 10µM glyburide exposure. All data 
represent mean ± S.E.M, N=6. *P<0.05 compared to “Before” (analysed using repeated measures 
one-way ANOVA with Tukey’s post-test). 
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ZnCl2 
To determine the role of TASK-1/3 channels in baseline tone and hypoxia-induced contraction of the 
PV, the TASK-1/3 blocker ZnCl2 (Ali et al., 2014) was used.  Baseline tension did not change over the 
course of a 30 minute application of 1mM ZnCl2 (tension before and after: 0.6 ± 0.1g, P>0.05, N=7). 
In addition, there was no effect of 1mM ZnCl2 on the hypoxia-induced response of inferior PVs.  There 
was no significant difference in hypoxic peak magnitude (before: 0.7 ± 0.1 A.U, during: 1.0 ± 0.2 A.U 
and after: 1.0 ± 0.2 A.U) or hypoxic relaxation post-peak (before: -0.02 ± 0.1 A.U, during: 0.04 ± 0.1 
A.U and after: 0.2 ± 0.1 A.U) with ZnCl2 exposure (P>0.05, N=6).  AUC (before: 0.8 ± 0.1 A.U, during: 
1.0 ± 0.2 A.U and after: 1.0 ± 0.2 A.U), time to 50% hypoxic peak (before: 241.8 ± 31.5s, during: 259.7 
± 20.1s and after: 235.6 ± 29.1s) and time to 75% relaxation (before: 557.2 ± 56.2s, during: 589.1 ± 
46.0s and after: 521.4 ± 50.7s) also did not change on application/washout of ZnCl2.  Mean and 
representative data for ZnCl2 are shown in Figure 40. 
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Figure 40. Hypoxic responses in inferior pulmonary veins before, during and after washout of 1mM 
ZnCl2.   A: Representative traces showing responses to hypoxia in inferior pulmonary veins before, 
during and after application of 1mM ZnCl2, tension values are expressed normalised to baseline 
tension.  B: magnitude of hypoxic peak (normalised to baseline tension and mean time control for 1st, 
2nd and 3rd responses, as appropriate) and C: magnitude of hypoxic relaxation post-contraction 
(normalised to baseline tension) before, during and after 1mM ZnCl2 exposure.  For the sake of clarity 
hypoxic relaxation data are expressed with a value of 1 subtracted to more clearly illustrate when 
relaxation below baseline occurs. D: area under the curve (AUC) for the hypoxic response normalised 
to mean time control data (traces for AUC were plotted standardised to baseline over a time period 
of 759 seconds); E: time to 50% peak magnitude and F: time to 75% maximal relaxation post-
contraction peak before, during and after 1mM ZnCl2 exposure. All data represent mean ± S.E.M, N=6 
(analysed using repeated measures one-way ANOVA with Tukey’s post-test).  
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Impact of L-NAME on Inferior PV Basal Tone and Hypoxic Responses  
For all drugs already discussed, data for baseline tension effects was taken from the point when the 
drug was added prior to 3rd hypoxia exposure.  In some experiments, L-NAME (100µM) was used 
before any exposure to hypoxia during endothelial function tests (see Results section “Endothelial 
Function Testing and Impact of L-NAME”).  Introduction of 100µM L-NAME at this point caused no 
significant change in baseline tension of inferior PVs (before: 0.3 ± 0.1g, after: 0.3 ± 0.2g, P>0.05, 
N=5).  However, when added to the organ bath before the 3rd hypoxic exposure (with no previous 
exposure to the drug), L-NAME resulted in a sustained increase in tension in inferior PVs from a 
baseline of 0.7 ± 0.1g to a significantly higher level of 2.8 ± 0.5g, even after 30 minutes exposure 
(P<0.01 compared to baseline, N=6).  As the experimental protocol involved two exposures to 
hypoxia before drug addition, it was decided to try running a time control where the protocol was 
run in exactly the same way but without exposure to hypoxia (this included all standard functional 
tests and resetting the tension to 1.5g at set intervals).  In the PVs which acted as time controls, 
100µM L-NAME still resulted in a sustained increase in basal tension from 0.4 ± 0.2g to 1.9 ± 0.4g 
(P<0.05 compared to baseline, N=3).  The change in tension was significantly larger in both hypoxia 
(2.1 ± 0.5g) and time control (1.6 ± 0.3g) compared to that seen in earlier endothelial tests (-0.03 ± 
0.1g, P<0.01).  However, the contractile response to L-NAME application in hypoxia and time control 
tests did not differ (P>0.05). 
L-NAME (100µM) had a significant impact on the hypoxic response of inferior PVs in terms of both 
magnitude and response dynamics.  The peak magnitude of the hypoxic response was significantly 
reduced with L-NAME (before: 0.8 ± 0.1 A.U, during: 0.3 ± 0.02 A.U, P<0.01, N=6) and the response 
did not recover on washout (0.3 ± 0.03 A.U, P<0.01 compared to “before”).  The same trend was 
observed for AUC (before: 0.8 ± 0.04 A.U, during: 0.4 ± 0.02 A.U and after: 0.4 ± 0.03 A.U, “during” 
and “after” both P<0.001 compared to “before”).  Hypoxic relaxation post-peak was enhanced in the 
presence of 100µM L-NAME (before: -0.1 ± 0.1 A.U and during: -0.6 ± 0.1 A.U, P<0.001) and also did 
not recover on washout of the drug (-0.6 ± 0.1 A.U, P<0.001 compared to “before”).  Time to 50% 
peak was significantly shorter in the presence of L-NAME (before: 235.5 ± 23.5s, during: 146.0 ± 
14.1s, P< 0.001) and washout did not change this (144.5 ± 14.3s, P<0.001 compared to “before”).  
Time to 75% relaxation was the only parameter which was not significantly different with L-NAME 
(before: 476.9 ± 24.1s, during: 530.3 ± 27.0s and after: 492.3 ± 21.5s, P>0.05).  Representative traces 
and mean data for results with 100µM L-NAME are shown in Figure 41. 
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Figure 41. Hypoxic responses in inferior pulmonary veins before, during and after washout of 
100µM L-NAME.   A: Representative traces showing responses to hypoxia in inferior pulmonary veins 
before, during and after application of 100µM L-NAME, tension values are expressed normalised to 
baseline tension.  B: magnitude of hypoxic peak (normalised to baseline tension and mean time 
control for 1st, 2nd and 3rd responses, as appropriate) and C: magnitude of hypoxic relaxation post-
contraction (normalised to baseline tension) before, during and after 100µM L-NAME exposure.  For 
the sake of clarity hypoxic relaxation data are expressed with a value of 1 subtracted to more clearly 
illustrate when relaxation below baseline occurs. D: area under the curve (AUC) for the hypoxic 
response normalised to mean time control data (traces for AUC were plotted standardised to 
baseline over a time period of 759 seconds); E: time to 50% peak magnitude and F: time to 75% 
maximal relaxation post-contraction peak before, during and after 100µM L-NAME exposure. All data 
represent mean ± S.E.M, N=6. **P<0.01 and ***P<0.001 compared to “Before” (analysed using 
repeated measures one-way ANOVA with Tukey’s post-test). 
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As L-NAME had a profound impact on the peak and relaxation phase and time course of the hypoxic 
response, the profile of the L-NAME sensitive component of the response was calculated by 
subtracting the “during” responses from initial “before” responses.  All profiles were then plotted as 
an averaged tension trace against time.  The component of the PV hypoxic response sensitive to L-
NAME appeared to be an initial small relaxation followed by a transient contraction then a small 
sustained contraction component (as seen in Figure 42).   
 
Figure 42. L-NAME sensitive component of the hypoxic response in inferior pulmonary veins.  
Averaged L-NAME sensitive component calculated by subtracting “during” responses from “before” 
responses (N=6).  Trace represents the mean difference in tension across all pulmonary veins tested. 
Please note that as both “before” and “during” traces were normalised to baseline and then 
subtracted from one another any value above 0 represents contraction and below 0 represents 
relaxation. 
 
Inferior PV Reoxygenation Responses 
When two heart and lungs were transported from the abattoir daily,  the success rate for 
reoxygenation contractions was only 2.1% on 1st exposure and 12.5% on 2nd exposure (N=12).  
Success rates for reoxygenation-induced contraction were still poor when one set of heart and lungs 
were transported daily: 20.5% (1st exposure) and 51.5% (2nd exposure) compared to previous success 
rates in fresh PVs in Chapter 3 experiments of 97%.  Notably, many of the contractions that did occur 
were very small and within the range of noise and detection limit of the software (0.1g or less).  On 
this basis, the reoxygenation contraction cannot be considered a stable and consistent functional 
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response and no in depth analysis of the reoxygenation contraction will be presented for the 
experiments performed in this chapter. 
The only consistent effect worthy of note with regards to reoxygenation contraction was the 
potentiation seen in the presence of 100µM L-NAME.  Exposure to L-NAME significantly increased 
the peak magnitude of the reoxygenation contraction from 1.3 ± 0.1 A.U to 4.5 ± 0.8 A.U (P<0.05, 
N=6).  After washout of L-NAME from the organ bath, the response increased further to 5.2 ± 1.0 
(P<0.05 compared to “before”).  (Please note that reoxygenation data is expressed normalised to 
baseline tension only.  This is because reoxygenation peak magnitude data from time controls did not 
show any significant trend over time (before: 1.6 ± 0.2 A.U, during: 1.7 ± 0.2 A.U and after: 2.2 ± 0.5 
A.U, P<0.05, N=17) and hence there was no justification for normalising data to time control data.)  
Reoxygenation AUC also increased over time in L-NAME experiments with AUC after washout being 
significantly larger than control response (“before”) L-NAME application (before: 384.9 ± 8.0, during: 
1213.2 ± 227.2 and after: 1723.0 ± 495.5, P<0.05 after compared with before, N=4).  Time to 50% 
peak of reoxygenation contraction was significantly longer in the presence of 100µM L-NAME 
(before: 30.0 ± 15.4s, during: 96.6 ± 2.5s, P<0.01, N=4).  The time to 50% peak did not recover on 
washout of the drug (112.1 ± 3.5s, P<0.001 compared with “before”).  Please note there is only an n 
of 4 for AUC and T0.5 peak data because, unfortunately, two raw traces did not have markers present 
which are used as a starting point for these calculations. 
Overall, L-NAME enhanced and prolonged the reoxygenation contraction as is seen in mean data and 
representative sample traces in Figure 43. 
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Figure 43. Reoxygenation responses in inferior pulmonary veins before, during and after washout 
of 100µM L-NAME.  A: Representative traces showing responses to reoxygenation after hypoxic 
exposure in inferior pulmonary veins before, during and after application of 100µM L-NAME, tension 
values are expressed normalised to baseline tension.  B: magnitude of reoxygenation peak, 
normalised to baseline tension (N=6) and C: area under the curve (AUC) for the reoxygenation 
response (traces for AUC were plotted standardised to baseline over a time period of 372.25 
seconds) and D: time to 50% peak magnitude before, during and after 100µM L-NAME exposure 
(N=4). All data represent mean ± S.E.M; *P<0.05, **P<0.01 and ***P<0.001 compared to “Before” 
(analysed using repeated measures one-way ANOVA with Tukey’s post-test). 
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Discussion 
Little is currently known about underlying pathways and mechanisms of hypoxia-induced contraction 
within the PV especially within the inferior PV.  Previous studies have investigated hypoxic 
contraction within superior/middle lobes (Dospinescu et al., 2012) however it cannot be assumed 
that mechanisms are the same within PVs from inferior lobes since clinical differences exist between 
superior/inferior PVs (Yamane et al., 2008).  This study has set out to identify the underlying 
pathways and mechanisms of hypoxia-induced responses and regulation of basal tone within fresh 
porcine inferior PVs.   
KV and TASK channel activity did not appear to affect hypoxia-induced contraction of inferior PVs as 
4AP, DPO-1 and ZnCl2 had no effect.  TEA inhibited the hypoxic contraction (reduced peak and AUC) 
whereas 5-10mM BDM completely abolished it.  Hypoxic relaxation was significantly inhibited after 
washout of glyburide: this could be due to incomplete washout and delayed onset of action.   
L-NAME reduced peak and AUC of the hypoxic contraction, enhanced hypoxic relaxation and 
shortened T0.5 peak.  L-NAME also resulted in a potentiated reoxygenation contraction in inferior PVs 
after hypoxic exposure.  Otherwise, contraction on reoxygenation was poor and inconsistent during 
the experiments in this chapter. 
 
KCl Viability Tests and Optimisation of Endothelial Function Test 
PGF2α (2µM) was not consistent in producing preconstriction before testing the endothelium with 
carbachol in experiments within this chapter whereas in the previous chapter PGF2α was more 
reliable.  Histamine was chosen as an alternative to PGF2α as it was already established as a stable 
vasoconstrictor in PVs in previous experiments (Chapter 3) and histamine is specific for PVs 
compared to PAs (Hasebe et al., 1992).  As concentration-response curves had also been performed 
previously (Chapter 3), a concentration for sub-maximal constriction was chosen as 1µM.   
Incubation with 100µM L-NAME converted endothelial-mediated relaxation with carbachol (synthetic 
acetylcholine analogue) to contraction in this study.  Reduced acetylcholine-induced endothelial 
relaxation after NOS inhibition has also been observed in PVs from newborn lambs (Gao et al., 1995) 
and in human PVs (Norel et al., 2004).  Results from studies in culture conditions (see Chapter 3) 
suggested that endothelial dysfunction may lead to enhanced hypoxic responses in PVs and L-NAME 
was used as a tool to simulate this dysfunction.  Therefore the aim of using L-NAME was achieved in 
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terms of simulating endothelial dysfunction (by blocking endothelial NOS (eNOS)) as it successfully 
impaired carbachol-mediated endothelial relaxation.   
The traditional classification of NOS as endothelial, neuronal and inducible was based on the cell type 
from which the isoform was originally isolated (endothelial, neuronal and activated macrophages, 
respectively).  They are now more commonly known as NOS1, NOS2 and NOS3 (neuronal, inducible 
and endothelial, respectively).  Each of these isoforms is also expressed in various other cell types 
including vascular smooth muscle (Buchwalow et al., 2002) suggesting that L-NAME could be having 
an effect not only in endothelial cells but in smooth muscle as well.  L-NAME is hydrolysed to L-NNA 
by biological esterases (Griffith and Kilbourn, 1996) and L-NNA (also known as L-NOARG and nitro-L-
arginine) has only minor selectivity for NOS1 and 3 (Moore et al., 1996).  It also binds to NOS2 
although the binding is immediate and can be reversed with arginine; binding to NOS1 and 3 is time-
dependent and reverses very slowly (Furfine et al., 1994, Klatt et al., 1994).  Therefore, despite the 
fact this experiment shows successful inhibition of endothelial-mediated relaxation with L-NAME, 
there may be effects on other isoforms and cell types such as smooth muscle. 
The effect of L-NAME on histamine contraction helped clarify the site of action of L-NAME.  L-NAME 
enhanced contractions to 1µM histamine compared to the first endothelial test whereas time control 
vessels which were not exposed to L-NAME showed inhibited histamine-induced contraction 
compared to the initial endothelial test.  Others have also shown enhanced PV constriction to 
histamine with NOS inhibition (Shi et al., 1998).  Histamine may result in NO synthesis (Ignarro et al., 
1990) via activation of endothelial H1 receptors (Toda, 1990) which would act to modulate any 
constriction via smooth muscle H1 receptors (Shi et al., 1998, Toda, 1990). The data from time control 
PVs taken alone could suggest desensitisation of pro-contractile smooth muscle H1 receptors (Shi et 
al., 1998, Toda, 1990).  However, the increased contraction to histamine seen when NOS was 
inhibited with L-NAME suggests endothelial H1 receptor upregulation occurs rather than smooth 
muscle H1 receptor desensitisation (Toda, 1990).  These results also support the role of L-NAME 
inhibition of endothelial NOS. 
 
Change in Hypoxic Responses of Inferior PVs with Repeated Exposure 
Contractions in response to hypoxia increased over time in this study in terms of peak magnitude and 
AUC.  Many investigators do not directly state their method for isolated vessel hypoxia experiments 
in terms of whether controls were run side by side on a separate vessel ring or performed in the 
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same vessel ring before drug exposure.  Both time differences and repeated exposure must be 
considered as a potential confounding factor for experiments yet there are few studies which 
address the issue.  Within rat isolated PAs, experiments have shown that hypoxic contractions either 
do not change over three separate exposures (Leach et al., 1994) or there is a small non-significant 
trend for run-down of the response between 2nd and 3rd exposures (Connolly et al., 2013).  Hypoxic 
responses within guinea pig pulmonary venules (~300µM) are repeatable and do not change 
significantly over 4 exposures (Tracey et al., 1989a, Tracey et al., 1989b).  Therefore, inferior porcine 
PVs (3.5 ± 0.2mm) appear to respond differently to repeated acute hypoxia exposures when 
compared with PAs and even pulmonary venules (although this may be due to difference in vessel 
size or species differences). 
However, a form of hypoxic preconditioning and upregulation of contractile mechanisms does exist 
within uterine smooth muscle during full-term pregnancy.  Repeated brief exposures to hypoxia 
gradually increase uterine contractions when the tissue is returned to normoxia.  Uterine contraction 
does not occur under hypoxic conditions per se but appears to increase contractile responses 
associated with labour (Alotaibi et al., 2015).  
In terms of data analysis within this chapter, the increase in hypoxic contraction over time justified 
normalising all further peak magnitude and AUC data to time control data to account for the intrinsic 
run-up in hypoxic contractions.  Other investigators have used a similar approach in PAs to take 
account of run-down in hypoxic responses over time and to determine the effect of the 
intervention/drug specifically (Connolly et al., 2013).   
 
Influence of K+ Channel Blockers on Hypoxic Responses and Baseline Tension of Inferior PVs 
4AP 
As 4AP is a base which increases extracellular pH when added to solution (Shahid and Rodger, 1989), 
the drug was made up in HEPES buffered solution and pH adjusted to 7.4 with HCl.  In accordance 
with other preliminary experiments, PVs were in Kreb’s solution before application of 4AP and on 
washout of the drug.  Normalising the data to mean time control data reveals the effect of 
4AP/HEPES buffer: significant inhibition of the hypoxic contraction compared to hypoxic contraction 
in Kreb’s buffer.  Results also showed significant inhibition of hypoxic relaxation on washout 
(compared to “during”).  Experiments with HEPES solution alone also inhibited hypoxic relaxation on 
washout (compared to “during”).  This inhibition of relaxation could be a secondary effect of the 
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large contraction to hypoxia on replacing HEPES with Kreb’s solution meaning the final response was 
not fully relaxed before reoxygenation began.  When HEPES solution was used for “before” and 
“after” responses in order to look at effects of 4AP only, there was no effect on the hypoxic response 
of PVs other than AUC being run-down over time. 
KV channels (sensitive to 4AP) regulate resting membrane potential and calcium levels in rat PASMCs 
and basal tone in rat PAs (Yuan, 1995, Archer et al., 1996).  Within superior/middle lobe porcine PVs, 
4AP inhibits hypoxic contraction (Dospinescu et al., 2012) and in both porcine and rat PVs 4AP 
application results in significant contraction above baseline tension (Dospinescu et al., 2012, 
Michelakis et al., 2001).  Both of the studies in PV used 4AP dissolved in bath/aqueous solution with 
no mention of re-checking pH yet 4AP increases extracellular pH (Shahid and Rodger, 1989). 
Unfortunately, the main limitation of the method used in this study was that pH adjustment of HEPES 
was performed at room temperature and then solutions were used at 37°C within organ baths and 
bubbled with 5% CO2.  The low pH seen in HEPES solutions within the experimental set-up (Chapter 
2) could be due to the increase in temperature (Barron et al., 2006) and/or use of high (5% CO2) 
which is known to lower pH of HEPES-buffered media within cell incubator set-ups (Elder et al., 
2015). 
A reduction in pH can cause relaxation of blood vessels from basal tone (Ishizaka and Kuo, 1996) or 
after precontraction with phenylephrine (Loutzenhiser et al., 1990) and KCl (Austin and Wray, 1993).  
Therefore it is possible that the effects seen with 5mM 4AP when Kreb’s was used for control (Figure 
30) and with HEPES buffer alone (Figure 31) were due to the change in pH rather than the drug.  The 
lack of relaxation from baseline tone as a result of reduction in pH on application of 5mM 4AP (in 
HEPES) or HEPES buffer alone is supported by similar findings in rat aorta (Loutzenhiser et al., 1990) 
and mesenteric artery (Austin and Wray, 1993) where no relaxation occurred unless vessels were 
preconstricted with a pharmacological agent.  All results within this section, including from control 
experiments with HEPES alone, showed a transient increase in baseline tension which was not 
sustained.  This may suggest a combination of change in pH and 4AP itself contributed to this 
contraction although pH change is unlikely as a reduction of extracellular pH generally leads to 
vasodilation (Austin and Wray, 1993, Ishizaka and Kuo, 1996, Loutzenhiser et al., 1990).  However as 
the effect of 4AP on baseline tension was not sustained, it is unlikely that KV channels are involved in 
long-term control of resting tension within inferior porcine PVs. 
Reducing pH to 7.14 in guinea pig pulmonary venules was enough to almost abolish hypoxic 
contractions (Tracey et al., 1989a).  This finding could explain why a reduction in hypoxic contraction 
was seen with 4AP (with Kreb’s control and washout) and HEPES alone (non-significant trend) but not 
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with 4AP where HEPES was used for control and washout.  The reduction in Ca2+ concentration by 
changing from Kreb’s solution to HEPES could also impair the hypoxic response as Ca2+ influx has 
been shown to be involved in hypoxic responses of PVs (Dospinescu et al., 2012) and isolated lungs 
(McMurtry et al., 1976).  
The run-down of response over time with 4AP (when HEPES was used for control and washout 
responses) could be due to reduced pH which is clearly documented to reduce contractile responses 
(Austin and Wray, 1993, Loutzenhiser et al., 1990) including hypoxia-induced contraction (Tracey et 
al., 1989a).  Maintaining pH between 6.56 and 6.60 (see Chapter 2) may also reduce tissue viability as 
it is below normal physiological range.  A final viability test with 80mM KCl could have helped clarify 
this but this was not performed as part of the protocol and the low pH alone could reduce force 
generated with KCl (Austin and Wray, 1993). 
 
TEA 
TEA (5mM) caused transient followed by sustained constriction of PVs from baseline tension, 
inhibited hypoxic contraction and inhibited hypoxic relaxation after washout.  TEA is as an inhibitor 
of BKCa channels (Archer et al., 1996, Moudgil et al., 2005) but is also known to inhibit KV channels in 
a concentration dependent manner (Gelband and Hume, 1992, Smirnov et al., 2002). Therefore the 
inhibition of inferior PV hypoxic contraction with 5mM TEA seen within this study and by Dospinescu 
et al. (2012) may be due to action on KV channels and/or BKCa channels.  The hypoxia sensitivity of KV 
is well documented (Archer et al., 1996, Archer et al., 1998, Archer and Michelakis, 2002, Archer et 
al., 2004, Moudgil et al., 2005, Platoshyn et al., 2006) and the BKCa channel is known to have a 
hypoxia-sensitive splice variant (STREX) (McCartney et al., 2005).  
If BKCa plays a role in attenuating hypoxic constriction as suggested by Peinado et al. (2008) and Yan 
et al. (2014) and TEA was inhibiting BKCa in this study, it would be expected that the hypoxic 
contraction of inferior PVs would be enhanced in the presence of the drug.  However, as TEA 
inhibited the contraction and had no effect on hypoxic relaxation, this suggests that BKCa is unlikely to 
play a role in attenuating hypoxic constriction in the case of inferior PVs.  Results from Chapter 3 
further support this as they showed no effect of the specific BKCa blocker Penitrem A (Dospinescu et 
al., 2012) on the hypoxic response.   
Another possibility for the mechanism of TEA is the existence of a specific KV current in inferior PVs 
which is sensitive to TEA but insensitive to 4AP.  Smirnov et al. (2002) identified two different KV 
132 
 
currents which existed within two separate SMC types identified on isolating cells from rat conduit 
PAs.  One type of KV current was 4AP-sensitive and TEA-insensitive and proposed to be mediated by 
KV channels containing KV1.5 α subunits (Grissmer et al., 1994).  The other was 4AP-insensitive and 
TEA-sensitive and proposed to involve KV2.1 α subunits (Patel et al., 1997, Shi et al., 1994).  KV 
channels containing KV2.1 α subunits may play a role in hypoxic contraction of the PV hence why 
inhibition is seen with TEA but not with 4AP or Penitrem A.  However, when KV channels contain only 
KV2.1 α subunits, they are rarely activated at membrane potentials more negative than -20mV (Patel 
et al., 1997).  This means that a homomeric KV2.1 channel is unlikely to be activated at the normal 
PVSMC RMP of −36 ± 4 mV (Dospinescu et al., 2012) and makes it an unlikely candidate for hypoxia-
induced KV current inhibition.  However, when KV2.1 is co-expressed with KV9.3, the heteromer 
channel formed shifts the activation to within the range of RMP of PVSMCs (-50 to -60mV) (Patel et 
al., 1997).  Therefore, a KV2.1/KV9.3 channel could play a role in the hypoxic response of inferior PVs.  
The sustained increase in baseline tension seen with application of 5mM TEA in this study may also 
indicate a role for KV2.1/KV9.3 channels in setting the resting tone of inferior PVs.  Notably, KV2.1 is 
expressed at the mRNA level within PVs – see Appendix 1 for more details.   
Since KV channels are inhibited by hypoxia (Archer et al., 1996, Archer et al., 1998, Archer and 
Michelakis, 2002, Archer et al., 2004, Moudgil et al., 2005, Platoshyn et al., 2006), prior block by TEA 
may mean that the initial KV trigger is unable to respond to hypoxia and hence the overall response is 
inhibited.  As the response is not completely abolished, there must be other mechanisms which 
mediate hypoxic contraction of PVs which do not require the involvement of KV
 channels. 
 
DPO-1 
Building on initial studies using the less selective agents 4AP and TEA, DPO-1 was chosen as a 
relatively selective inhibitor of KV1.5 (Lagrutta et al., 2006, Karczewski et al., 2009).  However even at 
10µM (much higher than the IC50 (30 – 266nM)), DPO-1 had no effect on any aspect of the hypoxic 
response.  KV1.5 channels are characterised as 4AP-sensitive and TEA-insensitive (Grissmer et al., 
1994, Smirnov et al., 2002) and the hypoxic response seen in inferior PVs is insensitive to 4AP and 
sensitive to TEA.  Therefore, the results with DPO-1 further support the existing data that KV1.5 is 
unlikely to mediate the hypoxic response in inferior PVs.  This demonstrates yet another difference 
between the hypoxic response in PVs and PAs; in the presence of anti-KV1.5 hypoxic depolarisation of 
PASMCs is inhibited suggesting KV1.5 plays a role in the hypoxic response of PASMCs.  Unfortunately, 
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there are no other known publications investigating the effect of DPO-1 specifically on hypoxic 
contraction within PVs or any other pulmonary vessels.   
DPO-1 (10µM) appeared to inhibit the vehicle (ethanol) induced relaxation in inferior PVs observed in 
previous solvent control experiments (Chapter 3).  This may suggest blocking KV1.5 results in 
contraction which cancels out ethanol-induced relaxation meaning KV1.5 contributes to resting tone 
in PVs.  Experiments earlier in this chapter showed a small, transient contraction of PVs in response 
to 4AP hence block of KV1.5 could suggest a common mechanism between the two drugs.  However, 
as the contraction with DPO-1 is also likely to be small and transient, if KV1.5 plays a role in 
controlling resting tone it is probably minor.  Despite these findings, KV1.5 is present at the mRNA 
level within PVs – see Appendix 1 for more details.   
 
BDM 
BDM had a concentration dependent effect on both resting tension and hypoxic contraction of 
inferior PVs.  There was no effect on ether baseline tone or hypoxic contraction until the 
concentration was 5mM.  At 5 and 10mM, baseline tension fell to a level significantly below baseline 
and hypoxic contraction was abolished.  The only difference between 5 and 10mM BDM was that the 
hypoxic response after washout of 5mM recovered fully whereas with 10mM the response did not 
fully recover.  This may suggest that reversibility of BDM is also concentration dependent. 
BDM was chosen as a known inhibitor of KV2.1 and this subunit is expressed at the mRNA level within 
PVs (see Appendix 1) yet the documented IC50 for KV2.1 channels expressed in Xenopus oocytes is 
16.7mM (Lopatin and Nichols, 1993).  Hence it may be that the results with BDM are not purely a 
result of KV2.1 inhibition but also action at another site.  BDM is known to be a non-selective agent 
with multiple sites of action.  In terms of outward K+ currents, BDM can inhibit KATP currents with an 
IC50 of 15 ± 1mM (Smith et al., 1994) however, as relaxation of basal tone and inhibition of hypoxic 
contraction occurred at a much lower level of 5mM, this site of action is also unlikely. 
Another non-specific effect of BDM is inhibition of L-type Ca2+ currents which has been demonstrated 
in guinea pig ventricular myocytes with an IC50 of 5.8 ± 0.4mM (Chapman 1993).  Within vascular 
SMCs (from uterine arteries), 10mM BDM also successfully inhibits voltage gated Ca2+ influx (Otun et 
al., 1993). This may explain the effects of BDM at 5-10mM and the lack of an effect of 1mM BDM on 
the hypoxic response.  Furthermore, this may help explain why 5-10mM BDM inhibits contractile 
responses to 80mM KCl in inferior PVs as Ca2+ entry through voltage-gated L-type Ca2+ currents is 
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essential to the depolarisation-induced contraction produced by KCl (Iino, 1990). The residual 
contraction could be a result of Ca2+ release which is known to occur in other smooth muscle cell 
types in response to KCl (Iino 1990).  L-type Ca2+ channel influx is known to contribute to the 
mechanism of hypoxic contraction in superior/middle PVs as the blocker nifedipine inhibits the 
contraction (Dospinescu et al., 2012).  However, 5-10mM BDM completely abolished hypoxic 
contraction in this study of inferior PVs whereas with nifedipine in superior/middle lobe PVs, the 
response was still present although it was significantly inhibited (Dospinescu et al., 2012).  Based on 
this, inhibition of L-type Ca2+ currents may only partly explain why BDM abolishes hypoxic responses 
in inferior PVs. 
If the actions of BDM (5-10mM) are related to Ca2+ channel inhibition, the relaxation in basal tone 
seen on drug application may suggest there is an intrinsic influx of Ca2+ which maintains tone in 
inferior PVs.  Within rat PAs, relaxation on blockade of L-type Ca2+ channel influx was only observed 
when vessels were maintained in culture for 4 days (Manoury et al., 2009).  However, mechanisms 
regulating resting tone in PVs may be different to those in PAs. 
BDM (at a concentration of 10mM) is also known to inhibit myosin light chain (MLC) phosphorylation 
within PASMCs (Polte et al., 2004) meaning it may have a more intrinsic effect on contraction.  MLC 
phosphorylation in the SMC is required for combination with actin which initiates cross-bridge cycling 
and contraction (Webb, 2003).  This could explain at a more fundamental level why BDM causes 
relaxation of inferior PVs and abolishes hypoxic contraction. 
Therefore, BDM inhibition of the hypoxic response could be as a result of one or a combination of 
KV2.1 inhibition, KATP inhibition, L-type Ca
2+ channel block and inhibition of MLC phosphorylation.  The 
relaxatory effect of BDM on baseline tension may be due to its inhibitory effect on L-type Ca2+ 
channel block and/or inhibition of MLC phosphorylation. 
 
Glyburide 
Application of glyburide (10µM) had no significant impact on baseline tension or on the magnitude or 
dynamics of the hypoxic contraction.  Relaxation was increasingly inhibited over time but this was 
only statistically significant when comparing hypoxic responses after washout to initial responses.  
The hypoxic contraction also became smaller after washout of the drug although this effect did not 
reach statistical significance.  The inhibition of both hypoxic relaxation and contraction could suggest 
that glyburide is not fully reversible and has a delayed onset of action.  This issue could be addressed 
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by allowing for a longer incubation time or increasing glyburide concentration in future experiments.  
Glyburide is a more specific K+ blocker than some of the others previously discussed, with effects on 
KATP (Dospinescu et al., 2012).  This may indicate that KATP channels are involved in modulation the 
hypoxic response of the inferior PV however Dospinescu et al. (2012) found that glyburide did not 
have an effect on hypoxic contraction of superior/middle lobe porcine PVs.  This could suggest a 
possible difference in underlying mechanisms between inferior and superior PVs.   
Within foetal and adult rabbit PASMCs, glyburide has no effect on RMP suggesting KATP does not 
contribute to membrane potential in these cells (Osipenko et al.,1997, Hong et al., 2005) and also 
does not affect resting tone in rat PVs (Michelakis et al., 2001).  This ties in with the results from this 
study; KATP channels are unlikely to be involved in regulation of resting tone in inferior PVs. 
 
ZnCl2 
Application of ZnCl2 (1mM) had no effect on baseline tension or any aspect of the hypoxic response.  
ZnCl2 was used to investigate the role of TASK-1/3 (Ali et al., 2014) in resting tone and the hypoxic 
response of inferior PVs.  At a concentration of 1mM, ZnCl2 would be expected to block TASK-3 as the 
IC50 for this channel is ~12 - 20µM (Gruss et al., 2004, Clarke et al., 2004).  Previous use of ZnCl2 as a 
TASK-1/3 blocker in human placental arteries used a concentration of 1mM (Ali et al., 2014).  
However, at this higher concentration ZnCl2 could also block TREK-1 (another member of the two-
pore domain K+ channel superfamily) as the IC50 is 659 ± 94µM (Gruss et al., 2004). 
TASK-1 channels are of particular interest because they are known to be inhibited by hypoxia and are 
involved in control of RMP in human PASMCs, implicating a role in regulation of basal tone in PAs 
(Olschewski et al., 2006).  Interestingly, within a TASK-1/3 knockout mouse model RMP in PASMCs 
was unchanged and even in wild type mice, hypoxic contraction was poor and inconsistent (Manoury 
et al., 2011). These findings challenge the use of a mouse model for studying the pulmonary 
circulation and support the exploration of different models e.g. porcine.   
On further investigation of use of ZnCl2 as a TASK-1 blocker, the results of Ali et al. (2014) do not 
provide definitive evidence that ZnCl2 blocks TASK-1 as they examined contractile responses of 
human placental arteries and did not dissect out the TASK-1 or -3 currents specifically.  The inhibitory 
effect on human TASK-3 is well established (Gruss et al., 2004, Clarke et al., 2004) however human 
TASK-1 (expressed within Xenopus oocytes) current was inhibited by less than 10% by 200µM ZnCl2 
(Clarke et al., 2004).  In rat TASK-1 (expressed within Xenopus oocytes), ZnCl2 showed an IC50 of 
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175µM (Leonoudakis, 1998). Despite this, the possibility that ZnCl2 was not effectively blocking TASK-
1 in these experiments must be considered. 
A more suitable alternative to ZnCl2 for investigating TASK-1 contribution specifically may be 
anandamide.  Anandamide has been shown to be a selective inhibitor of TASK-1 at a concentration of 
3µM with no effect on other members of the two-pore domain K+ channel superfamily (including 
TREK-1 and -2 and TASK-2 and -3) (Maingret et al., 2001).  Anandamide increases pulmonary arterial 
tone at a concentration of 10µM (Wenzel et al., 2013) which could suggest anandamide is acting via 
TASK-1 inhibition.  However, these studies were performed in a mouse model and as earlier 
described, RMP was unaffected in PASMCs from a TASK-1 knockout mouse model (Manoury et al., 
2011) therefore the increased PA tone may be a result of other non-specific effects.  As an 
endocannabinoid, anandamide is likely to have other effects on vascular contractility such as 
involvement in the fatty acid amide hydrolase pathway (Wenzel et al., 2013). 
Further investigation with other pharmacological agents is required before the role of TASK-1 (and 
other members of the two-pore domain K+ channel superfamily) in the regulation of basal tone and 
hypoxic responses in porcine inferior PVs can be established. 
 
Influence of L-NAME on Hypoxic Responses and Baseline Tension of Inferior PVs 
When introduced near the beginning of the experimental protocol, L-NAME (100µM) produced no 
change in tension however when introduced at a later time-point it produced a sustained increase in 
baseline tone.  These results cannot be explained by hypoxia exposure as time controls (where L-
NAME was applied at the same time-point but vessels were not exposed to hypoxia) also responded 
with a sustained contraction.  Stretch is documented to result in NO production within pulmonary 
capillary endothelial cells (Kuebler et al., 2003).  Tension was also readjusted to 1.5g in the time 
controls as part of the standard protocol therefore PVs were under more stretch at the later time 
point and this may explain the different effects of L-NAME at early and late time-points.     
L-NAME (100µM) also had a profound effect on the hypoxia-induced response of inferior PVs: 
inhibiting and shortening contraction and enhancing relaxation.  Plotting the difference between 
“before” and “during” traces revealed the component of the PV hypoxic response sensitive to L-
NAME.  This was an initial small relaxation followed by a transient contraction then a small sustained 
contraction component.  Therefore there appears to be a balance of pro-contractile and pro-relaxant 
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mechanisms during the response to hypoxia in PVs and L-NAME shifts the balance towards pro-
relaxant mechanisms particularly during the relaxation phase.   
Hypoxic responses showed no recovery after washout of L-NAME indicating the drug is poorly 
reversible.  The purpose for choosing L-NAME was to interfere with endothelial production of NO and 
therefore mimic the effects of PV maintenance in culture seen in Chapter 3.  However the hypoxic 
responses of inferior PVs seen in the presence of L-NAME did not resemble the hypoxic responses 
seen in PVs which had been maintained in culture.  With L-NAME, peak and AUC were reduced; after 
maintenance in culture they were increased.  Hypoxic relaxation was enhanced with L-NAME yet 
after maintenance in culture, relaxation was inhibited.  Others have also observed partial inhibition 
of hypoxic contraction in pig PVs with NOS inhibition (Félétou et al., 1995).  It is suggested that 
hypoxia usually results in inhibition of NO production allowing for a contraction to develop, whereas 
when NOS is already blocked this prevents hypoxic inhibition of the enzyme (Félétou et al., 1995).  
This could explain why L-NAME caused inhibition of hypoxic contraction of inferior PVs within this 
study.  The results of this study and those of Félétou et al. (1995) showed only partial inhibition of 
hypoxic contraction in PVs yet in PAs NOS inhibition abolishes the contraction (Félétou et al., 1995).  
Indomethacin (cyclooxygenase inhibitor) has been reported to partially (Félétou et al., 1995) or 
completely inhibit hypoxic contraction of pig PVs (Miller et al., 1989).  Therefore hypoxic inhibition of 
both NOS and cyclooxygenase may be required in order for development of a contractile response.  
Only blocking one endothelial vasodilatory pathway may also cause an imbalance and may explain 
the emergence of a much larger relaxation after hypoxic peak.  Inhibition of NOS may lead to 
increased release or enhanced reactivity to vasodilatory prostaglandins.  To investigate this theory 
further, experiments would need to be conducted in the presence of both L-NAME and 
indomethacin.   
NO can react with superoxide (O2
.-) to produce peroxynitrite (ONOO-) which is much less reactive and 
eventually leads to accumulation of the innocuous by-product NO3
-(Dweik et al., 2001). If NOS is 
inhibited and NO levels reduced, less NO is available to “mop up” O2
.-.  Reactive oxygen species (ROS) 
including O2
.- are proposed as second messengers during HPV in isolated lung and PASMCs; inhibitors 
of superoxide dismutase (which converts O2
.- to H2O2) inhibit HPV suggesting ROS signalling is 
important during HPV (Waypa et al., 2001).  However, reduced NO and increased O2
.- should lead to 
increased hypoxic contraction if a similar underlying mechanism is present in PVs.  There is another 
school of thought which suggests hypoxia leads to reduced ROS production followed by K+ channel 
inhibition (Archer et al., 1993), membrane depolarisation (Yuan, 1995) and voltage-gated Ca2+ influx 
(McMurtry et al., 1976).  Increased O2
.- during NOS inhibition may oppose this mechanism and lead to 
138 
 
reduced contraction.  Further investigations using antioxidants and inhibitors of ROS production are 
required before any of these mechanisms can be consolidated. 
Despite the profound impact of L-NAME on the hypoxic response of inferior PVs, there is no clear 
explanation for its effects as they were different to those anticipated.  It is likely to be a complex and 
multi-factorial process. 
 
Reoxygenation Contractile Responses of Inferior PVs and Impact of L-NAME 
Contractile responses to reoxygenation after hypoxic exposure were poor and inconsistent.  This was 
unexpected as reoxygenation contractions within previous experiments (Chapter 3) were consistent 
and occurred in the majority of PVs.  This may be due to the fact that different abattoirs were used to 
source the tissue and perhaps different sub-species of pig.   
A consistent response during reoxygenation was the potentiated contraction in the presence of 
100µM L-NAME.  The effect of L-NAME was irreversible as reoxygenation contractions were still 
significantly greater after removal of the drug when compared to initial control (“before”) responses. 
As discussed previously, if NOS is inhibited by L-NAME and NO levels reduced, less NO will be 
available to “mop up” O2
.- (Dweik et al., 2001).  ROS including O2
.- are proposed as second 
messengers within hypoxic vasoconstriction within isolated lung and PASMCs (Waypa et al., 2001).  
Perhaps ROS are involved in mediating the contractile response to reoxygenation which is 
potentiated after exposure to L-NAME as less NO is available to “mop up” O2
.- resulting in imbalance 
and increased availability of O2
.-  as a second messenger.  Others have proposed that ROS may 
mediate reoxygenation contraction of pig PAs (Liu et al., 2001).  Again, further investigation using 
antioxidants and inhibitors of ROS production would be required before any of these mechanisms 
can be consolidated. 
L-NAME had a consistent effect on both reoxygenation and hypoxic responses of inferior PVs but no 
definitive conclusions can be drawn as to how exactly it brought about these actions until further 
studies are performed. 
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Key Findings 
This study set out to investigate mechanisms regulating hypoxia-induced responses within inferior 
PVs.  Inhibition of NOS with L-NAME inhibited hypoxic contraction, enhanced relaxation and 
potentiated contraction on reoxygenation.  The K+ channel inhibitors TEA and BDM inhibited the 
hypoxic contraction whereas 4AP, DPO-1, glyburide and ZnCl2 had no effect.  Therefore, KATP, KV1.5 
and TASK do not appear to affect hypoxic contraction however a potential candidate for involvement 
is the KV2.1 α subunit as this is TEA- and BDM-sensitive and 4AP-insensitive (Lopatin and Nichols, 
1993, Patel et al., 1997, Shi et al., 1994, Smirnov et al., 2002).   
This study has highlighted that both NO and certain K+ channels contribute to the mechanism 
underlying hypoxia-induced contraction of porcine inferior PVs.  These pathways could provide 
possible targets for use in the treatment of hypoxia-related disease e.g. high altitude pulmonary 
oedema where inhomogeneous hypoxic pulmonary venoconstriction causes increased upstream 
capillary pressure (Bärtsch and Gibbs, 2007, Maggiorini et al., 2001).   
 
Further Work 
Regulation of contractile pathways within PVs is likely to be complex and multifactorial.  
Electrophysiology studies will be used to further investigate the functional contribution of specific K+ 
channels to RMP and voltage-activated whole-cell currents and to further explore the hypoxic 
response at the isolated smooth muscle cell level. 
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Chapter 5 
Impact of Maintenance in Culture Conditions on Morphological and 
Electrophysiological Characteristics of Inferior Pulmonary Vein 
Smooth Muscle Cells 
 
 
Introduction 
Isolated porcine PVs have shown marked vasoactive responses to hypoxia, agonists and some K+ 
channel inhibitors (Chapters 3 & 4). Exposure of PVs to culture conditions for 24 hours resulted in 
augmented contractile responses to hypoxia and agonists and endothelial dysfunction/damage was 
proposed to contribute.  However, when L-NAME was used to interfere with endothelial production 
of NO, hypoxic contraction was inhibited rather than being increased.   Therefore it was pertinent to 
investigate whether maintenance of PV in culture conditions has any direct effect on isolated smooth 
muscle cells.   
Smooth muscle cells (SMCs) are intrinsic to vasoactivity and maintenance of vascular tone in all blood 
vessels (Dospinescu, 2009).  SMC shape and width can both have an impact on contractile force 
(Tolic-Norrelykke and Wang, 2005) therefore cell morphology is important to characterise and 
compare between cells isolated from fresh PVs and PVs kept in culture.  Furthermore, total area of 
the cell is directly proportional to membrane capacitance which is a measurement of the 
phospholipid cell membrane’s ability to store electrical charge (Molleman, 2003).  Full 
characterisation of morphological and electrical membrane properties of SMCs isolated from 
superior/middle PVs has been performed previously (Dospinescu, 2009); the studies within this 
chapter (as in Chapter 4) will focus on SMCs isolated from inferior PVs. 
Further to morphological influences on contraction, resting membrane potential (RMP) and voltage-
activated currents of SMCs regulate contractility and resting tension of blood vessels,  via the second 
messenger Ca2+(Dospinescu, 2009, Yuan et al., 1993).  SMCs isolated from PAs kept in culture 
conditions for 4 days had depolarised membrane potentials and reduced K+ currents compared with 
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freshly isolated PASMCs (Manoury et al., 2009).  The impact of maintaining PVs in culture on the 
electrophysiological properties of PVSMCs remains to be established. 
 Potential K+ channel targets for electrophysiology studies were unfortunately not identified via RT-
PCR experiments (Appendix 1) due to persisting problems with tissue homogenisation and extracting 
RNA of sufficient yield and quality.  Due to this, targets and pharmacological agents were selected 
based on previous findings in isolated inferior PV studies (Chapter 4) and in PVSMCs (Dospinescu et 
al., 2012, Michelakis et al., 2001).  Within isolated inferior PVs, 5mM TEA caused a sustained increase 
in baseline tension and inhibited hypoxic contraction whereas 4AP had no clear effect on either.  
Voltage-activated outward currents in SMCs from porcine and rodent PVs were sensitive to both TEA 
and 4AP (Dospinescu et al., 2012, Michelakis et al., 2001).  Therefore the impact of both 4AP and TEA 
on RMP and whole-cell voltage-activated currents in inferior PVs was investigated.  TASK-1 is another 
K+ channel of particular interest as it is inhibited by hypoxia and involved in control of RMP in human 
PASMCs (Olschewski et al., 2006).  ZnCl2 can be used to inhibit TASK-1/3 (Ali et al., 2014, Patel et al., 
2013) in order to establish the role of TASK in controlling RMP and the contribution of TASK to 
whole-cell voltage-activated currents within fresh PVSMCs and SMCs isolated from PVs maintained in 
culture conditions. 
Hypoxic contraction within PVs is a robust and reproducible physiological response augmented by 
maintenance in culture conditions (Chapters 3 & 4) and hypoxia is known to cause depolarisation of 
SMCs from PAs (Archer et al., 1996, Archer et al., 2004, Hong et al., 2005, Olschewski et al., 2002, 
Osipenko et al., 1997, Post et al., 1992, Yuan et al., 1993).  Therefore, the impact of hypoxia on RMP 
of inferior PVSMCs required investigation in order to further explore underlying mechanisms of 
hypoxic contraction in PVs and the augmentation seen after maintenance in culture conditions.   
The aim of this study was to characterise and compare morphological properties and 
electrophysiological characteristics (RMP and voltage-activated currents) of SMCs isolated from fresh 
inferior PVs and from inferior PVs maintained in culture conditions for 24 hours. 
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Methods and Experimental Protocols 
Cell Morphology Measurements 
After enzymatic cell isolation was complete (see Chapter 2 for details), approximately 80-100µL of 
cell suspension was pipetted onto a glass slide and cells were allowed to settle for 15-20 minutes.  
The glass slide was mounted on the stage of a Leica DMI4000 B inverted microscope (Leica 
Microsystems CMS GmbH, Germany) fitted with a phase-contrast objective (magnification x40, 
numerical aperture 0.40).  The microscope was connected to a Leica DFC300 FX camera (Leica 
Microsystems Ltd, Heerbrugg, Switzerland) and Leica Application Suite (LAS) software which were 
used to capture phase-contrast photomicrographs of the PVSMCs. 
Image J software, version 1 (US National Institutes of Health, Betheseda, Maryland, USA; available 
from: http://imagej.net/Downloads) was used to analyse phase-contrast images and make cell 
measurements.  For every PVSMC analysed, the following measurements were made using Image J: 
perimeter (length of the cell boundary), area (two-dimensional area enclosed within the cell 
boundary), length and width (at widest point of the cell).  Cell length and width were also calculated 
using the perimeter and area values from Image J by approximation to an ellipse and compared to 
measured values.  Perimeter and area values were also used to calculate circularity of the smooth 
muscle cell and tri-dimensional membrane surface area was calculated by approximation to an 
ellipsoid. 
Morphological data are presented as mean ± SD, range (minimum – maximum values) and the 
coefficient of variation (CV).  CV is the ratio of SD to the mean and is useful for comparison of 
dispersion of values between different groups: 
𝐶𝑉 =  
𝑆𝐷
𝑚𝑒𝑎𝑛
 
          (Equation 4) 
In this case, it will be used to compare dispersion of morphological measurements between SMCs 
isolated from fresh inferior PVs and from PVs maintained in culture.  Histograms were plotted side-
by-side for fresh/culture PVSMCs for all morphological parameters and fitted with a Gaussian 
probability density function: 
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𝑓 𝑥 =
1
𝜎√2𝜋
𝑒
−
(𝑥−𝜇)2
2𝜎2  
          (Equation 5) 
where 𝜎 is the standard deviation and µ is the mean.  Differences between mean values were 
assessed using Students unpaired t-test. 
 
Membrane Capacitance and Series Resistance 
Membrane capacitance (Cm) refers to a measurement of the phospholipid cell membrane’s ability to 
store electrical charge at a given potential and is directly proportional to the total area of the cell 
membrane (Molleman, 2003). Therefore, Cm is often used to standardise whole cell currents to cell 
size which converts current values to current densities by dividing the current by the capacitance 
value measured for the cell in question.  Cm was calculated by the WinEDR software using the 
following equation: 
𝐶𝑚 = 𝜏(𝐺𝑎 + 𝐺𝑚 ) 
(Equation 6) 
Ʈ is the time constant of the exponential decay of the transient capacitive current; this current occurs 
as a result of a step change in potential (voltage) applied to the cell.  During the step change, charge 
builds up exponentially within the capacitor (cell membrane) before reaching steady state.  Visually, 
the transient capacitive current appears as a spike and then an exponential decay in current.  Ga is 
the access conductance and is the reciprocal of access resistance and Gm is the membrane 
conductance and is the reciprocal of membrane resistance.  Ga was calculated by WinEDR using the 
equation: 
 
𝐺𝑎 =
𝐼0
𝑉𝑝𝑢𝑙𝑠𝑒
 
(Equation 7) 
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where I0 is the initial current at the start of the capacitive transient (estimated from the amplitude of 
the fitted exponential at the start of the voltage step) and Vpulse is the steady state voltage amplitude.  
Gm was calculated by Win EDR using the equation: 
𝐺𝑚 =
𝐼𝑝𝑢𝑙𝑠𝑒
𝑉𝑝𝑢𝑙𝑠𝑒 −
𝐼𝑝𝑢𝑙𝑠𝑒
𝐺𝑎
 
(Equation 8) 
where Ipulse is the steady state current amplitude. Cm, Ga and Gm were logged via the WinEDR software 
after approximately 4 minutes of achieving the whole-cell configuration to allow for exchange 
between cell and pipette solution contents.   
During whole-cell patch clamping, series resistance (Rs) is the sum of all resistance encountered by 
the current before it reaches the cell and can be used as a measure of quality of the cell membrane 
patch clamp (Molleman, 2003).  Rs is made up of membrane resistance and access resistance (which 
refers to the patch resistance after the whole-cell configuration has been achieved and should be low 
since the membrane patch is ruptured at this stage).  Rs impacts on the voltage which cells are 
actually exposed to; the greater the series resistance, the greater the reduction in voltage which has 
adverse effects on voltage clamping and the quality of subsequent cell recordings.  Rs should ideally 
be maintained at less than 20 MΩ (Molleman, 2003) and was calculated using the following equation 
(knowing Ga and Gm as previously discussed): 
𝑅𝑠 =
1
𝐺𝑎 + 𝐺𝑚
 
(Equation 9) 
In order for Cm, Ga and Gm to be calculated correctly, series resistance was not compensated 
electronically as per WinEDR v3.7.0 instruction manual. 
 
Resting Membrane Potential – Baseline Values, Effect of Flow and Viability Testing 
After Cm, Ga and Gm were logged, the amplifier was switched to current clamp mode (at zero current) 
in order to measure RMP under resting conditions in extracellular bath solution.  No adjustment was 
made for potential differences arising from liquid junction potentials - justification for this is detailed 
within Chapter 2. 
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As experimental protocols involving drug application and exposure to hypoxic bath solution were to 
be performed in the presence of constant flow, RMP was recorded when flow was switched on to 
investigate whether introduction of flow alone had any impact on RMP.  KCl (80mM) was applied via 
Picospritzer® to test viability in some PVSMCs (in terms of membrane potential depolarisation).  RMP 
was recorded continuously before application (10 seconds), during application (2 seconds) and after 
washout (10 seconds) of KCl.   
 
Resting Membrane Potential – Effect of K+ channel Inhibitors and Hypoxia 
The contribution of different K+ channels to the RMP of inferior PVSMCs was investigated by 
application of K+ channel blockers via Picospritzer®.  RMP was recorded continuously before, during 
and after application of: the KV channel inhibitor 4AP (Dospinescu et al., 2012), BKCa inhibitor TEA 
(Archer et al., 1996, Moudgil et al., 2005), and TASK-1/3 blocker zinc chloride (ZnCl2) (Ali et al., 2014, 
Patel et al., 2013).  The concentrations used were the same as those used in myography experiments 
in Chapter 4 – 5mM 4AP, 5mM TEA and 1mM ZnCl2.  Baseline RMP (“before”) was recorded for 10 
seconds followed by a 90 second application of the drug via Picospritzer® and a 10-30 second 
washout period after application had stopped. 
The effect of exposure to hypoxic bath solution on the RMP of PVSMCs was also investigated by 
continuously recording RMP for 1 minute under baseline normoxic conditions (“before” – solution 
passively oxygenated with room air), followed by 5 minutes hypoxia (solution bubbled with 100% N2 
for at least 10 minutes) and 5 minutes recovery under normoxic conditions. 
 
Voltage-activated Whole-cell Currents - Effect of K+ Channel inhibitors 
A voltage clamp protocol was used to identify and characterise whole-cell voltage-activated currents 
within inferior PVSMCs.  To create a pharmacological profile of the outward K+ current, voltage-
activated currents were measured before, during and after washout of 5mM 4AP, 5mM TEA and 
1mM ZnCl2.  
A standard voltage step protocol was applied to identify whole-cell voltage-activated families of 
outward currents.  The resting potential was set at -80mV and 17 separate voltage step pulses were 
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applied for 400-ms starting at -80mV and increasing incrementally by 10mV up to the final voltage of 
+80mV (Figure 44 shows a diagram of the protocol used). 
 
Figure 44. Standard voltage step protocol.  Each voltage step was applied for 400-ms and steps went 
from -80mV to +80mV in 10mV increments. 
 
Voltage step protocols were applied before application of any drug followed by a 60 second rest 
period then the K+ channel inhibitor was applied by Picospritzer® for 90 seconds and in the last 30 
seconds of application the voltage step protocol was applied.  After 60 seconds washout of the K+ 
channel inhibitor under constant flow, the voltage step protocol was applied again to assess for 
recovery of currents. 
To calculate the rate of activation of whole-cell voltage-activated currents within inferior PVSMCs, 
raw traces were fitted with a “one-phase association” curve using GraphPad Prism 7 and the 
following equation:  
𝐼 = 𝐼0 +  𝐼𝑝𝑙𝑎𝑡𝑒𝑎𝑢 − 𝐼0 × (1 − 𝑒
−𝐾𝑎𝑐𝑡 𝑥) 
 (Equation 10) 
where I0 is the current at time=0 and Iplateau is the current value at steady state.  Kact is the rate 
constant of current activation, expressed in the reciprocal of time units and Ʈact is the time constant 
of current activation and is computed as the reciprocal of Kact.  Ʈact was used to compare activation 
rates of currents in the presence and absence of K+ channel inhibitors. 
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All RMP and whole-cell current protocols were performed using both SMCs isolated from fresh PVs 
and from PVs maintained in culture for 24 hours.  Data for fresh/culture SMCs were analysed 
separately owing to the differences observed in earlier contractile studies when PVs were exposed to 
culture conditions for 24 hours (see Chapter 3). 
 
Data Analysis – Electrophysiology 
Electrophysiological data (membrane potential and currents) were recorded using WinEDR software 
and exported to Microsoft Excel and GraphPad Prism 5/7 for analysis.  Membrane potential (mV) 
responses were complex and therefore the most objective method was to measure and average RMP 
values over the full time periods of “before”, “during” and “after” recordings.  This was aided by the 
marker on the recorded trace from the Picospritzer® system which was connected to the Axopatch 
amplifier.  Currents were measured as the average current once steady state was reached.  Raw 
trace data are presented as measured currents (pA) and mean data as current density (in pA/pF) by 
dividing current by respective capacitance values (pF) to standardise whole cell currents to cell size 
(as discussed previously) before data were combined.  Mean values before, during and after drug 
application/hypoxia were compared statistically using repeated measures one-way ANOVA with 
Tukey’s post test or repeated measures two-way ANOVA with Bonferroni’s post test.  Mean values 
for SMCs isolated from fresh PVs and from PVs maintained in culture were compared statistically 
using Students unpaired t-test or two-way ANOVA with Bonferroni’s post test.  Statistical significance 
for all tests was determined at P<0.05. 
For all cell morphology and electrophysiology, N=number of animals and n=number of cells.  For the 
purposes of all statistical analysis (including calculation of S.E.M.) within this chapter, n (number of 
cells) will be used.   
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Results 
Cell Morphology 
SMC shape and width can both have an impact on contractile force (Tolic-Norrelykke and Wang, 
2005) therefore it is important to investigate cell morphology when considering isolated PVSMCs.  
Furthermore, total cell area is directly proportional to membrane capacitance which is a 
measurement of the phospholipid cell membrane’s ability to store electrical charge (Molleman, 
2003).   
As described in Chapter 2, the yield and quality of cells produced from each daily isolation procedure 
were documented.  Both yield and quality (in terms of cell membrane and contractile state) varied 
when the protocol was used on tissue from different animals and on fresh PVs or PVs maintained in 
culture.  Cells which were viable for use in electrophysiology experiments were either relaxed, 
elongated and spindle-like or partially contracted whilst maintaining an elliptical shape.  All cells 
identified as viable SMCs for patch-clamping had no striations and a single, central nucleus.  No other 
identification of cell phenotype was undertaken beyond morphological and functional responses. 
 
Cell Perimeter and Projected Area 
From cell isolation experiments using fresh inferior PVs, measurements were made on 240 cells from 
24 different animals (n=240; N=24).  From cell isolation experiments using inferior PVs maintained in 
culture, measurements were made on 131 cells from 19 different animals (n=131; N=19).  Only 
relaxed or partially contracted elliptical cells were measured.  All cell membrane qualities were 
considered for measurements to give a wider cell sample as on some days the protocol only 
produced poor quality cells.  Cells that were fully contracted (spherical in shape) were not included in 
the analysis. 
Using ImageJ, outlines were drawn around each relaxed/partially contracted cell and perimeter (in 
pixels) and area (in pixels2) were measured.  The values were then converted to µm and µm2, 
respectively, using the conversion factor for 40x magnification (0.22 µm/pixel, as calculated from an 
image of a stage micrometer using ImageJ). 
Cells isolated from fresh inferior PVs had a minimum perimeter of 68.8 µm and a maximum of 489.4 
µm and cells isolated from PVs maintained in culture had a minimum perimeter of 56.5µm and a 
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maximum of 560.7 µm.  The CV values for cells from fresh PVs and from those maintained in culture 
were similar (0.37 and 0.44, respectively).   However the mean perimeter for cells isolated from PVs 
maintained in culture (265.7 ± 117.2 µm, n=131) was significantly larger than for fresh PVSMCs 
(240.7 ± 88.3 µm, P<0.05, n=240).  See Table 5 for details. 
The projected area of cells isolated from fresh PVs ranged from 158.1 to 1836.9 µm2; for cells from 
PVs maintained in culture the area ranged from 101.5 to 1946.5 µm2.  The CV for cells from fresh PVS 
was smaller (0.45) than the CV for cells from PVs maintained in culture (0.53) indicating a wider 
distribution of values in the latter.  Mean projected area values were not significantly different 
(Fresh: 785.3 ± 353.6 µm2 and Culture: 848.8 ± 446.4 µm2, mean ± SD, P>0.05).  See Table 5 for 
details.  Histograms comparing the distribution of values for perimeter and projected area for SMCs 
isolated from fresh PVs and from PVs maintained in culture are shown in Figure 45.  
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Figure 45. Perimeter and projected area of smooth muscle cells isolated from fresh pulmonary 
veins (PVs) and from PVs maintained in culture.  Histograms show the distribution of (A) perimeter 
and (B) projected area of smooth muscle cells (SMCs) isolated from fresh PVs (wide, grey bars 
(n=240; N=24)) and PVs maintained in culture (narrow, black bars (n=131; N=19)), as measured on 
photomicrographs.  Data values were fitted with Gaussian distributions (black curves).  
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Cell Length and Width 
Cell length and width were measured (in pixels) by drawing lines of length and width (at widest 
point) using ImageJ and converted to µm using the conversion factor 0.22 µm/pixel.  Cell length and 
width were also calculated by approximating PVSMC shape to an ellipse using the perimeter and 
projected area values measured for the cell using ImageJ software.  The length and width of the 
PVSMC were approximated as the major and minor axis, respectively, of the corresponding ellipse 
(see Figure 46).  
 
 
Figure 46. Estimation of cell shape for length and width calculations.  The shape of each measured 
PVSMC was approximated to an ellipse of the same area and perimeter as the measured cell in order 
to calculate cell length (major ellipse axis in figure) and width (minor ellipse axis in figure). 
The size of the major and minor ellipse axes were calculated from the standard equation for the area 
of an ellipse: 
𝐴 = 𝜋𝑎𝑏 
 (Equation 11) 
along with another equation by Euler which approximates the perimeter of an ellipse (Almkvist and 
Berndt, 1988): 
𝑃 =  𝜋 2(𝑎2 + 𝑏2) 
   (Equation 12) 
where a is the semi-major axis and b is the semi-minor axis of the ellipse.  From the two equations 
above considering area (A) and perimeter (P) were known, a biquadratic equation was produced: 
𝑥4 −
𝑃2
2𝜋2
𝑥2 +
𝐴2
𝜋2
= 0 
(Equation 13) 
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with the two positive solutions to Equation 13 being the semi-major axis (half length) and semi-minor 
axis (half width) of the approximated ellipse and corresponding PVSMC. 
Values from measurements directly from photomicrographs and those calculated from 
approximation to an ellipse were compared to investigate the reliability of each method.  For cells 
isolated from fresh inferior PVs, the mean measured length (± SD) was 112 ± 43.5 µm (range 27.3 – 
231.2 µm) whereas the mean length calculated from approximation to an ellipse was 107.8 ± 39.9 
µm (range 30.0 – 220.1 µm).  Coefficients of variation were similar indicating a similar dispersion of 
values – 0.39 and 0.37, respectively.  See Table 5 for details.  Calculated length values were 
significantly shorter than their corresponding measured values (P<0.001).  There was a strong and 
significant correlation between measured and calculated cell length (Pearson’s r coefficient = 0.9974, 
P<0.001), as shown in Figure 47. 
For cells isolated from PVs maintained in culture, the mean measured length (± SD) was 124.4 ± 57.3 
µm (range 25.2 –270 µm) whereas the mean length calculated from approximation to an ellipse was 
119.2 ± 52.9µm (range 25.0 – 252.2 µm).  Coefficients of variation were similar: 0.46 and 0.44, 
respectively.   See Table 5 for details. Length values calculated by approximation to an ellipse were 
significantly shorter than their corresponding measured values (P<0.001).  For cells isolated from PVs 
maintained in culture, there was also a significant correlation between measured and calculated 
length values (Pearson’s r coefficient = 0.9979, P<0.001), as shown in Figure 47.  Cells isolated from 
PVs maintained in culture were significantly longer than those isolated from fresh PVs when 
considering either measured or calculated values (P<0.05). 
The measured width of cells isolated from fresh PVs ranged from 2.5 to 19.3 µm with a mean of 9.3 ± 
3.0 µm; width values calculated from approximation to an ellipse ranged from 3.4 to 18.9 µm with a 
mean of 9.3 ± 2.7 µm.  CVs were similar – 0.32 and 0.29, respectively and there was no significant 
difference between measured and calculated width values (P<0.05).  See Table 5 for details.  There 
was a significant correlation between measured and calculated cell width (Pearson’s r coefficient = 
0.7959, P<0.001), see Figure 47. 
The measured width of cells isolated from PVs maintained in culture ranged from 3.0 to 19.9 µm with 
a mean of 8.8 ± 3.3 µm; width values calculated from approximation to an ellipse ranged from 4.4 to 
19.2 µm with a mean of 8.9 ± 2.7 µm.  CV for measured widths was larger (0.37) to CV for calculated 
widths (0.30) indicating more dispersion within the measured values.  See Table 5 for details.  There 
was no significant difference between measured and corresponding calculated width values (P<0.05).  
There was a significant correlation between measured and calculated cell width (Pearson’s r 
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coefficient = 0.7892, P<0.001), see Figure 47.  There was no significant difference between measured 
or calculated width values when comparing cells isolated from fresh PVs to those maintained in 
culture (P>0.05).  Histograms for measured and calculated lengths and widths are shown in Figure 48. 
 
Figure 47. Correlation of cell length and width values measured and calculated by approximation to 
an ellipse.  Measured values were plotted against calculated values for A: cell length in SMCs isolated 
from fresh inferior PVs; B: cell length in SMCs isolated from inferior PVs maintained in culture; C: cell 
width in SMCs isolated from fresh inferior PVs and D: cell width in SMCs isolated from inferior PVs 
maintained in culture.  Black lines represent the slopes calculated by linear regression analysis; r is 
Pearson’s correlation coefficient; R2 represents goodness of fit (calculated by linear regression).  
Fresh PVSMCs: n=240; N=24; SMCs from PVs maintained in culture: n=131; N=19. 
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Figure 48. Cell length and width – measured and calculated from approximation to an ellipse. 
Histograms show the distribution of A: measured length; B: length calculated by approximation to an 
equivalent ellipse; C: measured width and D: width calculated by approximation to an equivalent 
ellipse in smooth muscle cells (SMCs).  SMCs were either isolated from fresh pulmonary veins (PVs) 
(wide, grey bars (n=240; N=24)) or PVs maintained in culture (narrow, black bars (n=131; N=19)).  
Data values were fitted with Gaussian distributions (black curves).  
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Circularity 
Smooth muscle cell shape has an impact on contractile force (Tolic-Norrelykke and Wang, 2005) 
hence this was taken into account when undertaking morphological characterisation of inferior 
PVSMCs.  Circularity was calculated as a quantitative measure of SMC elongation (Auman et al., 
2007) using known projected area (A) and perimeter (P) measurements from ImageJ and the 
following equation: 
𝐶𝑖𝑟𝑐𝑢𝑙𝑎𝑟𝑖𝑡𝑦 = 4𝜋𝐴/𝑃2 
   (Equation 14) 
Circularity is a unit-less ratio which can range from 0 to 1; a value of 1 represents a perfect circle and 
values approaching 0 indicate increasing elongation of the cell.  Circularity in SMCs isolated from 
fresh inferior PVs had a mean value of 0.19 ± 0.09 and ranged from 0.06 to 0.58 (n=240).  In SMCs 
isolated from inferior PVs maintained in culture for 24 hours, mean circularity was 0.18 ± 0.09 and 
ranged from 0.05 to 0.51 (n=131, P>0.05 compared to fresh PVSMCs).  CV values for circularity were 
similar for SMCs isolated from fresh PVs (0.49) and from PVs maintained in culture conditions (0.52) 
indicating similar dispersion of values for both.  See Table 5 for details.  A histogram comparing the 
distribution of values for circularity for SMCs isolated from fresh PVs and from PVs maintained in 
culture is shown in Figure 50. 
 
Tri-dimensional Surface Area 
Measurements of projected area made from photomicrographs using ImageJ software (see Figure 
45) represent only a bi-dimensional projection of SMC area and therefore do not precisely quantify 
total membrane surface area.  For this reason, a more representative, tri-dimensional cell surface 
area was calculated by approximation to an ellipsoid.  The type of ellipsoid used for approximation 
was a prolate spheroid (where the polar axis is longer than the equatorial diameter) (see Figure 49).  
The long axis corresponds to cell length (l) and the two short axes correspond to cell width (w). 
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Figure 49. Approximation of pulmonary vein smooth muscle cell to a prolate spheroid.  Tri-
dimensional cell surface area was calculated using the length and width values calculated previously 
as the prolate axes. 
The ellipsoid surface area (S) was calculated using an equation by Knud Thomsen (Michon, 2004, 
McGahon et al., 2007): 
𝑆 ≈ 4𝜋  
𝑎𝑝𝑏𝑝 + 𝑎𝑝𝑐𝑝 + 𝑏𝑝𝑐𝑝
3
 
1/𝑝
 
 (Equation 15) 
where p = lg(3) = ln(3)/ln(2) ≈ 1.6075 and a is equal to half the length and b and c are both equal to 
half the width.  Please note that length and width values calculated from approximation to an ellipse 
were used in all calculations of tri-dimensional surface area rather than measured values.   
For SMCs isolated from fresh inferior PVs, mean (± SD) tri-dimensional surface area was 2459.5 ± 
1102.9 µm2 and ranged from 494.5 to 5734.5 µm2.  For SMCs isolated from PVs maintained in culture 
for 24 hours the mean tri-dimensional surface area was 2654.4 ± 1391.6 µm2 and ranged from 323.4 
to 6060.5 µm2 (P>0.05 compared to fresh PVSMCs).  CV values for circularity were larger in SMCs 
isolated from PVs maintained in culture conditions (0.52) compared to SMCs from fresh PVs (0.45) 
indicating a wider dispersion of values for cells isolated from PVs maintained in culture.  See Table 5 
for details.  A histogram comparing the distribution of values for tri-dimensional surface area for cells 
from fresh PVs and from PVs maintained in culture is shown in Figure 50. 
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Figure 50. Circularity and tri-dimensional membrane surface area of smooth muscle cells isolated 
from fresh pulmonary veins (PVs) and from PVs maintained in culture.  Histograms show the 
distribution of (A) circularity, an indicator of cell shape (calculated using projected area and 
perimeter measurements from photomicrographs) and (B) tri-dimensional membrane surface area 
(calculated by approximation to an ellipsoid) of smooth muscle cells isolated from fresh PVs (wide, 
grey bars (n=240; N=24)) and PVs maintained in culture (narrow, black bars (n=131; N=19)).  Data 
values were fitted with Gaussian distributions (black curves).  
  
159 
 
Table 5. Morphometric measurements of smooth muscle cells isolated from either freshly 
dissected inferior PVs (fresh) or inferior PVs maintained in culture conditions for 24 hours (culture).  
Area, perimeter, length and width were measured using ImageJ on photomicrographs; length and 
width were also separately calculated by approximation of cell shape to an ellipse; circularity was 
calculated using area and perimeter values; tri-dimensional surface area was calculated by 
approximation of cells to a prolate spheroid.  Fresh: N=24, n=240; culture: N=19, n=131. *P<0.05 
compared to fresh (analysis using Students unpaired t-tests). 
Cell 
measurement 
 
Mean value ± SD 
(Minimum value – 
Maximum value) 
 
CV 
 Fresh Culture Fresh Culture Fresh Culture 
Projected area 
(µm2) 
 
785.3 ± 353.6 848.8 ± 446.4 158.1 – 
1836.9 
101.5 – 
1946.5 
0.45 0.53 
Perimeter 
(µm) 
 
240.7 ± 88.3 265.7 ± 117.2* 68.8 – 
489.4 
56.5 – 
560.7 
0.37 0.44 
Measured 
Length (µm) 
112 ± 43.5 124.4 ± 57.3* 27.3 – 
231.2 
25.2 – 
270 
 
0.39 0.46 
 
Calculated 
Length (µm) 
107.8 ± 39.9 119.2 ± 52.9* 30.0 – 
220.1 
25.0 – 
252.2 
 
0.37 0.44 
Measured 
Width (µm) 
 
9.3 ± 3.0 8.8 ± 3.3 2.5 – 
19.3 
3.0 – 
19.9 
0.32 0.37 
Calculated 
Width (µm) 
 
9.3 ± 2.7 8.9 ± 2.79* 3.4 – 
18.9 
4.4 – 
19.2 
0.29 0.30 
 
Circularity 0.19 ± 0.09 0.18 ± 0.09 0.06 – 
0.58 
0.05 – 
0.51 
 
0.49 0.52 
Tridimensional 
surface area 
(µm2) 
2459.5 ± 1102.9 2654.4 ± 1391.6 494.5 – 
5734.5 
323.4 – 
6060.5 
0.45 0.52 
 
Membrane Capacitance and Series Resistance 
Cm was calculated and logged using WinEDR software from 91 cells isolated from fresh inferior PVs 
from 22 different animals (n=91; N=22).  Cm was also calculated for 72 cells isolated from inferior PVs 
maintained in culture for 24 hours and from 17 different animals (n=72; N=17).  Cm of SMCs isolated 
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from fresh PVs was 38.9 ± 20.6 pF (range: 12.0 – 133.5 pF). Cm of SMCs isolated from PVs maintained 
in culture conditions was 39.7 ± 16.6 (range: 11.5 – 135 pF) and was not significantly different from 
the Cm of fresh PVSMCs (P>0.05).  See Table 6 for details.  A histogram comparing the distribution of 
values for Cm for cells from fresh PVs and from PVs maintained in culture is shown in Figure 51. 
Specific membrane capacitance can be calculated by dividing the mean Cm value by the mean value 
for cell surface area (Firth et al., 2011).  For SMCs isolated from fresh PVs the specific membrane 
capacitance had a value of 1.6 µF/cm2 (38.9 pF/2459.5 µm2).  For SMCs isolated from fresh PVs the 
specific membrane capacitance was similar to fresh PVSMCs at 1.5 µF/cm2 (39.7 pF/2654.4 µm2). 
RS had a mean value of 25.7 ± 1.3 MΩ (mean ± S.E.M, n=155) when considering data from cells where 
Ga and Gm values had been logged via WinEDR.  A total of 7 cells were excluded from the mean data 
as they were considered to be significant positive outliers; any recordings made from these 7 cells 
were also excluded from further analysis. 
 
Resting Membrane Potential – Baseline Values 
RMP was measured under resting conditions (before experimental protocols were run) in 82 cells 
isolated from fresh inferior PVs (22 different animals: n=82; N=22) and 70 cells isolated from inferior 
PVs maintained in culture for 24 hours (18 different animals: n=70; N= 18).  SMCs isolated from fresh 
PVs had a mean RMP of -39.7 ± 14.2 mV with a range of -9.1 to -68.3 mV.  RMP in SMCs isolated from 
PVs kept in culture was less negative with a mean RMP of -36.6 ± 12.8 mV and a range of -7.9 to -63.8 
mV.   The difference between fresh/culture PVSMCs was not statistically significant (P>0.05).  See 
Table 6 for details.  A histogram comparing the distribution of values for baseline RMP for cells from 
fresh PVs and from PVs maintained in culture is shown in Figure 51. 
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Figure 51. Membrane capacitance and resting membrane potential of smooth muscle cells isolated 
from fresh pulmonary veins (PVs) and from PVs maintained in culture.  Histograms show the 
distribution of (A) membrane capacitance (calculated by WinEDR software) and (B) resting 
membrane potential (measured at baseline under current clamp (I=0)) of smooth muscle cells 
isolated from fresh PVs (wide, grey bars) and PVs maintained in culture (narrow, black bars).  Data 
values were fitted with Gaussian distributions (black curves).  For (A): n=91, N=22 for fresh PVSMCs 
and n=72, N=17 for SMCs isolated from PVs maintained in culture.  For (B): n=82, N=22 for fresh 
PVSMCs and n=70, N=18 for SMCs isolated from PVs maintained in culture. 
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Table 6. Passive electrical membrane properties of smooth muscle cells isolated from either freshly 
dissected inferior PVs (fresh) or from PVs maintained in culture conditions for 24 hours (culture).   
For resting membrane potential: n=82, N=22 for fresh PVSMCs and n=70, N=18 for SMCs isolated 
from PVs maintained in culture. For membrane capacitance: n=91, N=22 for fresh PVSMCs and n=72, 
N=17 for SMCs isolated from PVs maintained in culture. Analysis performed using Students unpaired 
t-tests. 
 
Cell measurement 
 
Mean value ± SD 
(Minimum value– 
Maximum value) 
 
N (n) 
 Fresh Culture Fresh Culture Fresh Culture 
Resting membrane 
potential, mV 
 
-39.7 ± 14.2 -36.6 ± 12.8 -68.3 – 
-9.1 
 
-63.8 – 
-7.9 
22 (82) 18 (70) 
Membrane 
capacitance, pF 
 
38.9 ± 20.6 39.7 ± 16.6 12.0 – 
133.5 
11.5 – 
135 
22 (90) 17 (72) 
 
Resting Membrane Potential – Effect of Flow and Viability Testing 
Effect of Flow 
As experimental protocols were to be performed in the presence of constant flow, RMP was 
measured at the time when flow was started in order to investigate whether introduction of flow 
alone had any impact on RMP.  In cells isolated from fresh PVs, RMP did not change when flow was 
commenced (before: -39.9 ± 13.9 mV; after: -39.6 ± 14.9 mV; P>0.05, n=52, N=18).  In cells isolated 
from PVs kept in culture conditions, RMP was also unchanged on introduction of flow (before: -36.7 ± 
12.5 mV; after: -36.5 ± 12.9 mV; P>0.05, n=53, N=16). 
 
Viability Testing with 80mM KCl 
Of cells tested for viability by applying 80mM KCl, 94% of those isolated from fresh PVs and 90% from 
PVs maintained in culture responded with depolarisation of RMP; of those cells which depolarised, 
97% responded with repolarisation on washout.  Cells which did not depolarise in response to KCl 
and/or repolarise on washout were excluded from further analysis.  Fresh PVSMCs had a starting 
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RMP of -37.1 ± 4.1 mV (mean ± S.E.M) which depolarised to -17.5 ± 3.3 mV (P<0.001 compared to 
baseline) on exposure to 80mM KCl.  After washout, RMP recovered to -33.9 ± 4.6 mV (P<0.001 
compared to during exposure, n=12; N=8).  SMCs isolated from PVs maintained in culture 
depolarised to KCl from an initial RMP of -32.4 ± 2.8 mV to -19.0 ± 2.4 mV (P<0.001 compared to 
baseline).  RMP then recovered to -29.6 ± 2.0 mV after washout of the drug (P<0.001 compared to 
during exposure, n=17; N=8).  The magnitude of depolarisation to KCl in cells isolated from PVs kept 
in culture was smaller (+13.4 ± 3.2 mV) than in fresh PVSMCs (+19.6 ± 3.6 mV), however this 
difference was not statistically significant (P>0.05).  See Figure 52 for raw traces and mean data for 
SMCs isolated from fresh PVs and from PVs maintained in culture which were exposed to 80mM KCl. 
 
Figure 52. Effect of 80mM KCl on resting membrane potential of smooth muscle cells isolated from 
fresh pulmonary veins (PVs) and from PVs maintained in culture.  Raw traces showing KCl 
application to A: cell isolated from fresh inferior PV and B: cell isolated from inferior PV maintained in 
culture for 24 hours.  Black bars represent 80mM KCl application by Picospritzer®.  Mean data (± 
S.E.M) showing resting membrane potential before, during and after application of 80mM KCl to 
smooth muscle cells C: isolated from fresh inferior PV (n=12; N=8) and D: isolated from inferior PV 
maintained in culture for 24 hours (n=17; N=8). ***P<0.001 compared to “Before”; ###P<0.001 
compared to “During” (analysis using repeated measures one-way ANOVA with Tukey’s post-test).. 
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Resting Membrane Potential – Effect of K+ channel Inhibitors and Hypoxia 
4AP 
In order to examine any putative role for KV channels in control of RMP in PVSMCs, the KV inhibitor 
4AP (Dospinescu et al., 2012) was used.  There was no clear and definitive effect of 5mM 4AP 
application on RMP in PVSMCs.  In cells isolated from fresh inferior PVs, RMP became progressively 
more depolarised over the experimental protocol from -36.5 ± 2.0 mV (before application) to -33.6 ± 
2.6 mV (during application) to -32.3 ± 2.7 mV (after application) (n=8; N=8).  The only significant 
difference was between baseline RMP and RMP after washout of 4AP (P<0.05).  Cells isolated from 
PVs maintained in culture became progressively more hyperpolarised during the protocol from -43.8 
± 1.6 mV (before application) to -46.1 ± 1.1 mV (during application) to -48.3 ± 3.2 mV (after 
application) (n=5; N=5).  However, RMP values before, during and after were not significantly 
different from one another (P>0.05).  There was also no significant difference in the magnitude of the 
change in RMP with 4AP application in fresh PVSMCs (+3.0 ± 1.5 mV) and SMCs isolated from PVs 
kept in culture (-2.3 ± 1.9 mV)( (P>0.05).  Figure 53 shows raw traces showing application of 5mM 
4AP and mean data for SMCs isolated from fresh PVs and from PVs maintained in culture. 
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Figure 53. Effect of 5mM 4AP on resting membrane potential of smooth muscle cells isolated from 
fresh pulmonary veins (PVs) and from PVs maintained in culture.  Raw traces showing 4AP 
application to A: a cell isolated from fresh inferior PV and B: a cell isolated from inferior PV 
maintained in culture for 24 hours.  Black bars represent 5mM 4AP application by Picospritzer®.  
Mean data (± S.E.M) showing resting membrane potential before, during and after application of 
5mM 4AP to smooth muscle cells C: isolated from fresh inferior PV (n=8; N=8) and D: isolated from 
inferior PV maintained in culture for 24 hours (n=5; N=5). *P<0.05 compared to “Before” (analysis 
using repeated measures one-way ANOVA with Tukey’s post-test). 
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TEA 
To determine whether BKCa played a role in setting RMP in PVSMCs, the blocker TEA (Archer et al., 
1996, Moudgil et al., 2005) was used.  Application of TEA (5mM) caused significant depolarisation in 
all SMCs isolated from fresh inferior PVs from -45.4 ± 5.0 mV at baseline to -38.4 ± 4.1 mV (P<0.01).  
On washout of the drug, RMP recovered to -43.1 ± 5.2 mV (P<0.05 compared to “during” exposure, 
n=6; N=6).  TEA caused depolarisation in five out of six SMCs isolated from PVs maintained in culture, 
the one cell which hyperpolarised on TEA application was excluded from further analysis.  Of the cells 
which depolarised, RMP increased from -40.3 ± 5.3 mV to -25.6 ± 56 mV (P<0.05).  Only three out of 
the five cells repolarised on washout of the drug, two cells depolarised further.  Hence the mean 
RMP on recovery was not significantly different from the RMP during exposure (-32.7 ± 5.4 mV, 
P>0.05, n=5; N=5).  Notably, the mean depolarisation induced by TEA was significantly larger in SMCs 
isolated from PVs maintained in culture (+14.7 ± 3.5 mV) than the depolarisation seen in fresh 
PVSMCs (+7.0 ± 1.2 mV, P<0.05).  Figure 54 shows raw traces showing depolarisation on application 
of 5mM TEA and mean data for SMCs isolated from fresh PVs and from PVs maintained in culture. 
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Figure 54. Effect of 5mM TEA on resting membrane potential of smooth muscle cells isolated from 
fresh pulmonary veins (PVs) and from PVs maintained in culture.  Raw traces showing TEA 
application to A: a cell isolated from fresh inferior PV and B: a cell isolated from inferior PV 
maintained in culture for 24 hours.  Black bars represent 5mM TEA application by Picospritzer®.  
Mean data (± S.E.M) showing resting membrane potential before, during and after application of 
5mM TEA to smooth muscle cells  C: isolated from fresh inferior PV (n=6; N=6) and D: isolated from 
inferior PV maintained in culture for 24 hours (n=5; N=5). *P<0.05 and ** P<0.01 compared to 
“Before”. # P<0.05 compared to “During” (analysis using repeated measures one-way ANOVA with 
Tukey’s post-test). 
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ZnCl2 
To evaluate whether TASK-1/3 channels were involved in controlling RMP of PVSMCs, the TASK-1/3 
blocker ZnCl2 was used (Ali et al., 2014, Patel et al., 2013).  Application of 1mM ZnCl2 had no 
significant effect on RMP of PVSMCs.  In fresh PVSMCs, 50% of cells tested depolarised on application 
of ZnCl2 and 50% hyperpolarised.  On washout, 70% became depolarised and 30% became 
hyperpolarised relative to during application.  Therefore, mean RMP in fresh PVSMCs did not change 
significantly over the course of experiments (before: -49.7 ± 2.9 mV, during: -50.1 ± 4.1 mV and after: 
-47.7 ± 4.1 mV; P>0.05, n=10; N=7). 
In SMCs isolated from PVs maintained in culture, application of 1mM ZnCl2 caused depolarisation in 
43% of cells tested; all other cells hyperpolarised in response to ZnCl2.  When ZnCl2 was washed out 
43% of cells became depolarised and the others hyperpolarised relative to during application.  Mean 
RMP in SMCs isolated from PVs kept in culture did not change significantly throughout the 
experimental protocol (before: -41.0 ± 4.3 mV, during: -43.6 ± 5.9 mV and after: -42.5 ± 4.2 mV; 
P>0.05, n=7; N=4).  The mean effect in cells isolated from fresh PVs and from PVs maintained in 
culture was a slight non-significant hyperpolarisation relative to baseline (-0.3 ± 3.8 mV and -2.6 ± 2.7 
mV, respectively).  The effect magnitudes were not significantly different from one another (P>0.05). 
Figure 55 shows raw traces demonstrating hyperpolarisation on application of 1mM ZnCl2 and mean 
data for SMCs isolated from fresh PVs and from PVs maintained in culture. 
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Figure 55. Effect of 1mM ZnCl2 on resting membrane potential of smooth muscle cells isolated from 
fresh pulmonary veins (PVs) and from PVs maintained in culture.  Raw traces showing ZnCl2 
application to A: a cell isolated from fresh inferior PV and B: a cell isolated from inferior PV 
maintained in culture for 24 hours.  Black bars represent 1mM ZnCl2 application by Picospritzer®.  
Mean data (± S.E.M) showing resting membrane potential before, during and after application of 
1mM ZnCl2to smooth muscle cells C: isolated from fresh inferior PV (n=10; N=7) and D: isolated from 
inferior PV maintained in culture for 24 hours (n=7; N=4) (analysis using repeated measures one-way 
ANOVA with Tukey’s post-test). 
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Hypoxia 
In fresh PVSMCs, exposure to hypoxic bath solution resulted in depolarisation of the RMP in all but 
one cell (which was then excluded from further analysis).  On removing hypoxic flow and reinstating 
normoxic bath solution, one cell hyperpolarised and all others continued to depolarise.  RMP started 
at an initial mean level of -39.9 ± 4.8 mV which increased to -34.9 ± 4.9 mV during hypoxic flow 
(P<0.001, n=8; N=5).  RMP then further depolarised on reoxygenation to -31.5 ± 5.2 mV (P<0.01 
compared to “before”, n=8; N=5).   
In SMCs isolated from PVs kept in culture conditions, exposure to hypoxic flow resulted in 
depolarisation of the RMP in all but one cell (which was then excluded from further analysis).  On 
reoxygenation, 2 cells hyperpolarised and all others continued to depolarise.  RMP increased from -
36.6 ± 5.8 mV to -29.4 ± 5.2 mV although the difference was not statistically significant (P>0.05, n=6; 
N=4).  RMP then further depolarised on reoxygenation to a level significantly higher than baseline 
RMP (-27.5 ± 5.9 mV, P<0.05, n=6; N=4). 
The magnitude of depolarisation in fresh PVSMCs (+5.0 ± 0.6 mV) was not significantly different from 
the depolarisation seen in SMCs from PVs maintained in culture (+7.2 ± 2.1 mV, P>0.05).  Similarly, 
there was no significant difference in the magnitude of depolarisation on reoxygenation (fresh: +3.4 
± 1.2 mV; culture: +1.8 ± 2.8 mV; P>0.05).  Figure 56 shows raw traces demonstrating depolarisation 
of RMP on hypoxic flow and reoxygenation and mean data for SMCs isolated from fresh PVs and 
from PVs maintained in culture. 
  
171 
 
 
 
Figure 56. Effect of hypoxia and reoxygenation on resting membrane potential of smooth muscle 
cells isolated from fresh pulmonary veins (PVs) and from PVs maintained in culture.  Raw traces 
showing hypoxic exposure to A: a cell isolated from fresh inferior PV and B: a cell isolated from 
inferior PV maintained in culture for 24 hours.  Black bars represent duration of hypoxic flow.  Mean 
data (± S.E.M) showing resting membrane potential before (normoxia), during (hypoxia) and after 
(reoxygenation) for smooth muscle cells C: isolated from fresh inferior PV (n=8; N=5) and D: isolated 
from inferior PV maintained in culture for 24 hours (n=6; N=4).  *P<0.05, ** P<0.01 and ***P<0.001 
compared to “Before” normoxic resting membrane potential (analysed using repeated measures 
one-way ANOVA with Tukey’s post-test). 
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Voltage-activated Whole-cell Currents - Effect of K+ Channel inhibitors 
To help further identify K+ channels which may contribute to RMP in PVSMCS and therefore be 
potential candidates for involvement in the hypoxic response, voltage-activated whole cell currents 
were studied in the presence of 4AP, TEA or ZnCl2. 
In order to characterise voltage-activated whole cell currents present in PVSMCs, a protocol involving 
400-ms depolarising voltage steps in 10mV increments was applied from a holding voltage of -80mV.  
In the absence of drugs (“before” traces), the voltage-activated whole-cell currents were large, 
rapidly activating, non-inactivating outward currents (Iout) with superimposed spontaneous transient 
outward currents (STOCs).  The presence of STOCs, particularly at the higher voltage steps suggested 
a complex current with multiple components.  In an attempt to identify the types of K+ channels 
contributing to the multi-component currents elicited, the protocol was run before, during and after 
application of 5mM 4AP, 5mM TEA and 1mM ZnCl2.  These drugs were chosen to investigate the role 
of KV, BKCa and TASK-1/3 channels, respectively, in the voltage-activated Iout of PVSMCs. 
 
4AP 
To evaluate the contribution of KV channels to the voltage-activated outward current in PVSMCs, the 
KV blocker 4AP (Dospinescu et al., 2012) was used.  In fresh PVSMCs, application of 5mM 4AP by 
Picospritzer® had no significant effect on the mean steady-state current density across the voltage 
step protocol.  Mean steady-state outward current density at +80mV was not significantly different 
before, during and after washout of 4AP: 45.4 ± 14.2 pA/pF, 39.5 ± 11.7 pA/pF and 42.0 ± 13.1 pA/pF, 
respectively (P>0.05, n=7; N=6).  Raw traces of currents before, during and after 4AP application and 
mean current density-voltage relationship for fresh PVSMCs are shown in Figure 57. 
In SMCs isolated from PVs maintained in culture conditions, 5mM 4AP application did not 
significantly alter the mean steady-state current density across the voltage step protocol.  Mean 
steady-state current at +80mV was not significantly different before, during and after washout of 
4AP: 78.2 ± 21.6 pA/pF, 66.6 ± 15.5 pA/pF and 78.1 ± 17.5 pA/pF, respectively (P>0.05, n=6; N=6).  
Raw traces of currents before, during and after 4AP application and mean current density-voltage 
relationship for SMCs isolated from PVs maintained in culture conditions are shown in Figure 58. 
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Figure 57. The effect of 5mM 4AP on voltage-activated outward currents in fresh pulmonary vein 
smooth muscle cells.  A: representative raw current traces recorded in response to application of 
voltage step protocol (B) before, during and after 4AP application; grey dashed line marks zero 
current level, capacitance transients have been truncated for clarity. C: Mean (± S.E.M) current 
density values for 7 cells before (filled circles), during (open circled) and after (half-filled circles) 4AP 
application plotted against test potential to give current-voltage relationship (n=7; N=6); analysis 
using repeated measures two-way ANOVA with Bonferroni’s post test.  Note that one cell was 
excluded from this data set as a positive outlier. 
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Figure 58. The effect of 5mM 4AP on voltage-activated outward currents in smooth muscle cells 
isolated from pulmonary veins maintained in culture conditions for 24 hours.  A: representative raw 
current traces recorded in response to application of voltage step protocol (B) before, during and 
after 4AP application; grey dashed line marks zero current level, capacitance transients have been 
truncated for clarity. C: Mean (± S.E.M) current density values for 6 cells before (filled circles), during 
(open circled) and after (half-filled circles) 4AP application plotted against test potential to give 
current-voltage relationship (n=6; N=6); analysis using repeated measures two-way ANOVA with 
Bonferroni’s post test. 
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TEA 
To determine whether BKCa channels contribute to the voltage-activated outward current in PVSMCs, 
the blocker TEA (Archer et al., 1996, Moudgil et al., 2005) was used.  In fresh PVSMCs, application of 
5mM TEA resulted in significant inhibition of the mean steady-state current density at voltage steps 
between +30 and +80mV.  At +80mV TEA produced a 49% inhibition of current density (from 40.5 ± 
8.5 pA/pF (before) to 20.6 ± 7.8 pA/pF (during), P<0.001, n=4; N=4).  One minute after washout of 
the drug, the current density at +80mV recovered to 97% of the original baseline (39.2 ± 10.1 pA/pF, 
P<0.001 compared to “during” TEA exposure).  Representative current traces and current density-
voltage relationships for fresh PVSMCs are shown in Figure 59. 
In SMCs isolated from PVs kept in culture, application of TEA also significantly reduced the mean 
steady-state current density starting from a higher test potential of +40mV (P<0.05).  At +80mV, TEA 
produced a marked 70% inhibition of the current density (from 101.6 ± 28.2 pA/pF (before) to 30.5 ± 
9.7 pA/pF (after), P<0.001, n=5; N=5).  After one minute of drug washout, current density at +80mV 
returned to 105% of the original baseline value (106.8 ± 58.1 pA/pF), P<0.001 compared to “during” 
TEA exposure).  Representative raw traces and current-voltage relationships are shown in Figure 60. 
As TEA had a marked effect on outward current magnitude in PVSMCs, the impact of TEA exposure 
was analysed in more detail by investigating the impact on outward current activation kinetics.  
“One-phase association” curves were fitted (using GraphPad Prism 7) for currents recorded at-10mV 
to +80mV.  At voltage steps between -80mV and -20mV, curve fitting was often ambiguous and 
values for Ʈact could not be calculated.  In fresh PVSMCs, no change in activation kinetics (assessed by 
Ʈact values) was observed across all test potentials applied (P>0.05, n=4; N=4).  Figure 61 shows raw 
traces with curve fitting and mean Ʈact values plotted against test potential for fresh PVSMCs.  In 
SMCs isolated from PVs kept in culture conditions, the only significant change in activation kinetics 
was observed at -10mV where currents “after” washout of TEA were significantly slower to activate 
(mean Ʈact= 162.2 ± 75.4 ms) than “during” TEA exposure (mean Ʈact= 55.2 ± 29.7 ms, P<0.05, n=5; 
N=5).  There was no significant difference between mean Ʈact for “during”/”after” and “before” TEA 
exposure at -10mV (80.4 ± 13.2 ms, P>0.05).  There was also no significant difference between Ʈact 
values at any other test potential.  Raw traces showing curve fitting and mean Ʈact values plotted 
against test potential for SMCs isolated from PVs kept in culture are shown in Figure 62. 
Overall, TEA reduced current magnitude at +80mV by approximately 50% in fresh PVSMCs and by 
70% in SMCs isolated from PVs maintained in culture conditions for 24 hours and significant 
inhibition began at test potentials between +30 and +40 mV.  There was no clear effect on the rate of 
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activation of voltage-activated outward currents in SMCs.  Therefore, it could be implied that the 
TEA-sensitive current in fresh inferior PVSMCs would have a steady-state Iout of approximately 50% of 
control “before” currents and in SMCs isolated from PVs kept in culture would have a steady-state Iout 
of approximately 70% of control “before” currents.  It could also be implied that activation kinetics 
would be similar to control currents.  In order to fully characterise the TEA-sensitive component of 
Iout in inferior PVSMCs in terms of shape and kinetics, current values recorded “during” TEA exposure 
were subtracted from values from “before” exposure to reveal the TEA-sensitive difference current 
(see Figure 63). 
The TEA-sensitive difference current was significantly larger in SMCs isolated from PVs maintained in 
culture compared to fresh PVSMCs at test potentials of +70 and +80 mV (P<0.01).  At +80mV the 
mean TEA-sensitive difference current in SMCs isolated from PVs kept in culture (expressed in 
current density) was 71.2 ± 22.3 pA/pF (n=5; N=5) whereas in fresh PVSMCs the current was 19.8 ± 
3.9 pA/pF (n=4; N=4).  The current was rapidly activating and non-inactivating as previously 
suspected owing to the lack of an effect of TEA on Ʈact values.  Mean (±S.E.M) difference current 
density values were plotted against test potential in order to illustrate and compare the difference 
current-voltage relationships for fresh and culture PVSMCs (shown in Figure 63).   
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Figure 59. The effect of 5mM TEA on voltage-activated outward currents in fresh pulmonary vein 
smooth muscle cells.  A: representative raw current traces recorded in response to application of 
voltage step protocol (B) before, during and after TEA application; grey dashed line marks zero 
current level, capacitance transients have been truncated for clarity. C: Mean (± S.E.M) current 
density values for 4 cells before (filled circles), during (open circles) and after (half-filled circles) TEA 
application plotted against test potential to give current-voltage relationship. **P<0.01 and 
***P<0.001 “during” compared to “before”.  ##P<0.01 and ### P<0.001 “after” compared to 
“during” (n=4; N=4); analysis using repeated measures two-way ANOVA with Bonferroni’s post test.  
Note that one cell was excluded from this data set as a positive outlier. 
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Figure 60. The effect of 5mM TEA on voltage-activated outward currents in smooth muscle cells 
isolated from pulmonary veins maintained in culture conditions for 24 hours.  A: representative raw 
current traces recorded in response to application of voltage step protocol (B) before, during and 
after TEA application; grey dashed line marks zero current level, capacitance transients have been 
truncated for clarity. C: Mean (± S.E.M) current density values for 5 cells before (filled circles), during 
(open circles) and after (half-filled circles) TEA application plotted against test potential to give 
current-voltage relationship.  *P<0.05 and ***P<0.001 “during” compared to “before”.  #P<0.05, 
##P<0.01 and ###P<0.001 “after” compared to “during” (n=5; N=5); analysis using repeated 
measures two-way ANOVA with Bonferroni’s post test. 
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Figure 61. The effect of 5mM TEA on activation of outward currents in fresh pulmonary vein 
smooth muscle cells.  A: raw traces showing activation of currents across different voltages in the 
presence of 5mM TEA.  Black solid lines represent currents recorded and red dashed lines are curves 
fitted using “one-phase association” (GraphPad Prism 7); for clarity, not all traces are shown.  B:  
Mean Ʈact plotted against test potential “before” (filled circles), “during” (open circles) and “after” 
(half-filled circles) TEA exposure by Picospritzer®. (n=4; N=4); analysis using repeated measures two-
way ANOVA with Bonferroni’s post test.  Note that one cell was excluded from this data set as a 
positive outlier. 
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Figure 62. The effect of 5mM TEA on activation of outward currents in smooth muscle cells isolated 
from pulmonary veins maintained in culture for 24 hours.  A: raw traces showing activation of 
currents across different voltages in the presence of 5mM TEA.  Black solid lines represent currents 
recorded and red dashed lines are curves fitted using “one-phase association” (GraphPad Prism 7); 
for clarity, not all traces are shown.  B:  Mean Ʈact plotted against test potential “before” (filled 
circles), “during” (open circles) and “after” (half-filled circles) TEA exposure by Picospritzer®. #P<0.05 
“after” compared to “during” (n=5; N=5); analysis using repeated measures two-way ANOVA with 
Bonferroni’s post test. 
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Figure 63. TEA-sensitive difference current in smooth muscle cells from fresh pulmonary veins 
(PVs) and from PVs maintained in culture for 24 hours.  A: representative family of TEA sensitive 
difference currents obtained by subtracting current values “during” 5mM TEA exposure from 
“before” current values.  Currents were elicited by depolarising voltage steps from -80mV to +80mV 
in 10mV increments starting from a holding potential of -80mV; grey dashed line marks zero current 
level, capacitance transients have been truncated for clarity. B: Mean (± S.E.M) current density 
values for 4 cells isolated from fresh inferior PVs (filled circles) and 5 cells isolated from PVs 
maintained in culture conditions (open circles) (fresh: n=4; N=4, culture: n=5; N=5). **P<0.01 fresh 
compared to culture (analysis using repeated measures two-way ANOVA with Bonferroni’s post test). 
Note that one cell was excluded for the “fresh” group as a positive outlier.
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ZnCl2 
To investigate the contribution of TASK channels to the voltage-activated whole cell currents in 
PVSMCs, the TASK-1/3 channel inhibitor ZnCl2 was used (Ali et al., 2014, Patel et al., 2013).  
Application of 1mM ZnCl2 significantly inhibited steady-state Iout at +60mV, +70mV and +80mV in 
fresh PVSMCs.  At a test potential of +80mV, ZnCl2 reduced voltage-activated currents by 32% from 
67.7 ± 17.8 pA/pF to 45.8 ± 9.2 pA/pF (P<0.001, n=6; N=4).  After one minute of washout of the drug, 
steady-state Iout at +80mV did not recover fully but returned to 82% of the original current elicited 
before application (55.8 ± 16.1 pA/pF, P>0.05 compared to “before” and “during”).  Representative 
current traces and current density-voltage relationships for fresh PVSMCs are shown in Figure 64. 
In PVSMCs isolated from vessels maintained in culture for 24 hours, ZnCl2 also reduced the mean 
steady-state outward current density however significant inhibition was present at a lower test 
potential of +30mV (P<0.05).  At +80mV, mean currents were reduced by 26% from 42.2 ± 7.2 pA/pF 
to 31.1 ± 4.0 pA/pF (P<0.001, n=6; N=5).  On washout for one minute, steady state Iout +80mV 
recovered to 104% of original baseline values (43.7 ± 9.1 pA/pF, P<0.001). Significant recovery of the 
current was also seen for test potentials between +40mV and +70mV. Representative current traces 
and current density-voltage relationships for PVSMCs isolated from vessels maintained in culture are 
shown in Figure 65. 
The impact of ZnCl2 exposure on PVSMC outward current activation kinetics was also analysed.  In 
fresh PVSMCs, the only significant difference in activation kinetics when comparing currents 
“before”, “during” and “after” ZnCl2 was at a test potential of 0mV.  Outward currents at 0mV 
became more rapidly activating over time reflected by decreasing values for time constant of 
activation (Ʈact) – before ZnCl2 exposure: 108.4 ± 21.5 ms, during ZnCl2 exposure: 80.7 ± 11.5 ms and 
after ZnCl2 washout: 60.9 ± 11.1 ms.  The only difference which reached significance was by 
comparing “before” to “after” activation (P<0.05, n=6; N=4).  In PVSMCs isolated from vessels 
maintained in culture no significant difference was seen across all test potentials when “before”, 
“during” and “after” current activation kinetics were compared (P>0.05, n=6; N=5). Raw traces 
showing curve fitting and mean Ʈact plotted against test potential for fresh PVSMCs and PVSMCs 
isolated from vessels maintained in culture are shown in Figure 66 and 67, respectively. 
Overall, ZnCl2 reduced current magnitude by 32% at test potentials of between +60 and +80mV for 
fresh PVSMCs and by 26% between +30 and +80mV for SMCs isolated from PVs maintained in culture 
conditions for 24 hours. However there was no clear effect on the rate of activation of voltage-
activated outward currents in SMCs.  Therefore, it could be suggested that the ZnCl2-sensitive current 
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in inferior PVSMCs would have a steady-state Iout of approximately 30% of control “before” currents 
and similar activation kinetics.  In order to fully characterise the ZnCl2-sensitive component of Iout in 
inferior PVSMCs, difference currents were calculated as described previously for TEA. 
In the majority of PVSMCs, the ZnCl2-sensitive difference current was rapidly activating and non-
inactivating (see representative current traces in Figure 68).  However in one cell from fresh PV and 
one cell from PV maintained in culture revealed that ZnCl2 appeared to activate an outward current 
at test potentials between +60 and +80 mV since the difference current was negative.  These two 
cells were excluded from further data analysis for the ZnCl2-sensitive difference current. 
Mean (±S.E.M) difference current density values were plotted against test potential in order to 
illustrate the difference current-voltage relationship.  Current-voltage plots for fresh and culture 
PVSMCs were compared to identify any differences (shown in Figure 68). At a test potential of 
+80mV the ZnCl2-sensitive difference current was significantly larger in fresh PVSMCs than SMCs 
isolated from PVs maintained in culture for 24 hours (P<0.01; n=5 and N=4 for both). 
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Figure 64. The effect of 1mM ZnCl2 on voltage-activated outward currents in fresh pulmonary vein 
smooth muscle cells.  A: representative raw current traces recorded in response to application of 
voltage step protocol (B) before, during and after ZnCl2 application; grey dashed line marks zero 
current level, capacitance transients have been truncated for clarity. C: Mean (± S.E.M) current 
density values for 6 cells before (filled circles), during (open circles) and after (half-filled circles) ZnCl2 
application plotted against test potential to give current-voltage relationship. **P<0.01 and 
***P<0.001 “during” compared to “before” (n=6; N=4); analysis using repeated measures two-way 
ANOVA with Bonferroni’s post test.  
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Figure 65. The effect of 1mM ZnCl2 on voltage-activated outward currents in smooth muscle cells 
isolated from pulmonary veins maintained in culture conditions for 24 hours.  A: representative raw 
current traces recorded in response to application of voltage step protocol (B) before, during and 
after ZnCl2 application; grey dashed line marks zero current level, capacitance transients have been 
truncated for clarity. C: Mean (± S.E.M) current density values for 6 cells before (filled circles), during 
(open circles) and after (half-filled circles) ZnCl2 application plotted against test potential to give 
current-voltage relationship.  *P<0.05, **P<0.01 and ***P<0.001 “during” compared to “before”.  
#P<0.05, ##P<0.01 and ###P<0.001 “after” compared to “during” (n=6; N=5); analysis using repeated 
measures two-way ANOVA with Bonferroni’s post test. 
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Figure 66. The effect of 1mM ZnCl2 on activation of outward currents in fresh pulmonary vein 
smooth muscle cells.  A: raw traces showing activation of currents across different voltages in the 
presence of 1mM ZnCl2.  Black solid lines represent currents recorded and red dashed lines are 
curves fitted using “one-phase association” (GraphPad Prism 7); for clarity, not all traces are shown.  
B:  Mean Ʈact plotted against test potential “before” (filled circles), “during” (open circles) and “after” 
(half-filled circles) ZnCl2exposure by Picospritzer®. *P<0.05 “after” compared to “before” (n=6; N=4); 
analysis using repeated measures two-way ANOVA with Bonferroni’s post test. 
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Figure 67. The effect of 1mM ZnCl2 on activation of outward currents in smooth muscle cells 
isolated from pulmonary veins maintained in culture for 24 hours.  A: raw traces showing activation 
of currents across different voltages in the presence of 1mM ZnCl2.  Black solid lines represent 
currents recorded and red dashed lines are curves fitted using “one-phase association” (GraphPad 
Prism 7); for clarity, not all traces are shown.  B:  Mean Ʈact plotted against test potential “before” 
(filled circles), “during” (open circles) and “after” (half-filled circles) ZnCl2 exposure by Picospritzer® 
(n=6; N=5); analysis using repeated measures two-way ANOVA with Bonferroni’s post test. 
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Figure 68. ZnCl2-sensitive difference current in smooth muscle cells from fresh pulmonary veins 
(PVs) and from PVs maintained in culture for 24 hours.  A: representative family of ZnCl2-sensitive 
difference currents obtained by subtracting current values “during” 1mM ZnCl2 exposure from 
“before” current values.  Currents were elicited by depolarising voltage steps from -80mV to +80mV 
in 10mV increments starting from a holding potential of -80mV; grey dashed line marks zero current 
level, capacitance transients have been truncated for clarity. B: Mean (± S.E.M) current density 
values for 5 cells isolated from fresh PVs (filled circles) and 5 cells isolated from PVs maintained in 
culture (open circles) (n=5; N=4). **P<0.01 fresh vs. culture (analysis using repeated measures two-
way ANOVA with Bonferroni’s post test).  
189 
 
Voltage-activated Whole-cell Currents - Effect of Maintaining PVs in Culture 
The identification of an enhanced TEA-sensitive current and a reduced ZnCl2-sensitive current in 
SMCs isolated from PVs maintained in culture highlighted the need to characterise other potential 
differences in the voltage-activated outward currents in SMCs when PVs are exposed to culture 
conditions.  To directly compare the current-voltage relationship for SMCs isolated from fresh PVs 
and those isolated from PVs maintained in culture conditions in the absence of any drug treatment, 
all baseline “before” currents were averaged and compared.  Current density was significantly 
increased in SMCs from PVs maintained in culture conditions at a test potential of +80mV compared 
with fresh PVSMCs (P>0.05).  Mean current density (±S.E.M) at +80mV for fresh PVSMCs was 52.1 ± 
8.8 pA/pF (n=17, N=11) and for SMCs isolated from PVs kept in culture was 72.4 ± 12.3 pA/pF (n=17, 
N=10).  Current-voltage relationships for fresh/culture PVSMCs are shown in Figure 69 A. 
Time constants for current activation (Ʈact) were compared for SMCs isolated from fresh PVs and 
those isolated from PVs maintained in culture at test potentials between -10 and +80mV for a total of 
21 cells.  Currents were more rapidly activating in SMCs isolated from PVs maintained in culture at -
10mV (P>0.001) and 0mV (P>0.01, fresh: n=10, N=7; culture: n=11, N=9), reflected in smaller Ʈact 
values.  At -10mV Ʈact was 56.3 ± 10.7 ms for SMCs isolated from PVs kept in culture and 110.3 ± 13.9 
ms for fresh PVSMCs.  At 0mV Ʈact was 46.5 ± 8.4 ms for SMCs isolated from PVs kept in culture and 
91.4 ± 14.3 ms for fresh PVSMCs.  Ʈact values are plotted against voltage for fresh/culture PVSMCs in 
Figure 69 B. 
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Figure 69. The effect of maintenance in culture conditions on magnitude and activation kinetics of 
voltage-activated outward currents in pulmonary vein smooth muscle cells.  A: Mean (± S.E.M) 
baseline “before” current density values for cells isolated from fresh pulmonary veins (PVs) (filled 
circles, n=17; N=11, two cells excluded from data set as positive outliers) and those isolated from PVs 
maintained in culture (open circles, n=17; N=10) plotted against test potential to give current-voltage 
relationship.  B: Mean (± S.E.M) Ʈact for baseline “before” currents plotted against test potential for 
fresh PVs (filled circles, n=10; N=7, one cell excluded as a positive outlier) and those isolated from 
PVs maintained in culture (open circles, n=11; N=9).  *P<0.01, **P<0.01 and ***P<0.001 fresh 
compared to culture (analysis using repeated measures two-way ANOVA with Bonferroni’s post test).  
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Discussion 
Exposure of PVs to culture conditions has a marked effect on contractility including enhanced 
hypoxic contraction which was hypothesised to be a result of endothelial damage (Chapter 3).  
However results of experiments using L-NAME to interfere with endothelial production of NO and 
mimic the effects of PV maintenance in culture produced unexpected results (Chapter 4).  In order to 
investigate differences at the smooth muscle cell level, cells were isolated from fresh PVs and from 
PVs maintained in culture conditions for 24 hours and morphological and electrophysiological 
characteristics were compared. 
Previous morphological/electrophysiological characterisation studies in PVSMCs were performed 
with cells isolated from superior/middle pulmonary lobes (Dospinescu, 2009) however it cannot be 
assumed that characteristics are the same in PVSMCs from different lung locations.  This study has 
focused on SMCs isolated from inferior PVs and morphological data and characterisation of 
electrophysiology in terms of RMP and voltage-activated whole cell currents are presented within 
this chapter.  RMP responses to hypoxia were investigated to explore whether exposure of PVs to 
culture conditions affects hypoxic responses in the isolated smooth muscle cell level as well as the 
isolated vessel level.  The KV channel inhibitor 4AP (Dospinescu et al., 2012), BKCa inhibitor TEA 
(Archer et al., 1996, Moudgil et al., 2005), and TASK-1/3 blocker zinc chloride (ZnCl2) (Ali et al., 2014, 
Patel et al., 2013) were used to provide a basic characterisation of K+ channels involved in setting 
RMP in order to highlight potential candidates for involvement in the hypoxic response of inferior 
PV/PVSMCs. 
Morphologically, SMCs isolated from fresh PVs and those isolated from PVs maintained in culture 
were similar in terms of area (bi- and tri-dimensional), width and circularity. However, on average 
PVSMCs from vessels maintained in culture were longer and had a larger perimeter.  Passive 
electrical membrane properties – membrane capacitance, specific membrane capacitance and 
baseline RMP - were all comparable between fresh PVSMCs and SMCs from PVs maintained in 
culture conditions. 
Hypoxia resulted in depolarisation of the RMP in both fresh PVSMCs and SMCs isolated from PVs 
maintained in culture (in the latter this did not reach statistical significance); the magnitude of 
hypoxic depolarisation was not significantly different between fresh/culture.  In both groups of 
SMCs, RMP continued to depolarise on reoxygenation to a level significantly less negative than 
baseline.  TEA caused depolarisation of RMP and inhibited voltage-activated outward currents in 
SMCs from fresh PVs and from PVs maintained in culture and TEA-induced depolarisation was larger 
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in SMCs from PVs maintained in culture.  KV channels do not appear to contribute to maintenance of 
the RMP or voltage-activated outward currents in PVSMCs owing to the lack of effect of 4AP.  TASK-
1/3 channels do not appear to be involved in controlling RMP of PVSMCs however they do appear to 
contribute to voltage-activated outward currents.   
Maintenance of PVs in culture conditions resulted in an increased TEA-sensitive current and reduced 
ZnCl2-sensitive current along with more rapid activation and increased magnitude of outward 
currents in PVSMCs at higher test potentials. 
 
Cell Morphology 
Morphological analysis within this study found that SMCs isolated from fresh PVs and those isolated 
from PVs maintained in culture were similar in terms of cell area, width and circularity. However, 
SMCs from PVs maintained in culture were longer and had a larger perimeter.   
Smooth muscle cells within blood vessels are involved in controlling vascular tone and blood flow; 
their width and shape can influence contractility (Tolic-Norrelykke and Wang, 2005).  In-depth 
quantitative morphological analysis has previously been performed in SMCs from 5th to 7th order 
superior/middle PVs (Dospinescu, 2009).  However, the focus of this study was on 4th to 5th order 
inferior PVs which were more than three times larger in terms of outer diameter (3.0 ± 0.7 mm 
compared with 0.91 ± 0.11 mm).  It was therefore important to characterise the morphology of cells 
from a different location in both the lung and the vascular tree.  Little else is known about PVSMCs in 
terms of morphology.  Michelakis et al. (2001) worked with SMCs isolated from rat PVs and 
measured average cell length but no further analysis was performed.  Another research group 
working with primary cultures of rat distal PVSMCs did not provide measurements of cell morphology 
but instead gave a qualitative description of cell division, shape and arrangement (Peng et al., 2010).  
SMCs isolated using the optimised protocol from both fresh inferior PVs and PVs maintained in 
culture were normally suitable for whole cell recordings during electrophysiology studies.  The 
PVSMCs isolated from fresh PVs and from PVs kept in culture were visually similar to each other and 
were comparable to those isolated by previous investigators (Dospinescu, 2009, Michelakis et al., 
2001).  SMCs isolated from superior/middle PVs by Dospinescu (2009) were spindle-like and relaxed 
and those types of cell were also identified in this study in inferior PVs.  Partially contracted cells 
(which remained elliptical in shaped) were also isolated and used in electrophysiology studies as this 
was considered to be another marker of viability.  Partially contracted cells were visually similar to 
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the PVSMC in the photomicrograph presented by Michelakis et al. (2001) and some cells in 
photomicrographs presented by Peng et al. (2010).  In general, a sufficient number of viable spindle-
like relaxed cells or partially contracted cells with intact membranes were present in order to 
attempt a range of current-clamp/voltage-clamp protocols on any given experimental day. 
A summary of cell size parameters are presented in Table 5.  SMCs isolated from porcine inferior PVs 
were comparably larger than PVSMCs isolated from rats (average cell length 8 ± 2 µM, Michelakis et 
al., 2001) but were smaller than SMCs isolated from more distally located porcine superior/middle 
PVs (average cell length 159.1 ± 36.8 µM, Dospinescu, 2009).  These differences may be explained by 
the size difference between species and PV location in the lung/vascular tree, respectively.  The 
smaller size of porcine PVSMCs from proximal (4th-5th order) compared with distal (5th-7th order) PVs 
is in keeping with studies of porcine PASMCs.  PASMCs from proximal vessels were shorter than 
those from distal vessels (55.8 ± 1.2 µM compared with 77.8 ± 2µM, Sham et al., 2000).  The length 
and perimeter of cells differed between cells isolated from fresh PVs and those from PVs maintained 
in culture with the latter being significantly longer.  However, this does not necessarily suggest a 
difference in contractility of smooth muscle cells as studies of human airway smooth muscle cells 
showed that contractility was not dependent on cell length but on projected area and cell width 
(Tolic-Norrelykke and Wang, 2005).  Projected area and width were not significantly different 
between SMCs from fresh PVs and those from PVs kept in culture conditions. 
Cell lengths and widths were measured directly from photomicrographs and also calculated from 
approximation to an ellipse using area and perimeter values for the cell.  Calculated length values 
were significantly shorter than their corresponding measured values however calculated width 
values were not significantly different from measured values.  Calculated values were considered to 
be more reliable as this excluded the error introduced by measurement identified by the significant 
difference between the two values for cell length.  Calculated values were therefore used for all 
other morphometric calculations.   
Morphological parameters for SMCs isolated from fresh inferior PVs could be directly compared to 
those of Dospinescu (2009) however information regarding the effect of maintenance of PVs in 
culture on SMC morphology was not readily available in the literature.  Most morphological 
parameters measured/calculated demonstrated that fresh PVSMCs from 4th-5th order inferior PVs 
were smaller than PVSMCs from 5th-7th order superior/middle PVs.  Projected cell area (785.3 ± 353.6 
compared with 1070.2 ± 267.6 µm2), cell perimeter (240.7 ± 88.3 compared with 354 ± 81.6 µm) and 
tri-dimensional surface area (2459.5 ± 1102.9 compared with 3336.7 ± 832 µm2).  On average, cells 
from inferior PVs were also slightly wider (9.3 ± 2.7 cf 8.6 ± 1.2 µm) and had higher circularity values 
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indicating they were less elongated (0.19 ± 0.09 cf 0.11 ± 0.03).  This makes sense however, owing to 
the wider inclusion criteria for cells measured in this study which included cells identified as “partially 
contracted”.  Dospinescu (2009) only measured cells which were fully relaxed and spindle-like.  This 
wider sample population also helps explain the larger CV values seen across all morphometric 
parameters in this study compared to CV values documented by Dospinescu (2009) indicating a wider 
dispersion of values. 
 Other than the extensive analysis performed by Dospinescu (2009), there is no data readily available 
in the literature documenting area, perimeter, width and circularity of PVSMCs. 
 
Membrane Capacitance and Series Resistance 
The membrane capacitance for freshly isolated inferior PVSMC was 38.9 ± 20.6 pF and membrane 
capacitance was not significantly different in SMCs isolated from PVs maintained in culture (39.7 ± 
16.6 pF).  In PVSMCs isolated from superior/middle PVs, capacitance was much higher at 108 ± 42 pF 
however as capacitance is directly proportional to the total area of the cell membrane (Molleman, 
2003) and cells in this study had a smaller area, this was to be expected.  The values observed in this 
study are closer to values reported for cultured human PASMC (35.27 ± 5.9 pF (Peng et al., 1996) and 
34.5 ± 5 pF (Firth et al., 2011) and freshly isolated rabbit PASMC (31 ± 7 pF, Franco-Obregon and 
Lopez-Barneo, 1996).  
SMCs isolated from rat PAs maintained under culture conditions for 4 days also showed no change in 
Cm when compared to freshly isolated PASMCs (12 ± 1 pF for both, Manoury et al., 2009).  Cm for 
these cells was considerably lower than seen in this study but as cell surface area was not 
documented, it cannot be concluded as to why this was the case.  Cm values for human PASMC kept 
in culture conditions did not change significantly over an 8 day period (Firth et al., 2011).  These 
results cannot be directly compared to the results within this chapter as the isolated PASMCs were 
kept in culture as opposed to intact vessels however they help provide further evidence that culture 
conditions do not appear to affect Cm directly. 
The average specific membrane capacitance for inferior PVSMCs was 1.5-1.6 µF/cm2 which is slightly 
higher than the standard proposed value of 1 µF/cm2 in SMCs (Toro et al., 1986).  The specific 
membrane capacitance for rat PASMCs is comparable to inferior PVSMCs at 1.25 µF/cm2 (Firth et al., 
2011).  Rat caudal artery SMCs kept in culture conditions and freshly isolated rat uterine SMCs also 
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have similar values of specific membrane capacitance: 1.3 µF/cm2 (Toro et al., 1986) and 1.42 µF/cm2 
(Yoshino et al., 1997), respectively.  
On the other hand, Dospinescu (2009) calculated a specific membrane capacitance for porcine 
PVSMCs which was double the value calculated in this study (3.2 µF/cm2).  The high value was 
proposed to be due to intrinsic membrane properties specific to the cell type and/or an 
underestimation of cell surface area.  However, this does provide an explanation for the discrepancy 
between specific membrane capacitance in this study for inferior PVSMCs and the value for superior 
PVSMCs.   
RS in these experiments had an average value of 25.7 ± 1.3 MΩ.  Ideally, Rs should be maintained 
below 20 MΩ; high Rs is detrimental to voltage clamping of the membrane.  Rs is less of a problem in 
current clamp mode therefore membrane potential recordings are less of a concern (Molleman, 
2003).   During voltage clamp however, high Rs can mean that the full magnitude of command 
potentials (in a voltage step) are not reached resulting in a degree of voltage error.  This high 
resistance may mean that cells are not exposed to the command potential expected and recorded 
currents are less than expected (Barbour, 2014).  Series resistance can be compensated electronically 
however this can impair the ability of WinEDR software to calculate Cm, Ga and Gm, as previously 
discussed.  Series resistance compensation can also increase high frequency noise in the recording 
leading to the need for filtering (Barbour, 2014) which can be problematic as cell-generated data may 
also be removed by the filter.  As the purpose of voltage-clamp protocols within this study was to 
provide a basic pharmacological characterisation of whole-cell currents in PVSMCs and not a detailed 
biophysical characterisation, Rs was not considered a major problem and hence was not 
compensated. 
 
Resting Membrane Potential – Baseline Values 
RMP values for SMCs isolated from fresh inferior PVs and those isolated from inferior PVs kept in 
culture were -39.7 ± 14.2 mV and -36.6 ± 12.8 mV, respectively.  Despite PVSMCs from vessels kept in 
culture being on average more depolarised than freshly isolated PVSMCs, this trend was not 
statistically significant (P>0.05).  Baseline RMP values in inferior PVSMCs are comparable to those 
seen for porcine superior/middle PVSMCs (-35.8 ± 5.9 mV, Dospinescu, 2009) and freshly isolated 
PASMC in mouse (-27.9 ± 0.9 mV, Ko et al., 2007), rat (-40 ± 1 mV, Hogg et al., 2002) and rabbit (-50.4 
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± 4mV, Osipenko et al., 1997).  RMP was also within the range seen in cultured human PASMC (-45.5 
± 5mV, Firth et al., 2011). 
SMCs isolated from PAs exposed to culture conditions for 4 days showed a small but significant 
depolarisation (+4mV) in RMP compared with freshly isolated PASMCs (Manoury et al., 2009).  The 
+3.1mV depolarisation in RMP of SMCs seen after 24 hours of PV maintenance in culture conditions 
in this study was comparable to the change seen in PASMCs yet statistical significance was not 
reached.  Perhaps a longer maintenance in culture conditions could have resulted in further 
depolarisation of baseline RMP in PVSMCs; further experiments would be required to test this 
theory. 
 
Resting Membrane Potential – Effect of Flow and Viability Testing 
Introduction of flow to the bath chamber caused no significant change to RMP in PVSMCs.  This was 
reassuring as all experimental protocols were run in the presence of flow and hypoxia experiments 
required flow changeover from normoxic to hypoxic bath solution.  Therefore, responses observed in 
PVSMCs can be considered to be a direct effect of the pharmacological agents or hypoxia rather than 
flow conditions. 
Examples of continuous RMP recordings from PVSMCs are not readily available in the literature.  
There are also a limited number of high quality RMP recordings presented in the literature in 
response to drugs/hypoxia in isolated smooth muscle cells in general, even in response to simple 
depolarising stimuli like high KCl solution. 
Exposure to 80mM KCl in this study caused a +19.6mV depolarisation in fresh PVSMCs and a +13.4 
mV depolarisation in SMCs isolated from PVs maintained in culture for 24 hours.  One report in 
freshly dissociated PASMCs which documented averaged responses (no raw traces) showed that 
exposure to high concentration KCl solution (concentration not stated) resulted in a depolarisation of 
11mV (from approximately -38 to -27mV) (Archer et al., 1996).  This is much smaller than the 
response seen in freshly dissociated PVSMC but similar to the depolarisation seen in PVSMCs isolated 
from vessels kept in culture conditions.  However results cannot be directly compared because the 
concentration of KCl used by Archer et al. (1996) was not documented.   
The reduction in depolarisation in cells isolated from PVs maintained in culture observed (non-
significant trend) is at odds with the data from contractile studies in isolated PV showing significantly 
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increased contraction in response to 80mM KCl after maintenance in culture (Chapter 3).  This 
increased contraction with no associated increase in depolarisation may be explained by increased 
Ca2+-sensitisation in response to KCl (Ratz et al., 2005) in PVs after maintenance in culture conditions.  
In isolated PAs, contraction in response to 50mM KCl was diminished after 3 days maintenance in 
culture conditions however RMP responses at the cellular level were not recorded (Manoury et al., 
2009). 
Depolarisation in response to 80mM KCl was used as a measure of viability of PVSMCs in this study.   
KCl was applied via Picospritzer® and change of Picospritzer® pipette was not possible once a cell was 
in whole-cell recording mode as this could have resulted in a seal break since both pipettes were in 
close proximity (see Chapter 2, Figure 11).  Therefore, a KCl viability test could not be performed for 
every cell which could be considered a study limitation.  The main indicators of viability in other cells 
were based on visual inspection (bright halo, intact membrane) and the ability to record stable 
RMP/currents. 
 
Resting Membrane Potential – Effect of K+ channel Inhibitors and Hypoxia 
4AP 
There was no clear or significant effect of 5mM 4AP application on the RMP of inferior porcine 
PVSMCs in this study.  The only significant effect was observed in fresh PVSMCs where RMP 
progressively depolarised and RMP recorded after washout was significantly less negative than 
baseline RMP.  This may indicate a delayed onset of action and poor reversibility of 4AP however this 
is unlikely as 4AP is well known for being readily reversible and onset of action is rapid (Osipenko et 
al., 1997, Yuan, 1995) and would usually occur within the exposure time used in these experiments.  
Osipenko et al. (1997) also used a 4AP exposure time of 90 seconds in rabbit PASMCs and saw 
membrane potential depolarise and reach a plateau within this time. 
In earlier experiments (Chapter 3), 4AP caused a transient increase in baseline tension of freshly 
isolated inferior PVs but this was not sustained.  Taken together with the lack of effect of 4AP on 
membrane potential, this suggests that KV channels sensitive to 4AP are unlikely to play a role in 
long-term control of resting membrane potential/tone in porcine inferior PVSMCs/PVs.  Previous 
research in PVs showed a significant increase in tension to 5mM 4AP in both porcine superior/middle 
PV (Dospinescu et al., 2012) and rat PV (Michelakis et al., 2001).  This discrepancy may be due to 
species differences or difference in location in the lung/vascular tree (Dospinescu et al. (2012) used 
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5th-7th order porcine PVs as opposed to 4th-5th order PVs used in this study).  Data investigating the 
effect of 5mM 4AP on RMP in PVSMCs is not readily available in the literature.  The general 
consensus within PASMCs is that 4AP (1-10mM) causes depolarisation of the membrane potential: 
this has been demonstrated within freshly dissociated PASMCs from rat (Archer et al., 1996, Archer 
et al., 1998) and rabbit (Hong et al., 2005, Osipenko et al., 1997) and primary cultured PASMCs from 
rat (Yuan, 1995). However freshly dissociated PASMCs from mouse did not depolarise after exposure 
to 1mM 4AP (Manoury et al., 2011).  This may suggest that mechanisms underlying control of RMP 
differ between PVSMCs and PASMCs and between species. 
An increased contractile response to 1mM 4AP was observed in PAs after 3-4 days of exposure to 
culture conditions compared to freshly dissected PAs (Manoury et al., 2009).  As was the case for KCl 
experiments, no membrane potential responses were recorded by Manoury et al. (2009).  After 24 
hours of blood vessel maintenance in culture conditions in this study, isolated PVSMCs showed no 
sign of increased sensitisation to 4AP.  In fact, SMCs became progressively more hyperpolarised over 
the course of the experimental protocol, a trend which did not reach statistical significance.  Overall, 
it is unlikely that KV channels sensitive to 4AP contribute to RMP within inferior porcine PVSMCs. 
 
TEA 
TEA (5mM) caused significant membrane depolarisation in SMCs isolated from both fresh PVs and 
PVs maintained in culture conditions for 24 hours.  In earlier experiments (Chapter 4), TEA (5mM) 
caused a sustained increased in baseline tension of freshly isolated inferior PVs.  This suggests that K+ 
channels sensitive to block by TEA contribute to control of RMP and resting tone in inferior porcine 
PVMSCs/PVs.  Previous research in rat PVs suggested that 5mM TEA only caused minimal constriction 
perhaps suggesting a difference in PVs between different species (Michelakis et al., 2001).   
There is no previous known research investigating the effect of TEA on RMP in PVSMCs specifically.  
Studies investigating the effect of TEA on membrane potential in PASMCs showed variable results.   
Unlike the consistent effect of TEA seen in this study, in mouse PASMCs, 10mM TEA resulted in 
depolarisation of only 29% of cells tested yet when all data was averaged there was a significant 
difference between RMP in the presence and absence of the drug (Manoury et al., 2011).  In PASMCs 
from rat, 5mM TEA had no effect on RMP (Archer et al., 1996).  The difference between the two 
studies could be accounted for in terms of species differences however Manoury et al. (2011) 
isolated cells from 1st-3rd order PAs and Archer et al. (1996) from 4th-5th order PAs which could be an 
alternative explanation.  Archer et al. (1996) proposed that different cell types and K+ currents 
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predominate in rat conduit and resistance PASMCs with Ca2+-activated K+ channels being more 
abundant in conduit PAs (1st-2nd order) and KV channels being more abundant in resistance PAs (4
th-
5th order).  However, TEA (10mM) had no effect on RMP in rabbit conduit PASMCs (Osipenko et al., 
1997) hence this points more towards potential species differences.  TEA appears to have a more 
clear and consistent effect on RMP in PVSMCs than PASMCs. 
TEA was used in these experiments primarily to determine the potential role of BKCa channels to the 
RMP of PVSMCs because at concentrations of 5mM and lower, TEA is reportedly selective for BKCa 
channels (Archer et al., 1996, Moudgil et al., 2005).  Hence results observed may indicate that BKCa 
plays a role in regulation of RMP within porcine inferior PVSMCs.  Other BKCa channel inhibitors have 
similarly variable effects on RMP to TEA within PASMCs with charybdotoxin having no effect on 
membrane potential on PASMCs from rat (Yuan, 1995) and adult rabbit (Osipenko et al., 1997) and 
iberiotoxin causing depolarisation in foetal rabbit PASMCs (Hong et al., 2005).  
As discussed in Chapter 4, TEA may also inhibit KV channels and specifically those with KV2.1 α 
subunits (Smirnov et al., 2002). A current which was 4AP-insensitive and TEA-sensitive was identified 
in some PASMCs from rat conduit PAs (Smirnov et al., 2002) and was proposed to be mediated by 
KV2.1 α subunits (Patel et al., 1997, Shi et al., 1994).  The depolarisation seen with TEA in this study 
could suggest that K+ channels expressing KV2.1 α subunits play a role in controlling RMP of PVSMCs. 
When KV channels contain only KV2.1 α subunits, they are rarely activated at membrane potentials 
more negative than -20mV (Patel et al., 1997).  This means that a homomeric KV2.1 channel is 
unlikely to be activated at the RMP of inferior porcine PVSMCs measured in this study (-39.7 ± 14.2 
mV (fresh); -36.6 ± 12.8 mV (culture)).  Activation is shifted to within the range of RMP of PVSMCs (-
50 to -60mV) when KV2.1 subunits form a heteromer with KV9.3 (Patel et al., 1997).  Therefore, a 
KV2.1/KV9.3 heteromeric channel could play a role in setting the RMP of inferior PVSMCs.   
The mean TEA-induced depolarisation in SMCs isolated from PVs maintained in culture was more 
than double the depolarisation seen in fresh PVSMCs (culture: +14.7 ± 3.5 mV; fresh: +7.0 ± 1.2 mV).  
This finding was particularly interesting as it was the first real suggestion that maintaining PVs in 
culture had a direct effect on isolated smooth muscle cells.  It also ties in with results from PAs 
whereby an increased contractile response to 10mM TEA was observed after 3-4 days maintenance 
in culture conditions compared to fresh PAs (Manoury et al., 2009) although the effect on membrane 
potential was not investigated.   
Maintenance in culture conditions appears to sensitise PVSMCs to the effects of TEA which could be 
due to upregulation or increased expression of BKCa channels or KV channels expressing KV2.1 α 
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subunits.  Baseline RMP was also slightly higher in culture (-36.6 ± 12.8 mV compared with fresh: 39.7 
± 14.2 mV; P>0.05), which could lead to increased activation of K+ channels hence why TEA had a 
more profound effect. 
 
ZnCl2 
Application of ZnCl2 had no consistent effect on the RMP of PVSMCs, some cells depolarised and 
some hyperpolarised with the mean effect of the drug remaining unclear.  If TASK-1/3 channels were 
involved in controlling RMP in PVSMCs then blocking these channels with ZnCl2 would result in 
depolarisation (Ali et al., 2014) which was not observed consistently.  In Chapter 4, the role of ZnCl2 
as a TASK-1 blocker was challenged and it was highlighted that ZnCl2 could block TREK-1 at the 
concentration used in this experiment (Gruss et al., 2004).  Therefore, the action of ZnCl2 as a 
selective blocker of TASK-1/3 channels should be viewed with caution. 
The hyperpolarisation observed on application of ZnCl2 in approximately 50-57% of cells could be a 
result of a repolarisation mechanism (e.g. BKCa channel activation) which results in negative-feedback 
regulation after initial depolarisation due to TASK/TREK blockade.  This repolarisation mechanism has 
been identified with 4AP whereby activation of BKCa occurs after 4AP-induced depolarisation and 
influx of Ca2+ (Yuan, 1995).  In order to further investigate this possible mechanism, responses to 
ZnCl2 would need to be recorded in the presence of a BKCa blocker (e.g. TEA or Penitrem A).  In order 
to record ZnCl2-sensitive currents, previous investigators have used 10mM TEA and 5mM 4AP during 
whole-cell recordings (Patel et al., 2013).  This may be a useful approach to use in future studies to 
ascertain the effect of ZnCl2 in the absence of any repolarisation mechanisms which may exist.   
As well as blocking TASK/TREK channels, ZnCl2 can cause inhibition of Ca
2+ channel currents (Ali et al., 
2014) which could provide an alternative explanation for the hyperpolarisation seen in some cells if 
basal Ca2+influx is present in PVSMCs.  In PAs, maintenance in culture conditions for 3-4 days resulted 
in the emergence of an uncharacteristic relaxation in response to the block of Ca2+ channels with 
nifedipine indicating that Ca2+ influx was contributing to basal tone (Manoury et al., 2009) and 
perhaps RMP of PASMCs.  However a similar proportion of cells isolated from fresh PVs (50%) and 
those isolated from vessels maintained in culture conditions (57%) became hyperpolarised on ZnCl2 
application.  As the effects of 1mM ZnCl2 on RMP are unclear and it is also unclear which channel(s) 
ZnCl2 is inhibiting, no real conclusions can be drawn as to the mechanism of action or contribution of 
ZnCl2-sensitive channels to RMP in PVSMCs. 
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Hypoxia 
Exposure to hypoxic bath solution lead to depolarisation in SMCs isolated from both fresh PVs and 
PVs maintained in culture however the hypoxic depolarisation only reached statistical significance in 
SMCs isolated from fresh PVs (when initial baseline RMP was compared to RMP during hypoxia).  The 
size of depolarisations seen in fresh/culture PVSMCs were not significantly different from one 
another.  On reoxygenation, SMCs continued to depolarise; RMP on reoxygenation was significantly 
more depolarised than baseline RMP in both fresh and culture PVSMCs.  Data from experiments 
investigating the effect of hypoxia on the RMP of PVSMCs are not readily available in the literature.  
Previous study of hypoxia in PVSMCs during whole-cell electrophysiology focussed on hypoxia-
sensitive whole cell currents as opposed to RMP under current-clamp conditions (Dospinescu et al., 
2012).   
Hypoxia is known to cause depolarisation in freshly dissociated PASMC from rat (Archer et al., 1996, 
Archer et al., 2004, Olschewski et al., 2002), dog (Post et al., 1992) and rabbit (Hong et al., 2005, 
Osipenko et al., 1997) and in primary cultured PASMCs from rat (Yuan et al., 1993).  When PASMCs 
were exposed to bath solution bubbled with gas containing 0% O2 (N2 with or without CO2), 
depolarisation magnitudes ranged from values similar to those seen in PVSMCs: approximately +7 to 
+10mV (Hong et al., 2005, Osipenko et al., 1997) up to much larger values of +22 to +30mV (Archer et 
al., 1996, Archer et al., 2004, Olschewski et al., 2002). Yuan et al. (1993) used sodium dithionite as an 
oxygen scavenger and PASMCs depolarised by approximately +15mV.  In this study of inferior 
PVSMCs, exposure time to hypoxic bath solution was 5 minutes as there were problems with holding 
the cell long enough to record baseline, hypoxia and recovery and recovery of the RMP to baseline 
levels was not achieved.  This challenge was also encountered by Osipenko et al. (1997) who found 
that the time course of the depolarisation and recovery was slow and RMP only partially recovered 
on re-equilibration with room air.  In contrast, others found that depolarisation of PASMCs in 
response to hypoxia was rapid (Archer et al., 1996, Archer et al., 2004) and RMP fully recovered on 
reoxygenation (Archer et al., 2004, Yuan et al., 1993).  Interestingly, one study found that when the 
solution was bubbled with 3% O2 PASMCs became depolarised and this was reversible on returning 
to normoxia however at 0% O2 depolarisation was irreversible (Olschewski et al., 2002), similar to the 
results observed in PVSMCs.  
A notable difference between these hypoxia studies in PASMCs was that some researchers 
conducted experiments at room temperature (22-25°C) (Osipenko et al., 1997, Yuan et al., 1993) 
similar to temperature used in this study (21-22°C) and others used temperatures of 30-35°C (Archer 
et al., 1996, Archer et al., 2004, Hong et al., 2005, Olschewski et al., 2002, Post et al., 1992).  The 
202 
 
reason for using this higher temperature was that the “O2-sensitive channel” within PASMCs is not 
active at room temperature (Archer et al., 1996).  This could help provide some explanation as to the 
variation in the size of depolarisations observed in PASMCs however the mechanism of hypoxic 
depolarisation in PVSMCs may be different; temperature may be a factor worth taking into 
consideration in future experiments. 
 
Voltage-activated Whole-cell Currents - Effect of K+ Channel inhibitors 
General characteristics of Voltage-activated Whole-cell Currents in PVSMCs 
Voltage-activated whole cell currents in inferior PVSMCs were outward, rapidly activating and non-
inactivating with spiky STOC components at more depolarised potentials and no inward rectification. 
These characteristics have all been observed previously within superior/middle PVSMCs and rat 
PVSMCs with the STOC components suggested to involve BKCa channels (Dospinescu, 2009, 
Michelakis et al., 2001).  
 
4AP 
Extracellular application of 4AP (5mM) had no effect on voltage-activated outward currents in SMCs 
isolated from either fresh PVs or PVs maintained in culture conditions.  In previous studies in porcine 
and rat PVSMCs, 5mM 4AP inhibited outward K+ currents (Dospinescu, 2009, Michelakis et al., 2001).  
Notably, Dospinescu (2009) performed experiments in the presence of Penitrem A to block 
contribution of BKCa currents to the overall whole cell K
+ current and saw ~25% inhibition with 4AP at 
a single depolarisation step of -80mV to +80mV.   On the other hand, Michelakis et al. (2001) saw 
partial inhibition of K+ currents with 4AP in the absence of BKCa blockade. Repolarisation mechanisms 
can occur whereby BKCa channels are activated after KV inhibition with 4AP (Yuan, 1995) which can 
overshadow the current inhibition.  To further ascertain whether KV channels contribute to outward 
K+ currents in PVSMCs, future experiments could be performed in conditions which inhibit the 
contribution of BKCa.  Pharmacological inhibition of BKCa is only one of the ways in which KV currents 
can be isolated; bath and pipette solutions can also be manipulated in favour of KV currents.  Optimal 
conditions for KV currents are Ca
2+ free bath solution (plus 1mM EGTA) and Ca2+ free intracellular 
pipette solution (plus 10mM EGTA) (Firth et al., 2011) to eliminate the BKCa current (Yuan, 1995).  The 
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experimental conditions used in this study were more in favour of BKCa; therefore solid conclusions 
about 4AP sensitive KV currents cannot be made from the results of this study. 
A possible alternative explanation for the differences seen with 4AP between this study and the 
study by Dospinescu (2009), as previously discussed, would be the order of PVs used for SMC 
isolation (5th-7th order superior/middle PVs (Dospinescu, 2009) and 4th-5th order inferior PVs).  Clear 
differences between K+ currents from SMCs isolated from larger conduit PAs and those from smaller 
resistance PAs have been identified with the former having a larger contribution from BKCa channels 
and the latter from KV (Archer et al., 1996, Archer et al., 2004, Smirnov et al., 2002).  The same 
relationship could exist between smaller and larger PVs however, without manipulation of 
experimental solutions/conditions, the reason for the differences observed cannot be inferred. 
 
TEA 
Applying TEA (5mM) to SMCs caused significant but reversible inhibition of the average steady state 
current over the depolarising steps of +30 to +80 mV for cells from fresh PVs and +40 to +80 mV for 
cells from PVs kept in culture.  A larger proportion of the current (70%) was inhibited in SMCs 
isolated from PVs kept in culture than in fresh PVSMCs (50%) at a test potential of +80mV.  It was 
therefore not surprising that the magnitude of the TEA-sensitive difference current was significantly 
increased in cells isolated from PVs maintained in culture (at +70 and +80mV voltage steps).  TEA 
(5mM) also inhibited voltage-activated outward currents in SMCs isolated from freshly dissected 
superior/middle PVs (Dospinescu, 2009) however the inhibition was greater (77.5%) than the 
inhibition seen in fresh inferior PVSMCs.  In rat PVSMCs, TEA inhibited outward currents by ~75% and 
to a greater extent than 5mM 4AP (~30% inhibition compared with control) (Michelakis et al., 2001).  
This suggests that in SMCs isolated from fresh inferior 4th-5th order porcine PVs, there is a larger 
proportion of the outward K+ current which is TEA-insensitive than for other PV locations/other 
species. 
TEA is likely to inhibit both BKCa and KV to some extent, as discussed in detail earlier in this chapter.  
Studies of voltage-activated currents within rabbit PASMCs provide further evidence to support this 
with TEA (10mM) causing 33% inhibition in contrast to iberiotoxin/charybdotoxin (more selective 
BKCa blockers) which inhibited only 14% of the current (Osipenko et al., 1997).  At a lower 
concentration of 1mM TEA, however, there is a negligible effect on KV currents (Firth et al., 2011).  
Bearing in mind that these experiments inadvertently provided experimental conditions favourable 
for recording BKCa currents (Firth et al., 2011), it may be more likely that TEA is blocking BKCa.  In 
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order to fully understand the role of BKCa currents within inferior PVSMCs, a more selective blocker 
of BKCa would be required, for example Penitrem A.  Another finding which warrants further 
investigation is the TEA-insensitive proportion of the current (particularly in fresh PVSMCs where 
50% of the outward current remained) although results from experiments with ZnCl2 helped shed 
some light on this residual current. 
 
ZnCl2 
ZnCl2 (1mM) inhibited 32% and 26% of the whole-cell voltage-activated currents in SMCs isolated 
from fresh PVs and from PVs maintained in culture, respectively, at a test potential of +80mV.  
Interestingly this is within the range of the proportion of current remaining after TEA-inhibition (50% 
and 30% TEA-insensitive current remaining in fresh/culture, respectively) and TEA is not known to 
inhibit currents sensitive to ZnCl2 (TASK/TREK) (Patel et al., 2013). 
The ZnCl2-sensitive difference current was significantly reduced at a voltage step of +80mV in SMCs 
isolated from culture conditions; this is opposite to the results seen with TEA where TEA-sensitive 
currents increased.  It can therefore be proposed that K+ currents within inferior PVSMCs are a 
balance of TEA-sensitive BKCa/KV channel currents and ZnCl2-sensitive TASK/TREK currents and that 
this balance shifts when inferior PVs are exposed to culture conditions for 24 hours.  To confirm this 
theory, experiments would need to be performed in the presence of both agents and in this case, 
near complete inhibition would be expected. 
ZnCl2 was initially chosen as an inhibitor of TASK-1 because this channel controls RMP and is hypoxia-
sensitive, however results within this chapter show ZnCl2 has no significant effect on RMP and there 
was no significant effect on hypoxic pulmonary venoconstriction (Chapter 4).  There was no definitive 
evidence from Ali et al. (2014) that ZnCl2 at the concentration used in this study (1mM) would block 
TASK-1 however evidence of TASK-3 and TREK-1 blockade has been reported (Gruss et al., 2004).  
Results within this chapter and Chapter 4 could suggest that although TASK-3 and TREK-1 currents 
appear to be present within PVSMCs, they are not active at RMP and are not involved in the hypoxic 
contraction of PVs.  In order to investigate the role of TASK-1, a more selective pharmacological 
inhibitor would be required such as anandamide (Maingret et al., 2001) however as an 
endocannabinoid it is likely to have other non-specific effects.  Alternatively, the experimental 
solutions/conditions could be manipulated.  Previous studies of TASK channels in freshly dissociated 
endometrial epithelial cells investigated TASK in the presence of 4AP and TEA (due to known lack of 
sensitivity towards several K2P channels) and by reducing extracellular pH from 7.4 to 6.6 (Patel et 
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al., 2013).  As TASK channels are the only members of the two-pore domain K+ channel superfamily 
inhibited by extracellular pH, any reduction in the whole-cell outward current could be attributed to 
TASK channel contribution (Patel et al., 2013).  This would not isolate TASK-1 from other TASK 
channels (TASK-2/3) however it may be the best approach to take given the lack of potent and 
specific blockers available.  
 
Voltage-activated Whole-cell Currents - Effect of Maintaining PVs in Culture 
Maintenance of PVs in culture conditions had a significant impact on both magnitude and activation 
kinetics of whole cell outward currents in PVSMCs.  Current density in SMCs isolated from PVs 
maintained in culture conditions was significantly greater at the +80mV voltage step and Ʈact values 
suggest currents were more rapidly activating at -10 and 0mV voltage steps compared with fresh 
PVSMCs.  There is no known previous work evaluating the effect of maintenance of PVs in culture on 
voltage activated currents in PVSMCs.  In contrast to the results observed in this study, SMCs isolated 
from PAs kept under culture conditions for 4 days had significantly reduced voltage-activated K+ 
currents compared with freshly isolated PASMCs (Manoury et al., 2009).   
Taken together with the results seen in PV contractile studies (Chapter 3), these results suggest that 
maintenance in culture condition not only has a significant impact on isolated PV function but also 
has minor effects on PVSMC function in terms of magnitude and kinetics of outward K+ currents and 
their sensitivity to TEA and ZnCl2.  Maintenance in culture conditions may have an impact on both 
endothelium and smooth muscle cells or even on the electrical coupling between the two (Emerson 
and Segal, 2000). 
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Key Findings 
This study set out to characterise inferior PVSMCs in terms of morphology and electrophysiology 
(RMP and whole-cell outward K+ currents) and to determine whether maintenance in culture had any 
impact on those characteristics.  Key findings within this chapter suggest that maintaining PVs in 
culture has minimal effect on isolated SMCs in terms of morphology, membrane capacitance, RMP 
and notably, RMP responses to hypoxia.  This implies that the increased contractions of intact PVs to 
hypoxia after maintenance in culture (Chapter 3) were not due to enhanced activity/altered RMP at 
the SMC level. 
 TEA caused a larger depolarisation of RMP in SMCs isolated from PVs maintained in culture and a 
larger TEA-sensitive current was present in SMCs isolated from PVs kept in culture.  ZnCl2-sensitive 
currents were reduced in SMCs isolated from PVs kept in culture.  As the effects on TEA- and ZnCl2-
sensitive currents were only observed at the highest test potentials (+70 to +80 mV), it is 
questionable whether these results are physiologically relevant since SMCs would not be exposed to 
these voltages under normal conditions (Moudgil et al., 2005).  ZnCl2 and 4AP had no impact on RMP 
and 4AP had no impact on whole-cell currents in PVSMCs.   
This study has provided a detailed morphological characterisation and basic electrophysiological 
characterisation of SMCs isolated from porcine inferior PVs.  It has highlighted that, although 
differences in function after PV maintenance in culture exist at the isolated vessel level, there is less 
of an impact on SMCs in terms of morphology and electrical membrane properties.   
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Chapter 6 
Conclusions and Further Work 
 
 
The studies presented within this thesis aimed to characterise and identify underlying mechanisms of 
hypoxic responses of porcine PVs and to evaluate the impact of maintenance in culture conditions.  
Myography studies successfully characterised the PV hypoxic response and identified likely 
regulatory pathways and also helped demonstrate the profound impact of culture conditions alone 
on PV contractility.  Studies using isolated PVSMCs aimed to characterise morphological and 
electrical membrane properties including the impact of PV maintenance in culture and responses to 
hypoxia.  A full morphological and basic electrophysiological characterisation was achieved which 
identified minimal impact on isolated SMCs when PVs were kept in culture conditions for 24 hours.  
The effect of K+ channel inhibitors on RMP and voltage-activated currents was studied along with the 
effect of hypoxia on RMP however underlying mechanisms of hypoxic responses in PVSMCs were not 
characterised.  
Initial myography studies identified a robust and reproducible hypoxic contraction in porcine PVs and 
revealed a novel contractile response on reoxygenation after hypoxic exposure. The effects of 
maintenance of PVs in culture conditions were also investigated using myography with a view to 
using the technique for future studies whereby environmental conditions could be manipulated in 
order to assess their impact on PV function.  Maintenance of PVs in culture conditions for 24 hours 
had a profound effect on PV contractile function, particularly in inferior PVs where contractions to 
histamine, KCl, U46619 and hypoxia were increased and hypoxic relaxation and reoxygenation 
contraction were inhibited.  These altered contractile and relaxant responses were suggested to 
result from endothelial dysfunction/damage as endothelium-dependent relaxations to carbachol 
were inhibited in PVs maintained in culture for 24 hours compared to fresh PVs. 
The contribution of endothelial-mediated pathways to hypoxic and reoxygenation responses was 
further investigated in fresh inferior PVs.  L-NAME, an inhibitor of NOS (Bardou et al., 2001, Félétou 
et al., 1995) was used in an attempt to simulate the effects of PV maintenance in culture.  The effect 
of L-NAME was unexpected and opposed the results seen after PV exposure to culture conditions 
(where hypoxic contraction was increased and hypoxic relaxation and reoxygenation contraction 
208 
 
were inhibited).  In terms of the hypoxic response, L-NAME inhibited the transient hypoxic 
contraction, enhanced relaxation and significantly altered dynamics of the response in fresh PVs.  The 
NOS inhibitor also potentiated the reoxygenation contraction.  Relatively simple experiments 
investigating the impact of L-NAME on endothelial function tests confirmed the drug was having an 
effect on NOS in the endothelium rather than in smooth muscle within PVs.  L-NAME inhibited 
endothelial-mediated relaxations to carbachol and enhanced contractions to histamine whereas time 
control PVs showed reduced histamine contraction on re-exposure. Taken alone, the data from time 
control PVs suggest possible desensitisation of pro-contractile smooth muscle H1 receptors (Shi et al., 
1998, Toda, 1990).  However, the increased contraction to histamine seen when NOS was inhibited 
with L-NAME suggests endothelial H1 receptor upregulation occurs rather than smooth muscle H1 
receptor desensitisation (Toda, 1990).  These results also support the role of L-NAME inhibition of 
endothelial NOS.   
Results of hypoxia studies using L-NAME were not in keeping with results seen after PV maintenance 
in culture and indicated that data from contractile studies were not explained fully by endothelial 
function/dysfunction. Hence, the impact of PV maintenance in culture was explored at the single 
smooth muscle cell level.  Morphologically, SMCs isolated from PVs maintained in culture were 
longer and had a larger perimeter than freshly isolated PVSMCs but were otherwise similar.  A 
difference in cell length and perimeter does not necessarily suggest a difference in contractility of 
SMCs as previous studies have found that contractility was not dependent on cell length but on area 
and width (Tolic-Norrelykke and Wang, 2005).  Furthermore, passive electrical properties (Cm and 
RMP) were not significantly different between SMCs isolated from PVs maintained in culture and 
those isolated from fresh PVs.  Hypoxia caused depolarisation of RMP in both fresh and culture 
PVSMCs but the effect only reached significance in fresh PVSMCs and the size of the depolarisation 
was comparable in fresh/culture PVSMCs.  Hence, initial results in SMCs suggested that maintenance 
of PVs in culture had no obvious effect on their morphology or function.   
PV K+ channel function and expression were explored as K+ channels were known to play a key role in 
hypoxic responses of both resistance PAs (Archer et al., 1996, Archer et al., 1998, Archer and 
Michelakis, 2002, Archer et al., 2004, Moudgil et al., 2005, Platoshyn et al., 2006) and 5th-7th order 
superior/middle PVs (Dospinescu et al., 2012).  K+ channel inhibitors were used to explore underlying 
mechanisms and pathways of hypoxic contraction in inferior PVs.  Penitrem A, 4AP, DPO-1, ZnCl2 and 
glyburide all failed to have an effect on hypoxic contraction however TEA and BDM both inhibited the 
hypoxic response.  This suggested that TASK, KV1.5, BKCa and KATP do not play a role in the mechanism 
of hypoxia-induced contraction of inferior PVs however KV channels containing KV2.1 α subunits could 
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modulate the response.  K+ channels appear to tell only part of the story regarding the hypoxic 
response in PVs.  This is notable because it highlights a fundamental difference between the hypoxic 
response of the PV and the PA.  In the latter, K+ channels play a pivotal role in the mechanism of HPV 
whereby inhibition of KV channels leads to PASMC depolarisation, VGCC influx and PA constriction 
(Archer et al., 1996, Archer et al., 1998, Archer and Michelakis, 2002, Archer et al., 2004, Leach et al., 
1994, McMurtry et al., 1976, Moudgil et al., 2005, Platoshyn et al., 2006).  This is in keeping with 
clinical findings where treatments for PAH (prostacyclin, bosentan, calcium channel blockers) may 
cause pulmonary oedema in patients with pulmonary venous involvement (Creagh-Brown et al., 
2008, Montani et al., 2008 and Palmer et al., 1998) suggesting mechanisms of dysregulation and 
disease may differ between PAs and PVs. 
 
Based on the in-depth functional characterisation performed and presented within this thesis, the 
underlying mechanism of the PV hypoxic reponse is now better understood at the isolated vessel 
level.  This could have implications physiologically, whereby hypoxic pulmonary venoconstriction is 
hypothesised to recruit upstream capillaries and optimise gas exchange in healthy humans (Taylor et 
al., 2011).  The experiments performed emphasise the importance of PV hypoxic constriction as a 
robust and reproducible physiological response which increases in magnitude with repeated 
exposure.  This research may also suggest mechanisms which play a role in hypoxia-related disease 
such as high altitude pulmonary oedema, where inhomogeneous hypoxic pulmonary 
venoconstriction is suggested to cause regional overperfusion and subsequent oedema in the lungs 
(Bärtsch and Gibbs, 2007).  Figure 70 summarises the proposed role of hypoxic pulmonary 
venoconstriction in normal physiology and disease. 
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Figure 70.  Diagram showing the proposed role of hypoxic pulmonary venoconstriction under 
normal physiological condtions and in disease (in the context of high altitude pulmonary oedema).  
Physiologically, hypoxic PV constriction is proposed to increase upstream pressure and recruit 
pulmonary capillaries leading to optimisation of gas exchange (Taylor et al., 2011).  Hypoxic PV 
constriction during high altitude pulmonary oedema is proposed to be inhomogeneous and lead to 
regional overperfusion (Bärtsch and Gibbs, 2007), increased pulmonary capillary pressure (Maggiorini 
et al., 2001) and ultimately, pulmonary oedema. 
 
K+ channel inhibitors for electrophysiology were selected based on previous findings in inferior PV 
contractile studies (Chapter 4) and isolated PVSMCs (Dospinescu et al., 2012, Michelakis et al., 2001). 
K+ channel blockers were used in attempt to identify any impact of maintaining PVs in culture 
conditions on K+ currents and their contribution to RMP in SMCs.  The BKCa/KV blocker TEA caused a 
significantly larger depolarisation in SMCs isolated from PVs kept in culture; this was the first 
suggestion that maintaining PVs in culture had any direct effect on electrical properties of SMCs.  In 
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terms of voltage-activated outward K+ currents, PVSMCs from vessels kept in culture had a larger 
TEA-sensitive current, smaller ZnCl2-(TASK/TREK blocker) sensitive current and larger overall current.  
These effects were only observed at the highest test potentials (+70 to +80 mV) therefore it is 
questionable whether these results are physiologically relevant since SMCs would not be exposed to 
such high voltages under normal conditions (Moudgil et al., 2005).  Therefore, maintaining PVs in 
culture conditions had minor effects on the K+ currents studied and their contribution to RMP and 
current effects occurred at voltages which cells may not be exposed to physiologically. 
K+ channels appear to play only a minor modulatory role in hypoxic contraction in inferior PVs and K+ 
currents in SMCs are only minimally affected after PV maintenance in culture.  Hypoxic responses 
with L-NAME and in PVs exposed to culture conditions suggest that endothelial regulation is a more 
important focus for research going forward in terms of hypoxia studies and for the development of 
PV culture as a disease model for investigation of a range of environmental conditions.  
The difference observed in hypoxic responses after exposure to culture and with L-NAME may be 
more related to the underlying balance between NO and other endothelial relaxing factors e.g. 
prostaglandins and endothelial contracting factors e.g. endothelin-1.  Exposure to culture conditions 
resulted in endothelial dysfunction/damage as demonstrated by the inhibition of endothelial-
mediated relaxation to carbachol. Dysfunction of or damage to the endothelium in response to 
maintenance in culture conditions may result in altered release of any combination of endothelial 
relaxing/contracting factors and further research is warranted  in this area.   
Endothelial cells within pulmonary capillaries are important for the detection of hypoxia and 
propagation of the HPV signal via connexin-40 gap junctions to the endothelium of pulmonary 
arterioles in mice (Wang et al., 2012).  It would be interesting to investigate whether this same signal 
propagation occurs on the venous side of the pulmonary circulation.  Endothelial cells not only 
communicate with one another but are electrically coupled to smooth muscle cells as demonstrated 
in hamster feed arteries (Emerson and Segal, 2000).  Hyperpolarisation and depolarisation of 
endothelial cells was directly linked to SMC hyperpolarisation/relaxation and 
depolarisation/contraction, respectively.  RMP measurements were made in isolated hamster feed 
arteries which were cannulated, pressurised and exposed to continuous flow; two microelectrodes 
were used to impale one endothelial and one smooth muscle cell for simultaneous recordings.  This 
approach could be used in future studies of pulmonary veins/venules.  It may be more physiologically 
relevant than electrophysiology studies of isolated SMCs since intercellular communication between 
endothelial and smooth muscle cells seems vital to vasoactivity. 
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Cannulated and pressurised blood vessels could be applied in studies where maintenance in culture 
conditions is used as a tool to manipulate environmental conditions and simulate disease states.  
Maintenance of PVs in an unpressurised state under conditions of no flow whilst exposed to culture 
conditions may have contributed to the impaired relaxation and enhanced contractility observed in 
studies presented here.  In addition to considering pressurisation and flow, the model would require 
appropriate controls, for example, if glucose was manipulated, PVs exposed to isosmotic culture 
conditions should act as control vessels rather than freshly isolated PVs or PVs exposed to standard 
culture medium.   
 
There is a distinct lack of research investigating the role of PVs in disease, as acknowledged by Tuder 
et al. (2013).  Research presented here demonstrates development and evaluation of a potential tool 
for use a disease model for manipulation of environmental conditions.  This is important because 
there is an established link between metabolic syndrome and pulmonary venous hypertension 
(Robbins et al., 2009) yet the direct impact of conditions associated with metabolic syndrome on PV 
function remains unknown.  Results also demonstrate the significant vasoactivity of PVs in response 
to hypoxia and agonists and sensitivity of PV function to short term exposure to culture conditions. 
Results from contractile studies are particularly intriguing because the large 4th-5th order inferior PVs 
studied would have historically been regarded as passive conduit vessels.  The considerable 
vasoactivity of PVs suggests that dysfunction may result in harmful physiological consequences 
including raised pulmonary vascular resistance (Gao and Raj, 2005, Her et al., 2010) and pulmonary 
oedema (Bärtsch and Gibbs, 2007, Maggiorini et al., 2001).  The findings presented within this thesis 
help begin to clarify mechanisms underlying physiological and pathophysiological responses of PVs 
and suggests potential therapeutic targets for diseases originating in the PV. 
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Appendix 1 
Molecular Profiling of K+ Channel Expression in Porcine Pulmonary 
Veins 
 
Introduction 
The aim of studies within this appendix was to investigate the molecular basis of K+ channels in PVs 
identified in myography experiments (Chapter 4) and to identify potential targets for 
electrophysiological experiments (Chapter 5).  To that aim, RNA was extracted from PVs before 
amplifying transcripts using a suite of molecular biology techniques called reverse transcription 
polymerase chain reaction (RT-PCR). 
Despite previous successful RNA extraction and RT-PCR from blood vessels by both this research 
group (Dospinescu et al., 2012) and others (Archer et al., 2004, Michelakis et al., 2001), data were 
disappointing.  The exact reason for this could not be pinpointed although achieving proper 
homogenisation of blood vessels (due to thick vessel walls and high content of connective tissue) was 
suspected as a major contributing factor to the large variations observed in RNA yield and quality.  
The findings within this appendix reflect attempts to optimise RNA extraction and RT-PCR from 
abattoir-derived porcine PVs and other blood vessels. 
 
RNA Extraction 
RNA of good quality and yield is required for transcripts (mRNAs) to get reliably amplified for 
molecular profiling.  Extraction results are summarised in Table 1.  The data illustrate the wide range 
of RNA yields and concentrations observed when extracting RNA from porcine blood vessels 
(including PVs).  Note that a significant proportion of extractions (18.6%) produced undetectable 
RNA. However, in extractions which yielded enough RNA to use for reverse transcription (RT) this 
was often not successful either which may have been due to poor RNA quality.  The issue of RNA 
quality will be discussed later in this appendix. 
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Table 1. Results of RNA extractions from porcine blood vessels.  RNA data were obtained with the 
fluorescent Qubit™ 2.0 kit (Life Technologies, UK); lower detection limit 4ng/µL. Data represent RNA 
extraction from porcine pulmonary veins, pulmonary arteries, coronary artery and vena cava and 
exclude data from freshly dissociated cells.   
 Porcine blood vessels 
Number of extractions (n) 43 
Number of animals (N) 14 
Sample weight (mg) 22.5 ± 2.6 (mean ± S.E.M); range:  4.8 – 42 
RNA yield (ng/mg tissue) 72.7  ± 22.2 (mean ± S.E.M); range: 3.3 – 326.5 
RNA concentration (ng/µL) 65.2 ± 35.2 (mean ± S.E.M); range: 5.0 – 760.7 
Volume of eluate (µL) 10 – 50 
% of samples with undetectable 
RNA (<4µg/mL) 
18.6 
 
 
In contrast to the variable results seen with blood vessels, RNA extractions from a variety of other 
tissues (liver, retina, adrenal gland and brain tissue) proved more reliable (Table 2).  Indeed, 
extractions from all tissues apart from diaphragm produced detectable RNA concentrations and 
resulting yields/concentrations were more reproducible.  Interestingly, diaphragm (where RNA levels 
were undetectable) is composed mainly of smooth muscle, similar to blood vessels, whereas the 
other tissues used contain little connective tissue. 
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Table 2. Results of RNA extractions from tissues other than blood vessels.  RNA data were obtained 
with the fluorescent Qubit™ 2.0 kit (Life Technologies, UK); lower detection limit 4ng/µL.  Diaphragm, 
liver and retina were obtained from pig; adrenal gland and brain tissue were obtained from mouse.  
Tissue Diaphragm Liver Retina Adrenal 
gland 
Brain tissue 
Number of extractions 1 3 1 1 2 
Sample weight (mg) 21 [16 – 43] 22 7 [9 – 10] 
 
RNA yield (ng/mg tissue) N/A [37.1 – 82.5] 49.4 71.1 [23.3 – 
103.1] 
RNA concentration 
(ng/µL) 
<4 [35 – 63.8] 43.5 19.9 [9.3 – 37.1] 
Volume of eluate (µL) 25 25 25 25 25 
% of samples with 
undetectable RNA 
(<4µg/mL) 
100 0 0 0 0 
 
Therefore it appears the difficulties experienced with RNA extraction in these experiments are likely 
to be intrinsic to blood vessels.  Within the next section, selected examples were chosen which best 
illustrate the findings of this study. 
 
Assessing RNA Quality 
Obtaining good quality, intact RNA is crucial when profiling gene expression.  A good test of RNA 
quality is to look at quality and intensity of 28S and 18S ribosomal RNA bands on an agarose gel.  For 
mammalian RNA, two bands are observed, the longer corresponding to the 28S and the shorter 
corresponding to the 18S.  A 28S:18S intensity ratio of 2:1 is generally indicative of good quality RNA.  
If genomic DNA is present this appears as another higher molecular weight band which has not run 
as far as the 28S and 18S.  Low quality RNA appears as a smear on the gel corresponding to 
degraded, small RNA fragments (Wieczorek et al., 2012).  
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By the criteria above, RNA extracted from blood vessels appeared fairly degraded in terms of low 
band intensity and smearing on the gel (Figure 1A).  RNA extracted from liver is shown for 
comparison (Figure 1B).   
RNA samples were combined with loading buffer (Promega, UK) and made up to a final volume of 
14µL with nuclease-free water.  Of this, 12µL was loaded on a  1.5% agarose gel in 1x TBE (Tris base, 
Boric Acid, EDTA, Life Technologies, UK) buffer containing 0.005% GelRed nucleic acid gel stain 
(Cambridge Bioscience, UK).  The gel was run in an electrophoretic gel tank (Thermo Fisher Scientific, 
UK) at 80V for 80 minutes.   
Figure 1 compares RNA samples obtained from blood vessels and liver.  Please note that, for the sake 
of clarity, these and all other gel images within the appendix have had contrast inverted using Image 
J software.   
 
Figure 1. RNA gel showing samples extracted from porcine blood vessels (A) and liver (B).  RNA 
amounts respectively loaded on gel – SPV (superior pulmonary vein): 418.5ng; IPV (inferior 
pulmonary vein): 307.7ng; coronary artery: 610ng and liver: 264ng.  Ladder: PCR Markers Ladder 50-
1000 bp (Promega, UK). 
 
As shown in Figure 1, 28S and 18S bands were present for all samples however there was some 
smearing for the RNA from blood vessels (Figure 1A) whereas RNA from liver shows less smearing 
with clearer 28S and 18S bands (Figure 1B).  This suggests RNA extracted from porcine blood vessels 
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was not of optimal quality due to lower molecular weight products suggesting RNA degradation.  
Note that the RNA amount loaded for the liver sample was less (264ng) than for the blood vessels 
(307-610ng) yet the 28S and 18S bands for liver appear more intense.  The extract from liver also 
appears to show an approximately 2:1 ratio of 28S:18S however RNA extracted from blood vessels 
was of similar intensity at both bands.  Taken together these data suggest that RNA extracted from 
liver was of better quality and less degraded than RNA from blood vessels.  Each band of the PCR 
markers ladder represents approximately 41 – 55ng product and the fact that all bands of the ladder 
appear saturated is a reflection of RNA band weakness in the samples.  
Crushing and homogenisation of liver tissue was noticeably easier than for blood vessels.  Note that 
in this particular instance different RNA extraction kits were used (for blood vessels: RNeasy mini kit 
+ DNAse (Qiagen) and for liver: High Pure RNA Tissue kit (Roche)).  To assess whether the difference 
in RNA quality was due to the extraction kit or tissue, the same kit (High Pure RNA Tissue kit (Roche)) 
was used to extract from porcine superior PV and murine pituitary gland.   
Homogenisation of murine pituitary gland was much easier than homogenisation of superior PV and 
was carried out by passing the tissue sample through an 18G then 21G needle whereas the superior 
PV sample required to be crushed using a mortar and pestle in preparation for needle work.  Results 
are shown in Figure 2.  
 
Figure 2. Gel image showing RNA extracted from pituitary gland and superior pulmonary vein.  M. 
Pit: murine pituitary gland (185.5ng) and SPV: porcine superior PV (70.5ng).  Ladder: PCR Markers 
Ladder 50-1000 bp (Promega, UK). 
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As shown in Figure 2, RNA extracted from porcine superior PV showed smearing on the gel while 
28S/18S bands were barely visible, both of which suggest degraded RNA.   On the other hand RNA 
extracted from murine pituitary gland showed two clear and distinct bands with an approximately 
2:1 ratio of 28S:18S.  This again suggests that RNA extracted from tissues “softer” than blood vessels 
was of better quality and less degraded.  Nonetheless, the ladder bands all appear saturated 
reflecting the overall weak intensity of bands in samples loaded (similar to Figure 1).  Note however 
the difference in RNA amounts loaded. 
Taken together, the data above show that the difference in RNA yield and quality between tissues 
could not be attributed to the RNA extraction kit but instead confirm the issue probably lies with 
intrinsic difficulties in homogenising blood vessels. 
 
Reverse Transcription/cDNA Synthesis 
After assessment of quality and concentration, RNA was reverse transcribed into complementary 
DNA (cDNA) prior to amplification because DNA is more stable by its nature than RNA.   Transcriptor 
High Fidelity cDNA Synthesis kit (Roche, UK) was used for reverse transcription (RT) according to 
manufacturer’s instructions and the cDNA produced was then used to investigate gene expression 
within the samples.   
Controls are crucial in the RT process in order to identify any potential genomic contamination within 
the sample.  Any genomic DNA which may be present within the sample will be amplified (alongside 
cDNA) and can act as a template during PCR producing false positive results.  In order to minimise the 
risk of such contamination, the High Pure RNA Tissue kit (Roche, UK) routinely includes a DNAse 
incubation step.  The RNeasy mini kit (Qiagen, UK) did not contain a specific DNAse step however this 
was introduced as a separate step of the protocol whereby DNAse was added directly to the column 
membrane for 15 minutes at room temperature according to manufacturer’s instructions.  RT 
controls were carried out as a further precautionary step towards identifying genomic DNA and any 
false positive results.  RT controls here were set up and run in the absence of RT enzyme in parallel 
with reverse transcribed RNA samples.  In such controls, any amplicons could only result from 
genomic DNA contamination.    
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PCR 
Synthesised cDNA was then used as a template to amplify transcripts of a range of genes by PCR 
using GoTaq DNA Polymerase (Promega, UK).  Primer sequences for each of the transcripts studied 
are shown in Table 3.    Primers were designed to amplify all known variants of a single gene.  The 
primers for BKCa used here were designed in such a way that they straddle the splice variant STREX, 
therefore two products may be expected here, depending on cell expression:  a shorter band, 
corresponding to no insert (ZERO) and a longer band corresponding to the STREX insert (Chen et al., 
2005, Dospinescu et al., 2012).  
Murine primers for Ipo8, Fbxl10 and 18S RNA came as part of QuantiTect Primer Assay kits (Qiagen, 
UK). 
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Table 3.  Primer sequences for polymerase chain reaction experiments. 
Gene Species Forward Primer (5’ to 3’) Reverse Primer (5’ to 3’) Expected 
Product 
Length 
(bp) 
Kv1.5 
(Kcna5) 
Porcine 
Sus scrofa 
ccttgtcatcctcatctccatca aggatctgcagccccttggagt 
 
505 
Kv2.1 
(Kcnb1) 
Porcine 
Sus scrofa 
tcctcgccataatttccatca ttgtcatggtaatggtggccc 
 
560 
BKCa 
(Kcnma1) 
Porcine 
Sus scrofa 
gtccttccctactgtttg gtgcttgagctcatggtagt 670 (zero) 
845 
(STREX) 
β-actin 
(ACTB) 
Porcine 
Sus scrofa 
tccctggagaagagctacga tgttggcgtagaggtccttc 182 
(cDNA) 
280 
(gDNA) 
Ipo8 Porcine 
Sus scrofa 
ctctttgaacgatatggaagcc gccatcatttttggcaacacc 427 
Fbxl10 Porcine 
Sus scrofa 
acgccatggagggcaaagattt ttctctgaaacatgggccaagg 235 
BKCa 
(Kcnma1) 
Murine 
Mus 
musculus 
gtttgtgagctgtgttttgtg gtgtttgagctcatgatagtg 611 (zero) 
791 
(STREX) 
β-actin 
(ACTB) 
Murine 
Mus 
musculus 
tcctccctgagaaagagcta accagacagcactgtgttgg 203 
 
DNA amplification via PCR was carried out along the parameters shown in Figure 3 with a T3000 
Biometra thermocycler (T3000, Biometra, Göttingen, Germany).  The steps of PCR include 
denaturation, annealing and elongation.  Denaturation involves breaking the hydrogen bonds 
between the two strands of cDNA allowing it to unwind and separate into single-strands.  Annealing 
involves the primers attaching to the complementary part of cDNA template.  Elongation requires 
DNA Polymerase enzyme and involves synthesis of a new strand of DNA complementary to the 
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starting cDNA template by addition of dNTPs starting from the annealed primer and moving in a 5’to 
3’ direction. 
 
Figure 3.  Diagram showing DNA amplification parameters for polymerase chain reaction.  Note 
denat. = denaturation.   
 
End products were run on an agarose gel in a gel tank (Bio-Rad, UK) at 100V for 40 – 90 minutes 
depending on tank size. 
 
Optimising Reverse Transcription 
In view of the often low RNA yields, it was thought worthwhile to spend some time optimising RT 
conditions.  This optimisation was carried out using murine pituitary RNA and concentrated on 
annealing temperatures and the type of RT primers.  The effects of varying these parameters were 
examined for the following amplicons: BKCa, IPO8 and Fbxl10 (see also section - “Choosing the most 
appropriate housekeeping gene”).  Note that the same amount of RNA (50ng) was used in each 
reverse transcription reaction to facilitate comparison.  Results are shown in Figure 4.  
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Figure 4. Reverse transcription optimisation: effect of annealing temperature and primer types on 
amplicons intensity.  DNA gel showing amplified transcripts of BKCa, IPO8 and Fbxl10 from mouse 
pituitary.  The gel was loaded in groups of four lanes for each transcript.  In each group, the four 
lanes from left to right represent: RT temperature 45oC with oligodT, RT temperature 55oC with 
oligodT, RT temperature 45oC with random hexamers and PCR control.  HyperLadder™ 100bp (left 
ladder) and HyperLadder™ 1kb (right ladder; both Bioline, UK).  
  
When RT was performed with oligodT primers at either 45°C or 55°C, all bands were very faint; by 
contrast bands were present and clear for all genes with random hexamers,.  Therefore using 
random hexamers in the RT (as opposed to oligodT) produced the most noticeable improvement in 
amplicon intensity.  This might be expected considering priming with oligodT means only RNA 
fragments with an intact poly-A tail (i.e. mRNA) will be reverse transcribed while random hexamers 
randomly prime any RNA fragments including RNA which is degraded and has subsequently lost the 
poly-A tail.  On the downside, DNA fragments may also get reverse transcribed hence increasing the 
risk of genomic contamination.  In light of the improved amplicon intensity with random hexamers, 
all further experiments were performed in the presence of random hexamers as well as oligodT.  The 
effect of temperature could not be assessed because bands were too weak in these instances. 
The bands for the ladders used in this experiment represent varying amounts of product (weight 
ladders) thus allowing a measure of amplicon intensity.  The 100 bp band, which was of comparable 
intensity to IPO8 in lane 7 (random hexamers), represents 40ng of product.  All other amplicon band 
intensities were lower than the least intense band of the ladder (200 bp) which represents only 20ng 
product suggesting a very low amount of transcript was produced in these reactions.   
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To rule out contamination, PCR controls were run on the gel beside samples.  PCR controls were 
performed by omitting cDNA template in the reaction, replacing it with H2O.  RT controls were not 
performed in this particular case as DNA levels were undetectable using Qubit™ (<2ng/µL DNA). 
 
Choosing the Most Appropriate Housekeeping Gene 
The rationale for using housekeeping genes during PCR is that they provide an internal control as 
they are expressed at stable levels in a given cell type (Thellin et al., 1999).  
 
β-actin 
β-actin is widely used as a housekeeping gene because of its essential function in all cells in the 
structure and kinetics of the cytoskeleton (Thellin et al., 1999).  Initial experiments with porcine RNA 
were performed with β-actin as the housekeeping gene however the intensity of the β-actin band 
was much stronger than for the K+ channels (see Figure 5).   
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Figure 5.  DNA gel image showing K+ channel amplicons alongside β-actin as a housekeeping gene 
in porcine pulmonary veins.  Gel showing amplicons of KV2.1, BKCa and β-actin from porcine superior 
and inferior pulmonary veins (PVs). The gel was loaded in groups of four lanes for each gene.  In each 
group, the first two lanes represent superior PV (2 separate PCR reactions with the same cDNA) while 
the third and fourth lanes represent inferior PV (2 separate PCR reactions with the same cDNA).  RNA 
amounts used in the RT, respectively – superior PV: 248ng; inferior PV: 537ng.  cDNA was diluted 1 in 
5 for all reactions. Ladder: PCR Markers Ladder 50-1000bp.  Each band of the ladder represents 
approximately 41-55ng of product. 
In Figure 5, there were no bands for BKCa, weak bands for KV2.1 and very strong bands for β-actin.  
The β-actin bands were saturated and of much higher intensity than both the K+ channels (BKCa and 
KV2.1).  The bands for KV2.1 were similar to the intensity of the ladder (41-55ng) however bands for 
BKCa were not visible.  The primers for β-actin were designed specifically by Wilkinson et al. (2010) to 
span an intron-exon boundary (intron 4) therefore when genomic DNA is used as a template the 
amplicon contains the intron (280 bp) and is larger than when cDNA acts as a template (182 bp).  
Hence in the presence of genomic DNA contamination two distinct bands would be visible on the gel.  
The bands for β-actin in Figure 5 represent cDNA as they appear at 182 bp. 
In an attempt to better match band intensity between β-actin and K+ channels, the cDNA was diluted 
10 times in the β-actin reaction tube (Figure 6).  In this experiment, 50ng RNA was used in the RT for 
both brainstem and adrenal gland.  RT controls were also performed as a double check as DNA levels 
were undetectable (<2ng/µL DNA) with Qubit™.   
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Figure 6.  DNA gel image showing BKCa channel amplicons alongside β-actin.  Gel showing 
amplicons of BKCa and β-actin from mouse brainstem and adrenal gland RNA, respectively.  Note that 
cDNA was diluted 1 in 10 for β-actin.  Gels were loaded in groups of three lanes for BKCa and β-actin.  
In each group from left to right: brainstem, adrenal gland and PCR control.   RT controls (with β-actin 
primers) were loaded on right of the ladder: mouse brainstem (7) and adrenal gland (8).  Ladder: 
HyperLadder™ 100bp. 
 
As can be seen in Figure 6, bands for BKCa and β-actin, respectively, were obvious in brainstem but 
not in adrenal gland.  As β-actin was missing this points to a failure in the RT reaction for adrenal 
gland.  This suspicion was later confirmed when a second RT was performed with the same adrenal 
gland RNA which produced a band for β-actin. 
When cDNA was diluted 1 in 10 for β-actin, the band intensity in mouse brainstem was similar to that 
for BKCa which allows for direct comparison of expression levels.  Band intensity for both genes in 
brainstem was similar to that of the 200bp band of Hyperladder™ 100bp which represents 20ng of 
product.  Hence even when bands are present for BKCa, intensity is low. 
PCR controls for both brainstem and adrenal gland were negative as were RT controls (RT performed 
in the absence of RT enzyme) confirming the absence of genomic DNA contamination in these 
samples.   
These data show that to get comparable band intensity between K+ channels and β-actin, the amount 
of cDNA template in the PCR reaction needed to be diluted 10 times.  To avoid the complication β-
actin was dropped in favour of a more adequate housekeeping gene in further experiments. 
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Alternative Housekeeping Genes to β-actin 
The difference in expression levels between K+ channels and β-actin prompted exploration of other 
more adequate housekeeping genes.  K+ channels are generally expressed at low levels, requiring a 
housekeeping gene with similar levels of expression. 
Following kind help and expert advice from Heather McClafferty (Professor Mike Shipston’s group, 
Centre of Integrative Physiology, University of Edinburgh), three housekeeping genes were selected, 
namely 18S rRNA, IPO8 and Fbxl10.  Heather also kindly provided the murine primers for these genes.  
18S rRNA has been suggested as a more suitable alternative to β-actin within human T lymphocytes 
(Bas et al., 2004) however the most stably expressed housekeeping genes in adipose tissue/cells 
were identified as IPO8 and Fbxl10 with 18S rRNA showing more variability (Hurtado del Pozo et al., 
2010).  
Expression of these housekeeping genes alongside BKCa in mouse pituitary gland RNA extracts is 
shown in Figure 7.  The RNA amount used in the RT for this experiment was 50ng. 
 
Figure 7. DNA gel comparing expression levels of BKCa with a range of housekeeping genes in 
murine pituitary gland.  The gel was loaded in pairs of lanes: odd numbered lanes represent 
amplicons of BKCa, Fbxl10, IPO8 and 18S rRNA in mouse pituitary RNA and even numbered lanes 
represent PCR controls for the corresponding transcripts.  Ladder: HyperLadder™ 100bp. 
 
Results from murine pituitary show bands were present although fairly weak for BKCa (two bands: 
STREX and ZERO - see section “PCR” for an explanation) and Fbxl10.  The band for IPO8 was robust 
while the band for 18S rRNA was very strong (Figure 7).  Amplicon band intensity for BKCa, Fbxl10 and 
IPO8 were comparable to each other as opposed to the 18S rRNA band.  However, bands for BKCa, 
Fbxl10 and IPO8 were of lower intensity than the 200bp (20ng) band of the HyperLadder™ 100bp, 
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illustrating once more the weakness of the signal.  Bands on the ladder were all saturated as was the 
band for 18S rRNA within mouse pituitary and was more reminiscent of β-actin.  PCR controls were 
all negative demonstrating the absence of contamination.  RT controls were not performed as DNA 
levels were undetectable using Qubit™ (<2ng/µL DNA).   
High concentrations of 18S rRNA have also been identified in human T Lymphocytes where a 1 in 10 
dilution of samples was required (Bas et al., 2004), as observed earlier with β-actin, making this 
particular gene less suitable as a housekeeping gene in this study. 
Based on these findings, IPO8 was retained as the housekeeping gene in subsequent experiments.   
 
Renewed Attempt at K+ Channel Profiling in Blood Vessels 
As a more adequate housekeeping gene was now available, the next step was to return to gene 
amplification in blood vessels.  Results from inferior PV are shown in Figure 8.  Noteworthy is that 
similar amounts of RNA were used in the RT reaction for this and for the previous experiment carried 
out with murine pituitary (Figure 7) (48.2ng and 50ng, respectively). 
 
Figure 8. DNA gel showing use of K+ channel expression in porcine inferior pulmonary vein.   Lanes 
on gel were loaded in pairs: odd numbered lanes represent amplicons of KV1.5 (1), KV2.1 (3), BKCa (5), 
and IPO8 (7) in pig inferior PV while even numbered lanes represent corresponding PCR controls.  
Ladder: HyperLadder™ 1kb. 
 
Bands were observed for KV1.5, KV2.1 and IPO8 however no band was apparent for BKCa within 
porcine inferior PV in this instance.  In addition, the band for IPO8 was of comparable intensity to the 
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bands for KV1.5 and KV2.1, in keeping with Figure 7 results showing that IPO8 band intensity was of 
comparable to BKCa
 channels.  Overall, all bands present were of weak intensity when compared to 
the ladder, a recurring finding within these studies.  PCR controls were negative in this experiment 
demonstrating the absence of contamination.  RT controls were not performed as DNA levels were 
undetectable using Qubit™ (<2ng/µL DNA).   
In conclusion, data showed here all illustrate an ongoing issue of weakness of signal which was worse 
in blood vessels but could be improved in other tissues.  Taken together, the data above pointed 
towards intrinsic difficulties when extracting RNA from blood vessels, most likely linked to the 
presence of thick vessel walls and high content of connective tissue and subsequent difficulty of 
homogenising the tissue properly. 
K+ Channel Profiling in Freshly Dissociated Cells from PVs 
In an attempt to overcome the difficulty with homogenisation, PV smooth muscle cells (PVSMCs) 
were dissociated (see protocol in Chapter 2) in order to remove collagen and fibrous tissue prior to 
extracting RNA  which helped with extraction columns getting blocked. 
As might be expected, this new approach presented its own issues, stemming this time from the 
limited numbers of freshly isolated cells - 71% of extractions produced below detection RNA 
concentrations (14 extractions performed).  A successful example of K+ channel profiling in superior 
and inferior PVSMCs is shown in Figure 9.  RNA amounts used in the RT were 47.4ng and 60ng for 
superior and inferior PVSMCs, respectively. 
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Figure 9. DNA gel showing K+ channels expression profile in dissociated pulmonary vein smooth 
muscle cells.  Note that lanes on the gel were loaded in groups of five for KV1.5, KV 2.1, BKCa and IPO8, 
respectively.  In each group from left to right, lanes represent superior pulmonary vein smooth 
muscle cells (PVSMCs): SPV, inferior PVSMCs: IPV, RT control for SPV, RT control for IPV and PCR 
control.  Ladder: HyperLadder™ 1kb. 
 
Bands were obtained for all genes for inferior and superior PVSMCs except for BKCa.  All PCR and RT 
controls were negative confirming the absence of contamination including genomic DNA (RT controls 
were a double check as DNA levels were undetectable (<2ng/µL DNA) with Qubit™).  Amplicon band 
intensities from dissociated PVSMC RNA for IPO8 were similar to the K
+ channels present.  Although 
not very strong, the intensity of bands obtained here were fair, demonstrating that dissociating 
blood vessel cells prior to RNA extraction could improve data quality.  However the high failure rate 
of this approach remained an issue. 
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Key Findings 
Where RNA was successfully extracted from PVs, expression of KV1.5 and KV2.1 was evident at the 
mRNA level.  Preliminary studies using murine brain tissue were successful in terms of RNA 
extraction and subsequent identification of BKCa expression at the mRNA level however expression of 
BKCa mRNA was not apparent in PVs.   Despite these findings, issues with extraction of RNA of 
sufficient yield and quality were persistent in PVs while there was less of a problem in other tissues, 
pointing to an intrinsic difficulty with blood vessels.  This difficulty was most likely linked to the 
presence of thick vessel walls and high content of connective tissue which both hampered proper 
homogenisation of the tissue.  A range of approaches for extracting RNA from PVs were explored 
(see details in Annex: Tissue samples – storage and homogenisation for a more complete view), 
however no optimal method could be identified that would provide reproducible, reliable results. For 
future applications, single cell RT-PCR (as used by Platoshyn et al., 2006 in PASMCs) could be 
considered.  This technique could provide a solution to the problem whereby the whole cell is 
aspirated into a micropipette and used immediately for RT-PCR. 
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Annex: Tissue Samples – Storage and Homogenisation 
Tissue storage and homogenisation are crucial steps in obtaining good quality RNA in sufficient 
amounts.  In view of continuing limited success on both counts in this study, various approaches 
were tried to improve the situation.  These are briefly described below. 
 
Tissue Storage 
Porcine abattoir tissue samples were obtained from either Scotch Premier Meat Ltd (Inverurie, 
Aberdeenshire) or Quality Pork Producers Ltd (Brechin, Angus).  Tissue samples were dissected out 
from heart and lung tissue within 1-2 hours of kill.  PVs were dissected from superior and inferior 
lobes.  Samples were variously: i) snap frozen in liquid N2 then stored at -80°C ii) snap frozen in liquid 
N2 then used on the day or iii) stored in RNAlater (Life Technologies, UK) at 4°C or -20°C according to 
manufacturer’s instructions. 
Murine brainstem, pituitary and adrenal gland were obtained from the animal house on the 
University site and dissected out within 30 minutes of kill before snap freezing in liquid N2 then 
storing at -80°C. 
Freshly isolated cells (for details see Chapter 2) from inferior and superior PVs were spun down in a 
centrifuge at 300g for 5 minutes at 4°C.  After supernatant elimination, the pellet was variously 
i)placed in  a freezer at -80°C, ii) kept in the fridge or iii) used immediately.  
No difference in results was observed when comparing storage methods for any of the tissues/cell 
samples. 
 
Tissue Homogenisation  
Homogenisation of porcine blood vessels was difficult and can partly be attributed to thick walls and 
high content of connective tissue.  A number of different homogenisation techniques were tried 
including: 
1. crushing whilst frozen with glass mortar and pestle and further crushing in lysis buffer 
2. crushing in lysis buffer alone 
3. crushing tissue directly in liquid N2 
4. mincing the tissue with a razor blade followed by addition of appropriate lysis buffer 
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5. mechanical homogenisation (with Stuart SHM1 with SHM/5 dispersing tool, Fisher Scientific, 
UK) alone and after mincing tissue with razor blades  
 
All of these crushing methods were followed by passing tissue and lysis buffer through an 18G and/or 
21G needle to further disrupt the tissue.  In some experiments, the use of needle work alone was 
used without initial crushing.   
There was a persisting difficulty in homogenisation of porcine blood vessel tissue across all 
approaches tried during optimisation.  In contrast, other tissues were easily homogenised therefore 
this suggests the problem lies with blood vessels specifically and is likely due to the presence of thick 
vessel walls and connective tissue. 
 
